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Abstract 
Sandeep Narayan Raikar, Ph.D. 
Department of Chemistry, July 2013 
University of Kansas 
 
There has been extraordinary progress in the field of chemical synthesis over 
the last couple of decades. Innovative methodologies and robust catalysts are 
emerging. Propelled by all these inventions the evolution of the field has reached the 
state when the principle concern of a synthetic chemist is not whether a molecule can 
be synthesized, but how rapidly and economically can it be produced. In this regard 
the development and application of one-pot reactions and multicomponent reactions 
play a major role because of their excellent overall economy of operation. The goal of 
this dissertation is to expand our understanding of regiocontrol of known transition 
metal-catalyzed reactions, and design one-pot protocols towards syntheses of 
medicinally relevant heterocycles.  
The first project described in chapter 2 of this dissertation, demonstrates the 
development of a synthetic method utilizing a Pd-catalyzed multicomponent reaction 
(MCR) previously developed in our laboratory for synthesis of highly substituted 
pyrrolidines and tetrahydrofurans. The project also helped us to unequivocally assign 
the relative stereochemistry of the precursors proposed in our previous reports. 
Methodology reported herein opens up possible future application towards synthesis 
iv 
 
of potent ETA antagonist-atrasentan and natural products like kainic acid and 
acromelic acid. 
The second project described in chapter 3, illustrates the concept of strategic 
sequencing of a MCR with transition metal-catalyzed annulation reactions. Herein, 
Cu-catalyzed MCR of imine, acid chloride and terminal alkyne was used to assemble 
highly functionalized enynes which upon ring closing enyne metathesis and Heck 
cyclization delivered N-heterocycles such as benzoindolines, dihydro 
pyrroloquinolines, cyclopropane fused dihydro indenopyridines and phenanthrolines. 
Divergence in an unexpected 5-exo vs 6-endo pathway during the Heck cyclization of 
homologous or isosteric substrates was observed. We believe the substrate 
conformation and the chelation are the factors which govern the regiodivergent Heck 
cyclization. A plausible mechanism for this regiodivergent Heck annulation is 
proposed.  
The third project described in chapter 4, presents efforts towards the 
successful design of a sequential one-pot protocol for the enyne metathesis and Heck 
cyclization illustrated in project two. A sequential one-pot methodology was realized 
for Ru/Pd catalyzed annulation reactions. Optimization of a common solvent for dual 
metal catalysis and a suitable base for Pd catalysis proved to be critical. The yields of 
pure heterocycles obtained via one-pot protocol were 2-22% higher in comparision 
with the stepwise procedure. 
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             The rapid generation of molecular complexity and diversity from simple and 
readily accessible starting materials is a contemporary research theme in the practice 
of modern organic synthesis. Along with achieving efficiency in syntheses, it’s high 
time that organic chemists considered its effects on the environment and the economy 
of synthesis.  
             In this context, our group utilizes the concept of combining multicomponent 
reaction with efficient post-transformation sequences typically performed as one-pot 
processes for the synthesis of complex heterocyclic compounds. A multicomponent 
reaction offers not only great molecular complexity and diversity per step but also the 
possibility of introducing matched functionalities suitable for further transformations. 
With one-pot reactions comes increased operational simplicity as well as reduction in 
energy and materials usage and waste output, with the purification of intermediates at 
each step no longer needed. However, the one-pot protocols have proven to be 
particularly difficult when transition metal-catalyzed reactions were involved due to 
the likelihood of catalyst poisoning in complex reaction mixtures. 
             The following paragraphs describe the layout and content of this dissertation. 
Part I of chapter two outlines the importance and types of one-pot protocols with 
recent examples involving either sequential Ru or Pd-catalyzed reactions followed by 
fundamental concepts to be considered while designing one-pot processes. Part II of 
chapter two portrays various methodologies incorporating multicomponent and 
transition metal-catalyzed reactions towards synthesis of highly substituted 
pyrrolidines, tetrahydrofurans and benzofused N-heterocycles. Part III of chapter two 
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overviews mechanistic aspects of ring closing enyne metathesis reaction and part IV 
illustrates the factors controlling regiochemistry in an intramolecular Heck 
cyclization. 
           The remaining chapters describe the challenges, solutions, results and 
experimental work accomplished in this dissertation. Chapter three describes our 
efforts aimed at demonstrating the synthetic utility of the Pd-catalyzed 
multicomponent reaction (MCR) previously developed in our laboratory for the 
synthesis of highly substituted pyrrolidines and tetrahydrofurans which are prevalent 
in variety of medicinally significant natural products and synthetic pharmaceutical 
agents. 
Chapter four discusses our construction of benzofused N-heterocycles via sequencing 
Cu-catalyzed MCR with sequential Ru and Pd catalysis and uncovering of an 
unexpected 5-exo vs 6-endo regiodivergent Heck cyclization.  
Chapter five presents our efforts towards the successful designing of sequential one-
pot protocol for the Ru/Pd catalysis discussed in chapter four.  
 
 
 
 
 
 
 
 
4 
 
 
 
 
 
 
 
 
 
 
 
Chapter two 
Introduction 
 
 
 
 
 
 
 
 
 
 
 
 
5 
 
 
 
 
 
 
 
 
 
 
Part I 
One-Pot Reactions and Sequential Transition Metal Catalysis 
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2.1 One-pot Reactions: Economy in Synthesis  
                  An important concern in any chemical process is the yield of a particular 
transformation – the effectiveness of converting given substrate into a single desired 
product. Modern organic synthesis faces other challenge of designing practical and 
efficient approaches to the most complex naturally occurring or synthetic medicinally 
relevant compounds. The conventional approach in organic synthesis is the stepwise 
formation of individual bonds to attain the desired target. Such a process requires the 
purification and isolation of intermediates at each step. As the number of steps 
increases there is potential loss in yield and efficiency. Thus, increasing the efficiency 
and minimizing the wastes is the need of the hour.
1
  
                 An attractive solution towards this problem would be strategically 
sequencing the powerful carbon-carbon bond-forming reactions that would proceed in 
one-pot without multiple isolation and purification steps.
2-3
 With one-pot reactions 
comes increased operational simplicity as well as reduction in energy and materials 
usage and waste output, with the purification of intermediates at each step no longer 
needed. Also, intermediates need not be stable enough for isolation; because they are 
quickly transformed by a subsequent reaction into a lower energy species.
4
 The use of 
one-pot reactions has obvious benefits both environmentally and economically. 
                 In particular, sequential transition metal-catalyzed reactions are well-suited 
for one-pot processes due to their broad range of carbon-carbon bond formation and 
functional group tolerance.
5-6
 Sequential transition metal-catalyzed reactions have 
been successfully employed in the synthesis of diverse heterocycles
7-9
 as well as 
7 
 
complex natural products.
10-11
 Moreover, along with sequencing with other metal 
catalyzed reactions, transition metal catalysis can be sequenced with bronsted acid 
catalysis,
12-15
 organocatalysis,
16-18
 and enzyme-catalyzed
19-21
 reactions.
 
One-pot reactions can be broadly classified as: 
1) Combined or Concurrent one-pot reactions.  
               Combined one-pot reactions are the processes involving sequential 
transformation of a substrate via two or more mechanistically distinct pathways by 
two or more functionally distinct, and ideally non-interfering, catalysts (Figure 2.1).
17
 
Another important criterion is that all the reaction components and catalysts are 
present at the outset of the reaction. There is no further addition of reagents or 
modification of conditions on commencement of the reaction. Thus monitoring of 
formation and isolation of the intermediate is not necessary. An important challenge 
in combined one-pot reaction is to avoid the unproductive path, wherein the second 
catalyst in the sequence reacts with the substrate. 
Figure 2.1 
 
2) Sequential one-pot reactions.  
Sequential one-pot reactions differ from combined one-pot reactions wherein another 
reagent, mediator, catalyst is added or the reaction condition is modified after the 
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initial transformation without purification of the product from the prior step. The 
subsequent reaction steps then lead to the final product (Figure 2.2). These are less 
challenging when compared to combined one-pot reactions. Although some 
operational simplicity is lost; the benefits associated with combined one-pot reaction 
remain. 
Figure 2.2 
 
2.2 Overview of Recent Applications of One-Pot Reactions Involving Pd or Ru: 
                  Initially, research into transition metal catalysis concentrated on the 
development of a single, highly selective and high yielding step. There are lots of 
carbon-carbon, carbon-hydrogen and carbon-heteroatom bond forming reactions 
known today. Subsequently metal catalysts have been applied to sequential reactions. 
As stated earlier they can be also sequenced with bronsted acid catalysis,
12-15
 
organocatalysis,
16-18
 and enzyme-catalyzed
19-21
 reactions. Unsurprisingly, palladium 
catalysts have been employed in the majority of metal-catalyzed sequential reactions. 
Since my research involves Ru and Pd-catalyzed sequential reactions, this overview 
mainly pertains to Ru and Pd catalysis.  
 
 
9 
 
2.2.1 Sequential Cu/Pd Catalysis: 
Feringa et al. reported a short, catalytic asymmetric synthesis of (-)-pumiliotoxin C. 
The key step of the sequence was a Cu/Pd catalyzed tandem asymmetric conjugate 
addition–allylic substitution reaction (Scheme 2.1).
22
   
Scheme 2.1 
 
The palladium catalyst and allylacetate were added after the completion of the 
catalytic asymmetric Michael addition of Me2Zn to cyclohexenone, to prevent the 
possible catalyst interference. The reaction created two stereocenters with excellent 
enantioselectivity and high diastereoselectivity. 
2.2.2 Sequential Pd/Ir Catalysis: 
Hartwig et al. developed a sequential palladium-catalyzed isomerization and iridium-
catalyzed asymmetric allylic substitution reaction (Scheme 2.2).
23
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Scheme 2.2 
 
This tandem reaction allows the conversion of easily synthesized branched aromatic 
carbonates 2.1 to branched allylic aromatic amines 2.2 in good yield and excellent 
regio and enantioselectivity. Simple filtration of the crude product through silica was 
needed to remove the bulk of palladium catalyst before the addition of chiral ligand, 
iridium catalyst, and nucleophile. This was to prevent the interference of palladium 
with chiral iridium catalyst to secure high yield and enantiomeric excess of the final 
product. 
2.2.3 Sequential Pd/Rh Catalysis: 
Jeong et al. reported
24
 sequential palladium and rhodium catalysis to synthesize 
functionalized bicyclopentenone 2.3. This transformation includes two reactions; the 
first allylation generates an enyne intermediate 2.4 via the Pd π-allyl complex from 
the mixture of propargyl amine 2.5 and allyl acetate 2.6. Subsequent Pauson-Khand 
type reaction of the resultant enyne yields bicyclopentenone (Scheme 2.3). 
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Scheme 2.3 
 
With careful optimization of ligand, solvent and temperature the sequence was 
performed as a combined one-pot operation. It was found that catalysts [RhCl(CO)2]2  
and [RhCl(CO)dppe] were not compatible with Pd(dba)2/dppb and suppressed the 
first allylation reaction.  [RhCl(CO)(dppp)]2 and [RhCl(CO)(dppb)]2 (generated in 
situ by mixing of [RhCl(COD)]2  and dppb) were compatible with the presumed 
Pd(dppb).  The author claims an improvement in the yield of 10% when compared to 
the stepwise process. 
2.2.4 Sequential Cu/Ru Catalysis: 
Alexakis et al. developed a new strategy using ω-ethylenic allylic substrates 2.7 to 
access highly enantioenriched cyclopentenes 2.8 via a one-pot enantioselective allylic 
alkylation and ring-closing metathesis (Scheme 2.4).
25
  The work demonstrates the 
use of an ω-ethylenic allylic substrate as synthetic equivalent, which can undergo 
copper-catalyzed asymmetric allylic alkylation using Grignard reagents and bears a 
convenient functionality to be cyclized through a ring closing metathesis reaction.  
12 
 
Scheme 2.4 
 
The asymmetric allylic alkylation was performed in dichloromethane at -78
o
C and 
after completion of the reaction monitored by gas chromatography, without 
quenching the Grubbs catalyst was added and the flask was warmed to room 
temperature. The author notes that the metathesis step was the most delicate and 
needed recently bought (or prepared) Grubbs catalyst. 
2.2.5 Grubbs Catalyst in Sequential Reactions: 
The ruthenium metathesis catalysts developed by Grubbs and co-workers
26
 have 
proven to be very effective in sequential reactions. McLain and co-workers found that 
an ethylene/methacrylate copolymer formed by ring-opening metathesis 
polymerisation using Grubbs-I catalyst could be successfully hydrogenated simply by 
placing the reaction vessel under an atmosphere of hydrogen (400 psi) after the 
polymerisation took place.
27
 Studies by Fogg have shown that the treatment of the 
catalyst with hydrogen forms the known hydrogenation catalyst RuCl2(H2)(PCy3)2.
28
 
The Grubbs research group incorporated the findings of McLain and Fogg, and used 
this methodology in a small molecule synthesis.
29 They showed that both the first or 
13 
 
second generation metathesis catalysts were able to mediate either ring-closing or 
cross metathesis followed by hydrogenation (Scheme 2.5). 
Scheme 2.5 
 
Extending the concept, Grubbs also found that these complexes act as a precatalyst 
for both the oxidation of alcohols and the reduction of ketones via transfer 
hydrogenation. Addition of base and a suitable hydrogen donor such as 2-propanol, 
led to reduction of ketones, or a suitable acceptor such as 3-pentanone led the 
oxidation of alcohols. Grubbs demonstrated the utility of this trifunctional catalyst in 
the synthesis of (R)-(–)-muscone 2.9 (Scheme 2.6), in which ring closing metathesis 
(RCM) followed by oxidation and hydrogenation was achieved with a single catalyst 
in one pot.
13 
Scheme 2.6 
 
Snapper and co-workers in 2006 reported tandem ring closing enyne metathesis 
(RCEYM) and cyclopropanation reaction to synthesize vinyl cyclopropanes (Scheme 
2.7).
30
 Treatment of enyne 2.10 with Grubbs-1 catalyst under an atmosphere of 
14 
 
ethylene formed diene 2.11, to which was added ethyl diazoacetate and caused 
cyclopropanation of the terminal alkene to afford the desired product 2.12 in 75% 
yield and a 1:1 ratio of E/Z isomers. 
Scheme 2.7 
 
                Yi and co-workers showed that ruthenium hydride complex 2.13 could 
facilitate the hydrovinylation of 1,3-dienes.
31
 Furthermore, this ruthenium hydride 
complex can be formed by reaction of Grubbs-I catalyst with a primary alcohol and 
an inorganic base.
32
 Thus, Snapper and co-workers proposed the development of a 
tandem RCEYM followed by hydrovinylation reaction catalyzed by Grubbs-I 
catalyst. Treatment of enyne 2.14 with Grubbs-I catalyst under an atmosphere of 
ethylene, followed by addition of sodium methoxide and methanol afforded the 1,4-
hydrovinylation product 2.15 exclusively in good yield (Scheme 2.8).
33 
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Scheme 2.8 
 
                   Taking advantage of 1,3-diene motif created during RCEYM, Perez-
Castells and co-workers explored the possibility of combining enyne metathesis with 
a Diels-Alder reaction.
34
 The group showed that by carrying out an isolated Diels-
Alder reaction on diene 2.16, the tetracyclic product 2.17 was formed in 60% yield 
(Scheme 2.9). However, by carrying out a tandem RCEYM reaction catalyzed by 
Grubbs-II catalyst, followed by the same Diels-Alder reaction, the desired tetracyclic 
product was afforded in 85% yield from enyne 2.18 under the same reaction 
conditions. These results would suggest that the presence of the ruthenium is assisting 
the Diels-Alder reaction resulting in a more efficient process. 
Scheme 2.9 
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2.2.6 Examples of Ru Catalyzed Metathesis Reactions Followed by a Pd    
         Catalyzed C-C Bond Forming Reactions: 
          Grigg and co-workers in 2000, reported combined as well as sequential one-pot 
RCM/Heck reaction (Scheme 2.10).
35
 The Ru and Pd catalysts could be added either 
sequentially, or in combination delivering comparable product yields (62% and 65%) 
during the preparation of bridged N-heterocycles 2.19 with a five-membered ring. 
However in preparations of N-heterocycles 2.20 with six- to eight-membered rings, 
the addition of the catalysts in combination caused a significant drop in the yields of 
the RCM/Heck sequence. To circumvent this problem polystyrene-bound (PS-bound) 
Pd catalyst was used which prevented the Ru poisoning by Pd catalyst species. More 
detail about this work is discussed in later (section 2.3 vide infra). However this 
solution is limited to sequences with facile RCM reactions that proceed at room 
temperature.   
Scheme 2.10 
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               In 2004 Mark Lautens reported a sequential olefin metathesis and an 
intramolecular asymmetric Heck reactions.
36
 A diastereoselective double ring closing 
metathesis of 2.21 using Grubbs-I catalyst afforded the bicylo-octadienes 2.22 in 70% 
yield. Upon subjecting to intramolecular asymmetric Heck reactions these 
bicyclodienes were converted to fused polycycles 2.23 with moderate to good yields 
and with good enantioselectivities (Scheme 2.11). However, Lauten had not reported 
any attempt of performing this sequence as a one-pot protocol. 
Scheme 2.11 
 
                  Trost et al. reported a sequential one-pot synthesis of enantio- and 
diastereopure N-and O-heterocyclic compounds using the combination of Ru catalyst 
and chiral palladium complex.
37
 After the completion of ruthenium-catalyzed 
alkene/alkyne cross metathesis reaction, the chiral ligand and palladium catalyst were 
added to afford the enantioselective intramolecular heterocyclization reaction 
(Scheme 2.12). This tandem reaction was employed for the concise synthesis of ring 
B of bryostatin, a potent antitumor agent. 
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Scheme 2.12 
 
2.3 Fundamental Concepts in Sequential Catalysis: 
                Designing a one-pot catalysis sequence is challenging and more so in case 
of combined one-pot sequences. Several factors must be considered for coupling the 
activity of multiple catalysts in a sequential catalysis. The primary and most obvious 
being compatibility. There should be no interference or poisoning between the 
catalytic species in an ideal situation. Furthermore, the active site reactivity must be 
well matched so that the order of reaction sequence is followed properly. Similarly, if 
the activity of one catalyst is disproportionately low, then subsequent catalysts may 
become substrate starved; a condition that can result in decomposition or unwanted 
side reactions. 
                   In this regard, Lautens described
38
 an impressive systematic optimization 
of the auxiliary phosphine ligands for discrete Rh(I) and Pd(0) catalysts. The catalysts 
were added in combination that allowed for a sequential Rh-catalyzed alkyne 
arylation and Pd-catalyzed C-N coupling to be selectively performed as a “one-pot 
19 
 
two-metal/two-ligand catalyst system” delivering substituted quinolines 2.24 (Scheme 
2.13). The reason for success of this methodology was meticulous optimization of 
ligands, catalyst loading, Rh/Pd and the metal/ligand ratios.  
Scheme 2.13 
 
To survey the reactivity of the possible metal–ligand combinations, several control 
experiments were carried out on each step. Use of phosphine-free [Rh(cod)OH]2 led 
primarily to the decomposition of  the substrate 2.25. Subjecting substrate to only 
[Pd(binap)] or [Pd(X-Phos)] did not lead to 2.26 or 2.24; instead, [Pd(X-Phos)] 
furnished the Suzuki cross-coupling product 2.27  in good yield (76%) (Scheme 
2.14). The arylation reaction using X-Phos as a ligand led to a low yield of 2.26 (5%) 
and a significant amount of decomposition (40%). The reaction of 2.26 with 
[Pd(binap)] yielded only trace amounts of 2.24.  
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Scheme 2.14 
 
             From these control experiments it was apparent that use of [Rh(binap)] 
resulted in the desired intermediate 2.26, and phosphine-free rhodium led to 
decomposition of 2.25. The ability to form [Pd(X-Phos)] was equally important since 
[Pd(binap)] was catalytically inactive in C-N coupling. Thus the combination of Rh 
with BINAP and Pd with XPhos was established. 
     Next the effect of Pd(OAc)2 or X-Phos addition on the rate of the alkyne 
arylation reaction was examined (Scheme 2.15). When the reaction was carried out 
with X-Phos present in the catalyst solution, a minimal effect on the rate of the 
reaction was observed affording 65% of 2.26. In contrast, addition of 5 mol% of 
Pd(OAc)2 led to the formation of only a trace of 2.26 (5%), while the conversion of 
2.25 returned to more than 70% with the addition of 5 mol% of [Pd(X-Phos)] solution 
to the reaction mixture. 
Scheme 2.15 
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No Suzuki products containing the arylated alkene, such as 2.28, were ever observed 
in the optimized reaction, thus indicating that even if an excess of the aryl boronic 
acid is used, the Suzuki coupling is slower than the intramolecular C-N coupling in 
2.25. This shows that it is important for [Pd(X-Phos)] complex to form at the initial 
stage of the one-pot reaction. So in the optimized conditions a premixed solution of 
Pd(OAc)2 and XPhos was added to the reaction mixture. The premixing also avoided 
the problem of ligand exchange between [Rh(binap)] and [Pd(X-Phos)] thus ensuring 
a smooth C-N coupling in step two. 
            Under the optimized conditions (Scheme 2.13), the sequence proceeded in one 
vessel, in which both catalysts exist concurrently and display correct reactivity even 
though other reaction pathways, including a Suzuki reaction, are available. 
Interestingly the one-pot reaction proceeded in an overall yield of 69%, in 
comparison to the two-step combined yield of 71%.  
            Another important fundamental investigation that contributed towards 
designing a one-pot reaction was made by Grigg
35
, discussed earlier (section 2.2.6 
vide supra). The combined one-pot sequence successfully afforded compound 2.19 
(Scheme 2.10 vide supra) in moderate yield using a RCM facile substrate. However, 
the yield significantly dropped in case of RCM challenging substrate compound 2.20 
(Scheme 2.10, n=2). Control experiments indicated that the RCM catalyst was being 
inhibited by the addition of Pd(OAc)2, Hermann’s catalyst,
39
 phoshine ligands, but 
unaffected by the carbonate bases (Table 2.1).   
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Table 2.1: Effect of additives on RCM 
 
Entry Additive Amount 2.29 (%)
a
 
1 None NA >95 
2 Pd(OAc)2 10 mol% 10 
3 Herman’s catalyst 10 mol% <5 
4 Pd(PPh3)4 10 mol% <5 
5 PPh3 20 mol% 8 
6 Cy3P 20 mol% 5 
7 K2CO3 2equiv >95 
8 Tl2CO3 2 equiv 93 
 
                         
a 
calculated from 
1
H NMR 
To address this problem, Grigg employed polystyrene-bound (PS-bound) Pd-catalyst, 
that could be used in combination with the Grubbs I catalyst to afford the entire range 
of bridged N-heterocycles in good yields. The author notes that the success of this 
method was due to poor polymer swelling at room temperature, limiting access of the 
Ru-catalyst to the palladium species and phosphine ligands. Thus the Ru-catalyst 
poisoning was prevented during the initial RCM reaction period. However, at higher 
temperature of Heck reaction (110
o
C) the swelling increased allowing access to the 
Pd-catalyst and promoting efficient Heck cyclization. Thus, carrying out the RCM at 
room temperature and the Heck reaction (with polymer supported Pd, PS-Pd) at 
110
o
C, ensured that both catalysts could be added together and the desired cascade 
was achieved. 
23 
 
 
 
 
 
 
 
 
 
 
Part II 
 
Sequencing Multicomponent Reactions and Transition metal catalysis: Methods for 
Synthesis of α-Arylated Pyrrolidine, Tetrahydrofurans and Benzofused Heterocycles 
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              The area of drug discovery
40
 and diversity oriented synthesis
41
 have grown 
rapidly over the past decade. Hence, there is high demand for expedite and efficient 
generation of collections of organic compounds that are structurally and functionally 
diverse and possess skeletal frameworks found in natural products and drug-like 
molecules.
42
 One of the promising ways to achieve this goal is by combining 
multicomponent reactions (MCRs),
43
 with transition metal-catalyzed reactions. The 
MCRs allow for a rapid synthesis of differentially substituted intermediates from 
three or more reactants. Selective functional groups pairing of these intermediates via 
transition metal-catalyzed cyclizations can give access to diverse combinatorial 
libraries
44-45
 of heterocycles. 
2.4 Sequencing MCR and Pd Catalysis: 
              Many of the MCRs are name reactions, for example, Ugi, Passerini, Van 
Leusen, Strecker, Hantzsch, Biginelli.
43
 Zhu in 2006 reported
46
 a two-step sequence 
involving an Ugi four-component reaction and a palladium-catalyzed intramolecular 
amidation of aryl iodide for rapid access to functionalized oxindole 2.30 with four 
diversity points (Scheme 2.16). Microwave heating was used to accelerate and to 
improve the efficiency of the intramolecular Buchwald−Hartwig reaction  
Scheme 2.16 
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          Yang et al. demonstrated the efficiency of sequencing MCR with a transition 
metal-catalyzed cyclization reaction. They reported synthesis of isoquinoline 
scaffolds 2.30a and 2.30b in a combinatorial format by sequencing the Ugi four-
component reaction and the Pd-catalyzed intramolecular Heck reaction, from readily 
available starting materials (Scheme 2.17) and (Scheme 2.18).
47
 
Scheme 2.17 
 
Scheme 2.18 
 
2.5 Sequencing MCR and RCM:             
           Sequencing Ugi-MCR and ring closing olefin metathesis, Westermann 
reported
48
 synthesis of bicyclic lactams 2.30c , materials that can be used as peptide 
mimics (Scheme 2.19) 
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Scheme 2.19 
 
2.6 Synthesis of α-Arylated Pyrrolidines and Tetrahydrofurans:            
             Recently there have been reports on the synthesis of substituted or α-arylated 
pyrrolidines and tetrahydrofurans using multicomponent reactions. Most of them 
employ (3+2) cycloaddition or by functionalization of an established heterocyclic 
core. In contrast, strategies relying on cyclizing an acyclic precursor featuring all the 
requisite stereocenters remain less explored
49-52
 owing to the challenges posed by 
acyclic stereocontrol.  
      In 2003, Schreiber reported catalytic asymmetric 1,3-dipolar cycloadditions 
of azomethine ylides with electron-deficient olefins for the enantioselective synthesis 
of substituted proline derivatives.
53
 The enantioselectivity was achieved using a chiral 
phosphine ligand (S)-QUINAP (Scheme 2.19).   
Scheme 2.19 
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As the methodology is developed using multicomponent reaction and due to its 
divergent nature, it is of considerable interest in diversity oriented synthesis (DOS).  
            Aron and coworkers in 2010 demonstrated the utility of multicomponent 
reaction in synthesis of pyrrolidines. They reported formation of azomethine ylide 
facilitated by metal chelation 2.31, which upon diastereoselective (3+2) cycloaddition 
afforded tri and tetra-substituted pyrrolidines (Scheme 2.20).
54
 Metal chelation 
stabilizes the dominant conformer of the reactant species and controls the 
diastereoselectivity in 1,3-dipolar cycloaddition reaction. 
Scheme 2.20 
 
              As mentioned earlier there are reports of α-arylation of pyrrolidines using a 
pre-functionalized heterocyclic precursor. O’Brien and coworkers in 2011 reported 
the directed metalation of pyrrolidines for the synthesis of α-arylated pyrrolidines 
(Scheme 2.21).
55
 Access to organolithium reagent 2.32 was achieved using s-BuLi/   
(-)-sparteine mediated asymmetric deprotonation of N-Boc pyrrolidine 2.33. 
Transmetallation of the organolithium intermediate with ZnCl2 affords 2.34 followed 
by a Pd-catalyzed Negishi coupling gave access to α-arylated pyrrolidines with good 
yield and enantioselectivity.  
28 
 
Scheme 2.21 
 
              Using the concept of nucleophilic addition of enamine to cyclic N-
acyliminium ion, Delpech and coworkers reported one-pot formation of α-pyridinium 
salt substituted piperidines and pyrrolidines (Scheme 2.22).
56
 The N-acyliminium ions 
2.35 were generated in situ from α-hydroxycarbamates 2.36 derived from pyrrolidine 
or piperidine, in the presence of zinc triflate. Nucleophilic addition of 
aminopentadienal 2.37 followed by a dehydrative cyclization afforded α-pyridinium 
salt substituted pyrrolidines 2.38. 
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Scheme 2.22 
 
           There are few reports
57-58
 involving ring closure of an acyclic precursor to 
synthesize α-arylated pyrrolidines. Hiemstra et al. reported an intramolecular 
cyclization of acyclic N-acyliminium ions with allyl silanes as nucleophiles to 
synthesize α-arylated vinyl pyrrolidines 2.39 (Scheme 2.23).
58
       
Scheme 2.23 
 
            Johnson et al. described an one-step diastereoselective synthesis of cis-2,5 
disubstituted tetrahydrofurans 2.40 via Lewis acid catalyzed [3 + 2] cycloadditions of 
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donor-acceptor cyclopropanes 2.41 and aldehydes (Scheme 2.24).
59
 The methodology 
facilitates the stereospecific synthesis of a range of optically active tetrahydrofurans 
derivatives from enantioenriched donor acceptor cyclopropanes. The reaction 
proceeds with inversion at the cyclopropane donor site and allows absolute 
stereochemical information to be transferred to the products with high fidelity. 
Scheme 2.24 
 
           Alternate approach to synthesis of substituted tetrahydrofurans was described 
by Nair
60
 using Rh(II)-catalyzed reaction of dimethyl diazomalonate with aryl 
aldehydes and β-nitrostyrenes (Scheme 2.25). The reaction afforded diversely 
substituted tetrahydrofurans. 
Scheme 2.25 
 
Mechanistically the reaction may be considered to involve the dipolar cycloaddition 
of the carbonyl ylide 2.41a formed by the reaction of the carbene and the aldehyde, to 
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the β-nitrostyrene, the latter being a very good dipolarophile (Scheme 2.26). The 
diastereoselectivity of the reaction may be rationalized by the concerted nature of the 
carbonyl ylide cycloaddition and the observed relative stereochemistry of the 
products may be attributed to the preferred trans geometry of the ylide and the 
dipolarophile. 
Scheme 2.26 
 
              Marsden and coworkers reported
61
 a reagent-controlled stereoselective 
synthesis of 2,3,4-trisubstituted tetrahydrofurans related to the furanolignan family of 
natural products (Scheme 2.27). Reaction of cyclic allylsiloxanes 2.42 with aldehydes 
in the presence of a Lewis acid produced tetrahydrofurans 2.43. The reactions 
proceeded with complete 3,4-trans stereoselectivity, whereas the C-2 stereochemistry 
was determined by both the aldehyde and Lewis acid used.  
Scheme 2.27 
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The predominant formation of 2,3-cis, 3,4-trans isomer 2.43a can be rationalized by 
assuming that the reaction takes place by condensation of the siloxane oxygen with 
the aldehyde, leading to the formation of an (E)-oxonium ion 2.44a which undergoes 
cyclization through a chair like transition state with all substituents equatorially 
disposed (path A, Scheme 2.28). 
Scheme 2.28 
 
2.7 Synthesis of Benzofused Heterocycles:           
                Reports dedicated exclusively to synthesis of these heterocyclic cores are 
scarce. Some of the elegant approaches incorporating cascade and sequential 
reactions along with few classical routes to synthesize these heterocycles and 
heterocycles analogous to them will be discussed in this section.  
               Synthesis of benzoindoline 2.45 by gold-catalyzed cascade cyclization of 
diynes was reported by Fujii (Scheme 2.29).
62
 This was achieved via an 
intramolecular gold-catalyzed cascade 5-endo-dig hydroamination followed by a 6-
endo-dig cycloisomerization. Some of the indole analogs synthesized using this 
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methodology exhibited good to excellent antifungal activities against T. 
mentagrophytes and T. rubrum, demonstrating the practical application of the cascade 
reaction for drug discovery, including the development of antifungal agents. 
Scheme 2.29 
  
               Recently Maiti et al. reported a one-pot imino Diels–Alder reaction for the 
synthesis of dihydrobenzoquinoline 2.46a derivatives catalyzed by antimony 
trichloride (Scheme 2.30).
63
 The fully aromatized benzoquinoline 2.46b was also 
formed as a minor product. Due to its operational simplicity, use of inexpensive 
catalyst, ease of product isolation, the author notes that the methodology is well 
suited for the library synthesis of dihydrobenzoquinoline derivatives. 
Scheme 2.30 
 
             Synthesis of fully aromatized analogs-benzoindoles 2.47 and benzoquinolines 
2.48 was reported by Ishii et al.
64
 It was achieved by N-heterocyclization of 
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naphthylamines with 1,2- and 1,3-diols catalyzed by an iridium chloride/BINAP 
system (Scheme 2.31). The reaction was found to be markedly influenced by the 
ligands employed. No reaction occurred in the absence of ligand. Monodentate 
ligands afforded lower yields. Typical bidentate phosphine ligands such as 1,2-
bis(diphenylphosphino) ethane (dppe) and 1,3-bis(diphenylphosphino) propane 
(dppp) were less efficient than monodentate. Finally rac-BINAP was found to be the 
efficient ligand.   
Scheme 2.31 
 
              Using a sequential hetero-Diels-Alder/Friedel-Crafts reaction, Chen et al. 
demonstrated a highly enantioselective synthesis of analogs of indeno 
dihydropyridines 2.52 (Scheme 2.32).
65
 The methodology relies on the chiral 
secondary amine-catalyzed aza-Diels-Alder of N-sulfonyl-1-aza-1,3-butadienes 2.49 
and aliphatic aldehydes via enamine catalysis using α,α-diphenylprolinol O-TMS 
ether 2.50. A subsequent intramolecular Friedel-Crafts reaction of the hemiaminal 
2.51 functional group with a tethered arene motif in the presence of TFA delivers 
analogs of indenodihydropyridine 2.52.  
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Scheme 2.32 
 
          Panek and Porco reported
66
 synthesis of indenopiperidine via radical 
cyclization of suitably functionalized tetrahydropyridine 2.53. Treatment of the 
substrate with tributyltin hydride in the presence of a catalytic amount of AIBN at 
80°C, cleanly afforded the indenopiperidine 2.54 in 81% isolated yield (Scheme 
2.33). 
Scheme 2.33 
 
            Exploiting the divergent reactivity of isocyanoacetates, Masson et al. 
reported
67
 three-component synthesis of furoquinolines 2.55 (Scheme 2.34). It is 
interesting to note that no external reagent was required and heating was the only 
external force needed to promote this mechanistically complex reaction that led to the 
creation of five chemical bonds and two heterocyclic rings.  
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Scheme 2.34 
 
The operational simplicity and good chemical yields makes this novel heterocycle 
synthesis appealing in diversity-oriented synthesis. 
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Part III 
Ring Closing Enyne Metathesis  
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Ring closing metathesis reactions can are classified into three categories depending 
on the interacting partners i.e., diene,
68
 enyne
69
 and diyne
70
 metathesis (Figure 2.3). 
These reactions can be further sub-divided into ring-opening metathesis (ROM), ring-
opening metathesis polymerization (ROMP) and cross metathesis (CM), based on the 
process that occurs during the reaction. Through these reactions, olefin metathesis 
provides a route to unsaturated molecules that are often challenging or impossible to 
prepare by any other means. Some of the most impressive achievements include the 
use of ROMP to make functionalized polymers,
71-72
 syntheses of small to large 
heterocyclic systems by RCM
73-74
 and the CM of olefins with pendant functional 
groups.
75-76
 Moreover the approach of natural product synthesis has changed after the 
advent of RCM.
77  
Figure 2.3 
 
Ring-closing enyne metathesis, as the name suggests is a rearrangement that occurs 
between a double and a triple bond. It is completely atom economical.
78
 During the 
course of this reaction, the terminal alkylidene moiety of alkene transfers on the 
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alkyne carbon and a new bond formation occurs between alkynic and olefinic carbons 
providing a cyclized product with a 1,3-diene moiety.
69 
Intermolecular enyne 
metathesis reactions lead to the formation of several products like olefins and 
polymers in addition to the desired diene. This is because; there are two types of 
metathesis occurring in addition to the intermolecular enyne metathesis. They are 
intermolecular diene metathesis and intermolecular alkyne metathesis. The catalyst 
can further react with these byproducts to provide complex mixture. Therefore 
intramolecular enyne metathesis is more popular than intermolecular enyne 
metathesis and widely used in synthetic organic chemistry. 
2.7 Catalysts for Olefin metathesis (OM): 
Transition metal carbenes have been used to catalyze metathesis reactions. Initially, 
tungsten, molybdenum and chromium carbenes were used as catalysts.
26, 79  
The 
chemoselectivity of the catalysts employed in olefin metathesis is important. They 
have to react selectively with the olefin in the presence of other functional groups 
either in the substrate or the solvent. Being an oxophilic metal, tungsten was 
extremely sensitive to a number of functional groups and reaction conditions. Schrock 
developed
80
 molybdenum-based catalysts that exhibited a larger functional group 
tolerance allowing OM to become a viable tool for organic syntheses.
81
 
Unfortunately, manipulation of Mo-based catalysts still required stringent air-free and 
water/alcohol-free conditions. Low functional group tolerance and instability have 
limited the application of these metathesis catalysts. A very small amount of active 
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form is generated from these catalysts and therefore, these reactions were difficult to 
initiate and to control.              
However, after the discovery of a ruthenium alkylidene catalyst by Grubbs, many of 
the problems encountered with previous catalysts were eliminated. OM process truly 
became a versatile tool for organic synthesis and polymer synthesis.
82
 Prof. Robert H. 
Grubbs was awarded Nobel Prize for chemistry in 2005, shared with Prof. Richard R. 
Schrock and Prof. Yves Chauvin, for the contribution to the metathesis chemistry.  
The functional group tolerance of metal carbenes increases from titanium < tungsten 
< molybdenum < ruthenium (Table 2.2) shows the tremendous functional group 
tolerance of ruthenium based catalysts compared to previous metathesis catalysts. In 
the table below, carbenes can tolerate only the functional groups listed underneath the 
olefins.
26
     
  Table 2.2: Functional tolerance of transition metal carbenes 
Titanium Tungsten Molybdenum Ruthenium 
Acids 
 
Alcohols, Water 
 
Aldehydes 
 
Ketones 
 
Esters, Amides 
 
Olefins 
 
Acids 
 
Alcohols, Water 
 
Aldehydes 
 
Ketones 
 
Olefins 
 
Esters, Amides 
 
Acids 
 
Alcohols, Water 
 
Aldehydes 
 
Olefins 
 
Ketones 
 
Esters, Amides 
 
Olefins 
 
Acids 
 
Alcohols, Water 
 
Aldehydes 
 
Ketones 
 
Esters, Amides 
 
 
The most commonly used Grubbs catalysts are the 1st generation catalyst (cat-I)
83
 
and the 2nd generation catalyst (cat-II)
84
(Figure 2.4). The latter, which is a N-
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heterocyclic carbene (NHC)-coordinated ruthenium benzylidene complex, has higher 
activity and air stability compared to the 1st generation. The presence of N-
heterocyclic carbene is the cause for these differences. This catalyst has been used for 
a broad range of reactions including metathesis of sterically demanding substrates
76, 
85-86
 and electron-deficient substrates.
87-89
 Hoveyda
90
 and Blechert
91
 independently 
developed a phosphine free Ru catalyst (cat-III). This catalyst is widely used for 
ring-closing metathesis of trisubstituted olefins and in cross metathesis processes. 
Recently, Grubbs introduced the third generation catalyst (cat-IV) which is 
synthesized by replacing the phosphine ligand in cat-II with a more labile pyridine 
ligand. Rapid dissociation of electron deficient 3-bromopyridine ligand and/or its 
slow rebinding has been postulated to account for this higher activity. This catalyst is 
most widely used in ROMP and CM of acrylonitrile.
92
  
Figure 2.4 
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2.9 Overview of Mechanism of Ring Closing Enyne Metathesis: 
 
Two types of mechanisms are proposed for enyne metathesis.
93
 
i) Metal-salt catalyzed mechanism: 
According to this mechanism (Scheme 2.35), first step is the bidentate coordination of 
the substrate-2.56 via the ene and yne component to the metal to form complex-2.57. 
Oxidative cyclization followed by reductive elimination produces cyclobutene 
intermediate-2.59. Finally the retrocyclization/ring opening of cyclobutene affords 
desired 1,3-diene product-2.60. 
Scheme 2.35 
 
 Mostly Pd(II) and Pt salts have been used for enyne bond reorganization.
94
  
ii) Metal-carbene catalyzed mechanism: 
This mechanism is sub-divided into two categories depending on the initial 
coordination of the substrate on to the metal. 
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iia) Yne-then-ene mechanism: 
Here the alkynyl moiety of the substrate 2.61 coordinates first to the ruthenium-
carbene complex. Depending on the regiochemistry of this coordination, the 
mechanism is further classified as “exo-pathway” and “endo-pathway”.
93
 If the metal 
combines with the internal alkynyl carbon of the alkyne motif, then it proceeds via 
the exo-pathway. The coordination affords a ruthenacyclobutene 2.62 which upon 
ring opening forms a vinylic ruthenium carbene complex 2.63. An intramolecular 
[2+2] cycloaddition of 2.63 gives rise to ruthenacyclobutane 2.64 and a 
retrocyclization affords product 2.65.  
The “endo-pathway” can be observed when the metal coordinates to the terminal 
alkynyl carbon. Similar to the exo-pathway, the coordination affords a 
ruthenacyclobutene 2.66 which upon ring opening yields a vinylic ruthenium carbene 
complex 2.67. An intramolecular [2+2] cycloaddition forms ruthenacyclobutane 2.68 
and a cycloreversion delivers product 2.69. Regeneration of ruthenium carbene 
complex occurs in both the pathways (Scheme 2.36). 
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Scheme 2.36 
 
iib) Ene-then-yne mechanism: 
In this route the alkene moiety of the substrate coordinates first to the ruthenium 
carbene complex.
93
 The mechanism is further classified as the exo-pathway and endo-
pathway, depending on the regiochemistry of the coordination of ruthenium 
alkylidene complex to the alkyne. Complex 2.70 is formed by the reaction between 
substrate 2.71 and the catalyst =Ru (Scheme 2.37).  
In exo-pathway the ruthenium in complex 2.70 coordinates with terminal carbon of 
the alkyne and undergoes ring closure to form ruthenacyclobutene 2.72. 
Retrocyclization yields vinylic ruthenium carbene complex 2.73 which reacts with the 
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second equivalent enyne substrate 2.71 to regenerate the complex 2.70 and the 
product 2.74.  
Alternatively, the endo-pathway produces strained ruthenocyclobutene 2.75, by the 
combination of the ruthenium metal center in 2.70 with the internal alkynyl carbon. 
Finally product 2.76 is obtained by the ring opening of ruthenocyclobutene. Since the 
intermediate 2.75 is unstable due to its high strain, it is expected that obtaining the 
endo-product from this mechanism is quite unlikely. 
Scheme 2.37 
 
There are examples of yne-then-ene mechanism as noted by Mori etal.
95
 It is 
explained that this is due to the higher reaction rate of the ruthenium-carbene with the 
alkyne moiety compared to that with the olefin moiety. On the other hand; Hoye, 
based on the NMR studies, favored the ene-then-yne mechanism for RCEYM.
96
 He 
suggests that substrate concentration has an influence on the mechanism and it is 
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beneficial to have a higher substrate and lower ruthenium carbene concentration for 
reactions that follow this pathway. It can be achieved by the slow addition of 
ruthenium carbene to the solution of substrate. 
The exo/endo selectivity is another important aspect of the enyne methathesis 
mechanism as it controls the ring size of the resulting product. It has been shown that 
for small ring formation (ring size = 5-9) exo-pathway is favored while formation of 
macrocycles (ring size = 11-15) desires the endo-pathway.
97
 This outcome can be 
explained by the ene-then-yne mechanism, considering the ring strains of 
ruthenocyclobutene intermediates.
69
 When the length of the tether increases, the strain 
of the endo-intermediate is reduced considerably and thus could provide an 
explanation for these observations. But this cannot be easily explained for the yne-
then-ene mechanism and the switch between exo/endo selectivity is still not clear. 
Potentially the steric and conformation of the tether could play a vital role. 
2.10 Effect of Ethylene Gas in Enyne Metathesis: 
 In some of the challenging enyne metathesis reactions, the yield was improved 
when they were performed under the ethylene atmosphere.
98-100
 Mechanistically the 
activity increase in the presence of ethylene is explained by a constant ‘reactivation’ 
of the ruthenium catalyst and thereby reducing amount of catalyst in resting state.  
During yne-then-ene pathway (Scheme 2.38) the ethylene forms ruthenacyclobutane 
2.77 with active ruthenium alkylidene. This helps the reaction push forward and 
prevents the ruthenium catalyst being trapped in less active species 2.78 and 2.79 
formed due to reaction between the product and ruthenium alkylidenes.  
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Scheme 2.38 
 
In the course of ene-then-yne pathway (Scheme 2.39), the less active species 2.80 
would be formed. Ethylene reacts with 2.80 to form ruthenacyclobutane 2.81 and thus 
pushes the reaction forward. 
Scheme 2.39 
 
Another important point to know is that the self-metathesis of ethylene is a neutral 
process and does not affect the progress of reaction (Scheme 2.40). 
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Scheme 2.40 
 
The benefits of ethylene atmosphere appear to be general in RCEYM reactions 
forming small to medium sized ring systems. But in formation of large membered 
rings, the use of ethylene can lead to CM products with starting materials.
69, 97
  This 
could be attributed to relatively slower rate of macrocyclization via enyne metathesis. 
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Part IV 
Regiocontrol in Intramolecular Heck Cyclization  
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             A significant challenge in the development of metal-catalyzed reactions is the 
suppression of competing mechanistic pathways without inhibiting desired steps in a 
catalytic cycle.
101-102
 In recent years, several remarkable transformations have been 
effected through the use of palladium catalysts that minimize side reactions (e.g., β-
hydride elimination) while still allowing reductive elimination or transmetalation 
processes to occur.
103-106
 Despite these achievements, the factors that affect the 
relative rates of competing mechanistic pathways in catalytic reactions (e.g., 
reductive elimination versus olefin insertion, or C-C versus C-N bond-forming 
reductive elimination) are not well understood. If these fundamental processes could 
be controlled, the selective construction of a diverse array of products from common 
starting materials could be achieved under similar reaction conditions by varying 
catalyst structure.  
2.11 Factors Controlling Competing Pathways: 5-exo- versus 6-endo Cyclization 
in Intramolecular Heck Cyclization 
             The intramolecular Heck reaction often proceeds with high regio- and 
stereoselectivity when compared to intermolecular Heck reaction. This is mainly 
dependent on the reaction conditions and the ring size of the heterocycles formed; 
with exo being particularly favored for 5, 6 and 7 membered rings due to 
conformational constraints.
107-109
 The transition state to form exo products, in 
reactions forming small rings is much lower in energy than the endo transition state 
due to length of the tether. Much longer and more flexible chains are needed to adopt 
the proper conformation of the endo insertion (Figure 2.5).  
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Figure 2.5  
 
             The 5-endo-trig and 6-endo-trig cyclizations are not very common; this 
circumstance is usually rationalized by Baldwin’s rules.
110
 Baldwin's rules in organic 
chemistry are a series of guidelines outlining the relative feasibilities of ring closure 
reactions in alicyclic compounds. Apart from Baldwin’s rules, some of the other 
factors which control the competing pathways in an intramolecular Heck cyclization 
are discussed in the following sections. 
2.11.1 Steric and Conformational Effects in the Substrate: 
            Dankwardt et al. reported
111
 that N-acryloyl-7-bromoindolines 2.82, which 
possibly could cyclize via either the 5-exo or 6-endo pathway, furnished exclusively 
6-endo products when treated under typical Heck reaction conditions (Scheme 2.41). 
The cyclization of acrylamides proceeded efficiently to give quinolone products 2.83 
via 6-endo-trig cylization.  
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Scheme 2.41 
 
However, it was found that the corresponding cyclization of tetrasubstituted amide 
2.84 attempted under the same conditions provided a mixture of compounds 2.85 and 
2.86 in a 1:1.4 ratio respectively (Scheme 2.42). Also this cyclization reaction 
proceeded slower than the previous cases (substrates 2.82) presumably due to 
increased steric hindrance.  
Scheme 2.42 
 
The author explains that the palladium-catalyzed cyclization of 2.82 through a 6-endo 
pathway is presumably due to strain involved in the approach of the palladium 
species to the α position of the double bond of these acrylamides, thus generally 
disfavoring the 5-exo-trig mode of closure. 
           In order to probe the effect of ring size on the regiochemistry of cyclization, 
amide 2.87 was subjected to the palladium cyclization conditions (Scheme 2.43). 
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Scheme 2.43  
 
The reaction afforded lactams 2.88a, 2.88b and 2.88c in a 5:1.3:1 mixture. Thus a 
6.3:l mixture of products favoring the 5-exo-trig pathway dominated in the reaction 
mixture. This result when compared to the reaction of indoline 2.82 (R
1
=Me) 
affording exclusively 2.83 (R
1
=Me) via 6-endo pathway, clearly depicts the effect of 
substrate ring conformation on the outcome of regiochemistry in Heck cyclization. 
            An enantioselective total synthesis of (+)-xesoquinone was developed by the 
Keay group using an asymmetric double Heck reaction (Scheme 2.44).
112
 The 
reaction produced 2.89 in 82% yield and 68% of enantiomeric excess.  
Scheme 2.44 
 
In the second Heck reaction (Scheme 2.45), 6-endo-trig cyclization of the 
intermediate 2.90 was observed to give a six-membered ring instead of the seemingly 
more favored exo-trig cyclization, which would form five-membered ring. Density 
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function theory calculations by Ziegler and coworkers
113
 revealed that this selectivity, 
at both thermodynamic and kinetic levels, is controlled by the stability of the cyclic 
system after the migratory insertion of the palladium into the exocyclic double bond. 
Scheme 2.45 
 
2.11.2 Catalysts and Reaction Conditions: 
           An interesting case of 6-endo versus 5-exo cyclization has been studied by 
Bombrun and Sageot who investigated the intramolecular Heck cyclization of 
enamide 2.91 (Scheme 2.46).
114
 Under Jeffery conditions the reaction proceeded 
nearly exclusively via the 6-endo cyclization mode to form piperidone fused product 
2.92. However when run under the reductive Heck conditions (in presence of hydride 
source), a 5-exo cyclization was mostly achieved and the lack of β–hydrogen in this 
case leads to pyrrolidinone fused product 2.93. 
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Scheme 2.46 
 
Mechanistically both the reactions would undergo kinetically controlled 5-exo 
cyclization, to begin with. In the case of Jeffery conditions reaction, due to lack of β–
hydrogen as well as due to absence of any nucleophile to terminate the reaction the 5-
exo route happens to be the dead end. So the reaction reverses and proceeds via the 
thermodynamically controlled 6-endo pathway. In contrast, under reductive Heck 
condition due to presence of the hydride anion (nucleophile) the reaction can 
successfully terminate the 5-exo pathway and regenerate the catalyst for the new 
catalytic cycle. 
             Another example giving exclusively 6-endo cyclized product was reported by 
Kim et al.
115
 The cyclization of methylenephtalimidine precursor 2.94 afforded 
tetracyclic amide 2.95 under the ligandless Heck condtion (Scheme 2.47). 
 
 
 
56 
 
Scheme 2.47 
 
               The influence of ‘ligand’ and ‘ligandless’ conditions on the regioselectivity 
of Heck cyclization was reported by Hii et al. (Scheme 2.48).
116
 The reaction was 
found to be highly dependent on the catalytic conditions, particularly the nature and 
presence and absence of the ligand. Biaryl coupled product 2.96 was preferred over 8-
exo cyclization under “ligandless” conditions, whereas eight membered heterocycles 
2.97 formed via 8-exo cyclization was the exclusive product using PPh3 ligand. 
Scheme 2.48 
 
             The remarkable effect that minor change in reaction conditions and substrate 
composition can have on the outcome of a palladium-catalyzed transformation is very 
well illustrated in the following examples. The Heck group described
117
 the 
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palladium-catalyzed reaction of iodobenzene and twofold excess of tolane 2.98 in the 
presence of triphenylphosphine and triethylamine to give the substituted naphthalene 
2.99 (Scheme 2.49). Dyker and Kellner
118
 obtained the phenanthrene 2.100 when 
using a 2:1 mixture of iodobenzene and tolane in the presence of n-Bu4NBr and 
K2CO3 (Scheme 2.50). Furthermore, Cacchi’s group
119
 employed almost identical 
conditions but added formic acid, which led to the formation of triphenylethene 2.101 
(Scheme 2.51). Moreover, Larock and Tian
120
 have recently reported an efficient 
synthesis of fluorenes 2.102, again using iodobenzene and tolane as substrates 
(Scheme 2.52). 
Scheme 2.49 
 
Scheme 2.50 
 
Scheme 2.51 
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Scheme 2.52 
 
2.11.3 Suppression of a Pathway via Chelation: 
            Suppression of competing β-hydride elimination is important especially in 
metal-catalyzed cross-coupling reactions. Kim and Ahn
101
 have reported a sequential 
Heck-cyclization-Suzuki coupling that provides an efficient synthetic access to 4-
methylene-3-arylmethylpyrrolidine 2.103a (Scheme 2.53). 
Scheme 2.53 
 
However, studies on the scope of this sequence revealed that the substrate had to be 
an N-tosyl sulfonamide and that certain boronic acids did not transmetalate but rather 
gave rise to the formation of pyrrole 2.104 or a pyridine 2.105 derivative (Table 2.3) 
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Table 2.3 
 
Entry Substrate ArB(OH)2 Product Yield (%)
a
  
1 R=Ts 4-fluorophenylboronic acid 2.103      92 
2  1-napthylboronic acid 2.103      88 
3  3-nitrophenylboronic acid 2.103      49 
4  2-furanboronic acid 2.104+2.105   26
b
(58) 
5  ferroceneboronic acid 2.104+2.105   61
c
(19) 
6 R=Bn 4-fluorophenylboronic acid 2.103      30 
7 R=Ac n-butylboronic acid -     (69) 
8 R=Boc phenylboronic acid - - 
         
        aYield in parenthesis indicates that of recovered starting material, bb/c= 3.3/1,cb/c=3.2/1     
The peculiar outcome of carbopalladation-Suzuki sequence was rationalized by 
coordinative stabilization of the insertion intermediate 2.106 by the sulfonyl oxygen 
atom, as represented in structure 2.107, thus suppressing the usual β-hydride 
elimination (Scheme 2.54).  
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Scheme 2.54 
 
If the transmetallation is rapid the Suzuki product 2.103 is obtained. However if the 
transmetallation is slow, as for furyl or ferrocene boronic acids (entries 4 and 5), 
either β-hydride elimination or a subsequent cyclic carbopalladation occurs. The β-
hydride elimination of 2.106 leads to the formation of the diene 2.108 that is 
isomerized to the pyrrole 2.105. The carbopalladation of 2.106 furnishes the 
cyclopropylmethyl Pd species 2.109, which rearranges with concomitant ring 
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expansion via β-carbon elimination to furnish piperidyl-Pd intermediate 2.110 that 
suffers β-hydride elimination to afford the methylene tetrahydro pyridine 2.104.              
             Negishi reported
102
 a palladium-catalyzed carbonylative cyclization in which 
the β-H-elimination was suppressed under higher CO pressure (Scheme 2.55). It was 
suggested that an adjacent carbonyl oxygen atom coordinatively stabilizes an 
alkylpalladium intermediate. Fast CO insertion is also considered to be a contributing 
factor to the success of the process, which proceeds prior to the decomposition of the 
alkylpalladium intermediate. 
Scheme 2.55 
 
Under the higher CO pressure, the initial carbonylation generates cyclohexenone 
intermediate which coordinatively stabilizes the putative alkylpalladium 2.111. The 
latter upon carbonylation and methanolysis furnished observed product 2.112. Under 
lower or in absence of CO atmosphere the reaction followed normal Heck pathway of 
carbopalladation followed by either β-H-elimination or isomerization to afford dienes 
2.113 and 2.114 respectively (Scheme 2.56) 
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Scheme 2.56 
 
2.11.4 Chelation Driven Heck Cyclization: 
            Harran and coworkers reported
121
 an interesting example of Heck 
macrocyclization of 2.115 driven by a phenolic hydroxyl group (R=H, Scheme 2.57). 
Use of the corresponding methyl ether resulted in a marked decrease in cyclization. 
The formation of palladium phenoxide 2.116 from a free hydroxyl group appeared to 
be pivotal for preorganization prior to macrocyclization. 
Scheme 2.57 
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Another example of unusual behavior driven by chelation was observed by Pinel and 
coworkers.
122
 The reaction of 8-bromoquinoline with acrolein diethyl acetal using the 
Herrmann-Beller catalyst
39
 led to the formation of the saturated ester 2.117, while the 
reaction with acrolein afforded a tricyclic quinolinone 2.118 (Scheme 2.58). 
Scheme 2.58 
 
To explain the outcome the authors proposed the following mechanism (Scheme 
2.59). After the insertion step a six-membered palladacycle 2.119 is formed by 
coordination to the nitrogen. As a consequence, only the formyl hydrogen is 
conformationally accessible, thus forming a reactive ketene 2.120 upon β-hydride 
elimination. In the next step, a syn H-Pd addition to the C-N bond occurs followed by 
β-hydride elimination that leads to the formation of the intermediate 2.122 which 
undergoes reductive elimination to generate the tricyclic quinolinone 2.118. 
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Scheme 2.59 
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Chapter Three 
 
Diastereocontrol in the Synthesis of 2,3,4-Trisubstituted Pyrrolidines and 
Tetrahydrofurans via a Palladium(II)-Catalyzed Three-Component Coupling 
Reaction. 
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     A Variety of medicinally significant natural products and synthetic 
pharmaceutical agents contain substituted pyrrolidines and tetrahydrofurans as their 
structural cores.
123-124
 Among these heterocycles, structures featuring an α-aryl 
functionality
125
 as well as the neuroexcitatory amino acids
126
 present particularly 
challenging targets for diastereocontrolled syntheses (Figure 1).  
Figure 1 
 
3.1 Project Aim: 
   As mentioned in introductory chapter, MCRs are excellent tools for diversity-
oriented synthesis. Our group had reported a modular palladium-catalyzed three 
component syntheses of N-4-methoxyphenyl (N-PMP) protected homoallylic 
amines
127
 and homoallylic alcohols.
128
 The palladium-catalyzed three component 
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coupling of imines, allenes and boronic acids afforded diastereoenriched N-PMP 
protected homoallylic amines 3.1 with anti-stereochemistry. Replacing the imines 
with aldehydes, the reaction delivered diastereoenriched homoallylic alcohols 3.2 
with syn-stereochemistry (Scheme 3.1).  
Scheme 3.1 
 
   The aim of this project was to demonstrate the utility of these homoallylic 
precursors to gain access to drug-like scaffolds as well as to unequivocally confirm 
the mechanistically significant stereochemical divergence in their preparation by 
completing a thorough structure assignment for the resulting pyrrolidines 3.3 and 
furans 3.4 (Scheme 3.2). We envisioned converting the N-PMP protected homoallylic 
amines to pyrrolidines and homoallylic alcohols to tetrahydrofurans using simple 
classical organic transformations. We proposed hydroboration followed by an 
intramolecular displacement of the primary alcohol would deliver the desired cyclized 
products.  
Scheme 3.2 
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3.2 Results and Discussion: 
             As noted by Chad Hopkins, N-alkylation of N-PMP protected amines 3.1 
required harsh conditions and at times did not produce desired results.
129
 Moreover, 
the hydroboration of these amines was unsuccessful which is most likely due to 
interference caused by the basic amine functionality.
129
 Also the PMP protecting 
group proved to be critical in the initial Pd-catalyzed three component coupling 
reaction. To overcome this problem, we planned to deprotect the N-PMP group and 
replace it with a non-interfering N-Ts protecting group. Thus my first challenge was 
to come up with a protocol for deprotection of the N-PMP group. Efforts to elaborate 
the homoallylic alcohols showed that in the presence of a base they underwent 
retroallylation to afford corresponding aldehyde and alkene (Scheme 3.3). So, I 
embarked on exploring feasibility of furan and pyrrolidine syntheses. 
Scheme 3.3 
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3.2.1   N-PMP Deprotection and Tosylation: 
             Most reports describe oxidative deprotection of N-PMP with ceric ammonium 
nitrate (CAN) at neutral pH.
130-133
 But the disadvantage associated with this procedure 
is the requirement for excess of CAN (4-5 equiv), a laborious work-up and toxicity of 
CAN. Some of these drawbacks also apply to phenyl iodoacetate PhI(OAc)2.
134-137
 
Based on these arguments I decided to use periodic acid (H5IO6)
138
 as the oxidant, 
which is relatively less toxic, cheaper and easily accessible. Following is the 
description of   N-PMP-deprotection. 
            To a yellow solution of the corresponding diastereomerically pure amine 3.1a 
in MeCN was added solid H5IO6 (1.2 equiv) followed by H2O (dropwise), and 1 M aq 
H2SO4. The resulting bright purple-red mixture was stirred at r.t. for 24 h. The 
mixture was diluted with H2O, and extracted with Et2O. For small-scale preparations, 
the crude mixture was directly loaded on the silica column for separation eluting with 
MeOH : CH2Cl2 mixture. Henceforth this protocol will be called as ‘method A’. 
              Detailed workup optimization is described in Table 1. Upon completion of 
the reaction, TLC analysis showed a prominent base spot, the mixture was diluted 
with ether and quenched with saturated aq solution of NaHCO3. The aqueous layer 
was extracted with ether. The combined ether layer was dried over Na2SO4, filtered 
and evaporated at r.t using rotavap. The crude mixture was purified using silica 
column chromatography. The pure amine was eluted in EtOAc : Hexane (5:1) 
mixture as yellow oil in 10% yield (entry 1). The low yield could be due adsorbtion 
of amines on to silica during column chromatography.  
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Table 1 
 
Entry H5IO6 (eq) Work up % yield 
1 1.0 Normal
a
 10% 
2 1.0 Normal and tried to isolate by prep TLC 0% 
3 1.2 Work up at 0ºC
b
 and isolate by prep TLC 0% 
4 1.2 Directly to flash column 55-75% 
 
           a) Normal workup: Neutralize the acidic reaction mixture with NaHCO3 solution and extracted with Et2O,  
             dried over Na2SO4, and evaporated at RT using rotavap. b) used ice cold solutions 
 
Substituting the chromatography with prep TLC after the workup or performing the 
workup at 0
o
C did not improve the yield (entries 2 and 3). Interestingly, the desired 
amine was successfully isolated by not performing any aqueous workup, instead 
directly loading the reaction mixture onto the silica column and eluting with the 
MeOH : CH2Cl2 mixture to obtain reasonably pure amines in moderate yield (entry 
4). (Note: Eluting with EtOAc : Hexane mixture gave lower yield).  
             Using the above optimized N-PMP deprotection protocol, Dr. Benoy, a 
postdoctoral associate in our lab successfully synthesized N-PMP deprotected amines 
3.10, 3.11 and 3.12 in good yields (Scheme 3.3). However, compound 3.9 afforded 
lower yields with method A. To overcome this problem, Benoy employed CAN 
mediated N-PMP deprotection to furnish compound 3.13 in moderate yield. The 
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procedure is as follows: To the solution of the diastereomerically pure amine 3.9 (1.0 
equiv) in MeCN was added a solution of CAN (1.3 equiv) in H2O at 0 °C. The 
mixture was stirred for 30 min at 0 °C and then for 3h at r.t. EtOAc was added, and 
the mixture was washed with 5% aq NaHCO3 and partially purified by silica column 
chromatography. Henceforth this protocol will be called ‘method B’. 
Scheme 3.3 
 
3.6: R
1
 = p-(MeO2C)C6H4; R
2
 = CO2Me; R
3 
= n-hexyl  3.10: 73% (method A) 
3.7: R
1
 = p-(MeO2C)C6H4; R
2
 = NO2; R
3
 = n-hexyl                          3.11: 72% (method A) 
3.8: R
1
 = p-(MeO2C)C6H4; R
2
 = CO2Me; R
3
 = 2-ethyl-1-hexyl  3.12: 76% (method A) 
3.9: R
1
 = 2-naphthyl; R
2
 = CO2Me; R
3
 = n-hexyl   3.13: 48% (method B) 
               Deprotected amines 3.10-3.13 were obtained as brown to yellow oils that 
yielded acceptable 
1
H and 
13
C NMR spectra. However, they were not fully 
characterized and were quickly used for subsequent tosylation with tosyl chloride 
(TsCl). The primary amine (1.0 equiv) was dissolved in THF, TsCl (1.6 equiv) and 
Et3N (1.1 equiv) were added to the solution at 0°C, and the mixture was stirred at r.t. 
under argon for 18 h. Quenched the reaction with H2O and extracted with Et2O. The 
organic extracts were dried (MgSO4), and the solvents were removed under reduced 
pressure to afford the crude product. Upon flash column chromatography using silica 
gel and eluting with EtOAc : Hexane mixture pure N-tosylamines 3.14-3.17 were 
isolated in good yields (62–72%) (Scheme 3.4). 
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Scheme 3.4 
 
3.10: R
1
 = p-(MeO2C)C6H4; R
2
 = CO2Me; R
3 
= n-hexyl  3.14: 64% 
3.11: R
1
 = p-(MeO2C)C6H4; R
2
 = NO2; R
3
 = n-hexyl                          3.15: 62% 
3.12: R
1
 = p-(MeO2C)C6H4; R
2
 = CO2Me; R
3
 = 2-ethyl-1-hexyl 3.16: 72% 
3.13: R
1
 = 2-naphthyl; R
2
 = CO2Me; R
3
 = n-hexyl   3.17: 65% 
 
3.2.2   Hydroboration and Cyclization: 
  Protocols involving acyclic stereoinduction affording synthetically useful 
functionality are challenging. Asymmetric hydroborations of alkenes are outstanding 
examples of reactions which proceed with high acyclic stereoselection,
139-140
 and have 
been employed in synthesis of many natural products.
141-143
 Hydroboration with 
optically active boranes followed by oxidation gives optically active alcohols; often 
with high enantiomeric excess.
139-140
 Chiral alkenes undergo attack by achiral boranes 
preferentially from one side of the double bond. This occurs when the chiral center is 
attached to the C which is attacked by the boron (Scheme 3.5a),
144
 or when the chiral 
center is attached to the C to which hydride is transferred (Scheme 3.5b).
145
 High 
asymmetric induction is found even when the chiral center is one atom away from the 
C to which hydride is being transferred (Scheme 3.5c).
146
 Thus, chiral centers 
attached to either boron or to alkene C promote highly stereoselective reactions. 
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Scheme 3.5 
 
  Taking inspiration from these works Benoy successfully converted 
sulfonamides 3.14-3.17 to N-tosylamino alcohols using the standard conditions of 
BH3.THF and H2O2 and NaOH. The protocol afforded N-tosylamino alcohols 3.18-
3.21 in moderated to good yields as single diastereomers (Scheme 3.6) as confirmed 
by 
1
H NMR. The Mechanistic rationale for diastereoselectivity is discussed later 
(section 3.4 vide infra). 
 Scheme 3.6 
 
3.14: R
1
 = p-(MeO2C)C6H4; R
2
 = CO2Me; R
3 
= n-hexyl  3.18: 65% 
3.15: R
1
 = p-(MeO2C)C6H4; R
2
 = NO2; R
3
 = n-hexyl                          3.19: 61% 
3.16: R
1
 = p-(MeO2C)C6H4; R
2
 = CO2Me; R
3
 = 2-ethyl-1-hexyl 3.20: 66% 
3.17: R
1
 = 2-naphthyl; R
2
 = CO2Me; R
3
 = n-hexyl   3.21: 56% 
74 
 
              The relative stereochemistry of the newly formed chiral center during 
hydroboration was not determined at this stage. The successful hydroboration on N-
tosyl protected amines confirmed the interference of N-PMP protected amines as 
noted by Hopkins. Thus replacing the N-PMP group with N-tosyl was crucial for the 
success of hydroboration. Other hydroborating reagents
147
 surveyed (BH3·SMe2 and 
9-BBN-H) led only to low conversions of substrates. Finally, treating with TsCl and 
pyridine,
148
 Benoy was able to convert N-tosylamino alcohols 3.18-3.21 into desired 
pyrrolidines 3.22-3.25 as single diastereomers in good to high yields (66–86%)  
(Scheme 3.7). 
Scheme 3.7 
 
3.18: R
1
 = p-(MeO2C)C6H4; R
2
 = CO2Me; R
3 
= n-hexyl  3.22: 66% 
3.19: R
1
 = p-(MeO2C)C6H4; R
2
 = NO2; R
3
 = n-hexyl                          3.23: 82% 
3.20: R
1
 = p-(MeO2C)C6H4; R
2
 = CO2Me; R
3
 = 2-ethyl-1-hexyl 3.24: 78% 
3.21: R
1
 = 2-naphthyl; R
2
 = CO2Me; R
3
 = n-hexyl;   3.25: 86% 
           The relative stereochemistry was assignment based on the X-ray 
crystallographic analysis of a single crystal of pyrrolidine 3.22 which unequivocally 
established its relative stereochemistry as 2,3-anti and 3,4-anti, confirming the 
original assignment of homoallylic amines as anti (Scheme 3.1).
127
 This also 
confirmed the stereochemical course of the hydroboration reaction. I calibrated the 
nuclear Overhauser effect (NOE) analysis using the compound 3.22. This was used to 
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establish the relative stereochemistry of amino acid derivative which is discussed 
later in the following section. Selective nuclear Overhauser effect (NOE) analysis of 
pyrrolidine 3.22 revealed the indicative correlation between the syn-hydrogens at C-2 
and C-4 (Figure 2). The relative stereochemistry of pyrrolidines 3.23-3.25, were 
assigned by analogy with product 3.22.  
  Thus utilizing my optimized N-PMP deprotection and N-tosylation protocols, 
Dr. Benoy successfully converted structurally flexible N-PMP protected amines 3.6-
3.9 to rigid pyrrolidines 3.22-3.25. Using the X-ray analysis of the pyrrolidines3.22, 
he was able to unequivocally confirm the relative stereochemistry of the homoallylic 
amines (anti) as previously reported from our group.
127
 
Figure 2 
              
3.2.3   Amino acid derivative: 
            We were interested to apply the above ring closing sequence to the 
preparation of pyrrolidines with α-amino ester functionality; an important motif seen 
in the neuroexcitatory amino acids (see Figure 1). During this study, an interesting 
observation was made by Dr. Benoy. He had observed an unexpected decarboxylation 
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(loss of ester motif) of compound 3.26 during hydroboration and afforded amine 3.27 
(Scheme 3.8). The decarboxylation could be potentially due to stronger basic 
oxidative conditions used in hydroboration reaction. Unfortunately, at this point 
Benoy had to leave our group and I was assigned the task of solving the 
decarboxylation problem.   
Scheme 3.8  
 
  The N-PMP-protected amine 3.28 was synthesized (dr 9:1) in 59% yield after 
column chromatography (Scheme 3.9). The derivative was selected with the goal to 
have a single ester motif in the molecule unlike compound 3.26 which has two ester 
groups. The established PMP removal/tosylation sequence afforded N-tosylamine 
3.30 as a single diastereomer in acceptable yields (60% deprotection, 55% tosylation). 
The synthesis required no purification of the intermediate deprotected amine 3.29.  
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Scheme 3.9 
 
             I envisioned the use of milder oxidizing agent instead of H2O2 would be the 
right initial step in overcoming the decarboxylation problem. Kabalka
149
 notes that 
use of H2O2 sometimes requires quite harsh conditions that are incompatible with 
many functional groups for the oxidation of organoboranes, while sodium perborate 
offers an interesting mild alternative. He assumes that the mild nature of the oxidant 
is a result of having borate as a leaving group as compared to hydroxide, which is 
formed in hydrogen peroxide oxidations (Scheme 3.10)  
Scheme 3.10 
  
It was exciting to observe that compound 3.30 under milder basic conditions 
(NaBO3)
149
 and with a limited reaction time for the oxidation (1 h max) delivered the 
desired N-tosylamino alcohol 3.31 as a single diastereomer in good yield (65%) 
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(Scheme 3.11). Unexpectedly, lactone 3.32 formed via an intramolecular 
lactonization was also isolated in 25% yield. Again no attempt was made to elucidate 
the relative stereochemistry of the newly formed stereocenter. 
Scheme 3.11 
 
Treatment of N-tosylamino alcohol 3.31 with TsCl and pyridine
148
 provided a mixture 
of diastereomeric pyrrolidines as observed in 
1
H-NMR (Scheme 3.12). The formation 
of a diastereomeric mixture could be due to the epimerization of the sensitive α-
amino ester functionality. However the ring closure was successfully performed 
under milder Mitsunobu conditions
150
 which afforded the desired pyrrolidine 3.33 as 
a single diastereomer in an excellent yield (84%) (Scheme 3.13). 
Scheme 3.12 
 
Scheme 3.13 
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The relative stereochemistry for pyrrolidines 3.33 was assigned based on the 
calibrated NOE correlation (pyrrolidine 3.22, Figure 2) which indicated the anti, anti 
relative stereochemistry. The correlation was seen for the syn-hydrogens at C-2 and 
C-4, as well as that of hydrogens H-3 and H-5 shown in (Figure 3). 
Figure 3 
 
3.2.4 2,3,4-Trisubstituted Tetrahydrofurans:   
  We recognized that the successful application of the above hydroboration and 
ring closing protocol to homoallylic alcohols 3.34 would open up access to 
trisubstituted tetrahydrofurans structurally related to biologically active lignans
151
 
(Figure 1). Alcohols 3.34a–d were prepared by the palladium-catalyzed MCR 
reported by our group.
128
 As reported, mixtures of diastereomeric alcohols 
(determined by 
1
H NMR spectroscopy) were produced, and the single major 
diastereomers 3.34a–d were easily isolated from the crude reaction mixtures, using 
column chromatography, in 54–65% yield (Scheme 3.14).  
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Scheme 3.14 
 
                R = C6H5          3.34a: 65%  
             R
 
= p-(MeO)C6H4                               3.34b: 54%  
                          R = p-(NO2)C6H4          3.34c: 55%  
            R =2-furyl                   3.34d: 60%  
Applying the previously established hydroboration conditions to homoallylic alcohols 
3.34 afforded diols 3.35a-d. Disappointingly, unlike the hydroboration of homoallylic 
amines the diastereoselectivity of the hydroboration of the alcohols suffered, and 
diols 3.35a-d were isolated as 3:1 mixtures of chromatographically inseparable 
diastereomers (Scheme 3.15) (determined by 
1
H NMR spectroscopy). The relative 
stereochemistry of major and minor diols was not assigned at this stage. A 
Mechanistic rationale for the diastereoselectivity is discussed later in the following 
section. 
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Scheme 3.15 
 
3.34a: R = C6H5          3.35a: 85% , dr 3:1 
3.34b: R
 
= p-(MeO)C6H4                               3.35b: 92% , dr 3:1 
3.34c: R = p-(NO2)C6H4         3.35c: 62% , dr 3:1 
3.34d: R =2-furyl                   3.35d: 68%, dr 3:1 
Diols 3.35b and 3.35d showed few additional signals in 
13
C NMR. This is potentially 
due to dehydration caused by acid contaminated CDCl3. The additional signals 
disappeared when the sample filtered through plug of basic alumina was used (spectra 
enclosed). 
We were pleased to note that the treatment of the 3:1 diastereomeric mixture of diols 
3.35a–d with TsCl and pyridine afforded tetrahydrofurans 3.36a–d as single 
diastereomers (as analyzed from 
1
H NMR) and a monotosylated alcohol 3.37a (22%)  
(Scheme 3.16). Although the yields of tetrahydrofurans 3.36a–d were only moderate 
to good (60-73%), the isolation of single diastereomers proved to be a synthetically 
practical process. The relative stereochemistry of compound 3.37a was not 
established. The corresponding monotosylated alcohol compounds 3.37b-d were not 
isolated but were observed in crude 
1
H NMR. The mass balance ratio of 3.36:3.37 
approximately 3:1, is similar to the diastereomeric ratio of diols. Therefore we believe 
that the tetrahydrofurans are derived from the respective major diastereomers of diols 
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and the monotosylated alcohols are produced from the minor diastereomers of the 
diols. 
Scheme 3.16 
 
3.35a: R = C6H5     3.36a: 65%, dr 1:0
a
 
3.35b: R
 
= p-(MeO)C6H4   3.36b: 73%, dr 1:0
a
 
3.35c: R = p-(NO2)C6H4   3.36c: 65% , dr 1:0
a
 
3.35d: R =2-furyl                  3.36d: 60%, dr 1:0
a 
                                                                       a) 
dr ratio based on 
1
H NMR 
The relative stereochemistry of tetrahydrofuran 3.36a was assigned based on selective 
NOE analysis. The indicative signals in the NOE spectra showed the correlation of 
hydrogens H-2/H-3 with the same hydrogen H-6 and absence of H-2 and H-4 
correlation. Thus it was concluded that tetrahydrofuran 3.36a possessed syn, anti 
relative stereochemistry (Figure 4). The structures of analogous furans 3.36b–d were 
assigned based on the NOE correlations. The above results are in agreement with the 
previously assigned syn-stereochemistry for the major diastereomers of homoallylic 
alcohols 3.34.
128
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Figure 4 
 
The ratio of 3.36:3.37 is approximately 3:1 which is similar to the diastereomeric 
ratio of diols 3.35. Based on this data we believe that the major diastereomer of the 
diol undergoes ring closure faster than the minor diastereomer under these conditions. 
To answer the question if the minor diastereomer of the diol undergoes cyclization, 
the diastereomeric mixture of diol 3.35a was treated with Mitsunobu conditions. 
Surprisingly, unlike the TsCl/Py conditions which afforded mixture of 
tetrahydrofurans and monotosylated alcohol (Scheme 3.15), the Mitsunobu reaction 
afforded tetrahydrofuran 3.36a in high yield (85%) as a mixture of 
chromatographically inseparable diastereomers (dr 9:1 by GC analysis). (Scheme 
3.17). So the minor diastereomer did cyclize under Mitsunobu conditions. 
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Scheme 3.17 
 
3.3 Mechanistic Rationale for Stereochemical Outcome in Hydroboration 
Reaction: 
  The transformation of a prochiral group into a chiral center can be achieved 
by (a) the use of a chiral reagent (reagent control of stereoselectivity)
61, 152
 or (b) as a 
consequence of asymmetric induction by stereocenters already present in the substrate 
(substrate control of diastereoselectivity).
153-154
 The facial selectivity of the 
hydroboration of homoallylic amines and alcohols appears to arise from a substrate-
directed approach of borane (BH3) to the olefin.
145
 The notion that non-eclipsed 
conformation of the transition states operates in such hydroboration reactions is 
strongly supported.
155-156
 Using this model of non-eclipsed transition state, Evans 
explained the stereochemical outcome of hydroboration in the synthesis of 
Lonomycin A.
157
  
  The stereochemical outcome of our hydroboration reaction can be explained 
using the concept of substrate controlled approach and the non-eclipsed transition 
state. The diastereomers of the non-eclipsed transition states in which the steric 
interactions between the n-hexyl and C-3 aryl groups in the substrates are minimized 
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are shown in Figure 5.
157
 The approach of BH3 from the face opposite to the ‘large’ 
substituent at the allylic carbon delivers the observed alcohols. The more efficient 
diastereocontrol observed in the hydroborations of N-tosyl amines 3.14-3.17 and 3.30 
correlates with the greater steric bulk of the N-tosyl group in comparison with the 
hydroxy group in alcohols 3.34a-d. 
Figure 5 
 
3.4 Conclusions: 
             Using a Pd-catalyzed MCR followed by two or three classical 
transformations the easily accessible building blocks were converted to medicinally 
relevant drug like molecules. Boronic acids, allenes, and imines or aldehydes were 
converted into single diastereomers of contiguously trisubstituted 2,3-trans and 3,4- 
trans-pyrrolidines or 2,3-cis and 3,4-trans–tetrahydrofurans, respectively.
158
 The 
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homoallylic amines and alcohols, which served as precursors for pyrrolidines and 
tetrahydrofurans respectively, were rapidly assembled via Pd-catalyzed MCR, thus 
showcasing the importance of MCRs. The MCR sets up the stereocenters at C2 and 
C3 positions of cyclized products. A substrate controlled hydroboration establishes 
the C4 stereocenter.  
              Unequivocal assignment of the relative stereochemistry in the heterocycles 
was achieved and serves to confirm the stereochemical divergence observed in the 
previously reported palladium-catalyzed three component preparation of homoallylic 
alcohols (syn) and homoallylic amines (anti). The modular synthetic sequence can be 
applied towards the construction of combinatorial libraries of pyrrolidines with 
structures related to biologically active natural products and synthetic pharmaceutical 
agents. Also, the methodology reported herein opens up possible future application 
towards synthesis of potent ETA antagonist-atrasentan and natural products like kainic 
acid and acromelic acid. 
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Chapter Four 
 
Divergent Reaction Pathways of Homologous and Isosteric Propargyl 
Amides in Sequential Ru/Pd-Catalyzed Annulations for the Synthesis of 
N-Heterocycles. 
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            The Malinakova lab is actively involved in developing methodologies 
amenable for diversity oriented and combinatorial library synthesis.
44-45
 One of the 
efficient strategies we employ is sequencing Cu-catalyzed MCR with transition 
metal-catalyzed annulation reactions giving rapid access to diverse heterocycles 
(Figure 1).
159
 In this chapter, the methodology development and interesting 
mechanistic insights observed during RCEYM and Heck annulations will be 
discussed in detail. The built-in potential of the methodology to incorporate diversity 
points in MCR followed by varied annulations is the key for the design and synthesis 
of combinatorial library with multiple distinct core structures. Therefore, along with 
studying fundamental interesting chemistry, the methodology has its utility in 
diversity oriented synthesis of drug like heterocycles. 
Figure 1 
 
 
 
 
89 
 
4.1 Results and Discussions: 
            My first project involved sequencing a MCR generating enyne precursors, 
with Ru/Pd catalyzed cyclization reactions. 
4.1.1 Synthesis of Enyne Precursors: 
              Looking for the MCR protocol to assemble the enyne precursors we found 
that the methodology reported by Arndtsen
160
 was well suited for our goals. This 
protocol would allow us to access functionalized 1,6-enynes and 1,7-enynes. 
Arndtsen described an elegant Cu-catalyzed MCR of imines, acid chlorides and 
terminal alkynes to synthesize propargylamides 4.1 (Scheme 4.1) in good to excellent 
yields (Table 1) 
Scheme 4.1 
 
Table 1 
Entry R
1
 R
2
 R
3
       R
4
 4.1 (%) 
1 
 
Bn Ph Ph 95 
2 
 
Et Ph Ph 87 
3 
 
Bn Ph TMS 77 
4 
 
Et 
 
Ph 81 
5 
 
Bn 
 
      Ph 93 
90 
 
6       Tol Ph Ph       Ph 99 
7      Tol Et Ph    CH2Cl 84 
8      Tol Bn Ph   CH2OAc 89 
 
 The 
1
H-NMR monitoring of the reaction revealed that CuI is immediately 
converted to the copper acetylide 4.2, and the imine quickly reacts with acid chloride 
to form N-acyliminium salt 4.3. Moreover, the control experiments demonstrated that 
the addition of imine and acid chloride to CuI does not lead to any appreciable 
oxidative addition in contrast to the palladium-catalyzed cross-coupling reactions. 
Based on this information the following mechanism was proposed (Scheme 4.2). A 
nucleophilic attack of copper acetylide 4.2 on insitu generated N-acyl iminium ion 4.3 
delivers the desired propargylamide 4.1.   
Scheme 4.2 
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Method Development:  
              We decided to use R
1
= o-bromo substituted aryl/heteroaryl ring and R
2
 = N-
allyl or homoallyl (Scheme 4.1) which were not reported by Arndtsen (Table 1). This 
would provide us with the required functional handle for subsequent RCEYM and 
Heck annulation. Using the Arndtsen protocol, we began exploring the synthesis of 
required enynes. The initial line of thought was to use acryloyl chloride as the source 
of acyl chloride wherein, the C=C motif of the acryloyl chloride would serve as the 
‘ene’ component for the subsequent RCEYM (Scheme 4.3). Note the incorporation of 
o-bromo motif in the imine substrate 4.4. 
             All imines were prepared according to a modified literature procedure
161
 by 
condensation of a 1 : 1 mixture of aldehyde and amine in methylene chloride in the 
presence of activated 3Å (8-12 mesh) molecular sieves for 24 h at rt followed by 
filtration through celite and removal of solvent under vacuum to afford pure imines 
that were used immediately. 
Scheme 4.3 
 
The yields of the enynes 4.5 and 4.6 were moderate due to the formation of 
corresponding amide side product 4.7. This is formed because the acyl iminium ion 
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intermediate is very sensitive to the moisture and undergoes hydrolysis. Therefore it 
was important to perform the reaction under strictly anhydrous conditions. During 
purification it was observed that DIPEA co-eluted with the product when silica was 
used for column chromatography. Efficient separation and purification was achieved 
with basic a alumina column.            
Following is the experimental procedure of how the enynes were synthesized. 
Henceforth this procedure will be addressed as “conditions A”. The mixture of imine 
and excess of benzoyl chloride and alkyne (1.5 equiv) in acetonitrile (5-10 mL) was 
premixed in a 25mL 2-neck round bottom flask and stirred for 5 min at rt under 
argon. This generates the N-acyliminium ion. The resulting yellow solution and neat 
iPr2NEt (1.5 equiv) were added dropwise simultaneously to a solution of CuCl (0.2 
equiv) in acetonitrile (2 mL) resulting in formation of yellow precipitate. The reaction 
mixture was stirred at rt under argon for 2 h. Solvents were removed under reduced 
pressure to afford crude products that were separated by flash chromatography over 
basic alumina eluting with EtOAc/Hexanes mixtures to yield pure enynes. 
 Enynes 4.5 and 4.6 proved to be challenging substrates for RCM (Scheme 4.8 
vide infra). Enyne 4.5 produced an approximately (3:2) mixture of cyclic 
constitutional isomers. This poor selectivity in RCEYM forced us to transpose the 
amide carbonyl away from the ene component. Thus, using the imine generated from 
allyl amine 4.8a in the aforementioned Cu-catalyzed MCR, the desired 1,6-enyne 
4.9a was synthesized in moderate yield (Scheme 4.4). 
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Scheme 4.4 
 
Pleased with this result series of 1,6 and 1,7-enynes were synthesized using 
conditions A (Table 2). 
Table 2 
 
Entry Imines 
(4.8) 
    n  R
1
 
 
R
2
 Enynes   
  (4.9) 
% yield 
1 4.8a    1  H H 4.9a 
 
55 
2 4.8b    1  4,5-(OMe)2 H 4.9b 
 
49 
3 4.8c    1  5-F H 4.9c 
 
52 
4 4.8a    1  H F 4.9d 
 
53 
5 4.8a    1  H OMe 4.9e 
 
61 
6 4.8d    2  H H 4.9f 
 
55 
7 4.8e    2  4,5-(OMe)2 H 4.9g 
 
45 
8 4.8f    2  5-F H 4.9h 
 
52 
9 4.8d    2  H F 4.9i 
 
  58 
94 
 
10 4.8d    2  H OMe 4.9j 
 
53 
 
Aiming to diversify and incorporate additional heteroatoms, the following 
heteroaromatic imines 4.8g-j were synthesized (Figure 2) and used in Cu-catalyzed 
MCR. 
Figure 2 
 
Thiophene derived imines 4.8g-h delivered enynes 4.9k-l in similar yields as that of 
non-heteroaromatic imines, under conditions A (Scheme 4.5). On the contrary, 
pyridine derived imine 4.8i afforded lower yield (41%) of enyne 4.9m (Scheme 4.6). 
This could be due to the electron withdrawing nature of the pyridine ring which 
increases the electrophilicity of N-acyliminium ion and makes it more susceptible to 
hydrolysis. 
Scheme 4.5 
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Scheme 4.6 
 
 To address the problem of low yield in the pyridine case 4.8i, I reversed the order of 
addition of N-acyliminium and CuCl solutions. In conditions A the solution of N-
acyliminium was drawn out and injected along with neat DIPEA into the solution of 
CuCl in acetonitrile. This exposed iminium ion to air during withdrawing and 
injecting process. In modified conditions the CuCl solution and neat DIPEA was 
added to the solution of iminium ion, thus minimizing the exposure of iminium ion to 
air and thereby reducing the hydrolysis to some extent. The modified conditions will 
be called “conditions B” and are as follows: The solution of imine (1.0 equiv) and 
excess of benzoyl chloride and phenylacetylene (1.2 equiv) in acetonitrile (5 mL) was 
stirred at rt under argon for 5 min. to afford a yellow solution of N-acyliminium ion. 
Note the use of lower equivalent of benzoyl chloride as compared to conditions A. 
This was to avoid formation of N-benzoyl pyridinium ion. To this solution neat 
DIPEA (1.2 equiv) and the solution of CuCl (0.2 equiv) in acetonitrile (1 mL) were 
added simultaneously dropwise. The reaction mixture was allowed to stir at rt under 
argon for 1 h. Solvents were removed under reduced pressure and the resulting crude 
product was separated by flash chromatography over silica eluting with 
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EtOAc/Hexanes mixtures to yield pure enyne 4.9m (Table 3). Pleased with this result 
two more analogs of 1,6-enynes and three analogs of 1,7-enynes were synthesized.  
Table 3  
 
Entry Imines (4.8) n    R
1
 
 
       Enynes (4.9)            % yield 
1 4.8i 1    H           4.9m 
 
59 
2 4.8i 1    F  4.9n 
 
60 
3 4.8i 1    OMe  4.9o 
 
62 
4 4.8j 2    H  4.9p 
 
62 
5 4.8j 2    F  4.9q 
 
61 
6 4.8j 2    OMe  4.9r 
 
63 
 
The signals in 
1
H-NMR spectrum of all these enynes were broad and short (Figures 3 
and 4). This is due to existence of rotamers caused by the restricted rotation along the 
amide bond. One of the analogs from the 1,6-enyne series (Figure 3) and 1,7-enynes 
series (Figure 4) were picked to perform the 
1
H-NMR spectroscopy at higher 
temperature. As the temperature increased, the signals sharpened and also gave the 
expected integration.  
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Figure 3 
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4.1.2 Investigation of RCEYM: 
1,6- enyne series: 
               Enyne 4.6 was treated with Grubbs II catalyst and did not afford any 
product, and was recovered (Scheme 4.7). This is potentially due to the sterically 
hindered and electronically deficient ene component which makes the enyne less 
favorable to coordinate with the metal center.  
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Scheme 4.7 
 
So enyne 4.5 with sterically accessible ene component was used as the model system 
for the investigation of RCEYM. The initial study with Grubbs II catalyst and DCM 
as the solvent at 40
o
C did not afford any product and the enyne was recovered (entry 
1, Table 4). A similar result was observed at elevated temperature of 80
o
C and 
toluene as the solvent (entry 2). At 115
o
C the starting material was consumed and the 
reaction produced multiple products as analyzed by TLC. Only less than 20% yield of 
crude product was isolated, probably due to polymerization of the enyne (entry 3). 
Maintaining the temperature between 100-110
o
C and increasing the catalyst loading 
did not improve the reaction. 
Table 4 
 
Entry Reaction conditions Catalyst                    
 (equiv)    
Results 
 
1 
 
DCM, 40
o
C, 20+15 h 
     
    0.2 
 
 
   Recovered starting material    
  (SM) 
          
100 
 
2 Toluene, 80
o
C, 20 h     0.05 
 
   Recovered SM 
3 Toluene, 115
o
C, 18 h     0.06 
 
   No SM, TLC-multiple spots 
 GCMS shows mass. NMR 
complicated. Yield<20% 
 
4 Toluene, 100
o
C, 20 h 0.1 
 
   No SM, TLC-multiple spots 
5 Toluene, ethylene atm, 
85
o
C, 20 h 
 0.1 
 
   Clean reaction; observed    
   distinct spots on TLC and  
    no streak of line 
    
 
Mori and coworkers
95
 reported RCEYM under ethylene atmosphere which proved to 
be critical for success of the reaction. Therefore, we ran our model reaction under 
ethylene atmosphere (entry 5) as follows: The solution of enyne 4.5 in toluene was 
degassed with ethylene for 5 min. and solid Grubbs II catalyst (0.1 equiv) was added. 
The reaction mixture was stirred at 85
o
C under ethylene atmosphere. After 20 h, TLC 
analysis showed complete conversion and formation of two new spots. The mixture 
was cooled to rt and directly loaded on a silica column and purified by flash 
chromatography, eluting with EtOAc/Hexane. The reaction furnished two isomeric 
products piperidone 4.10 and pyrrolidinone 4.11 (Scheme 4.8).  
Scheme 4.8 
 
101 
 
The poor selectivity is due to the presence of electron deficient olefin which slows 
down the coordination of enyne through the ene component with the metal center and 
allowing the yne component to initiate the reaction. Formation of piperidone can be 
explained via yne-then-ene pathway wherein the coordination of enyne with the metal 
center is initiated by the yne component. The formation of pyrrolidone can be 
explained via ene-then-yne pathway wherein the coordination of enyne with the metal 
center is initiated by the ene component (Section 2.3.2 vide supra).  
               The major and minor product assignment was successfully achieved using 
HMBC (Figure 5). In piperidone we see a three bond correlation between methine 
carbon C6 (62.47 ppm) and the methylene proton H7 (5.43). But in pyrrolidinone this 
interaction is a four bond correlation and is not observed 
Figure 5 
 
              We envisioned transposition of the amide carbonyl away from the olefin 
would provide us with a more reactive enyne. As expected, enyne 4.9a when treated 
with of Grubbs I catalyst according to procedure described for (Scheme 4.8), and for 
2 h under the ethylene atmosphere underwent efficient metathesis reaction to afford 
diene 4.12a in 93% yield (Scheme 4.9). Grubbs II catalyst also produced similar 
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results. However, Grubbs I catalyst was used to synthesize other analogs (Table 5) as 
it is less expensive than Grubbs II catalyst.  
Scheme 4.9 
 
Table 5 
 
Entry Enyne 
(4.9) 
R
1
 
 
R
2
       4.12  
(% Yield) 
1 4.9a H H 4.12a (93) 
2 4.9b 4,5-(OMe)2 H 4.12b (81) 
3 4.9c 5-F H 4.12c (72) 
4 4.9d H F 4.12d (87) 
5 4.9e H OMe 4.12e (63) 
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Enynes (4.9k, 4.9m and 4.9n) containing additional heteroatoms also afforded the 
RCM products 4.12f, 4.12g and 4.12h in good yields respectively (Figure 6). 
Surprisingly enyne 4.9o afforded only trace amount of RCM product and was 
recovered after column chromatography. 
Figure 6 
 
All the 4.12 dienes proved to be somewhat unstable and were stored at below 0
o
C and 
had to be used within 24 h. The 
1
H-NMR spectra contained a few additional signals 
integrating for less than 1H. This is due to the restricted rotation created by the amide 
functional group and also due to the atropisomerism. This was proved by running 
temperature dependent 
1
H-NMR spectroscopy for one of the analogs. As the 
temperature increased, the additional signals merged giving a proper integration value 
to the respective signals (Figure 7) 
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Figure 7 
 
At 45
o
C
 
At 65
o
C 
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At 85
o
C
 
1,7- enyne series:               
              The metathesis reaction of the homologous series (1,7-enynes) under the 
same conditions with Grubbs I catalyst  did not go to completion. However, upon 
using the more reactive Grubbs II catalyst and longer reaction time, the substrate 
underwent complete conversion affording tetrahydropyridine 4.13a in excellent yield 
(Scheme 4.10). 
Scheme 4.10 
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Using the optimized conditions of Grubbs II catalyst and longer reaction time, various 
analogs were synthesized. (Table 6).  
Table 6. 
 
Entry Enyne 
(4.9) 
R
1
 
 
R
2
       4.13  
(% Yield) 
1 4.9f H H 4.13a (92) 
2 4.9g 4,5-(OMe)2 H 4.13b (87) 
3 4.9h 5-F H 4.13c (88) 
4 4.9i H F 4.13d (85) 
5 4.9j H OMe 4.13e (80) 
                             
Enynes 4.9l and 4.9p-r, containing additional heteroatoms also afforded the RCM 
products in good yields (Figure 8). The lower yields of 4.13h and 4.13i are due to loss 
during silica column chromatography because the reaction proved to be clean based 
on TLC analysis. 
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Figure 8 
 
The signals in 
1
H-NMR spectra of all the 4.13 tetrahydropyridines were broad and 
short but had no additional signals as seen in 4.12. Running a high temperature 
1
H-
NMR sharpened the signals considerably (Figure 9).  
Figure 9                  
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4.1.3 Regiodivergent via 6-endo and 5-exo Heck Cyclization 
 
The 1,3-diene system generated by the RCEYM can be potentially used as the handle 
to further diversify the RCEYM products. We decided to perform an intramolecular 
Heck reaction using the aryl bromide motif which is already incorporated in the 
scaffold and the 1,3-diene as the coupling partners. This would give rapid access to a 
variety of fused N-heterocycles 4.16-4.19 (Figure 10) possessing drug like 
scaffolds
162
 potentially endowed with valuable medicinal properties.
163-165
 The Heck 
cyclization of dienes 4.12 and 4.13 may proceed via the kinetically favored 5-exo 
pathway
166
 or the 6-endo route
166
 generating an allylpalladium intermediate 4.14.
167
 
Both these pathways are potentially reversible via β-carbon elimination.
168
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Figure 10 
 
Proof of Concept: 
Compound 4.13a (n=2 and X=CH) was picked as our model system to optimize the 
Heck reaction (Table 7). We proposed that the reaction would favor the 5-exo 
pathway, generating 4.15 like intermediate which can be trapped via reductive Heck 
or by a boronic acid via Suzuki coupling (Figure 10). When the reaction was 
performed under the reductive Heck conditions
114
 (Table 7, entries 1-3), the reaction 
afforded an unknown product ‘A’ in moderate yield. We call it unknown because the 
1
H NMR spectrum of A did not match with the expected 5-exo product 4.19 (n=2 and 
X=CH) or with the 6-endo products 4.16 and 4.17 (n=2 and X=CH). The change of 
catalyst (entry 2) or the ligand (entry 3) did not seem to alter the reaction pathway. 
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Unknown A was obtained in a good yield even under the simple Heck reaction 
conditions (entry 4).  
Table 7 
 
 
Attempts to trap the allylpalladium complex 4.14 (n=2 and X=CH) with amine 
nucleophiles were not successful and once again the reaction afforded unknown A 
(entries 5 and 6). Under the ligandless condition (entry 7) previously reported by our 
group,
159
 the reaction did not go to completion and afforded unknown A (55%) along 
with unreacted diene (25%).  
In all these entries, formation of a minor product with very close Rf value to the major 
product was observed by TLC analysis and also in the crude 
1
H NMR spectrum. A 
careful silica column chromatographic separation was needed to isolate the pure 
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minor product. The 
1
H NMR spectrum of the minor product was not conclusive 
because the spectra featured more signals than expected, and the signals were broad. 
Again this could be due to the hindered rotation about the amide bond. Fortunately, 
X-ray quality crystals were obtained for the minor product and the X-ray structure 
revealed an interesting product benzoquinoline 4.20 (Figure 11).  
Figure 11 
 
        At first glance the structure seemed to have formed via 6-endo cyclization. 
But the position of the aryl ring ‘A’ puzzled us. If the product was derived via 6-endo 
cyclization, the position of the aryl ring ‘A’ should have been on C-5 and not on C-6. 
Meanwhile we were working on the structural elucidation of the major product –the 
“unknown A”. After a long time and with the help of 2D NMR techniques (HMBC 
and HSQC) the structure of unknown A was elucidated and was found to be 
cyclopropane fused indenopyridine 4.21a (Scheme 4.11). The structure and the 
relative stereochemistry was further confirmed by X-ray crystallographic analysis of 
one the analogs 4.21b (Figure 12). 
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Scheme 4.11 
 
Figure 12 
                     
            The optimized conditions for the production of “unknown A” proved to be 
entry 4, Table 7. Various analogs were synthesized to explore the substrate scope of 
the reaction (Table 8). Incorporation of electron donating or electron withdrawing 
groups in R
1 
and R
2
 position did not seem to change the regioselectivity of the 
reaction. In all the cases, the 5-exo regioselectivity of the Heck annulation uncovered 
in the original studies was followed. Thus no electronic effects of the substituents on 
the course of the Pd-catalyzed annulations were detected. The 
1
H NMR analyses of 
crude reaction mixtures from the reactions providing indenopyridines 4.21b-e 
indicated the presence (less than 10%) of benzoquinoline byproducts analogous to 
heterocycle 4.20 (Scheme 4.11). They were easily separated by column 
chromatography. Except for heterocycle 4.20 others were not isolated pure or 
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characterized. The relative stereochemistry in indenopyridine series wase established 
by X-ray crystallographic analysis, utilizing an indenopyridine analogue 4.21b 
prepared as shown in (Table 8). All the analogs were stored in refridgerator and 
seemed to be stable. 
Table 8 
 
Entry Diene 
(4.13) 
R
1
 
 
R
2
       4.21  
(% Yield) 
1 4.13a H H 4.21a (80) 
2 4.13b 4,5-(OMe)2 H 4.21b (78) 
3 4.13c 5-F H 4.21c (71) 
4 4.13d H F 4.21d (81) 
5 4.13e H OMe 4.21e (80) 
 
Despite running the reaction under various conditions: reductive conditions, 
ligandless conditions, in presence of ligand (Table 7), the reaction afforded 5-exo 
cyclized product. Therefore we believe that the formation of 4.21 from 4.13 is a 
substrate controlled reaction. To understand if the conformational change in the 
piperidine ring had any effect on the regiochemistry we synthesized the pyran analog 
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4.42 (Scheme 4.41 vide infra), which too underwent 5-exo cyclization to produce 
cyclopropane fused indenopyran scaffold 4.43 (Scheme 4.41 vide infra). 
Proposed Mechanism 
 Based on the structures formed in the Heck reaction, we propose the following 
mechanism for the formation of cyclopropane fused tetrahydroindenopyridine 
(Scheme 4.12). 
Scheme 4.12 
 
115 
 
The intermediate A formed by oxidative addition of the Pd(0) catalyst with compound 
4.13a, undergoes kinetically favored 5-exo cyclization
166
 affording the intermediate 
B. We believe the alternate 6-endo path is disfavored due to its slower reaction rate as 
compared to the 5-exo cyclization. The intermediate B rapidly undergoes a 
diastereoselective 3-exo cyclization giving rise to the cyclopropane ring
169-170
, 
intermediate C. The intermediate C upon -H-elimination followed by readdition of 
H-Pd(II) to the olefin forms intermediate D. -H-elimination of the intermediate D 
delivers observed cyclopropane fused tetrahydro indenopyridines 4.21a. We propose 
that the formation of the minor product-benzoquinoline 4.20 is due to -C-elimination 
of intermediate C to form intermediate E, followed by -H-elimination and 
aromatization delivers the observed benzoquinoline 4.20.  
Heck cyclization of pyrrolidines series 
               Excited with this unexpected outcome during Heck cyclization of 
tetrahydropyridine dienes 4.13, we were curious to study and extend this protocol to 
pyrrolidine dienes 4.12. Surprisingly, diene 4.12a followed the 6-endo pathway when 
treated either with ligandless catalyst (as in Table 8, entry 7) or with the added 
phosphine (entry 2) affording benzoindoline 4.22a in good yields (Table 9). Not 
much of optimization was done with dienes 4.12. However the ligandless conditions 
were employed to study the substrate scope because, addition of fewer number of 
reagents would be more practical during library synthesis. The varied substituents of 
electron donating and electron withdrawing at R
1
 and R
2 
positions did not seem to 
alter the course of the reaction. In all the cases the regioselectivity of 6-endo 
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uncovered in the original studies was followed (Table 9). The position of the phenyl 
ring ‘A’ was confirmed by the X-ray crystallography on 4.22a. All the analogs were 
stored in refridgerator and seemed to be stable. 
Table 9 
 
Entry Diene 
(4.12) 
R
1
 
 
R
2
       4.22  
(% Yield) 
1 4.12a H H 4.22a (71) 
 
2 4.12a H H  4.22a (73)
a
 
2 4.12b 4,5-(OMe)2 H 4.22b (68) 
3 4.12c 5-F H 4.22c (65) 
4 4.12d H F 4.22d (65) 
5 4.12e H OMe 4.22e (66) 
 
              a
Yield with Pd(OAc)2/PPh3/Cs2CO3 
Proposed Mechanism                   
           The formation of benzoindolines 4.22 is explained as shown in (Scheme 4.13). 
The intermediate A can undergo a kinetically controlled 5-exo cyclization. However 
the subsequent 3-exo cyclization of the intermediate B generates product with 5-5-3 
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fused system C. We believe, due to the conformational strain involved in the 
formation of fused 5-5-3 system, intermediate C reverts back to intermediate A and 
proceeds through 6-endo pathway to form the intermediate D. The intermediate D 
upon β-hydride elimination and aromatization delivers observed benzoindolines 4.22. 
Scheme 4.13  
 
Dienes with heteroaromatic rings 
              With this success of eventful Heck reaction on dienes 4.12 and 4.13, we 
wanted to extend it to heteroaryl dienes (Figure 6 and Figure 8) and explore if the 
additional heteroatom had any role in controlling the regioselectivity of the Heck 
cyclization. Also, incorporation of additional heteroatoms in the scaffolds would be 
desirable from medicinal chemistry point of view. Thus the diene with a thiophene 
ring 4.13f was subjected to Heck conditions. Interestingly it did not undergo any 
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reaction and was recovered (Scheme 4.14). We believe it could be due to the 
poisoning of Pd catalyst via chelation by sulphur and amide oxygen (Figure 13).  
 
Scheme 4.14 
 
Figure 13 
 
On the contrary, dienes with pyridine rings 4.13g-i afforded quinolines 4.23a-c 
respectively via 6-endo cyclization in moderate yields when treated under 
[Pd(OAc)2/PPh3/Cs2CO3] (Scheme 4.15). To asses if the choice of reagents effected 
the regiochemistry of Heck cyclization, diene 4.13g was subjected to the ligandless 
condition [Pd(OAc)2, NaOAc]. Once again the reaction produced quinoline 4.23a in 
49% yield, but the reaction did not proceed to complete conversion with 25% of 
starting material recovered.  
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Scheme 4.15 
 
Electron withdrawing and donating substituents on ring ‘A’ 4.13h and 4.13i 
respectively afforded corresponding quinolines 4.23b and 4.23c in moderate yields. 
Thus the regiochemistry was unaffected by the substituents on ring A. Looking 
closely at this reaction, it is apparent that the 5-exo cyclization pathway was 
suppressed by the dienes with pyridine ring. This was unlike their isostere dienes 
4.13a-e (X=N vs CH) which afforded cyclopropane fused tetrahydro indenopyridines 
via 5-endo cyclization and diene 4.13f did not furnish any product. The structures of 
phenanthrolines 4.23a-c were assigned by NMR spectroscopic analysis. Most 
importantly, the position of the phenyl ring ‘A’ was unequivocally assigned by X-ray 
crystallography on compound 4.23a (Figure 14).  
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Figure 14 
              
The 
1
H NMR spectra of quinolines resembled that of benzoquinoline 4.20. Along 
with spectral signals being broad and short, the spectra contained additional signals 
that integrated for less than 1H (Figure 15). Running 
1
H NMR spectra of quinoline 
4.23a at elevated temperatures, the additional signals merged to provide required 
integration values. 
Figure 15 
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  At 50
o
C 
 
At 65
o
C 
 
  At 75
o
C 
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            The heteroaryl containing pyrrolidine dienes 4.12f-h (Figure 6) followed the 
6-endo pathway (Scheme 4.16 and 4.17) just like their isosteres (X=CH) dienes 
4.12a-e. The diene 4.12f afforded pyrrolo benzothiophene 4.24 (Scheme 4.16), but 
the reaction did not proceed to complete conversion and diene 4.12f was recovered in 
31% yield. This could be potentially due to poisoning of the Pd catalyst via chelation 
by sulphur and amide oxygen (Figure 16).  
Scheme 4.16 
 
Figure 16  
 
Diene 4.12g furnished pyrroloquinoline 4.25a when treated with both 
[Pd(OAc)2/PPh3/Cs2CO3] and [Pd(OAc)2/NaOAc] conditions (Scheme 4.17), thus 
suggesting that the choice of the reagents did not affect regiochemistry of the 
cyclization.   
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Scheme 4.17 
 
We were concerened with the 
1
H NMR based purity of the quinolines 4.23a-c and 
dihydro pyrroloquinolines 4.25a-b. So the purity of all these compounds were 
confirmed via GCMS analysis which showed acceptable purity of greater than 97% 
(chromatograms enclosed in appendix). However, the chromatogram of dihydro 
pyrroloquinoline 4.25b (R
1
=F) showed the presence of fully aromatized analog 4.25c 
in 8.5% arising due to air-catalyzed oxidation of 4.25b, facilitated by the electron 
deficient aromatic ring. 
          The anomaly observed in cyclization of pyridine dienes 4.13g-i affording 6-
endo product rather than 5-exo can be explained by the kinetic chelation trapping of 
the Pd(II) by the pyridine nitrogen via intermediate F (Scheme 4.18). As a 
consequence of this chelation the subsequent 3-exo cyclization is suppressed and the 
reaction reverts back to productive 6-endo pathway to afford phenanthroline 4.25a. 
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Scheme 4.18 
 
4.1.4 Efforts Towards Synthesis of Pyridine Derivatives: 
             To support our proposed mechanism of chelation-controlled synthesis of 
phenanthrolines, we decided to synthesize other pyridine regioisomers. We 
envisioned preparation of analogs with respect to pyridine nitrogen at different 
positions either to 4, 5 or 6 (Figure 17) should overcome the chelation of Pd catalyst 
with the pyridine nitrogen and allow the subsequent 3-exo cyclization to furnish 
compound 4.26 (Scheme 4.19).  
Figure 17 
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Scheme 4.19 
 
To begin with we had to synthesize corresponding dienes 4.27 which can be derived 
from enynes 4.28. Dr. Sarvesh, a postdoctoral associate in Malinakova lab was 
working on synthesis of enyne 4.29 (Scheme 4.20), with nitrogen at C-4 as in 
compound 4.28a. Unexpectedly he found that the reaction produced indolizidine 4.30 
in low yield and the amide side product 4.31 as the major product formed due to 
premature hydrolysis of the N-acyliminium ion. He did not observe any formation of 
the desired enyne 4.29. Thus we learned that the Cu-catalyzed MCR was not suitable 
for the synthesis of enyne 4.28a with nitrogen at C-4 position. 
Scheme 4.20 
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Next I directed my efforts to synthesize enyne 4.28c with nitrogen at C-6 position. 
The aldehyde 4.32a needed to synthesize corresponding imine 4.33 was prepared in 
gram scale using lithiation chemistry as reported in the literature (Scheme 4.21).
171
 
Scheme 4.21 
 
Unfortunately, the synthesis of enyne 4.28c could not be achieved either by 
Arndtsen’s Cu-catalyzed MCR (Scheme 4.22) or by Carreira’a Zn-catalyzed
172
 MCR 
(Scheme 4.23). In both the cases the amide side product 4.34 formed due to 
premature hydrolysis of the N-acyliminium ion was obtained as the major product. 
Scheme 4.22 
 
Scheme 4.23 
 
 
Unable to synthesize enyne 4.28c via MCR approach, we decided to take a stepwise 
approach via the propargyl alcohol precursor 4.36a (Scheme 4.24). An SN2 
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displacement of the alcohol functional group with nucleophiles 4.37a-b would furnish 
the desired enynes with benzoyl protected amine 4.28c or with tosyl protected amine 
4.35. 
Scheme 4.24 
 
The propargyl alcohol 4.36a was synthesized by nucleophilic attack of lithium phenyl 
acetylide on to the aldehyde 4.32a (Scheme 4.25).
173-174
 The solution of aldehyde in 
THF was added to the insitu generated lithium phenyl acetylide in THF at -75
o
C. The 
reaction proceeded cleanly with only traces of impurities being formed as suggested 
by 
1
H NMR spectroscopy of the crude reaction mixture. The crude propargyl alcohol 
4.36a was used as such for further reactions. Initially we were worried about the 
lithium halogen exchange problem, but we were pleased to see the aryl bromide motif 
remained intact.  
Scheme 4.25 
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Next we envisioned to transform the alcohol group into a good leaving group such as 
mesylate and then perform a SN2 displacement with the N-tosylamide 4.37a. This 
would give us access to enyne 4.35. Mesylation of the alcohol did not seem to 
progress when performed at 0
o
C. Warming the reaction mixture to rt decomposed the 
propargyl alcohol (Scheme 4.26). This observation agreed with the report by Shi and 
coworkers (Scheme 4.27).
175
 In their attempts to functionalize the propargyl alcohol 
4.36c, they observed complex mixtures.  
Scheme 4.26 
 
Scheme 4.27 
 
An alternate route via Mitsunobu reaction created multiple products as observed by 
TLC analysis (Scheme 4.28). 
Scheme 4.28 
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Unable to synthesize enyne 4.35 via the classical approach, we sought to use Fe- 
catalyzed activation of the C-O bond reported by Shi
175
 and Zhan
176
 (Scheme 4.29). 
Notice the formation of ether tethered 1,7-enyne 4.38 which could be a potential 
substrate for the synthesis of oxygen containing heterocycles via our sequential 
RCM/Heck strategy. 
Scheme 4.29 
 
 
Taking inspiration from these works when the propargyl alcohol 4.36a was treated 
with 4-pentenol and FeCl3, the reaction produced an unexpected result. Instead of 
delivering the enyne 4.39 (Scheme 4.30), the reaction afforded ynone 4.40 and enone 
4.41 along with unreacted 4.36a. 
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Scheme 4.40 
 
The chelation of ferric chloride activates the pyridine ring and thus increases the 
acidity of the propargyl proton, which upon depronation, generates enol intermediate 
A via path A or allenol intermediate B via path B (Scheme 4.41). The ketone 
intermediate C upon a single electron transfer oxidation followed by aromatization 
delivers ynone 4.40. The allenol intermediate B upon tautomerization delivers enone 
4.41. 
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Scheme 4.41 
 
However, unlike the pyridine propargyl alcohol 4.36a which afforded unexpected 
results, propargyl alcohol 4.36b did furnish expected enyne 4.42 along with unreacted 
alcohol (Scheme 4.42). 
Scheme 4.42 
 
Enyne 4.42, when subjected to the optimized RCEYM conditions, used previously for 
synthesis of piperidine dienes (Table 6, vide supra), produced pyran 4.43 in a good 
yield (Scheme 4.43). With pyran 4.43 in hand we were curious if the conformational 
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difference between the pyran and the piperidine 4.13a had any effect on the 
regiochemistry of the Heck cyclization. When the Heck reaction was performed the 
pyran 4.43 delivered the cyclopropane fused indenopyran 4.44 as the major product 
via 5-exo cyclization (Scheme 4.43) as analyzed from the crude 
1
H NMR spectrum. 
The outcome was in agreement with the nitrogen analog-piperidine diene (NCOPh) 
4.13a (Scheme 4.11 vide supra). The isolation of pure 4.44 via silica column 
chromatography was problematic. In spite of repeated column, the compound eluted 
along with few close impurities. The relative stereochemistry of 4.44 is not 
established.  
Scheme 4.43 
 
4.2 Conclusions: 
              The utility of strategic sequencing of MCR with transition metal-catalyzed 
annulation reactions in synthesis of complex N-heterocycles was demonstrated.
177
 
The enynes generated from simple starting materials via Cu-catalyzed MCR, were 
converted to pharmaceutically interesting fused N-heterocycles by sequencing ring 
closing metathesis and Heck cyclization reactions. The unexpected 5-exo vs 6-endo 
regiodivergency during Heck annulation was uncovered affording distinct 
heterocyclic cores from homologous (n=1 or 2) or isosteric (X =CH or N) substrates. 
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The chelation trapping of the kinetic product in pyridine analogs was intriguing. A 
mechanism accounting for unexpected Heck cyclization was proposed.  
            It was experimentally concluded that the aldehyde 4.32a was not suitable for 
the synthesis of cyclopropane fused pyridine analog 4.26. This incompatibility of 
aldehyde 4.32a we believe is due to para positioning of the pyridine nitrogen and the 
aldehyde functional group which facilitates hydrolysis of N-acyliminium ion during 
Cu-catalyzed MCR approach (Schemes 4.22 and 4.23) or causes side reastion in Fe-
catalyzed functionalization of C-O bond (Scheme 4.40). It would be interesting to use 
3-carboxyaldehyde 4-bromo pyridine and perceive synthesis of 4.26.  
          Development of a sequential one-pot enyne−RCM/Heck annulation, 
underscoring the practicality of the new methodology will be discussed in chapter 
five. 
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Chapter Five 
Sequential One-Pot Ring Closing Enyne Metathesis and Heck cyclization. 
 
 
 
 
 
 
 
 
 
 
 
 
135 
 
          Ring closing metathesis and Heck reaction are two of the most powerful and 
widely used C-C bond forming reactions. Therefore performing them in one-pot 
sequences will create complex molecules with high efficiency and economy. 
Extensive research and explorations are being done on these two as separate 
reactions. However, less effort is invested in combining them as a one-pot protocol. 
Deriving inspiration from Grigg’s work
35
 (Section 2.3 chapter one vide supra) we 
decided to develop a one-pot protocol for the aforementioned RCEYM and Heck 
cyclization (Chapter 4 vide supra). This chapter describes our efforts towards this 
goal.  
5.1 Proof of Concept: 
We chose the two step transformation of enyne 4.9a to benzoindoline 4.22a as our 
model reaction (Scheme 5.1). 
Scheme 5.1 
 
To begin with, a simple filtration through silica plug was done after the first step of 
RCM. This should separate the Grubbs catalyst. The solvent (toluene) was evaporated 
and the crude 4.12a was used for the subsequent Heck reaction in DMF. We were 
pleased to observe that even with the crude 4.12a the Heck reaction afforded 
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benzoindoline 4.22a in good yield 69%, (Scheme 5.2) which was on par with the 
yield (71%) of the stepwise process. 
Scheme 5.2 
 
Excited with this outcome, a sequential one-pot reaction was performed as follows in 
toluene. After completion of the metathesis step as analyzed by TLC, the reaction 
mixture was cooled to rt, degassed with argon for 5 mins. and then solid 
Pd(OAc)2/NaOAc was added and the reaction was stirred at 120 
o
C under argon 
atmosphere. TLC after 24 h showed most of the pyrrolidine diene 4.12a still present 
and a trace of 4.22a was formed (Scheme 5.3). Increasing the Pd catalyst loading 
from 0.1 equiv to 0.3 equiv did not help the cause but produced traces of multiple 
products. 
Scheme 5.3 
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5.2 Method optimization: 
Looking carefully at the reaction we realized that during the stepwise protocol these 
two reactions were being performed in two different solvents- RCEYM in toluene and 
Heck reaction in DMF. But in sequential one-pot reaction we had used toluene as the 
common solvent for both the reactions. Therefore we rationalized that the failure of 
sequential one-pot reaction was due to poor solubility of Pd(OAc)2/NaOAc in 
toluene. Thus a catalytic system that could realize both the RCM and the Heck 
cyclizations in toluene was needed and this is when I teamed up with Monica Trejo, 
an undergraduate research student in our lab.  
Not many metathesis friendly solvents are known, in contrast the Heck reaction can 
be performed in variety of solvents. So we decided not to optimize the metathesis 
reaction, and instead optimize the Heck reaction in toluene. Monica took up the 
challenge of optimizing the Heck reaction of compound 4.12a in toluene. Just 
substituting toluene with DMF, did not help the cause and the starting material was 
recovered (Scheme 5.4). 
Scheme 5.4 
 
Next she performed the reaction with added phosphine ligand to improve the 
solubility of Pd catalyst in toluene (Scheme 5.5). Surprisingly the reaction went to 
138 
 
completion and produced three different products. However after purification it was 
found that the 
1
H NMR spectra of all the products did not match with the expected 
benzoindoline 4.22a. Repeating the reaction for second time produced same results. 
Nevertheless we were excited to know that the reaction has produced different 
products with added phosphine. The structures of the three new products have not 
been established yet. 
Scheme 5.5 
 
The solution to the problem of performing the Heck cyclization of pyrrolidine diene 
4.12a in toluene to afford benzoindoline 4.22a was found when I employed the 
original Heck conditions [Pd(OAc)2/PPh3/Cs2CO3] used in synthesis of cyclopropane 
fused indenopyridines (Scheme 4.11 vide supra). Under these conditions performed 
in toluene, 4.12a successfully afforded benzoindoline 4.22a in moderate yield 
(Scheme 5.6). 
Scheme 5.6  
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With this optimized result of Heck cyclization in toluene, I ventured into performing 
the sequential one-pot reaction in toluene. The reaction was performed on 0.18 mmol 
scale with respect to enyne. After completion of the metathesis reaction in toluene 
under ethylene atmosphere, the reaction mixture was cooled to rt and degassed with 
argon for 5 minutes. This saturated the reaction vessel with argon atmosphere. Then 
solid Pd(OAc)2, PPh3 and Cs2CO3 were added one after the another and the reaction 
was stirred at 120
o
C for 18 h.  It was gratifying to see that the reaction was clean as 
seen from 
1
H NMR of the crude mixture (Figure 1) and afforded desired 
benzoindolines in good yield calculated per the corresponding enynes 4.9a after silica 
flash column chromatography (Scheme 5.7). The substituents and their electronics did 
not seem to have much effect on the yields. Analogs 4.22c (R
1
=F) and 4.22e 
(R
2
=OMe) were obtained in comparable yields 61-64% (Scheme 5.7). Table 1 shows 
percent increase in the yield via one-pot operation in comparision with the stepwise 
protocol.  
Scheme 5.7 
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The improvement in the yields is due to overcoming the isolation and loss of 
metathesis product during column chromagraphy. Also it is important to note that the 
remains of the metathesis reagents did not alter the regiochemistry of Heck 
cyclization. 
Figure 1 
Crude reaction mixture of 4.22a (Scheme 5.7) 
1
H NMR in CDCl3
 
Purified 4.22a
 1
H NMR in CDCl3
 
Extending the optimized sequential one-pot protocol to the homologous piperidine 
series also produced the desired result (Scheme 5.8). Treating enynes 4.9 sequentially 
with metathesis and Heck conditions afforded cyclopropane fused indenopyridines 
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4.21 in good yields along with the minor side product benzoquinolines 4.20. The 
substituents and their electronics did not seem to have much effect on the yields and 
the analogs 4.21c (R
1
=F) and 4.21e (R
2
=OMe) were obtained in comparable yields 
69-70% (Scheme 5.8). Table 1 shows percent increase in the yield via one-pot 
operation in comparision with the stepwise protocol. Once again it was gratifying to 
know that the reaction was clean as seen from 
1
H NMR spectroscopy (Figure 2). 
Importantly the course of the Heck cyclization was not altered. 
Scheme 5.8 
 
Figure 2 
Crude reaction mixture of 4.21f (Scheme 5.8) 
1
H NMR in CDCl3 
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Purified 4.21a
 1
H NMR in CDCl3 
 
The pyridine-containing enyne 4.9m furnished pyrroloquinoline 4.25a (Scheme 5.9). 
Quinolines 4.23a-b were also successfully synthesized for their respective enynes 
4.9p-q. However they were accompanied by residual dienes 4.13g-h formed by the 
metathesis reaction (Scheme 5.10). The crude mixtures of 4.23 and 4.13 were easily 
separated by flash chromatography over silica, delivering pure quinolines. Table 1 
shows percent increase in the yield via one-pot operation in comparision with the 
stepwise protocol. The improved yields via one-pot operation highlights the isolation 
loss of dienes on silica column during the stepwise protocol. 
Scheme 5.9 
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Scheme 5.10 
 
The improvement in the yields of phenanthrolines 4.23a-b in the one-pot process 
despite the presence of unreacted dienes 4.13g-h is notable (Table 1). The 
involvement of the proposed N−Pd chelation interactions as well as interferences of 
the metathesis catalytic system with the Pd-catalyst could be the reasons for 
incomplete conversion. The enynes 4.9p-q furnishing phenanthrolines 4.23a-b 
proved to be challenging substrates for the one-pot protocol. Additional optimization 
of the Heck reaction conditions for these series may be needed to finetune this 
protocol for the preparation of phenanthrolines. 
              The yields of the products from both the two-step sequence and the one-pot 
protocol are provided in Table 1. The yields of heterocycles 4.21, 4.22, 4.23, and 4.25 
obtained via the one-pot protocol (56−75% calculated per the respective enynes) 
represent 2−22% improvement in comparison to the yields of  respective heterocycles 
achieved via the two-step process.  
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Table 1 
 
Ent.   n X  R
1
 
 
  R
2
    % yield 
    Dienes  
  
   
 % yield of 
 Heck rxn.     
   from dienes 
(stepwise) 
% yield of 
Heck rxn. 
from enyne 
(one-pot) 
%yield   
increase 
in one-
pot
a
 
1    1 CH H  H 4.12a (93) 
 
4.22a (71) 
 
4.22a (69) 
 
  +3 
2    1 CH           F  H 4.12c (72) 
 
4.22c (65) 
 
4.22c (61) 
 
  +14 
3    1 CH H OMe 4.12e (63) 
 
4.22e (66) 
 
4.22e (64) 
 
  +22 
4    2 CH H  H 4.13a (92) 
 
4.21a (80) 
 
4.21a (75) 
 
  +2 
5    2 CH F  H 4.13c (88) 
 
4.21c (71) 
 
4.21c (69) 
 
  +7 
6    2 CH H OMe 4.13e (80) 
 
4.21e (80) 
 
4.21e (70) 
 
  +6 
7    1 N H  H  4.12g (69) 
 
 4.25a (77) 
 
 4.25a (71) 
 
  +18 
8    2 N H  H 4.13g (69) 
 
4.23a (65) 
 
4.23a (61) 
 
  +17 
9    2 N H  F 4.13h (62) 
 
4.23b (61) 
 
4.23b (56) 
 
  +18 
 
a
Calcutated as the % yield (column 8) −[% yield (column 7) × % yield (column 6)/100] 
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Elimination of the material loss during the chromatographic purification of dienes 
4.12 and 4.13 appears to be largely responsible for the success of the one-pot protocol 
for the preparation of heterocycles. Moreover the one-pot protocol provided more 
economical syntheses by avoiding the expense of time, silica, and solvents involved 
in chromatographic purification of the RCM products. 
5.3 Conclusions: 
             A sequential one-pot protocol for the enyne metathesis and Heck cyclization 
described in the previous chapter was designed.
177
 We believe this is the first ever 
report on sequential one-pot enyne-RCM/Heck reaction. The analogs synthesized via 
one-pot protocol showed improved percentage yield (2-22%) when compared to the 
yields obtained via stepwise protocol. Realizing the Heck reaction in toluene (DMF in 
stepwise route) was the key for the success. Additional optimization may be needed 
to finetune this protocol specifically for the preparation of 1,7-tetrahydro 
phenanthrolines. 
 
 
 
 
 
 
146 
 
Overall Conclusions 
  Efficient transformation of readily available building blocks into drug-like 
molecules is the need of the hour. We have demonstrated that sequencing MCRs with 
transition metal catalyzed annulation reactions is a useful tool for rapid generation of 
medicinally relevant heterocycles. Treatment of the homologous and isosteric analogs 
under the same reaction conditions afforded products via different reaction pathways, 
thus creating a rediodivergent sequence. Moreover designing one-pot protocols for 
these sequences provides routes for efficient and economical syntheses which would 
be interesting to medicinal chemists and for the overall profitable pharmaceutical 
developments   
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Chapter Six 
Experimental 
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General Experimental 
Unless otherwise indicated, all NMR data were collected at room temperature in 
CDCl3 with internal CHCl3 as the reference (δ 7.26 ppm for 
1
H and 77.00 ppm for 
13
C). The 
1
H NMR and 
13
C NMR were performed on a 400 MHz and 125 MHz 
instrument respectively, unless otherwise mentioned. IR spectras were measured as 
thin films on salt (NaCl) plates. Melting points are uncorrected and were taken in 
open capillary tubes. MS were measured under electrospray ionization (ES) or fast 
atom bombardment (FAB) conditions. Analytical thin-layer chromatography (TLC) 
was carried out on commercial Merck silica gel 60 plates, 250 mm thickness, with 
fluorescent indicator (F-254) or stained with aqueous KMnO4 solution. Column 
chromatography was performed with 32-63 mm silica gel (Sorbent) or with 150 mesh 
58Å pore size basic alumina. Where appropriate neat liquid reagents were added via  
microliter syringes. Tetrahydrofuran (THF) was freshly distilled from 
sodium/benzophenone. Methylene chloride and toluene were distilled over CaH2 and 
sodium metal respectively. DMF and ACN were kept over 3Å (8-12 mesh) molecular 
sieves under an atmosphere of dry argon; other solvents were used as received. 
Unless otherwise specified, all reactions were carried out under an atmosphere of dry 
argon in oven-dried (at least 6h at 140
o
C) glassware. All imines were prepared 
according to a modified literature procedure
161
 by condensation of a 1 : 1 mixture of  
aldehyde and amine in methylene chloride in the presence of activated 3Å (8-12 
mesh) molecular sieves for 24 h at rt followed by filtration through celite and removal 
of solvent under vacuum to afford pure imines that were used immediately. The 1-
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amino-3-butenes 3.6 and 3.7
127
 and alcohol 3.34a-d
128
 were prepared according to 
literature protocols. Grubbs I and Grubbs II catalysts were purchased from 
commercial supplier and used as such. Other materials were used as received from 
commercial suppliers. 
 
 
(±)-(2R,3R)-Ethyl-3-(1-hexyl)-4-(phenyl)-2-(N-p-methoxyphenylamino)-4-
pentenoate (3.8).  
Following the published method,
127
 amine 3.8 (0.170 g, 51%) was obtained as a 
mixture of inseparable diastereomers (9 : 1) as a yellow oil: Rf  = 0.58 
(EtOAc/Hexane 1 : 7).  
1
H NMR (400 MHz, CDCl3) δ 7.35-7.29 (m, 5H), 6.75 (d, J = 8.8 Hz, 2H), 6.55 (d, J 
= 8.8 Hz, 2H), 5.43 (s, 0.1H), 5.39 (s, 0.9H), 5.22 (s, 0.9H), 5.21 (s, 0.1H), 3.87-3.79 
(m, 1H), 3.74 (s, 3H), 3.77-3.67 (m, 1H), 3.15 (quintet, J = 6.4 Hz, 0.9H), 3.08 
(quintet, J = 4.4 Hz, 0.1H), 1.75-1.60 (m, 2H), 1.55-1.45 (m, 1H), 1.45-1.20 (m, 
10H), 1.06 (t, J = 7.2 Hz, 3H), 0.90 (t, J = 7.2 Hz, 3H). 
13
C NMR (125 MHz, CDCl3) δ 13.9, 14.0, (14.1), 22.6 (27.1), 27.3, 29.4, (29.39) 
(30.4), 31.0, (31.6), 31.7, (47.0), 47.3, 55.7, 60.6, 60.7, (60.8), (62.3), (114.6), 114.7 
(2C), 115.3 (2C), (115.5), 116.0, (126.8), 127.2 (2C), 127.4, 128.1 (2C), (128.3), 
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141.2, (141.3), 142.4, 148.1, (148.4), 152.6, (152.7), 173.3 signals for the minor 
diastereomer are given in parentheses.  
IR (cm
-1
) 3373, 1731, 1512; HRMS (ES
+
): calcd for C26H36NO3 (M+H)
+
 410.2695, 
found 410.2685. 
 
 
()-(1R,2R)-1-(N-p-methoxyphenylamino)-1-(p-methoxycarbonylphenyl)-2-(1-
hexyl)-3-(2-naphthyl)-3-butene (3.9).  
Following the published method,
127 
amine 3.9 (0.540 g, 60%) was obtained as a 
colorless oil: Rf = 0.25 (EtOAc/Hexane 1 : 9).  
1
H NMR (500 MHz, CDCl3)  7.92 (d, J = 8.0 Hz, 2H), 7.81 (t, J = 6.0 Hz, 1H), 7.76 
(d, J = 8.5 Hz, 1H), 7.72 (t, J = 5.0 Hz, 1H), 7.65 (s, 1H),  7.40-7.38 (m, 2H), 7.36-
7.31 (m, 3H), 6.62 (d, J = 9.0 Hz, 2H), 6.35 (d, J = 9.0 Hz, 2H),  5.50 (s, 1H), 5.30 (s, 
1H), 4.26 (s br, 1H), 4.18 (d, J  = 8.5 Hz, 1H), 3.87 (s, 3H), 3.66 (s, 3H), 2.90 (td,  J = 
10.0 Hz, 4.0 Hz, 1H), 1.45-1.35 (m, 2H), 1.33-1.25 (m, 2H), 1.22-1.12 (m, 6H), 0.81 
(t, J = 7.0 Hz, 3H). 
13
C NMR (125 MHz, CDCl3)  14.1, 22.5, 27.4, 29.2, 30.6, 31.6, 51.9, 53.1, 55.7, 
62.3, 114.6 (2C), 114.7 (2C), 117.1, 125.7, 125.9 (2C), 126.2, 127.5, 127.8 (2C), 
127.9, 128.1, 128.9, 129.6, 130.2, 132.6, 133.1, 139.3, 141.3, 148.8, 149.6, 152.1, 
166.9. 
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IR (cm
-1
): 3300, 1720, 1512; HRMS (ES
+
): calcd for C35H40NO3 (M+H)
+
 522.3008, 
found 522.2993. 
 
 
(±)-Ethyl (2R,3R)-3-hexyl-2-[(4-methoxyphenyl)amino]-4-phenylpent-4-enoate 
(3.28). 
Following the published method,
127
 amine 3.28 was obtained as a mixture of 
inseparable diastereomers (9:1).Yield: 0.170 g (51%); yellow oil. Rf = 0.58 (EtOAc–
Hexane, 1:7).  
1
H NMR (400 MHz, CDCl3): δ = 7.35–7.29 (m, 5 H), 6.75 (d, J = 8.8 Hz, 2 H), 6.55 
(d, J = 8.8 Hz, 2 H), 5.43 (s, 0.1 H), 5.39 (s, 0.9 H), 5.22 (s, 0.9 H), 5.21 (s, 0.1 H), 
3.87–3.79 (m, 1 H), 3.74 (s, 3 H), 3.77–3.67 (m, 1 H), 3.15 (quin, J = 6.4 Hz, 0.9 H), 
3.08 (quin, J = 4.4 Hz, 0.1 H), 1.75–1.60 (m, 2 H), 1.55–1.45 (m, 1 H), 1.45–1.20 (m, 
10 H), 1.06 (t, J = 7.2 Hz, 3 H), 0.90 (t, J = 7.2 Hz, 3 H).  
13
C NMR (125 MHz, CDCl3): δ = 13.9, 14.0, (14.1), 22.6, (27.1), 27.3, 29.4, (29.39), 
(30.4), 31.0, (31.6), 31.7, (47.0), 47.3, 55.7, 60.6, 60.7, (60.8), (62.3), (114.6), 114.7 
(2 C), 115.3 (2 C), (115.5), 116.0, (126.8), 127.2 (2 C), 127.4, 128.1 (2 C), (128.3), 
141.2, (141.3), 142.4, 148.1, (148.4), 152.6, (152.7), 173.3; signals for the minor 
diastereomer are given in parentheses. 
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IR (neat): 3373, 1731, 1512 cm
–1
; HRMS (ES
+
): calcd for C26H36NO3 (M + H)
+
 
410.2695, found 410.2685. 
 
Preparation of N-tosylamines 3.14-3.17 and 3.30, via amines 3.10-3.13 and 3.29:  
Method A: To solutions of N-PMP protected amines 3.6-3.8 and 3.28 (1.0 equiv) in 
CH3CN (3-8 mL) was added H5IO6 (1.2 equiv) and water (0.2–1.0 mL) was added 
dropwise, followed by H2SO4 (1M aqueous) (0.5-2.0 mL). The mixture was stirred at 
rt for 24 hours. Water (20 mL) was added, and the mixture was extracted with ether 
(4 x 20 mL). For small scale preparations, the crude mixture was directly loaded on 
the silica column for separation eluting with methanol/DCM mixtures to afford 
deprotected amines 3.10-3.12 and 3.29 as brown to yellow oils that yielded 
acceptable 
1
H and 
13
C NMR spectra. However, they were not fully characterized. 
Method B: To solution of N-PMP protected amine 3.9 (1.0 equiv) in CH3CN (2.0 
mL) was added a solution of CAN (1.3 equiv) in water (3.0 mL) at 0 
o
C and the 
mixture was stirred for 30 minutes at 0 
o
C and 3 hours at rt. Ethyl acetate (30 mL) 
was added, and the mixture was extracted with 5% aqueous NaHCO3 (30 mL). For 
methods A and B, organic extracts were dried (MgSO4), and solvents were removed 
under reduced pressure to afford crude products that were partially purified by flash 
chromatography over silica eluting with methanol/DCM mixtures to afford amine 
3.13 as yellow oil. However, it was not fully characterized and was used as such for 
further reaction. 
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General procedure for N-tosylation: 
Amines 3.10-3.13 and 3.29 (1.0 equiv) were dissolved in THF (5-12 mL), p-
toluenelsulfonyl chloride (1.6 equiv) and triethylamine (1.1 equiv) were added at 0
o
C 
and the mixture was stirred at rt under argon for 18 hours. Water (6-10 mL) was 
added, and the mixture was extracted with ether (4 x 20 mL). Organic extracts were 
dried (MgSO4), and the solvents were removed under reduced pressure to afford 
crude products that were separated by flash chromatography over silica to afford N-
tosylamines 3.14-3.17 and 3.30 as colorless to yellow oils.  
 
 
 ()-(1R,2R)-1-(N-tosylamino)-2-hexyl-1-(p-methoxycarbonylphenyl)-3-(p-
methoxycarbonylphenyl)-3-butene (3.14).    
Following Method A, amine intermediate 3.10 and following N-tosylation protocol N-
tosylamine 3.14 were isolated.  
Analytical data for 3.10: 
Yield: 0.216 g (73%); brown oil. 
Rf = 0.35 (MeOH–CH2Cl2, 1:19). 
1
H NMR (500 MHz, CDCl3): δ = 7.99 (d, J = 7.0 
Hz, 2 H), 7.97 (d, J = 8.0 Hz, 2 H), 7.48 (d, J = 8.5 Hz, 2 H), 7.42 (d, J = 8.5 Hz, 2 
H), 5.52 (s, 1 H), 5.29 (s, 1 H), 4.00 (d, J = 9.0 Hz, 1 H), 3.92 (s, 3 H), 3.90 (s, 3 H), 
2.83–2.72 (m, 1 H), 2.29 (br s, 2 H), 1.34–1.01 (m, 10 H), 0.77 (t, J = 7.0 Hz, 3 H). 
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13
C NMR (125 MHz, CDCl3): δ = 13.9, 22.5, 27.1, 29.2, 29.7, 31.6, 32.4, 52.1, 52.7, 
60.3, 116.2, 126.8 (2 C), 127.5 (2 C), 128.9, 129.2, 129.6 (2 C), 129.7 (2 C), 148.0, 
149.6, 150.2, 166.92, 166.98. 
Analytical data for 3.14: 
Yield: 0.379 g (64%); yellow oil. Rf = 0.32 (EtOAc/Hexane 1 : 4). 
1
H NMR (500 MHz, CDCl3)  7.79 (d, J = 8.5 Hz, 2H), 7.62 (d, J = 8.5 Hz, 2H), 7.33 
(d, J = 8.0 Hz, 2H), 7.16 (d, J = 8.5 Hz, 2H), 6.98 (d, J = 8.0 Hz, 2H), 6.91 (d, J = 8.0 
Hz, 2H), 5.61 (d, J = 6.5 Hz, 1H), 5.35 (s, 1H), 5.07 (s, 1H), 4.28 (t, J = 6.5 Hz, 1H),  
3.83 (s, 3H), 3.80 (s, 3H), 2.18-2.77 (m, 1H), 2.21 (s, 3H), 1.20-1.15 (m, 4H), 1.14-
1.09 (m, 2H), 1.05-0.87 (m, 4H), 0.70 (t, J = 6.5 Hz, 3H). 
13
C NMR (125 MHz, CDCl3)  13.9, 21.3, 22.4, 26.8, 29.1, 30.7, 31.5, 50.7, 52.0, 
52.1, 60.6, 118.2, 126.7 (2C), 127.0 (2C), 127.5 (2C), 128.9, 129.0, 129.1 (2C), 129.2 
(2C), 129.6 (2C), 137.1, 143.1, 144.3, 146.4, 147.2, 166.7, 166.8.  
IR (cm
-1
) 3276, 1722; HRMS (ES
+
): calcd for C33H39NO6SNa (M+Na)
+
 600.2396, 
found 600.2380. 
 
 
()-(1R,2R)-1-(N-tosylamino)-1-(p-nitrophenyl)-2-(1-hexyl)-3-(p-
methoxycarbonylphenyl)-3-butene (3.15).  
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Following method A amine intermediate 3.11 and following N-tosylation protocol N-
tosylamine 3.15 were isolated  
Analytical data for 3.11: 
Yield: 0.212 g (72%); brown oil. 
Rf = 0.40 (MeOH–CH2Cl2, 1:19); 
1
H NMR (500 MHz, CDCl3): δ = 8.15 (d, J = 8.5 
Hz, 2 H), 7.99 (d, J = 8.5 Hz, 2 H), 7.52 (d, J = 8.5 Hz, 2 H), 7.47 (d, J = 8.5 Hz, 2 
H), 5.54 (s, 1 H), 5.29 (s, 1 H), 4.08 (d, J = 8.5 Hz, 1 H), 3.92 (s, 3 H), 2.79 (td, J = 
9.0, 3.0 Hz, 1 H), 1.90–1.69 (m, 2 H), 1.34–1.05 (m, 10 H), 0.78 (t, J = 7.0 Hz, 3 H). 
13
C NMR (125 MHz, CDCl3): δ = 13.9, 22.5, 27.1, 29.2, 31.6, 32.2, 52.2, 52.6, 59.9, 
116.5, 123.5 (2 C), 126.8 (2 C), 128.4 (2 C), 129.1, 129.7 (2 C), 147.2, 147.7, 149.6, 
151.8, 166.8.  
Analytical data for 3.15: 
Yield: 0.280 g (62%); yellow oil. Rf = 0.30 (EtOAc/Hexane 1 : 4). 
1
H NMR (500 MHz, CDCl3)  7.91 (d, J = 8.5 Hz, 2H), 7.88 (d, J = 8.5 Hz, 2H), 7.41 
(d, J = 8.0 Hz, 2H), 7.19 (d, J = 4.5 Hz, 2H), 7.17 (d, J = 4.5 Hz, 2H), 7.08 (d, J = 8.0 
Hz, 2H), 5.51 (s, 1H), 5.19 (s, 1H), 5.09 (d, J = 5.5 Hz, 1H), 4.37 (dd, J = 8.0 Hz, 5.0 
Hz, 1H), 3.92 (s, 3H), 2.85-2.81 (m, 1H), 2.34 (s, 3H), 1.32-1.04 (m, 10H), 0.80 (t, J 
= 7.0 Hz, 3H). 
13
C NMR (125 MHz, CDCl3)  13.9, 21.4, 22.5, 27.0, 29.0, 30.8, 31.5, 51.2, 52.2, 
60.0 118.9, 123.2 (2C), 126.6 (2C), 127.1 (2C), 128.4 (2C), 129.4 (2C), 129.5, 129.8 
(2C), 136.8, 143.8, 145.6, 146.9, 147.0, 147.1, 166.6. 
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IR (cm
-1
) 3276, 1720; HRMS (ES
+
): calcd for C31H36N2O6SNa (M+Na)
+
 587.2192, 
found 587.2180. 
 
 
 (±)-(1R,2R)-2-(2-Ethylhexyl)-1,3-bis[4-(methoxycarbonyl)phenyl]- 
1-(tosylamino) but-3-ene (3.16). 
Following Method A, the amine intermediate 3.12 and following N-tosylation 
protocol the N-tosylamine 3.16 were isolated.  
Analytical data for 3.12: 
Yield: 0.224 g (76%); brown oil. Rf = 0.30 (MeOH–CH2Cl2, 1:19). 
1
H NMR (500 MHz, CDCl3): δ = 7.99 (t, J = 8.0 Hz, 4 H), 7.52 (dd, J = 8.5, 2.0 Hz, 2 
H), 7.45 (dd, J = 8.0, 1.5 Hz, 2 H), 5.54 (s, 1 H), 5.33 (s, 1 H), 4.00 (d, J = 9.0 Hz, 1 
H), 3.92 (s, 3 H), 3.91 (s, 3 H), 2.93–2.87 (m, 1 H), 2.06–1.77 (m, 2 H), 1.36–0.94 
(m, 9 H), 0.91–0.88 (m, 2 H), 0.80 (t, J = 7.5 Hz, 1.5 H), 0.72 (t, J = 7.5 Hz, 1.5 H), 
0.65 (t, J = 7.5 Hz, 1.5 H), 0.46 (t, J = 7. Hz, 1.5 H); two diastereomers arise from the 
stereocenter in the branched alkyl substituent. 
Analytical data for 3.16: 
Yield: 0.270 g (72%); pale-yellow oil. Rf = 0.45 (EtOAc/Hexane, 1:5). 
1
H NMR (500 MHz, CDCl3): δ = 7.91 (dd, J = 8.5, 1.5 Hz, 2 H), 7.74 (d, J = 8.5 Hz, 
2 H), 7.37(d, J = 8.0 Hz, 2 H), 7.22 (d, J = 8.0 Hz, 2 H), 7.07 (d, J = 8.0 Hz, 2 H), 
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7.02 (d, J = 8.0 Hz, 2 H), 5.43 (s, 1 H), 5.16 (s, 1 H), 5.03 (t, J = 4.5 Hz, 1 H), 4.29 
(quin, J = 3.5 Hz, 1 H), 3.86 (s, 3 H), 3.82 (s, 3 H), 2.85 (td, J = 11.3, 3.0 Hz, 1H), 
2.32 (s, 3 H), 1.35–1.23 (m, 2 H), 1.21–0.82 (m, 9 H), 0.79 (t, J = 7.5 Hz, 1.5 H), 0.75 
(t, J = 7.5 Hz, 1.5 H), 0.63 (t, J = 6.0 Hz, 1.5 H), 0.51 (t, J = 7.5 Hz, 1.5 H).  
13
C NMR (125 MHz, CDCl3): δ = 9.4 (10.8), 14.0, 21.3, 22.8 (22.9), 24.4, 26.3, 27.6 
(28.7), 31.5 (33.0), 34.7, 35.3 (35.7), 49.0 (49.1), 52.1 (52.2), 60.8 (60.9), 119.10 
(119.11), 126.8 (2 C) (126.9), 127.1 (2 C), 127.6 (2 C) (127.7), 129.1 (2 C) (129.2), 
129.31 (2 C) (129.32), 129.37, 129.61 (129.65), 129.68 (2 C) (129.69), 136.94 
(136.96), 143.2, 144.4 (144.5), 145.8 (145.9), 147.9, (166.63) 166.65, 166.7. Signals 
for the minor diastereomer arising from the stereocenter in the side chain are given in 
parentheses.  
IR (neat): 3278, 1722 cm
–1
; HRMS (ES
+
): calcd for C35H43NO6SNa (M+Na)
+
 
628.2709, found 628.2701. 
 
 
()-(1R,2R)-1-(N-tosylamino)-1-(p-methoxycarbonylphenyl)-2-(1-hexyl)-3-(2-
napththyl)-3-butene (3.17).  
Following method B amine intermediate 3.13 was obtained and was not 
characterized; following N-tosylation protocol N-tosylamine 3.17 was isolated.  
Analytical data for 3.14: 
Yield: 0.043 g (48%); yellow oil. 
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Analytical data for 3.17: 
Yield: 0.213 g (65%); yellow oil. Rf = 0.33 (EtOAc/Hexane 1 : 4). 
1
H NMR (500 MHz, CDCl3)  7.86-7.74 (m, 2H), 7.72 (d, J = 8.5 Hz, 2H), 7.66 (d, J 
= 5 Hz, 1H), 7.60 (d, J = 1.0 Hz, 1H), 7.48 (t, J = 1.5 Hz, 1H), 7.39 (t, J = 2.0 Hz, 
1H), 7.36 (d, J = 8.0 Hz, 2H), 7.37-7.30 (m, 1H), 7.11 (d, J = 8.5 Hz, 2H), 6.98 (d, J 
= 7.5 Hz, 2H), 5.54 (s, 1H), 5.18 (s, 1H), 5.09 (d, J = 5.0 Hz, 1H),  4.37 (dd, J = 8.5 
Hz, 5.0 Hz, 1H), 3.86 (s, 3H), 2.93 (td, J = 8.5 Hz, 4.0 Hz, 1H), 2.27 (s, 3H), 1.36-
1.06 (m, 10H), 0.78 (t, J = 7.0 Hz, 3H). 
13
C NMR (125 MHz, CDCl3)  13.9, 21.1, 21.8, 27.1, 29.1, 30.8, 31.5, 51.5, 52.0, 
60.8, 117.5, 123.6, 125.0, 125.5, 126.1, 126.3, 127.1, 127.5, 127.7, 128.1, 128.2, 
128.5, 129.1 (2C), 129.2 (2C), 129.8, 132.7, 133.1, 136.9, 138.6, 143.1, 144.6, 148.0, 
166.7. 
IR (cm
-1
) 3200, 1722; HRMS (ES
+
): calcd for C35H39NO4SNa (M+Na
+
) 592.2498, 
found 592.2480. 
 
 
(±)-(2R,3R)-Ethyl-3-(1-hexyl)-4-(phenyl)-2-(N-tosylamine)-4-pentenoate (3.30). 
Following Method A, the amine intermediate 3.29 was obtained as a mixture of 
inseparable diastereomers (9:1), and following N-tosylation protocol N-tosylamine 6e 
was isolated as a single diastereomer. 
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Analytical data for 3.29: 
Yield: 0.150 g (60%); brown oil. Rf = 0.25 (EtOAc/Hexane, 1:2). 
1
H NMR (400 MHz, CDCl3): δ = 7.44–7.23 (m, 5 H), 5.45 (s, 0.1H), 5.40 (s, 0.9 H), 
5.17 (s, 0.9 H), 5.14 (s, 0.1 H), 3.83–3.75 (m, 1 H), 3.53 (d, J = 5.2 Hz, 1 H), 3.52–
3.45 (m, 1 H), 3.15 (quin, J = 5.6 Hz, 1 H), 2.36 (br s, 2 H), 1.75–1.60 (m, 2 H), 
1.55–1.10 (m, 8 H), 1.04 (t, J = 7.2 Hz, 3 H), 0.90 (t, J = 6.8 Hz, 3 H).  
Analytical data for 3.30: 
Yield: 0.118 g (55%); yellow oil. Rf  = 0.7 (EtOAc/Hexane 1 : 7). 
1
H NMR (400 MHz, CDCl3) δ 7.69 (d, J = 8.0 Hz, 2H), 7.26-7.21 (m, 7H), 5.40 (s, 
1H), 5.20 (s, 1H), 5.09 (d, J = 10.0 Hz, 1H), 3.97 (dd, J = 4.0 Hz, 10.4 Hz, 1H), 3.37-
3.27 (m, 1 H), 3.21-3.15 (m, 1H), 3.14-3.06 (m, 1H), 2.39 (s, 3H), 1.78-1.66 (m, 2H), 
1.48-1.23 (m, 8 H), 0.92 (t, J = 6.8 Hz, 3H), 0.77 (t, J = 7.2 Hz, 3H). 
13
C NMR (125 MHz, CDCl3) δ 13.4, 14.1, 21.4, 22.6, 27.1, 29.3, 31.6, 31.7, 45.8, 
57.5, 61.1, 116.4, 126.8 (2C), 127.2 (2C), 127.5, 128.1 (2C), 129.4 (2C), 136.8, 
142.4, 143.4, 146.6, 170.2. 
IR (cm
-1
) 3276, 1737, 1598; HRMS (ES
+
): calcd for C26H35NO4SNa (M+Na)
+
 
480.2185, found 480.2169. 
Preparation of aminoalcohols 3.18-3.21 and diols 3.35a-d:  
To a solution of N-tosylamines 3.14-3.17 or alcohols 3.35a-d (1.0 equiv) in THF (5-
10 mL) at 0 
o
C was added BH3.THF complex (1M in THF, 5.0 equiv) and the 
solution was stirred at rt under argon for 24 hours or only 4 hours for alcohols 3.35. 
An aqueous solution of NaOH (3M, 9.0 equiv) was added at 0 
o
C, followed by H2O2 
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(30% aqueous solution, 9.0 equiv) and the mixture was stirred for 30 minutes at 0 
o
C 
and 2 hours at rt. Water (20 mL) was added, and the mixture was extracted (EtOAc, 4 
x 20 mL). Organic extracts were dried (MgSO4), and the solvents were removed 
under reduced pressure to afford crude products that were separated by flash 
chromatography over silica to afford aminoalcohols 3.18-3.21 or diol 3.35. 
 
  
()-(1R,2R,3S)-1-(N-tosylamino)-2-hexyl-1-(p-methoxycarbonylphenyl)-3-(p-
methoxycarbonylphenyl)-4-hydroxy-1-butane (3.18).  
Aminoalcohol 3.18 (0.048 g, 65%) was obtained as a colorless oil: Rf = 0.45 
(EtOAc/Hexane 1 : 1). 
1
H NMR (500 MHz, CDCl3)  7.98 (d, J = 8.0 Hz, 2H), 7.70 (d, J = 8.5 Hz, 2H), 7.38 
(d, J = 8.0 Hz, 2H), 7.31 (d, J = 8.0 Hz, 2H), 7.08 (d, J = 8.0 Hz, 2H), 6.98 (d, J = 8.0 
Hz, 2H), 6.20 (d, J = 8.5 Hz, 1H), 4.44 (t, J = 8.0 Hz, 1H), 3.93-3.85 (m, 1H), 3.91 (s, 
3H), 3.88 (s, 3H), 3.79 (dd, J = 10.5 Hz, 8.0 Hz, 1H), 3.32 (q, J = 6.0 Hz, 1H), 2.52 (s 
br, 1H), 2.27 (s, 3H), 2.25-2.20 (m, 1H), 1.10-1.10 (m, 3H), 0.92-0.75 (m, 7H), 0.72 
(t, J = 7.5 Hz, 3H). 
13
C NMR (125 MHz, CDCl3)  14.0, 21.3, 22.4, 27.7, 28.3, 29.2, 31.3, 45.6, 48.0, 
52.1, 52.2, 59.7, 64.2, 126.8 (2C), 127.3 (2C), 128.7, 128.8, 128.9 (2C), 129.2 (2C), 
129.4 (2C), 129.8 (2C), 137.5, 143.1, 145.4, 145.9, 166.7, 167.0.  
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IR (cm
-1
) 3500, 3271, 1722; HRMS (ES
+
): calcd for C33H41NO7SNa (M+Na)
+
 
618.2501, found 618.2510. 
 
 
()-(1R,2R,3S)-1-(N-tosylamino)-1-(p-nitrophenyl)-2-hexyl-3-(p-
methoxycarbonylphenyl)-4-hydroxy-1-butane (3.19).  
Aminoalcohol 3.19 (0.140 g, 61%) was obtained as a colorless oil: Rf = 0.30 
(EtOAc/Hexane 1 : 1). 
1
H NMR (500 MHz, CDCl3)  7.98 (d, J = 8.5 Hz, 2H), 7.87 (d, J = 9.0 Hz, 2H), 7.40 
(d, J = 8.0 Hz, 2H), 7.30 (d, J = 8.5 Hz, 2H), 7.19 (d, J = 8.5 Hz, 2H), 7.01 (d, J = 8.0 
Hz, 2H), 6.51 (d, J = 8.5 Hz, 1H), 4.47 (t, J = 8.5 Hz, 1H), 3.95-3.89 (m, 1H), 3.91 (s, 
3H), 3.82 (dd, J = 10.5 Hz, 3.0 Hz, 1H), 3.33 (q, J = 5.5 Hz, 1H), 2.78 (s br, 1H), 
2.32-2.25 (m, 1H), 2.28 (s, 3H), 1.12-0.99 (m, 3H), 0.90-0.65 (m, 7H), 0.72 (t, J = 7.5 
Hz, 3H). 
13
C NMR (125 MHz, CDCl3)  13.9, 21.3, 22.3, 27.7, 28.4, 29.2, 31.3, 45.5, 48.0, 
52.2, 59.6, 64.1, 125.9, 126.3, 126.6, 126.8 (2C), 127.1, 127.6, 127.7, 128.5, 128.8, 
129.2, 129.4, 132.5, 133.4, 137.7, 137.8, 143.0, 146.0, 166.7. 
IR (cm
-1
) 3492, 3375, 3269, 1720; HRMS (ES
+
): calcd for C31H38N2O7SNa (M+Na)
+
 
605.2297, found 605.2310. 
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(±)-(1R,2R,3S)-2-(2-Ethylhexyl)-4-hydroxy-1,3-bis[4-(methoxycarbonyl) 
phenyl]-1-(tosylamino)butane (3.20). 
Aminoalcohol 3.20 (0.166 g 66%) was obtained as colorless oil: Rf = 0.41 (EtOAc–
Hexane, 3:7). 
1
H NMR (500 MHz, CDCl3): δ = 8.00 (dd, J = 8.5, 7.0 Hz, 2 H), 7.76 (d, J = 8.0 Hz, 
2 H), 7.41 (dd, J = 8.0, 5.5 Hz, 2 H), 7.25 (dd, J = 8.5, 5.0 Hz, 2 H), 7.09 (d, J = 8.5 
Hz, 2 H), 7.02 (d, J = 7.5 Hz, 2 H), 5.62 (t, J = 9.5 Hz, 1 H), 4.52 (t, J = 6.0 Hz, 1 H), 
3.92 (s, 3 H), 3.89 (s, 3 H), 3.82–3.77 (m, 1 H), 3.75–3.67 (m, 1 H), 3.20 (quin, J = 5 
Hz, 1 H), 2.35–2.29 (m, 1 H), 2.29 (s, 3 H), 1.76 (br s, 1 H), 1.22–0.97 (m, 4 H), 
0.94–0.82 (m, 7 H), 0.81 (t, J = 6.0 Hz, 1.5 H), 0.77 (t, J = 7.5 Hz, 1.5 H), 0.57 (t, J = 
7.0 Hz, 1.5 H), 0.50 (t, J = 7.0 Hz, 1.5 H).  
13
C NMR (125 MHz, CDCl3): δ = 14.1 (14.2), 21.1 (21.3), 23.06 (23.09), 24.0 (25.5), 
27.7 (28.2), 31.2, 32.5, 32.9 (33.0), 35.9 (36.0), 43.7, 43.8, (48.3) 48.4, 52.1, 59.8 
(60.4), 64.0, 126.81 (126.83) (2 C), 127.1 (2 C), 128.81 (128.84), 128.92 (128.95), 
129.0, 129.2 (2 C), 129.4 (2 C), 129.8 (2 C), 137.6 (137.7), 143.10 (143.13), 145.7, 
145.84, 145.88, 166.65 (166.66), 166.83 (166.86); signals for the minor diastereomer 
arising from the stereocenter in the side chain are given in parentheses. 
 IR (neat): 3494, 3272, 1722 cm
–1
; HRMS (ES
+
): calcd for C35H46NO7S (M+H)
+
 
624.2995, found 624.3000. 
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()-(1R,2R,3S)-1-(N-tosylamino)-1-(p-methoxycarbonylphenyl)-2-hexyl-3-(2-
napththyl)-4-hydroxy-1-butane (3.21).  
Aminoalcohol 3.21 (0.066 g, 56%) was obtained as a pale yellow oil: Rf = 0.25 
(EtOAc/Hexane 3 : 7).  
1
H NMR (500 MHz, CDCl3)  7.87-7.79 (m, 5H), 7.62 (s br, 1H), 7.52-7.47 (m, 2H), 
7.38 (d, J = 8.0 Hz, 2H), 7.32 (dd, J = 8.0 Hz, 2.0 Hz, 1H), 7.19 (d, J = 8.0 Hz, 2H), 
7.01 (d, J = 8.0 Hz, 2H), 5.54 (d, J = 8.0 Hz, 1H), 4.65 (t, J = 6.5 Hz, 1H), 3.91-3.87 
(m, 1H), 3.90 (s, 3H), 3.82-3.74 (m, 1H), 3.18 (q, J = 5.5 Hz, 1H), 2.35-2.28 (m, 1H), 
2.30 (s, 3H), 1.66-1.59 (s br, 1H), 1.14-1.06 (m, 2H), 1.03-0.90 (m, 8H), 0.75 (t, J = 
7.5 Hz, 3H). 
13
C NMR (125 MHz, CDCl3)  14.0, 21.4, 22.5, 27.8, 28.5, 29.2, 31.5, 46.3, 48.2, 
52.1, 59.3, 64.8, 125.9, 126.4, 126.7, 126.8 (2C), 127.1 (2C), 127.6, 127.8 (2C), 
128.6, 128.8, 129.2 (2C), 129.4 (2C), 132.6, 133.4, 137.7, 137.8, 143.0, 146.0, 166.7. 
IR (cm
-1
) 3488, 3365, 3272, 1722; HRMS (ES
+
) calcd for C35H41NO5SNa (M+Na)
+
 
610.2603, found 610.2570. 
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 (±)-(2R,3R,4S)-Ethyl-3-(1-hexyl)-4-(phenyl)-2-(N-tosylamino)-5-hydroxy-
pentanoate (3.31).  
To a solution of N-tosylamine 3.30 (0.105 g, 0.23 mmol, 1 equiv) in THF (5 mL) at 0 
o
C was added BH3
.
THF (1M solution, 0.75 mL, 1.38 mmol, 6 equiv) dropwise. The 
mixture was stirred for 1 h at 0
o
C, and the stirring was continued for 10 h at rt. Water 
(2 mL) was added, followed by and NaBO3·4H2O (0.531 g, 3.45 mmol, 15 equiv) and 
the mixture was stirred for 1h at rt. Purification procedure described for alcohols 
3.18-3.21 above was followed to afford alcohol 7d (0.070 g, 65%) as a colorless oil 
and lactone 3.32 (0.027 g, 25%).  
Aminoalcohol 3.31:  Rf  = 0.25 (EtOAc/Hexane 1 : 7). 
1
H NMR (400 MHz, CDCl3) δ 7.72 (d, J = 8.4 Hz, 2H), 7.37-7.25 (m, 5H), 7.18 (d, J 
= 8.4 Hz, 2H), 5.48 (d, J = 9.6 Hz, 1H), 4.18 (dd, J = 3.2 Hz, 10.0 Hz, 1H), 4.01 (dq, 
J = 7.2 Hz, 2.0 Hz, 2H), 3.76 (t, J = 5.6 Hz, 2H), 2.87 (q, J = 6.4 Hz, 1H), 2.43 (s, 
3H), 2.38-2.30 (m, 1H), 1.75 (t, J = 5.2 Hz, 1H), 1.35-0.97 (m, 10H), 1.16 (t, J = 7.2 
Hz, 3H), 0.84 (t, J = 7.2 Hz, 3H). 
13
C NMR (125 MHz, CDCl3) δ 13.9, 14.0, 21.5, 22.5, 27.3, 28.9, 29.1, 31.5, 43.7, 
49.4, 56.7, 61.7, 65.3, 127.2 (2C), 127.3, 128.5 (2C), 128.8 (2C), 129.5 (2C), 137.2, 
140.7, 143.4, 172.2. 
IR (cm
-1
) 3575, 3200, 1745; HRMS (ES
+
): calcd for C26H37NO5SNa (M+Na)
+
 
498.2290, found 498.2286.  
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Lactone 3.32:  Rf  = 0.55 (EtOAc/Hexane 1 : 7);  
1
H NMR (400 MHz, CDCl3) δ 7.76 
(d, J = 8.4 Hz, 2H), 7.42-7.26 (m, 7H), 5.57 (d, J = 4.8 Hz, 1H), 4.44 (dd, J = 5.2 Hz, 
6.8 Hz, 1H), 4.43 (dd, J = 6.8 Hz, 12.0 Hz, 1H), 4.20 (t, J = 11.6 Hz, 1H), 3.13-3.08 
(m, 1H), 2.69-2.62 (m, 1H), 2.43 (s, 3H), 1.78-1.68 (m, 1H), 1.34-1.07 (m, 7H), 1.05-
0.95 (m, 2H), 0.84 (t, J = 6.8 Hz, 3H). 
13
C NMR (125 MHz, CDCl3) δ 14.0, 21.5, 22.5, 26.0, 29.0, 30.5, 31.5, 42.6, 44.5, 
53.9, 70.8, 127.0 (2C), 127.4 (2C), 127.7, 129.2 (2C), 129.9 (2C), 136.3, 139.7, 
144.0, 170.9. 
IR (neat, cm
-1
) 3285, 1755; HRMS (ES
+
): calcd for C24H31NO4SNa (M+Na)
+
 
452.1872, found 452.1869. 
 
 
(±)-(1R,2S,3R)-1-phenyl-2-(1-hexyl)-3-(p-methoxyphenyl)-1,4-dihydroxybutane 
(3.35a).  
Diol 3.35a (0.143 g, 85%) was obtained as a heavy oil as a mixture (3 : 1) of 
inseparable diastereomers: Rf  = 0.58 (EtOAc/Hexane 1 : 7). 
1
H NMR (400 MHz, CDCl3) δ 7.28 (m, 7H), 6.95 (d, J = 8.4 Hz, 0.5H), 6.90 (d, J = 
8.4 Hz, 1.5H), 5.05 (s, 0.75H), 4.67 (s, 0.25H), 4.09 (d, J = 4.8 Hz, 1.5H), 4.03-3.96 
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(br, 0.25H), 3.88 (t, J = 9.2 Hz, 0.25H), 3.83 (s, 3H), 3.13-3.07 (m, 0.25H), 3.49 (q, J 
= 6.0 Hz, 0.75H), 2.70-2.57 (m, 1H), 2.47-2.33 (m, 1H), 2.05-2.00 (m, 0.75H), 1.96-
1.87 (m, 0.25H), 1.41-1.23 (m, 2H), 1.20-0.86 (m, 8H), 0.79 (t, J = 7.2 Hz, 3H). 
13
C  NMR  (125  MHz, CDCl3) δ 14.0, 22.4, (22.5), (25.4), 25.7, 28.1, (28.9), 29.3, 
(29.5), 31.4, 47.9, (48.1), 49.4, (50.1), 55.2, (55.3), 64.1, (65.0), 72.8, (73.8), 113.9 
(2C), (114.4), (125.3), 125.6 (2C), (126.6), 126.8, (128.0), 128.1 (2C), (129.41), 
129.45 (2C), (133.6), 134.5, 143.9, (144.0), 158.2, (158.5) signals for the minor 
diastereomer are given in parentheses. 
IR (cm
-1
) 3373, 1724, 1606; HRMS (FAB): calcd for C23H32O3 (M)
+
 356.2351, found 
356.2347. 
 
 
(±)-(1R,2S,3R)-1-(p-methoxyphenyl)-2-(1-hexyl)-3-(p-methoxyphenyl)-1,4-
dihydroxybutane (3.35b).  
Diol 3.35b (0.09 g, 92%) was obtained as a heavy oil as a mixture (3 : 1) of 
inseparable diastereomers: Rf  = 0.45 (EtOAc/Hexane 1 : 7). 
1
H NMR (400 MHz, CDCl3) δ 7.27 (d, J = 8.8 Hz, 2H), 7.19-7.16 (m, 2H), 6.94 (d, J 
= 8.4 Hz, 0.5H), 6.90-6.84 (m, 3.5H), 4.98 (d, J = 2.0 Hz, 0.75H), 4.63 (d, J = 2.4 Hz, 
0.25H), 4.06 (d, J = 5.2 Hz, 1.5H), 3.98 (dd, J = 10.8 Hz, J = 5.2 Hz, 0.25H), 3.86 
(dd, J = 10.8 Hz, J = 8.4 Hz, 0.25H), 3.83 (s, 3H), 3.81 (s, 3H), 3.10-3.05 (m, 0.25H), 
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3.02 (q, J = 6.8 Hz, 0.75H), 2.33 (br, 2H), 2.02-1.96 (m, 0.75H), 1.90-1.83 (m, 
0.25H), 1.40-1.24 (m, 2H), 1.21-0.98 (m, 7H), 0.96-0.87 (m, 1H), 0.81 (t, J = 7.2 Hz, 
3H). 
13
C  NMR  (125  MHz, CDCl3) δ (14.02), 14.05, 22.51, (22.57), (25.4), 25.9, (28.0), 
28.1, (29.0), 29.4, 31.51, (31.58), 47.8, (48.3), 49.3, (50.0), 55.2, (55.6), 64.1, (65.0), 
72.6, (73.6), (74.64), 75.4, (113.7) , 113.8 (2C), 114.0 (2C), (114.3), (126.4), 126.7 
(2C), (127.6), 128.0 (2C), (132.9), (133.7), 134.0, 134.3, 158.2, (158.3), 158.4, 
(158.5), signals for the minor diastereomer are given in parentheses. 
IR (cm
-1
) 3650, 1512, 1247; HRMS (ES
+
): calcd for C24H34O4Na (M+Na)
+
 409.2355, 
found 409.2384. 
 
 
(±)-(1R,2S,3R)-1-(p-nitrophenyl)-2-(1-hexyl)-3-(p-methoxyphenyl)-1,4-
dihydroxybutane (3.35c).  
Diol 3.35c (0.065 g, 62%) was obtained as a heavy oil as a mixture (3 : 1) of 
inseparable diastereomers: Rf = 0.38 (EtOAc/Hexane 1 : 7). 
1
H NMR (400 MHz, CDCl3) δ 8.17 (d, J = 8.8 Hz, 2H), 7.45 (d, J = 8.4 Hz, 2H), 7.35 
(d, J = 8.8 Hz, 2H), 6.92 (d, J = 8.4 Hz, 0.5H), 6.87 (d, J = 8.8 Hz, 1.5H), 5.14 (s, 
0.75H), 4.77 (s, 0.25H), 4.13 (m, 1.5H), 4.03 (dd, J = 10.8 Hz, J = 5.6 Hz, 0.25H ), 
3.91 (dd, J = 10.4 Hz, J = 7.6 Hz, 0.25H ) 3.83 (s, 3H), 3.14-3.06 (m, 1H), 2.51 (br, 
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2H), 2.09-2.01 (m, 0.75H), 1.99-1.94 (m, 0.25H), 1.31-1.24 (m, 2H), 1.17-0.92 (m, 
7H), 0.85-0.74 (m, 1H),  0.78 (t, J = 7.2 Hz, 3H). 
13
C NMR (125 MHz, CDCl3) δ 13.9, 22.4, (22.5), (25.3), 25.7, 27.9, (28.8), 29.2, 
(29.4), 31.7, 47.6, (48.1), (50.0), 50.2, 55.2, (55.3), 64.0, (64.8), 71.7, (73.4), 114.1 
(2C), (114.6), 123.2 (2C), (123.3), (126.3), 126.5 (2C), 129.3 (2C), (133.1), 134.2, 
146.7, 152.0, 158.4, (158.8), signals for the minor diastereomer are given in 
parentheses. 
IR (cm
-1
) 3440, 1637, 1550, 1250; HRMS (FAB): calcd for C23H31NO5 (M)
+
 
401.2202, found 401.2197. 
 
 
(±)-(1R,2S,3R)-1-furyl-2-(1-hexyl)-3-(p-methoxyphenyl)-1,4-dihydroxybutane 
(3.35d). 
Diol 3.35d (0.082 g, 68%) was obtained as a heavy oil as a mixture (3 : 1) of 
inseparable diastereomers: Rf = 0.5 (EtOAc/Hexane 1 : 7). 
1
H NMR (400 MHz, CDCl3) δ 7.38 (dd, J = 1.6 Hz, J = 0.8 Hz, 0.75H), 7.33 (dd, J = 
2.0 Hz, J = 0.8 Hz, 0.25H), 7.26 (d, J = 1.6 Hz, 0.5H), 7.22 (d, J = 8.8 Hz, 1.5H), 
6.92 (d, J = 8.8 Hz, 0.5H), 6.88 (d, J = 8.4 Hz, 1.5H), 6.37 (dd, J = 3.2 Hz, J = 2.0 
Hz, 0.75H), 6.33 (dd, J = 3.2 Hz, J = 2.0 Hz, 0.25H), 6.28 (dt, J = 3.2 Hz, J = 0.8 Hz, 
0.75H), 6.20 (dt, J = 3.2 Hz, J = 0.8 Hz, 0.25H), 5.03(d, J = 2.4 Hz, 0.75H), 4.63 (d, J 
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= 1.6 Hz, 0.25H), 4.07-3.94 (m, 1.75H), 3.88-3.83 (m, 0.25H), 3.82 (s, 3H), 3.07-3.02 
(m, 0.25H), 2.94-2.89 (m, 0.75H), 2.36 (br, 2H), 2.27-2.21 (m, 0.75H), 2.13-2.08 (m, 
0.25H), 1.40-1.03 (m, 10H), 0.83 (t, J = 6.8 Hz, 3H). 
13
C NMR (125  MHz, CDCl3) δ 14.02, (14.06), 22.52, (22.53), 27.8, (27.94), (27.97), 
28.0, (29.31), 29.33, 31.48, (31.59), (47.7), (48.2), 49.7, 51.2, (55.24), 55.28, (68.9), 
(74.2), 74.9, 75.2, (107.7), 108.1, 109.9, (110.1), (113.7), 114.0 (2C), 128.8 (2C), 
(129.3), 132.3, (132.7), 142.0, (142.5), 154.5, (154.6), (158.2), 158.4, signals for the 
minor diastereomer are given in parentheses. 
IR (cm
-1
) 3700, 1610, 1514, 1249; HRMS (FAB): calcd for C21H30NO4 (M)
+
 
346.2144, found 346.2170. 
 
Preparation of pyrrolidines 3.22-3.25, 3.33 and tetrahydrofuran 3.36a-d:  
To a solution of aminoalcohols 3.18-3.21, 3.30 or diols 3.35a-d (1.0 equiv) in DCM 
(2-5 mL) at 0
o
C was added pyridine (12 equiv) and tosylchloride (3.0 equiv). The 
solution was stirred for 30 minutes at 0
o
C and 24 h at rt. Cold water (5 mL) was 
added, and the mixture was extracted with DCM (4 x 20 mL). Combined organic 
layers were dried (MgSO4), and solvents were removed under reduced pressure to 
afford crude products that were separated by flash chromatography over silica to 
afford pyrrolidines 3.22-3.25 and tetrahydrofuran 3.36a-d.  
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()-(2R,3R,4S)-N-toluenesulfonyl-3-(1-hexyl)-2-(p-methoxycarbonylphenyl)-4-(p-
methoxycarbonylphenyl)-pyrrolidine (3.21).  
Pyrrolidine 3.21 (0.037 g, 66%) was obtained as a white solid: mp 169-171 
o
C; Rf = 
0.8 (EtOAc/Hexane 3 : 7). 
1
H NMR (500 MHz, CDCl3)  7.96 (dd, J = 6.5 Hz, 1.5 Hz, 4H), 7.53 (d, J = 8.5 Hz, 
2H), 7.39 (d, J = 8.5 Hz, 2H), 7.24 (dd, J = 8.0 Hz, 2.0, 4H), 4.40 (d, J = 9.0 Hz, 1H), 
4.10 (dd, J = 11.0 Hz, 8.0 Hz, 1H), 3.92 (s, 3H), 3.89 (s, 3H), 3.56 (t, J = 11.5 Hz, 
1H), 2.79 (hex, J = 7.5 Hz, 1H), 2.41 (s, 3H), 2.35-2.28 (m, 1H), 1.30-1.21 (m, 2H), 
1.08-1.02 (m, 2H), 0.95-0.88 (m, 4H), 0.84-0.77 (m, 2H), 0.73 (t, J = 6.5 Hz, 3H). 
13
C NMR (125 MHz, CDCl3)  13.9, 21.5, 22.3, 26.2, 29.1, 30.2, 31.3, 49.9, 52.1, 
52.2, 55.9, 56.3, 69.1, 127.3 (2C), 127.4 (2C), 127.7 (2C), 129.3, 129.4, 129.6 (2C), 
129.8 (2C), 130.1 (2C), 135.5, 143.6, 144.2, 147.1, 166.7, 166.8. 
IR (cm
-1
) 1722; HRMS (ES
+
): calcd for C33H39NO6SNa (M+Na)
+
 600.2396, found 
600.2372. 
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()-(2R,3R,4S)-N-toluenesulfonyl-3-(1-hexyl)-4-(p-methoxycarbonylphenyl)-2-(p-
nitrophenyl)-pyrrolidine (3.22).  
Pyrrolidine 3.22 (0.060 g, 83%) was isolated as a white solid: 140-143
o
C, Rf = 0.42 
(EtOAc/Hexane 1 : 4). 
1
H NMR (500 MHz, CDCl3)  8.17 (d, J = 9.0 Hz, 2H), 7.96 (d, J = 8.5 Hz, 2H), 7.58 
(d, J = 8.5 Hz, 2H), 7.52 (d, J = 9.0 Hz, 2H), 7.29 (d, J = 8.0 Hz, 2H), 7.23 (d, J = 8.5 
Hz, 2H), 4.40 (d, J = 9.0 Hz, 1H), 4.07 (dd, J = 11.5 Hz, 8.0 Hz, 1H), 3.89 (s, 3H), 
3.60 (t, J = 11.0 Hz, 1H), 2.75 (sext, J = 7.5 Hz, 1H), 2.43 (s, 3H), 2.33-2.27 (m, 1H), 
1.29-1.21 (m, 2H), 1.06-1.02 (m, 2H), 0.92 (pent, J = 3.5 Hz, 4H), 0.82-0.77 (m, 2H), 
0.73 (t, J = 7.5 Hz, 3H). 
13
C NMR (125 MHz, CDCl3)  13.9, 21.6, 22.4, 26.2, 29.1, 29.9, 31.3, 49.7, 52.2, 
55.9, 56.3, 68.7, 123.8 (2C), 127.4 (2C), 127.6 (2C), 128.1 (2C), 129.4, 129.8 (2C), 
130.1 (2C), 134.9, 143.8, 144.1, 147.3, 149.6, 166.7. 
IR (cm
-1
) 1719; HRMS (ES
+
): calcd for C31H36N2O6SNa (M+Na)
+
 587.2192, found 
587.2206. 
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(±)-(2R,3R,4S)-3-(2-Ethylhexyl)-2,4-bis[4-(methoxycarbonyl) phenyl]-1-tosyl 
pyrrolidine (3.24). 
Pyrrolidine 3.24 (0.060 g, 78%) was isolated as colorless oil: Rf = 0.45 (EtOAc–
Hexane, 1:5). 
1
H NMR (500 MHz, CDCl3): δ = 7.96 (dd, J = 8.5, 6.5 Hz, 4 H), 7.49 (dd, J = 8.5, 
6.0 Hz, 2 H), 7.39 (d, J = 8.5 Hz, 2 H), 7.26 (d, J = 8.5 Hz, 2 H), 7.21 (d, J = 7.0 Hz, 
2 H), 4.34 (dd, J = 9.0, 5.0 Hz, 1H), 4.13–4.08 (m, 1 H), 3.92 (s, 3 H), 3.89 (s, 3 H), 
3.57 (td, J = 11.0, 2.5 Hz, 1 H), 2.76 (qd, J = 10.5, 2.0 Hz, 1 H), 2.45–2.36 (m, 1H), 
2.40 (s, 3 H), 1.29–1.22 (m, 1 H), 1.20–1.13 (m, 1 H), 0.97–0.86 (m, 2 H), 0.78–0.67 
(m, 7 H), 0.67 (t, J = 7.0 Hz, 3 H), 0.37 (dt, J = 10.0, 3.0 Hz, 3 H). 
13
C NMR (125 MHz, CDCl3): δ = 10.1, 13.94 (13.95), 14.2, 21.5, 22.7 (22.8), 25.31 
(25.39), 28.2, 32.3 (32.4), 35.71 (35.79), 36.15 (36.25), 51.5, 52.15 (52.12), 53.65 
(53.60), 56.39 (56.30), 70.50 (70.44), 127.29 (127.31) (2 C), 127.53 (127.56) (2 C), 
127.75 (127.78) (2 C), 129.31, 129.38, 129.54 (2 C), 129.75 (2 C), 130.04 (2 C), 
135.58 (135.63), 143.54, 144.36 (144.44), 146.95 (147.00), 166.69, 166.82; signals 
for the minor diastereomer arising from the stereocenter in the side chain are given in 
parentheses.  
IR (neat): 1722 cm
–1
; HRMS (ES
+
): calcd for C35H43NO6SNa (M + Na)
+
 628.2709, 
found 628.2702. 
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()-(2R,3R,4S)-N-toluenesulfonyl-3-(1-hexyl)-2-(p-methoxycarbonylphenyl)-4-(2-
naphthyl)-pyrrolidine (3.25).  
Pyrrolidine 3.25 (0.042 g, 86%) was isolated as a colorless oil: Rf = 0.3 
(EtOAc/Hexane 1 : 4). 
1
H NMR (500 MHz, CDCl3)  8.00 (d, J = 8.0 Hz, 2H),  7.81-7.76 (m, 3 H), 7.59 (s, 
1H), 7.57 (d, J = 8.0 Hz, 2H), 7.49-7.46 (m, 2H), 7.44 (d, J = 8.0 Hz, 2H), 7.30 (dd, J 
= 8.5 Hz, 1.5 Hz, 1H), 7.26 (d, J = 8.0 Hz, 2H),  4.47 (d, J = 9.0 Hz, 1H), 4.16 (dd, J 
= 11.0 Hz, 7.5 Hz, 1H), 3.93 (s, 3H), 3.67 (t, J = 11.0 Hz, 1H), 2.91 (sext,  J = 8.0 Hz, 
1H), 2.48-2.40 (m, 1H), 2.44 (s, 3H), 1.34-1.29 (m, 2H), 1.07-1.00 (m, 2H), 0.93-0.90 
(m, 4H), 0.89-0.84 (m, 2H), 0.71 (t, J = 5 Hz, 3H). 
13
C NMR (125 MHz, CDCl3)  13.9, 21.6, 22.4, 26.1, 29.3, 30.1, 31.3, 50.0, 52.1, 
55.7, 56.5, 69.2, 125.2, 125.9, 126.3, 126.7, 127.3 (2C), 127.4 (2C), 127.5, 127.7, 
128.6, 129.3, 129.6 (2C), 129.8 (2C), 132.7, 133.4, 135.7, 136.1, 143.5, 147.5, 166.9; 
IR (cm
-1
) 1721; HRMS (ES
+
): calcd for C35H39NO4SNa (M+Na)
+
 592.2498, found 
592.2489. 
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(±)-(2R,3R,4S)-N-toluenesulfonyl-3-(1-hexyl)-2-(ethoxycarbonyl)-4-(phenyl)-
pyrrolidine (3.33) using Mitsunobu conditions. 
To a solution of amino alcohol 3.33 (0.011 g, 0.023 mmol, 1 equiv) in dry THF (1.5 
mL) at 0
o
C was added triphenylphosphine (0.006 g, 0.023 mmol, 1 equiv) and DEAD 
(4 μL, 0.025 mmol, 1.1 equiv). The solution was stirred at 0
o
C for 8 h, directly loaded 
on silica and purified using flash column chromatography eluting with 
EtOAc/Hexane (1 : 10) to afford pyrrolidine 3.33 (0.009 g, 84%) as a colorless oil: Rf  
= 0.65 (EtOAc/Hexane 1 : 7). 
1
H NMR (400 MHz, CDCl3) δ 7.80 (d, J = 8.4 Hz, 2H), 7.36 (d, J = 8.0 Hz, 2H), 
7.34-7.23 (m, 3H), 7.18 (d, J = 8.4 Hz, 2H), 4.26-4.21 (m, 2H), 4.05 (d, J = 8.0 Hz, 
1H), 3.87 (dd, J = 10.8 Hz, J = 8 Hz, 1H), 3.47 (t, J = 10.8 Hz, 1H), 2.73-2.66 (m, 
1H), 2.47 (m, 4H), 1.42-1.35 (br, 2H), 1.37 (t, J = 7.2, 3H) 1.24-1.01 (m, 8H), 0.84 (t, 
J = 7.2, 3H). 
13
C NMR (125 MHz, CDCl3) δ 12.9, 13.0, 20.5, 21.4, 25.5, 28.1, 30.4, 30.6, 49.6, 
50.6, 54.3, 60.4, 65.0, 126.3, 126.5 (2C), 126.6 (2C), 127.7 (2C), 128.6 (2C), 134.5, 
137.5, 142.6, 171.2. 
IR (cm
-1
) 1741; HRMS (ES
+
): calcd for C26H35NO4SNa (M+Na
+
) 480.2185, found 
480.2165. 
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(±)-(2R,3S,4R)-2-phenyl-3-(1-hexyl)-4-(p-methoxyphenyl)-tetrahydrofuran 
(3.36a).  
Tetrahydrofuran 3.36a (0.075 g, 65%) was isolated as a colorless oil: Rf = 0.7 
(EtOAc/Hexane 1 : 7). 
1
H NMR (400 MHz, CDCl3) δ 7.37-7.27 (m, 5H), 7.23 (d, J = 8.4 Hz, 2H), 6.90 (d, J 
= 8.4 Hz, 2H), 5.30 (d, J = 8.0 Hz, 1H), 4.48 (t, J = 8.4 Hz, 1H), 3.92 (t, J = 8.8 Hz, 
1H), 3.83 (s, 3H), 3.18 (q, J = 8.8 Hz, 1H), 2.48 (quintet, J = 7.2 Hz, 1H), 1.19-0.96 
(m, 8H), 0.93-0.85 (m, 2H), 0.80 (t, J  =  7.2 Hz, 3H). 
13
C NMR (125 MHz, CDCl3) δ 14.0, 22.4, 27.9, 29.2, 29.4, 31.5, 49.8, 51.5, 55.2, 
75.0, 84.1, 114.0 (2C), 126.8 (2C), 127.1, 127.9 (2C), 128.7, 133.2, 140.8 (2C), 
158.3; IR (cm
-1
) 1610, 1514, 1249; HRMS (FAB): calcd for C23H30O2 (M)
+  
338.2246, found 338.2254.  
 
 
Analytical data for the monotosyldiol 3.37a:  Rf  = 0.5 (EtOAc/Hexane 1 : 7).  
1
H NMR (400 MHz, CDCl3) δ 7.62 (d, J = 8.4 Hz, 2 H), 7.31-7.23 (m, 4.0 H), 7.20 (t, 
J = 7.2 Hz, 3.0 H), 7.13 (d, J = 8.8 Hz, 2 H), 6.83 (d, J = 8.8 Hz, 2 H),  4.58 (d, J = 
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2.4 Hz, 1.0 H), 4.34 (dd, J = 9.6 Hz, J = 4.8 Hz, 1.0 H), 4.25 (dd, J = 9.6 Hz, J = 7.6 
Hz, 1.0 H), 3.82 (s, 3.0 H), 3.06 (sextet, J = 4.4 Hz, 1.0 H), 2.35 (s, 3.0 H), 1.94-1.89 
(m, 1.0 H), 1.64-1.48 (br, 1 H), 1.50-1.39 (m, 2 H), 1.23-1.12 (m, 4 H), 1.09-0.86 (m, 
4 H), 0.82 (t, J = 7.2 Hz, 3.0 H). 
13
C NMR (125 MHz, CDCl3) δ 13.9, 21.6, 25.5, 28.4, 29.4, 31.4, 45.8, 47.1, 55.2, 
72.3, 73.12, 114.1 (2C), 125.3 (2C), 126.8, 127.8 (2C), 128.1 (2C), 129.1 (2C), 129.6 
(2C), 132.2, 132.7, 143.7, 144.5, 158.5. 
 IR (neat, cm
-1
) 3413 (w br), 1512 (s), 1176 (s); HRMS (ES
+
) calcd for C30H38O5SNa  
(M+Na
+
), 533.2338, found 533.2341. 
 
 
(±)-(2R,3S,4R)-2-(p-methoxyphenyl)-3-(1-hexyl)-4-(p-methoxyphenyl)-
tetrahydrofuran (3.36b).  
Tetrahydrofuran 3.36b (0.048 g, 73%) was isolated as a colorless oil: Rf = 0.7 
(EtOAc/Hexane 1 : 7). 
1
H NMR (400 MHz, CDCl3) δ 7.23 (d, J = 8.4 Hz, 4H, 6.90 (dd, J = 8.8 Hz, J = 2.4, 
4H), 5.25 (d, J = 8.0 Hz, 1H), 4.45 (t, J = 8.4 Hz, 1H), 3.89 (t, J = 8.8 Hz, 1H), 3.84 
(s, 3H), 3.83 (s, 3H), 3.16 (q, J = 8.8 Hz, 1H), 2.44 (quintet, J = 7.6 Hz, 1H), 1.21-0.9 
(m, 8H), 0.93-0.86 (m, 2H), 0.80 (t, J  =  7.2 Hz, 3H). 
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13
C NMR (125 MHz, CDCl3) δ 14.0, 22.4, 27.9, 29.2, 29.5, 31.5, 49.9, 51.5, 55.24, 
55.27, 74.9, 83.8, 113.3 (2C), 114.0 (2C), 128.0 (2C), 128.7 (2C), 132.9, 133.1, 
158.3, 158.7.  
IR (cm
-1
) 1612, 1512, 1247; HRMS (ES
+
): calcd for C24H33O3 (M+H)
+
 369.2430, 
found 369.2404. 
 
 
(±)-(2R,3S,4R)-2-(p-nitrophenyl)-3-(1-hexyl)-4-(p-methoxyphenyl)-
tetrahydrofuran (3.36c).  
Tetrahydrofuran 3.36c (0.033 g, 65%) was isolated as a colorless oil: Rf = 0.5 
(EtOAc/Hexane 1 : 7). 
1
H NMR (400 MHz, CDCl3) δ 8.24 (d, J = 8.8 Hz, 2H), 7.49 (d, J = 8.8 Hz, 2H), 7.23 
(d, J = 8.8 Hz, 2H), 6.92 (d, J = 8.8 Hz, 2H), 5.35 (d, J = 7.6 Hz, 1H), 4.49 (t, J = 8.4 
Hz, 1H), 3.97 (t, J = 8.8 Hz, 1H), 3.83 (s, 3H), 3.19 (q, J = 8.0 Hz, 1H), 2.53 (quintet, 
J = 7.2 Hz, 1H), 1.21-0.94 (m, 10H), 0.80 (t, J  =  7.2 Hz, 3H). 
13
C NMR (125 MHz, CDCl3) δ 13.9, 22.4, 27.8, 29.1, 29.7, 31.5, 49.8, 51.6, 55.3, 
74.9, 83.0, 114.1 (2C), 123.3 (2C), 127.5 (2C), 128.5 (2C), 132.8, 147.1, 148.5, 
158.5; IR (cm
-1
) 1606, 1514, 1346, 1249; HRMS (FAB): calcd for C23H29O4 (M)
+
 
383.2097, found 338.2095. 
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(±)-(2R,3S,4R)-2-furyl-3-(1-hexyl)-4-(p-methoxyphenyl)-tetrahydrofuran (3.36d). 
Tetrahydrofuran 3.36d (0.038 g, 60%) was isolated as a colorless oil: Rf = 0.65 
(EtOAc/Hexane 1 : 7). 
1
H NMR (400 MHz, CDCl3) δ 7.43 (t, J = 0.8 Hz, 1H), 7.22 (d, J = 8.4 Hz, 2H), 6.90 
(d, J = 8.4 Hz, 2H), 6.39-6.33 (m, 1H), 6.29 (d, J = 3.2 Hz, 1H), 5.27 (d, J = 7.6 Hz, 
1H), 4.43 (t, J = 8.4 Hz, 1H), 3.88-3.80 (m, 1H), 3.82 (s, 3H), 3.35 (q, J = 8.8 Hz, 
1H), 2.56-2.44 (m, 1H), 1.25-0.91 (m, 10H), 0.82 (t, J  =  7.2 Hz, 3H). 
13
C NMR (125 MHz, CDCl3) δ 14.0, 22.4, 28.0, 28.4, 29.3, 31.4, 49.7, 51.3, 55.2, 
75.2, 77.8, 108.1, 109.9, 114.0 (2C), 128.8 (2C), 132.3, 142.0, 154.5, 158.4. 
IR (cm
-1
) 1610, 1514, 1249; HRMS (FAB): calcd for C21H28O3 (M)
+
 328.2038, found 
328.2061. 
 
Preparation of tetrahydrofuran 3.36a by Mitsunobu conditions: 
(±)-(2R,3S,4R)-2-phenyl-3-(1-hexyl)-4-(p-methoxyphenyl)-tetrahydrofuran 
(3.36a).  
To a solution of diol 3.35a (0.03 g, 0.084 mmol, 1 equiv) in dry THF (3.0 mL) at 0
o
C 
under argon was added triphenylphosphine (0.022 g, 0.084 mmol, 1 equiv) and 
DEAD (13 μL, 0.084 mmol, 1.0 equiv). The solution was stirred at 0
o
C for 2.5 h. The 
reaction mixture was directly loaded on silica and purified using flash column 
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chromatography eluting with EtOAc/Hexane (1 : 10) to afford an inseparable mixture 
of diastereomeric furans 3.36a (0.024 g, 85%) as a colorless oil. The ratio of 
diastereomers was measured by GC (dr 9 : 1) (See GC in appendix). 
 
General procedure for Cu-catalyzed 3-component coupling reactions to afford 
1,6-enynes 4.5, 4.6 and 4.9a-e and 1,7-enynes 4.9f-j: Conditions-A 
Imines (1.0 equiv), benzoyl chloride (1.5 equiv) and alkynes (1.5 equiv) were mixed 
in acetonitrile (5-10 mL) and stirred for 5 min at rt under argon. The resulting yellow 
solution and EtNiPr2 (1.5 equiv) were added dropwise simultaneously to a solution of 
CuCl (0.2 equiv) in acetonitrile (2 mL). The reaction mixture was allowed to stir at rt 
under argon for 2h. Solvents were removed under reduced pressure to afford crude 
products that were separated by flash chromatography over basic alumina eluting 
with EtOAc/Hexanes mixtures to yield pure enynes 4.5, 4.6 and 4.9a-j. 
 
 
N-benzyl-N-(1-(2-bromophenyl)-3-phenyl) prop-2-yn-1-yl) acrylamide (4.5).  
The treatment of imine 4.4 (0.43 g, 1.58 mmol, 1.0 equiv), acryloyl chloride (195 µL, 
2.37 mmol, 1.5 equiv) and phenylacetylene (225 µL, 2.37 mmol, 1.5 equiv) with 
EtNiPr2 (410 µL, 2.37 mmol, 1.5 equiv) and CuCl (0.031 g, 0.32 mmol, 0.2 equiv) 
according to the general procedure described above, followed by flash 
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chromatography over basic alumina eluting with EtOAc/Hexane (1:4) afforded enyne 
4.5 (0.393 g, 58%) as a colorless oil: Rf = 0.6 (EtOAc/Hexane 3:7). 
1
H NMR (400 MHz, CDCl3) δ 7.83 (br s, 0.8H), 7.63 (br s, 0.2H), 7.51 (br s, 1H), 
6.88-7.43 (m, 12H), 6.50-6.32 (m, 2H), 5.72 (br s, 1H), 4.75-4.44 (m, 2H); In 
1
H 
NMR, the signal for the methine proton was not detected due extensive broadening 
(see the temperature dependent 
1
H NMR spectra for 4.9a). 
13
C NMR (125 MHz, CDCl3) δ (48.0), 48.1, (49.9), 50.9, (85.4), 85.6, 86.4, (86.9), 
(122.3), 124.5, 126.1 (2C), 127.0, 127.3, 127.8, 128.1, 128.2 (2C), (128.40), 128.46, 
(128.5), 128.6, (129.6), (129.8), 130.0, 131.0, 131.5, 131.7 (2C), 133.3 (2C), (135.8), 
137.5, (137.6), 138.0, 166.6, (166.8); Signals for the minor rotamer are given in the 
parentheses; Significant broadening of some signals in 
1
H and 
13
C NMR arises due to 
hindered rotation about the amide bond. Temperature dependent 
1
H NMR spectra 
were recorded (vide infra).  
IR (cm
-1
) 1654, 1490, 1425; HRMS (ES
+
): calcd for C25H21BrNO (M+H)
+
 430.0807, 
found 430.0812.  
 
 
N-allyl-N-(1-(2-bromophenyl)-3-phenyl) prop-2-yn-1-yl) benzamide (4.9a).  
The treatment of imine 4.8a (0.33 g, 1.48 mmol, 1.0 equiv), benzoyl chloride (260 
µL, 2.22 mmol, 1.5 equiv) and phenylacetylene (210 µL, 2.22 mmol, 1.5 equiv) with 
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EtNiPr2 (385 µL, 2.22 mmol, 1.5 equiv) and CuCl (0.055 g, 0.55 mmol, 0.2 equiv) 
according to the general procedure described above, followed by flash 
chromatography over basic alumina eluting with EtOAc/Hexane (1:4) afforded enyne 
4.9a (0.349 g, 55%) as a light yellow solid: mp 98-101
o
C; Rf  = 0.55 (EtOAc/Hexane 
3:7). 
1
H NMR (400 MHz, CDCl3) δ 8.01 (d, J = 7.6 Hz, 1H), 7.79 (br s, 1H), 7.67-7.57 (m, 
4H), 7.49-7.33 (m, 7H), 7.25 (t, J = 6.8 Hz, 1H), 7.09 (br s, 0.5H), 6.08 (br s, 0.5H), 
5.62 (br s, 1H), 4.86 (d, J = 10 Hz, 1.5H), 4.77 (br s, 0.5H), 4.01 (br s, 1.5H), 3.66 (br 
s, 0.5H). 
13
C  NMR  (125  MHz, CDCl3) δ 49.5, 50.8, 86.0, 116.5, 122.3, 124.6, 127.3 (2C), 
127.5, 128.2 (2C), 128.4, 128.7, 129.8, 130.2, 131.70, 131.76 (2C), 133.4 (2C), 134.1, 
135.4, 136.1, 170.7; Significant broadening of some signals in 
1
H  and 
13
C NMR 
arises due to hindered rotation about the amide bond. Temperature dependent 
1
H 
NMR spectra were recorded (vide infra). In 
13
C NMR spectra only one signal for the 
two sp carbons was observed.  
IR (cm
-1
) 2223, 1643, 1394; HRMS (ES
+
): calcd for C25H21BrNO (M+H)
+
 430.0807, 
found 430.0808.  
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N-allyl-N-(1-(2-bromo-4,5-dimethoxyphenyl)-3-phenyl) prop-2-yn-1-yl) 
benzamide (4.9b). 
The treatment of imine 4.8b (0.275 g, 0.97 mmol, 1.0 equiv), benzoyl chloride (170 
µL, 1.46 mmol, 1.5 equiv) and phenylacetylene (139 µL, 1.46 mmol, 1.5 equiv) with 
EtNiPr2 (255 µL, 1.46 mmol, 1.5 equiv) and CuCl (0.029 g, 0.28 mmol, 0.2 equiv) 
according to the general procedure described above, followed by flash 
chromatography over basic alumina eluting with EtOAc/Hexane (1:3) afforded enyne 
4.9b (0.232 g, 49%) as a light yellow oil: Rf  = 0.46 (EtOAc/Hexane 3:7). 
1
H NMR (400 MHz, CDCl3) δ 7.76 (br s, 1.75H), 7.55 (t, J = 4.0 Hz, 3.25H), 7.49-
7.34 (m, 6H), 7.06 (br s, 1H), 6.01 (br s, 1H), 5.69 (br s, 1H), 4.91 (d, J = 8.4 Hz, 
1.25H), 4.83 (br s, 0.75H), 4.05 (br s, 1H), 3.93 (s, 3H), 3.92 (s, 3H), 3.70 (br s, 1H). 
13
C NMR  (125 MHz, CDCl3) δ 42.4, (45.9), 49.3, (50.3), (56.0), 56.1, (56.2), 56.3, 
86.4, 114.4, 114.8, 115.8, 116.3, 122.4, 127.2, 128.2 (2C), 128.5 (2C), 128.6, 128.8, 
129.8, 131.6 (2C), 134.4, 136.2 (2C), 148.0, 149.7, 171.5; Signals for the minor 
rotamer are given in parentheses; In 
13
C NMR spectra only one signal for the two sp 
carbons was observed.  
IR (cm
-1
) 1643, 1477, 1236, 1035; HRMS (ES
+
): calcd for C27H25BrNO3 (M+H)
+
 
490.1018, found 490.1018. 
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N-allyl-N-(1-(2-bromo-5-fluorophenyl)-3-phenyl) prop-2-yn-1-yl) benzamide 
(4.9c).  
The treatment of imine 4.8c (0.276 g, 1.14 mmol, 1.0 equiv), benzoyl chloride (200 
µL, 1.71 mmol, 1.5 equiv) and phenylacetylene (165 µL, 1.71 mmol, 1.5 equiv) with 
EtNiPr2 (295 µL, 1.71 mmol, 1.5 equiv) and CuCl (0.022 g, 0.22 mmol, 0.2 equiv) 
according to the general procedure described above, followed by flash 
chromatography over basic alumina eluting with EtOAc/Hexane (1:9) afforded enyne 
4.9c (0.264 g, 52%) as a colorless heavy oil: Rf  = 0.65 (EtOAc/Hexane 3:7). 
1
H NMR (400 MHz, CDCl3) δ 7.75 (dd, J = 9.6 Hz, J = 3.2 Hz 1H), 7.60-7.53 (m, 
4H), 7.49-7.36 (m, 7H), 6.99 (dt, J = 8.4 Hz, J = 2.8 Hz 1H), 5.63 (br s, 1H), 4.88 
(dd, J = 10.0 Hz, J = 0.8 Hz 1H), 4.81 (br s, 1H), 4.06-3.97 (m, 1H), 3.79 (br s, 1H); 
In 
1
H NMR the signal for methine proton could not be detected likely due to 
extensive broadening (see the temperature dependent 
1
H NMR spectra for 4.9a).  
13
C NMR (125 MHz, CDCl3) δ (46.2), 49.4, 50.5, (55.9), 85.2, 116.8, 117.2 (d, J = 
22.3 Hz), 118.5 (d, J = 3.2 Hz), 119.0 (d, J = 24.5 Hz), (122.0), 125.5, 126.8, (127.3), 
128.2 (2C), (128.44), 128.49 (2C), 128.7 (d, J = 26.1 Hz), 128.9, 129.9, 130.0, 
(130.4), 131.8 (2C), (133.8), 134.5 (d, J = 7.7 Hz), 135.9 (2C), (137.9), 161.8 (d, J = 
246.2 Hz), 171.7; Signals for the minor rotamer are given in parentheses; In 
13
C NMR 
spectra only one signal for the two sp carbons was observed.  
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IR (cm
-1
) 1647, 1467; HRMS (ES
+
): calcd for C25H20BrFNO (M+H)
+
 448.0712, 
found 448.0707. 
 
 
N-allyl-N-(1-(2-bromophenyl)-3-(4-fluorophenyl) prop-2-yn-1-yl) benzamide 
(4.9d).  
The treatment of imine 4.8a (0.212 g, 0.95 mmol, 1.0 equiv), benzoyl chloride (165 
µL, 1.42 mmol, 1.5 equiv) and p-fluorophenylacetylene (0.171 g, 1.42 mmol, 1.5 
equiv) with EtNiPr2 (210 µL, 1.42 mmol, 1.5 equiv) and CuCl (0.019 g, 0.19 mmol, 
0.2 equiv) according to the general procedure described above, followed by flash 
chromatography over basic alumina eluting with EtOAc/Hexane (1:9) afforded enyne 
4.9d (0.225 g, 53%) as a light white solid: mp 89- 93
o
C; Rf  = 0.72 (EtOAc/Hexane 
3:7). 
1
H NMR (400 MHz, CDCl3) δ 7.98 (d, J = 7.6 Hz, 1H), 7.61 (br s, 2H), 7.58-7.50 (m, 
3H), 7.49-7.36 (m, 4H), 7.25 (t, J = 7.6 Hz, 1H), 7.09 (t, J = 8.0 Hz, 2H), 6.09 (br s, 
1H), 5.62 (br s, 1H), 4.86 (dd, J = 10.0 Hz, J = 1.2 Hz 1H), 4.77 (br s, 1H),  
4.01 (d, J = 14.0 Hz, 1H), 3.70 (br s, 1H); In 
1
H NMR, the signal for methine proton 
appeared to integrate for only 0.1H due to extensive broadening (see the temperature 
dependent 
1
H NMR spectra for 4.9a). However the signal was recorded as 1H (6.09 
ppm).  
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13
C NMR (125 MHz, CDCl3) δ 46.3, (49.0), 50.4, (56.1), 85.7, 115.7 (d, J = 21.8 Hz, 
2C), 116.5, 118.4, 124.6, 127.2, 127.3 (2C), 128.2 (2C), 129.8, 130.2 (d, J = 43.8 
Hz), 131.6, 133.4, 133.7 (d, J = 8.3 Hz, 2C), 133.9, 135.3, 136.1, 162.7 (d, J = 248.6 
Hz), 171.7; Signals for the minor rotamer are given in parentheses; In 
13
C NMR 
spectra only one signal for the two sp carbons was observed. 
IR (cm
-1
) 2227, 1643, 1506; HRMS (ES
+
): calcd for C25H20BrFNO (M+H)
+
 
448.0712, found, 448.0707.  
 
 
N-allyl-N-(1-(2-bromophenyl)-3-(4-methoxyphenyl) prop-2-yn-1-yl) benzamide 
(4.9e).  
The treatment of imine 4.8a (0.15 g, 0.673 mmol, 1.0 equiv), benzoyl chloride (120 
µL, 1.01 mmol, 1.5 equiv) and p-methoxyphenylacetylene (122 µL, 1.01 mmol, 1.5 
equiv) with EtNiPr2 (0.13 g, 174 µL, 1.01 mmol, 1.5 equiv) and CuCl (0.013 g, 0.135 
mmol, 0.2 equiv) according to the general procedure described above, followed by 
flash chromatography over basic alumina eluting with EtOAc/Hexane (1:4) afforded 
enyne 4.9e (0.19 g, 61%) as a colorless heavy oil: Rf  = 0.55 (EtOAc/Hexane 3:7). 
1
H NMR (400 MHz, CDCl3) δ 8.01 (d, J = 7.2 Hz, 1H), 7.82 (br s, 1H), 7.59 (br s, 
2H), 7.50 (d, J = 8.8 Hz, 2H), 7.47-7.35 (m, 4H), 7.24 (t, J = 6.8 Hz, 1H), 7.08 (br s, 
0.5H), 6.92 (d, J = 8.0 Hz, 2H), 6.05 (br s, 0.5H), 5.61 (br s, 1H), 4.84 (d, J = 10.4 
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Hz, 1H), 4.7 (br s, 1H), 3.98 (br s, 1.5H), 3.86 (s, 3H), 3.68 (br s, 0.5H); In 
1
H NMR 
the signal for the methine proton appeared as two broad singlets (7.08 and 6.05 ppm)  
that integrate for only 0.5H when combined due to extensive broadening (see the 
temperature dependent 
1
H NMR spectra for 4.9a). However the signals were 
presented herein as 0.5H (7.08 ppm) and 0.5H (6.05 ppm).  
13
C NMR (125 MHz, CDCl3) δ 44.0, (47.2), 48.6, 53.4, (54.4), 82.6, 112.1, 114.5, 
122.6, 125.3 (2C), 125.5, 126.2 (2C), 126.4, 127.9, 128.2, 129.8 (2C), 131.2 (2C), 
131.4, 132.1, 133.7, 134.3, 158.0, 169.7; Significant broadening of some signals in 
1
H 
and 
13
C NMR arises due to hindered rotation about the amide bond. Temperature 
dependent 
1
H NMR spectra were recorded (vide infra). In 
13
C NMR spectra only one 
signal for the two sp carbons was observed. 
 IR (cm
-1
) 2210, 1643, 1396, 1027; HRMS (ES
+
): calcd for C26H23BrNO2 (M+H)
+
 
460.0912, found 460.0911.  
 
 
N-(1-(2-bromophenyl)-3-phenyl) prop-2-yn-1-yl)-N-(but-3-en-1-yl) benzamide 
(4.9f).  
The treatment of imine 4.8d (0.325 g, 1.36 mmol, 1.0 equiv), benzoyl chloride (235 
µL, 2.04 mmol, 1.5 equiv) and phenylacetylene (195 µL, 2.04 mmol, 1.5 equiv) with 
EtNiPr2 (350 µL, 2.04 mmol, 1.5 equiv) and CuCl (0.027 g, 0.27 mmol, 0.2 equiv) 
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according to the general procedure described above, followed by flash 
chromatography over basic alumina eluting with EtOAc/Hexane (1:4) afforded enyne 
4.9f (0.332 g, 55%) as a white solid: mp 75-80
o
C; Rf  = 0.6 (EtOAc/Hexane 3:7). 
1
H NMR (400 MHz, CDCl3) δ 8.04 (br s, 1H), 7.79 (br s, 1H), 7.69-7.53 (m, 4H), 
7.50-7.36 (m, 7H), 7.31-7.23 (m, 1H), 7.06 (br s, 0.5H), 6.05 (br s, 0.5H), 5.80-5.36 
(m, 1H), 4.89 (br s, 2H), 3.58-2.86 (m, 2H), 2.46 (br s, 1H), 1.81 (br s, 1H); In 
1
H 
NMR the signal for the methine proton appeared as two broad singlets (7.06 and 6.05 
ppm)  that integrate for only 0.5H when combined, due to extensive broadening (see 
the temperature dependent 
1
H NMR spectra for 4.9f). However the signals were 
presented herein as 0.5H (7.06 ppm) and 0.5H (6.05 ppm).  
13
C NMR (125 MHz, CDCl3) δ 32.5, (33.9), 43.3, (46.0), (50.4), 56.2, 86.2, 116.3, 
(116.7), 122.2, 124.4, 127.1, 127.5 (2C), 127.6, 128.2, 128.41, 128.49, 128.7, (128.8), 
129.8, 130.3, 131.3 (2C), 131.7 (2C), 133.5 (2C), (135.5), 136.4, 171.6; Signals for 
the minor rotamer are given in parentheses; In 
13
C NMR spectra only one signal for 
the two sp carbons was observed.  
IR (cm
-1
) 2223, 1641, 1402; HRMS (ES
+
): calcd for C26H22BrNONa (M+Na)
+
 
466.0782, found 466.0778. 
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N-(1-(2-bromo-4,5-dimethoxyphenyl)-3-phenyl) prop-2-yn-1-yl)-N-(but-3-en-1- 
yl) benzamide (4.9g).  
The treatment of imine 4.8e (0.329 g, 1.11 mmol, 1.0 equiv), benzoyl chloride (190 
µL, 1.66 mmol, 1.5 equiv) and phenylacetylene (160 µL, 1.66 mmol, 1.5 equiv) with 
EtNiPr2 (285 µL, 1.66 mmol, 1.5 equiv) and CuCl (0.022 g, 0.22 mmol, 0.2 equiv) 
according to the general procedure described above, followed by flash 
chromatography over basic alumina eluting with EtOAc/Hexane (1:4) afforded enyne 
4.9g (0.248 g, 45%) as a colorless oil: Rf  = 0.45 (EtOAc/Hexane 3:7). 
1
H NMR (400 MHz, CDCl3) δ 7.89-7.71 (m, 1H), 7.68-7.50 (m, 4H), 7.49-7.33 (m, 
6H), 7.08 (br s, 1H), 7.05 (br s, 0.5H) 6.35-5.91 (m, 0.5H), 5.87-5.35 (m, 1H), 5.21-
5.10 (m, 0.2H), 4.92 (br s, 1.8H), 3.95(s, 3H), 3.92 (s, 3H), 3.60-2.86 (m, 2H), 2.67-
2.25 (m, 1H), 1.88 (br s, 1H); In 
1
H NMR the signal for the methine proton appeared 
as a broad singlet and a multiplet (7.05 and 6.35-5.91 ppm)  that integrate for only 
0.5H when combined, due to extensive broadening (see the temperature dependent 
1
H 
NMR spectra for 4.9f). However the signals were presented herein as 0.5H (7.05 
ppm) and 0.5H (6.35-5.91 ppm).  
13
C NMR (125 MHz, CDCl3) δ 32.6, (33.9), 43.1, (46.0), (50.1), 55.9, 56.21, 56.29, 
86.6, 114.0, 114.6, (115.2), 115.9, (116.3), 117.4, (122.1), 126.8, (127.5), 128.2 (2C), 
128.54 (2C), 128.58, (128.9), 129.8, 131.3, 131.6 (2C), 131.7, (134.7), 135.3, (135.6), 
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136.4 (2C), 148.1, 149.7, (167.4), 171.5; Signals for the minor rotamer are given in 
parentheses; In 
13
C NMR spectra only one signal for the two sp carbons was 
observed.  
IR (cm
-1
) 2225, 1487, 1280, 1031; HRMS (ES
+
): calcd for C28H26BrNO3Na (M+Na)
+
 
526.0994, found 526.0985. 
 
 
N-(1-(2-bromo-5-fluorophenyl)-3-phenyl) prop-2-yn-1-yl)-N-(but-3-en-1-yl)  
benzamide (4.9h).  
The treatment of imine 4.8f (0.32 g, 1.25 mmol, 1.0 equiv), benzoyl chloride (215 µL, 
1.87 mmol, 1.5 equiv) and phenylacetylene (180 µL, 1.87 mmol, 1.5 equiv) with 
EtNiPr2 (240 µL, 1.87 mmol, 1.5 equiv) and CuCl (0.025 g, 0.25 mmol, 0.2 equiv) 
according to the general procedure described above, followed by flash 
chromatography over basic alumina eluting with EtOAc/Hexane (1:9) afforded enyne 
4.9h (0.299 g, 52%) as a colorless oil: Rf  = 0.6 (EtOAc/Hexane 3:7). 
1
H NMR (400 MHz, CDCl3) δ 8.16 (dd, J = 7.2 Hz, J = 1.2 Hz, 0.25H), 7.77 (d, J = 
7.6 Hz, 1.25H), 7.71 (t, J = 7.2 Hz, 0.5H), 7.64-7.52 (m, 4H), 7.50-7.34 (m, 7H), 7.01 
(td, J = 8.0 Hz, J = 2.8 Hz, 1H), 6.20-5.35 (m, 1H), 5.25-4.72 (m, 2H), 3.75-2.90 (m, 
2H), 2.49 (br s, 1H), 2.16-2.05 (m, 0.15H), 1.92 (br s, 0.85H). 
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13
C NMR (125 MHz, CDCl3) δ (32.6), 33.8, 43.2, (46.3), (50.3), 56.0, 85.4, [115.4, 
(d, J = 24.7 Hz)], [116.5, (d, J = 3.2 Hz)], 117.3, (117.4), 118.3 (d, J = 3.3 Hz), 118.6 
(d, J = 24.3 Hz), 126.8, (127.4), 128.3 (2C), 128.4 (d, J = 9.6 Hz), 128.5 (d, J = 8.0 
Hz), 128.8, (129.0), 129.87 (2C), (129.89), (129.9), 130.3, 131.4, 131.8 (2C), 133.9, 
134.8 (d, J = 7.7 Hz), [135.0, (d, J = 7.8 Hz)], (135.5), 136.2 (2C), (138.0), (164.1), 
161.8 (d, J = 246.6 Hz), [161.9, (d, J = 246.8 Hz)], 171.7, (172.8); Signals for the 
minor rotamer are given in parentheses; In 
13
C NMR spectra only one signal for the 
two sp carbons was observed.  
IR (cm
-1
) 1643, 1467; HRMS (ES
+
): calcd for C26H22BrFNO (M+H)
+
 462.0869, 
found 462.0877. 
 
 
N-(1-(2-bromophenyl)-3-(4-fluorophenyl) prop-2-yn-1-yl)-N-(but-3-en-1-yl) 
benzamide (4.9i). 
The treatment of imine 4.8d (0.193 g, 0.811 mmol, 1.0 equiv), benzoyl chloride (140 
µL, 1.21 mmol, 1.5 equiv) and p-fluorophenylacetylene (0.145 g, 1.21 mmol, 1.5 
equiv) with EtNiPr2 (210 µL, 1.21 mmol, 1.5 equiv) and CuCl (0.016 g, 0.16 mmol, 
0.2 equiv) according to the general procedure described above, followed by flash 
chromatography over basic alumina eluting with EtOAc/Hexane (1:9) afforded enyne 
4.9i (0.22 g, 58%) as a colorless oil: Rf = 0.6 (EtOAc/Hexane 3:7). 
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1
H NMR (400 MHz, CDCl3) δ 8.01 (d, J = 7.6 Hz, 1H), 7.86-7.59 (m, 2H), 7.54 (dd, 
J = 5.2 Hz, J = 3.2 Hz, 2H), 7.49-7.39 (m, 4H), 7.25 (t, J = 7.6 Hz, 1H), 7.09 (t, J = 
8.0 Hz, 2H), 7.03 (br s, 0.5H), 6.03 (br s, 0.5H), 5.83-5.27 (m, 1H), 4.89 (br s, 2H), 
3.94-2.86 (m, 2H), 2.40 (br s, 1H), 1.81 (br s, 1H); In 
1
H NMR the signal for the 
methine proton appeared as two broad singlets (7.03 and 6.03 ppm)  that integrate for 
only 0.5H when combined, due to extensive broadening (see the temperature 
dependent 
1
H NMR spectra for 4.9f). However the signals were presented herein as 
0.5H (7.03 ppm) and 0.5H (6.03 ppm).  
13
C NMR (125 MHz, CDCl3) δ 32.5, (33.8), 43.3, (46.0), 50.1, (56.1), 85.9, 115.8 (d, 
J = 21.6 Hz, 2C), 116.6, (118.3), 124.4, 125.5, (127.2), 127.5, 128.2, 128.4, 128.6, 
[128.7 (d, J = 5.2 Hz)], 129.8 (d, J = 5.2 Hz), 130.5, 131.2 (2C), 133.6 (2C), 133.7 (d, 
J = 8.3 Hz, 2C), (135.4), 136.3, 138.9, 162.8 (d, J = 248.6 Hz), (171.0), 172.6; 
Signals for the minor rotamer are given in parentheses; In 
13
C NMR spectra only one 
signal for the two sp carbons was observed.  
IR (cm
-1
) 2225, 1643, 1400; HRMS (ES
+
): calcd for C26H21BrFNONa (M+Na)
+
 
484.0688, found 484.0685. 
 
 
N-(1-(2-bromophenyl)-3-(4-methoxyphenyl) prop-2-yn-1-yl)-N-(but-3-en-1- 
yl) benzamide (4.9j).  
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The treatment of imine 4.8d (0.19 g, 0.798 mmol, 1.0 equiv), benzoyl chloride (140 
µL, 1.19 mmol, 1.5 equiv) and p-methoxyphenylacetylene (155 µL, 1.19 mmol, 1.5 
equiv) with EtNiPr2 (205 µL, 1.19 mmol, 1.5 equiv) and CuCl (0.016 g, 0.16 mmol, 
0.2 equiv) according to the general procedure described above, followed by flash 
chromatography over basic alumina eluting with EtOAc/hexane (1:4) afforded enyne 
4.9j (0.2 g, 53%) as a colorless oil: Rf = 0.6 (EtOAc/hexane 3:7). 
1
H NMR (400 MHz, CDCl3) δ 8.04 (br s, 1H), 7.80 (br s, 1H), 7.60 (br s, 2H), 7.50 
(d, J = 10.4 Hz, 2H), 7.47-7.38 (m, 4H), 7.30-7.22 (m, 1H), 7.04 (br s, 0.5H), 6.92 (d, 
J = 7.2 Hz, 2H), 6.03 (br s, 0.5H), 5.80-5.13 (m, 1H), 4.90 (br s, 2H), 3.86 (s, 3H), 
3.56-2.82 (m, 2H), 2.47 (br s, 1H), 1.79 (br s, 1H); In 
1
H NMR the signal for the 
methine proton appeared as two broad singlets (7.04 and 6.03 ppm) that integrate for 
only 0.5H when combined, due to extensive broadening (see the temperature 
dependent 
1
H NMR spectra for 4.9f). However the signals were presented herein as 
0.5H (7.04 ppm) and 0.5H (6.03 ppm). 
13
C NMR (125 MHz, CDCl3) δ 32.4, (33.9), 43.3, (46.0), (50.4), 55.3, 56.3, 84.7, 
114.3, 116.2, (116.8), 124.4, 126.9, 127.5 (2C), 128.2, 128.6, 129.8, 130.2, 131.4 
(2C), 133.2 (2C), 133.4, 133.5 (2C), 135.6, 136.5, 160.0, 171.6; Signals for the minor 
rotamer are given in parentheses; In 
13
C NMR spectra only one signal for the two sp 
carbons was observed.  
IR (cm
-1
) 2221, 1643, 1510, 1027; HRMS (ES
+
): calcd for C27H25BrNO2 (M+H)
+
 
474.1069, found 474.1072. 
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N-allyl-N-(1-(3-bromothiophen-2-yl)-3-phenyl) prop-2-yn-1-yl) benzamide 
(4.9k).  
The treatment of imine 4.8g (0.41 g, 1.78 mmol, 1.0 equiv), benzoyl chloride (310 
µL, 2.67 mmol, 1.5 equiv) and phenylacetylene (255 µL, 2.67 mmol, 1.5 equiv) with 
EtNiPr2 (460 µL, 2.67 mmol, 1.5 equiv) and CuCl (0.036 g, 0.36 mmol, 0.2 equiv) 
according to the general procedure described above, followed by flash 
chromatography over basic alumina eluting with EtOAc/hexane (1:9) afforded enyne 
4.9k (0.48 g, 62%) as a colorless oil: Rf = 0.6 (EtOAc/hexane 3:7). 
1
H NMR (400 MHz, CDCl3) δ 7.65 (br, s, 1.75H), 7.58-7.53 (m, 2.25H), 7.50-7.35 
(m, 6H), 7.29 (d, J = 5.6 Hz, 1H), 7.17 (br s, 0.5H), 6.99 (br s, 1H), 6.18 (br s, 0.5H), 
5.73 (br s, 1H), 4.93 (d, J = 10.0 Hz, 2H), 4.29-3.78 (m, 2H); In 
1
H NMR the signal 
for the methine proton appeared as two broad singlets (7.17 and 6.18 ppm) that 
integrate for only 0.5H when combined, due to extensive broadening (see the 
temperature dependent 
1
H NMR spectra for 4.9a). However the signals were 
presented herein as 0.5H (7.17 ppm) and 0.5H (6.15 ppm).  
13
C NMR (125 MHz, CDCl3) δ 45.2, (46.0), 49.2, (50.9), 85.5, 110.9, 116.4, 121.9, 
126.0, 127.3, 128.3 (2C), 128.4 (2C), 129.2, 130.0, 131.0 (2C), 131.8 (2C), 132.0, 
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133.8, 135.8, 171.4; Signals for the minor rotamer are given in parentheses; In 
13
C 
NMR spectra only one signal for the two sp carbons was observed.  
IR (cm
-1
) 2223, 1643, 1394; HRMS (ES
+
): calcd for C23H18BrNOSNa (M+Na)
+
 
458.0190, found 458.0199. 
 
 
N-(1-(3-bromothiophen-2-yl)-3-phenylprop-2-yn-1-yl)-N-(but-3-en-1-yl) 
benzamide (4.9l). 
The treatment of Imine 4.8h (0.32 g, 1.32 mmol, 1.0 equiv), benzoyl chloride (230 
µL, 1.98 mmol, 1.5 equiv) and phenylacetylene (189 µL, 1.98 mmol, 1.5 equiv) with 
EtNiPr2 (342 µL, 1.98 mmol, 1.5 equiv) and CuCl (0.026 g, 0.26 mmol, 0.2 equiv) 
according to the general procedure described above, followed by flash 
chromatography over basic alumina eluting with EtOAc/Hexane (1:9) afforded enyne 
4.9l (0.355 g, 60%) as a yellow oil: Rf = 0.65 (EtOAc/Hexane 1:7);  
1
H NMR (400 MHz, CDCl3) δ 7.80-7.82 (br, 1.5H), 7.60-7.54 (m, 2.5H), 7.52-7.35 
(m, 6H), 7.32 (d, J = 5.2 Hz, 1H), 7.19 (br, s, 0.5H), 7.09-6.94 (br, 1H), 6.11 (br, s, 
0.5H), 5.93-5.36 (br, 1H), 5.11-4.75 (br, 2H), 3.80-3.14 (br, 2H), 2.30-2.67 (br, 1H), 
2.20-1.96 (m, 1H); In 
1
H NMR the signal for the methine proton appeared as two 
broad singlets (7.19 and 6.11 ppm) that integrate for only 0.75H when combined, due 
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to extensive broadening (see the temperature dependent 
1
H NMR spectra for 4.9f). 
However the signals were presented herein as 0.5H.  
13
C NMR (125 MHz, CDCl3) δ 32.7, (34.0), 43.3, (45.0), 46.0, (51.0), 85.8, 110.8, 
116.5, 121.8, 125.5, 126.1, 127.3, 128.42 (2C), 128.49 (2C), 129.0, 129.9, 131.1 (2C), 
131.8 (2C), 135.5, 136.1, 171.4; Signals for the minor rotamer are given in 
parentheses; In 
13
C NMR spectra only one signal for the two sp carbons was 
observed. 
IR (cm
-1
) 2226, 1647, 1436; HRMS (ES
+
): calcd for C24H20BrNOSNa (M+Na)
+
 
472.0347 found 472.0340. 
 
General procedure for Cu-catalyzed 3-component-coupling reactions to afford 
enynes 4.8m-o and 4.9p-r: Condition B 
Imine (1.0 equiv), benzoyl chloride (1.2 equiv) and phenylacetylene (1.2 equiv) were 
mixed in acetonitrile (5 mL) and stirred at rt under argon for 5 min to afford a yellow 
solution. To this solution neat EtNiPr2 (1.2 equiv) and the solution of CuCl (0.2 
equiv) in acetonitrile (1 mL) were added simultaneously dropwise. The reaction 
mixture was allowed to stir at rt under argon for 1 h. Solvents were removed under 
reduced pressure and the resulting crude product was separated by flash 
chromatography over silica eluting with EtOAc/Hexanes mixtures to yield pure 
enynes 4.8m-o and 4.9p-r.   
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N-allyl-N-(1-(2-bromopyridin-3-yl)-3-phenylprop-2-yn-1-yl) benzamide (4.9m).  
The treatment of imine 4.8i (0.12 g, 0.53 mmol, 1.0 equiv), benzoyl chloride (0.091 g, 
75 µL, 0.64 mmol, 1.2 equiv) and phenylacetylene (0.065 g, 61 µL, 0.64 mmol, 1.2 
equiv) with EtNiPr2 (0.082 g, 110 µL, 0.64 mmol, 1.2 equiv) and CuCl (0.011 g, 0.11 
mmol, 0.2 equiv) according to the general procedure described above, followed by 
flash chromatography over silica eluting with EtOAc/Hexane (1:3) afforded enyne 
4.9m (0.135 g, 59%) as a colorless oil: Rf  = 0.4 (EtOAc/Hexane 3:7). 
1
H NMR (400 MHz, CDCl3) δ 8.39 (dd, J = 4.6 Hz, J = 1.6 Hz, 1H), 8.30 (d, J = 7.6 
Hz, 1H), 7.65 (br s, 1.5H), 7.56 (dd, J = 7.6 Hz, J = 2.4 Hz, 2.5H), 7.50-7.39 (m, 
5.75H), 7.37 (dd, J = 7.6 Hz, J = 4.4 Hz, 1.25H), 5.69 (br s, 1H), 4.87 (d, J = 10.4 Hz, 
1H), 4.76 (dd, J = 17.2 Hz, J = 1.2 Hz, 1H), 4.29-3.56 (m, 2H); In 
1
H NMR the signal 
for the methine proton was not detected due extensive broadening (see the 
temperature dependent 
1
H NMR spectra for 4.9a). 
13
C NMR (125 MHz, CDCl3) δ 50.1, 55.8, 84.7, 99.9, 116.8, 121.9, 122.5 (2C), 
127.3, 128.3 (2C), 128.5 (2C), 129.0, 130.1, 131.8(2C), 133.4, 133.9, 135.7, 139.9, 
144.0, 149.8, 171.8; Signals for the minor rotamer are given in parentheses. 
IR (cm
-1
) 2223, 1643, 1400; HRMS (ES
+
): calcd for C24H19BrN2ONa (M+Na)
+
 
453.0578, found 453.0571. 
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N-allyl-N-(1-(2-bromopyridin-3-yl)-3-(4-fluorophenyl)prop-2-yn-1-yl) benzamide  
(4.9n).  
The treatment of imine 4.8i (0.12 g, 0.53 mmol, 1.0 equiv), benzoyl chloride (0.091 g, 
75 µL, 0.64 mmol, 1.2 equiv) and p-fluorophenylacetylene (0.076 g, 73 µL, 0.64 
mmol, 1.2 equiv) with EtNiPr2 (0.082 g, 110 µL, 0.64 mmol, 1.2 equiv) and CuCl 
(0.011 g, 0.11 mmol, 0.2 equiv) according to the general procedure described above, 
followed by flash chromatography over silica eluting with EtOAc/Hexane (1:3) 
afforded enyne 4.9n (0.142 g, 60%) as a colorless oil: Rf  = 0.4 (EtOAc/Hexane 3:7). 
1
H NMR (400 MHz, CDCl3) δ 8.39 (br s, 1H), 8.27 (d, J = 6.0 Hz, 1H), 7.83 (br s, 
0.75H), 7.77-7.31 (m, 7.25H), 7.09 (t, J = 7.6 Hz, 2H), 6.91 (br s, 0.5H), 6.40 (br s, 
0.5H), 5.98 (br, 0.30H), 5.68 (br s, 0.70H), 5.25 (dd, J = 34.8 Hz, J = 16.8 Hz, 0.5H), 
4.82 (dd, J = 42.8 Hz, J = 9.6 Hz, 1.5H), 4.42-4.72 (m, 2H); In 
1
H NMR the signal for 
the methine proton appeared as two broad singlets (6.91 and 6.40 ppm) that integrate 
for only 0.5H when combined, due to extensive broadening (see the temperature 
dependent 
1
H NMR spectra for 4.9a). However the signals were presented herein as 
0.5H (6.91 ppm) and 0.5H (6.40 ppm).  
13
C NMR (125 MHz, CDCl3) δ 33.1, 84.4, 99.9, 115.8 (d, J = 22.0 Hz), 116.7, 
(116.9), (118.0), 122.6 (2C), (123.4), 126.9 (2C), 127.3, 128.5 (d, J = 27.3 Hz, 2C), 
130.2, 131.5, (133.3), 133.8 (d, J = 9.3 Hz, 2C), 133.9, (134.2), 135.6, (138.0), 139.8, 
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144.0, 149.8, (154.5), 162.9 (d, J = 249.4 Hz), 171.9; Signals for the minor rotamer 
are given in parentheses. 
IR (cm
-1
) 2223, 1643, 1400; HRMS (ES
+
): calcd for C24H18BrFN2ONa (M+Na)
+
 
471.0484, found 471.0487. 
 
 
N-allyl-N-(1-(2-bromopyridin-3-yl)-3-(4-methoxyphenyl)prop-2-yn-1-yl) 
benzamide (4.9o).  
The treatment of imine 4.8i (0.14 g, 0.63 mmol, 1.0 equiv), benzoyl chloride (103µL, 
0.76 mmol, 1.2 equiv) and p-methoxyphenylacetylene (99 µL, 0.76 mmol, 1.2 equiv) 
with EtNiPr2 (1320 µL, 0.76 mmol, 1.2 equiv) and CuCl (0.013 g, 0.12 mmol, 0.2 
equiv) according to the general procedure described above, followed by flash 
chromatography over silica eluting with EtOAc/Hexane (1:2) afforded enyne 4.9o 
(0.180 g, 62%) as a colorless oil: Rf  = 0.35 (EtOAc/Hexane 3:7). 
1
H NMR (400 MHz, CDCl3) δ 8.37 (d, J = 4.4 Hz, 1H), 8.29 (d, J = 6.0 Hz, 1H), 
7.53-7.40 (m, 5H), 7.34 (dd, J = 7.6 Hz, J = 4.8 Hz, 1H), 6.92 (d, J = 8.4 Hz, 2H), 
5.69 (br, 1H), 4.85 (d, J = 10.0 Hz, 1H), 4.74 (dd, J = 17.2 Hz, J = 1.2 Hz, 1H), 3.96 
(br s, 1.5H), 1.5H), 3.88 (br, 0.5H), 3.86 (s, 3H); In 
1
H NMR the signal for the 
methine proton was not observed due to extensive broadening (see the temperature 
dependent 
1
H NMR spectra for 4.9a).  
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13
C NMR (125 MHz, CDCl3) δ 50.0, 55.4, 83.3, 113.8, 114.1 (2C), 116.8, 122.5 (2C), 
127.3, 128.3 (2C), 130.1, 133.2 (2C), 133.5, 134.0, 135.8, 139.9, 144.0, 149.7, 160.1, 
171.8. 
IR (cm
-1
) 2213, 1643, 1249; HRMS (ES
+
): calcd for C25H21BrN2O2Na (M+Na)
+
 
483.0684, found 483.0692. 
 
 
N-(1-(2-bromopyridin-3-yl)-3-phenylprop-2-yn-1-yl)-N-(but-3-en-1-yl) enzamide  
(4.9p).  
The treatment of imine 4.8j (0.12 g, 0.5 mmol, 1.0 equiv), benzoyl chloride (0.084 g, 
70 µL, 0.6 mmol, 1.2 equiv) and phenylacetylene (0.061 g, 57 µL, 0.6 mmol, 1.2 
equiv) with EtNiPr2 (0.078 g, 104 µL, 0.6 mmol, 1.2 equiv) and CuCl (0.010 g, 0.1 
mmol, 0.2 equiv) according to the general procedure described above, followed by 
flash chromatography over silica eluting with EtOAc/Hexane (1:3) afforded enyne 
4.9p (0.137 g, 62%) as a colorless oil: Rf  = 0.4 (EtOAc/Hexane 3:7). 
1
H NMR (400 MHz, CDCl3) δ 8.41 (dd, J = 4.4 Hz, J = 1.2 Hz, 1H), 8.32 (d, J = 5.4 
Hz, 1H), 7.67 (br s, 2H), 7.56 (dd, J = 7.6 Hz, J = 2.4 Hz, 2H), 7.52-7.36 (m, 7H), 
6.83 (br s, 0.5H), 6.05 (br s, 0.5H), 5.60 (br s, 1H), 4.97-4.81 (m, 2H), 3.55-3.43 (m, 
1H), 3.25 (br s, 1H), 2.47 (br s, 1H), 1.95 (br s, 1H); In 
1
H NMR the signal for the 
methine proton appeared as two broad singlets (6.83 and 6.05 ppm) that integrate for 
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only 0.5H when combined, due to extensive broadening (see the temperature 
dependent 
1
H NMR spectra for 4.9f). However the signals were presented herein as 
0.5H (6.83 ppm) and 0.5H (6.05 ppm). 
13
C NMR (125 MHz, CDCl3) δ 33.0, (33.6), 43.5, (47.0), 50.0, (55.4), 84.8, 117.0, 
121.8, 122.7 (2C), 127.2, 128.3 (2C), 128.5 (2C), 128.8, 129.1, 129.8, 130.0, 131.7 
(2C), 136.0, 139.5, 143.8, 149.8, 171.8; Signals for the minor rotamer are given in 
parentheses; In 
13
C NMR spectra only one signal for the two sp carbons was 
observed.  
IR (cm
-1
) 1637, 1490, 1446; HRMS (ES
+
): calcd for C25H21BrN2ONa (M+Na)
+
 
467.0735, found 467.0741. 
 
 
N-(1-(2-bromopyridin-3-yl)-3-(4-fluorophenyl) prop-2-yn-1-yl)-N-(but-3-en-1- 
yl) benzamide (4.9q).  
The treatment of imine 4.8j (0.15 g, 0.627 mmol, 1.0 equiv), benzoyl chloride (0.128 
g, 106 µL, 0.752 mmol, 1.2 equiv) and p-fluorophenylacetylene (0.092 g, 87 µL, 
0.752 mmol, 1.2 equiv) with EtNiPr2 (0.072 g, 97 µL, 0.752 mmol, 1.2 equiv) and 
CuCl (0.013 g, 0.13 mmol, 0.2 equiv) according to the general procedure described 
above, followed by flash chromatography over silica eluting with EtOAc/Hexane 
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(1:3) afforded enyne 4.9q (0.175 g, 61%) as a colorless oil: Rf  = 0.4 (EtOAc/Hexane 
3:7). 
1
H NMR (400 MHz, CDCl3) δ 8.42 (dd, J = 4.8 Hz, J = 2.0 Hz, 1H), 8.30 (br s, 1H), 
7.78-7.58 (m, 2H), 7.57-7.51 (m, 2H), 7.49-7.37 (m, 4H), 7.10 (t, J = 8.4 Hz, 2H), 
5.95-5.38 (m, 1H), 4.90 (dd, J = 22.8 Hz, J = 10.4 Hz, 2H), 3.60-3.40 (m, 1.25H), 
3.23 (br s, 0.75H), 2.55-2.34 (m, 1H), 1.95 (br s, 1H); In 
1
H NMR the signal for the 
methine proton was not observed.  
13
C NMR (125 MHz, CDCl3) δ 84.6, 115.9 (d, J  
= 22 Hz, 2C), (117.0), 117.5, (122.6), 122.7 (2C), 126.7, 127.2, 128.4 (2C), 128.5, 
130.0, 131.4, 133.7 (d, J = 8.5 Hz, 2C), (135.3), 135.9, 139.4, 143.8, 149.9, 163.0 (d, 
J = 249 Hz), 171.8; In 
13
C NMR spectra only one signal for the two methylene 
carbons and only one signal for the two sp carbons was observed. No signal was 
observed for methine due to significant broadening. Signals for the minor rotamer are 
given in parentheses. 
IR (cm
-1
) 2230, 1643, 1506, 1400; HRMS (ES
+
): calcd for C25H20BrFN2ONa 
(M+Na)
+
 485.0641, found 485.0640. 
 
 
N-(1-(2-bromopyridin-3-yl)-3-(4-methoxyphenyl) prop-2-yn-1-yl)-N-(but-3-en-1- 
yl) benzamide (4.9r).  
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The treatment of imine 4.8j (0.166 g, 0.694 mmol, 1.0 equiv), benzoyl chloride 
(0.115 g, 95 µL, 0.832 mmol, 1.2 equiv) and p-methoxyphenylacetylene (0.110 g, 
108 µL, 0.832 mmol, 1.2 equiv) with EtNiPr2 (0.107 g, 144 µL, 0.832 mmol, 1.2 
equiv) and CuCl (0.014 g, 0.14 mmol, 0.2 equiv) according to the general procedure 
described above, followed by flash chromatography over silica eluting with 
EtOAc/Hexane (1:3) afforded enyne 4.9r (0.207 g, 63%) as a colorless oil: Rf  = 0.3 
(EtOAc/Hexane 3:7). 
1
H NMR (400 MHz, CDCl3) δ 8.41 (dd, J = 4.4 Hz, J = 1.2 Hz, 1H), 8.36-8.26 (m, 
1.4H), 7.67 (br, 1.6H), 7.53-7.36 (m, 6H), 6.92 (d, J = 8.4 Hz, 1H), 6.91 (br s, 0.5H), 
6.80 (d, J = 9.2 Hz, 1H), 6.01 (br s, 0.5H), 5.76-5.44 (m, 1H), 5.04-4.76 (m, 2H), 3.86 
(s, 2H), 3.82 (s, 1H), 3.57-2.87 (m, 2H), 2.45 (br s, 0.75H), 2.17-1.82 (m, 1.25H); In 
1
H NMR the signal for the methine proton appeared as two broad singlets (6.91 and 
6.01 ppm) that integrate for only 0.7H when combined, due to extensive broadening 
(see the temperature dependent 
1
H NMR spectra for 4.9f). However the signals were 
presented herein as 0.5H (6.91 ppm) and 0.5H (6.01 ppm).  
13
C NMR (125 MHz, CDCl3) δ 33.4, 49.1, 55.33, (55.39), 56.5, (83.4), 83.8, 88.7, 
113.8, (113.9), 114.1, (114.6), 115.7, 122.6, 122.7 (2C), (127.3), 128.3 (2C), (130.0), 
(133.1), 133.2 (2C), 135.9, 136.0, 136.3, 139.6 (2C), (140.6), 143.8, 144.2, 149.1, 
(149.8), 159.7, 171.8. 
IR (cm
-1
) 2221, 1641, 1510, 1029; HRMS (ES
+
): calcd for C26H24BrN2O2Na (M+H)
+
 
475.1021, found 475.1017. 
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1-Benzyl-6-(2-bromophenyl)-5-methylene-4-phenyl-5,6-dihydropyridin-2-one 
(4.10) and 1-Benzyl-5-(2-bromophenyl)-4-(1-phenylvinyl)-pyrrol-2-one (4.11). 
 
The solution of enyne 4.5 (0.13 g, 0.30 mmol, 1.0 equiv) in toluene (20 mL) was 
degassed with ethylene for 5 min, Grubb’s II catalyst (0.025 g, 0.03 mmol, 0.1 equiv) 
was added and the reaction mixture was stirred at 85
o
C under ethylene atmosphere for 
20 h. The mixture was cooled to rt, directly loaded on a silica column and purified by 
flash chromatography, eluting with EtOAc/Hexane (1:9) to afford pure diene 4.10 
(0.045 g, 35%) as a colorless heavy oil and continuous elution with EtOAc/Hexane 
(1:4) afforded pure diene 4.11 (0.03 g, 23%) as a colorless heavy oil. 
 
 
Analytical data for 4.10: Rf  = 0.52 (EtOAc/Hexane 3:7). 
1
H NMR (400 MHz, CDCl3) δ 7.63 (d, J = 8.0 Hz, 1H), 7.53 (d, J = 7.6 Hz, 1H), 
7.38-7.31 (m, 8H), 7.25-7.17 (m, 4H), 6.21 (s, 1H), 5.83 (s, 1H), 5.75 (s, 1H), 5.45 (d, 
J = 14.8 Hz, 1H), 5.16 (s, 1H), 3.57 (d, J = 14.4 Hz, 1H). 
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13
C NMR (125 MHz, CDCl3) δ 46.1, 61.0, 119.1, 119.6, 121.3, 126.1, 126.2, 126.9, 
127.15 (2C), 127.16 (2C), 127.18 (2C), 127.2 (2C), 127.8, 128.3, 132.2, 135.3, 135.5, 
137.5, 138.9, 147.0, 162.8. 
IR (cm
-1
) 1689, 1494, 1265; HRMS (ES
+
): calcd for C25H21BrNO (M+H)
+
 430.0807, 
found 430.0808. 
 
 
Analytical data for 4.11: Rf  = 0.45 (EtOAc/Hexane 3:7). 
1
H NMR (400 MHz, CDCl3) δ 7.59 (d, J = 8.0 Hz, 1H), 7.37-7.31 (m, 5H), 7.25-7.16 
(m, 7H), 7.07 (dd, J = 7.6 Hz, J = 1.6 Hz, 1H), 6.13 (s, 1H), 5.90 (s, 1H), 5.38 (s, 1H), 
5.26 (s, 1H), 5.01 (d, J = 15.2 Hz, 1H), 3.71 (d, J = 15.2 Hz, 1H). 
13
C NMR (125 MHz, CDCl3) δ 44.0, 64.2, 120.1, 125.1, 127.3, 127.5, 128.00, 128.03 
(2C), 128.2, 128.3 (2C), 128.4 (2C), 128.5 (2C), 130.2, 130.4, 133.2, 135.2, 137.2, 
139.4, 141.6, 158.9, 170.8. 
IR (cm
-1
) 1650, 1494, 1261; HRMS (ES
+
): calcd for C25H21BrNO (M+H)
+
 430.0807, 
found 430.0803. 
 
General procedure for the preparation of dihydropyrroles 4.12a-h:  
The solution of 1,6-enynes 4.9a-e, 4.9k or or 4.9m-n (1.0 equiv) in toluene (5-15 
mL) was degassed with ethylene for 5 min, Grubb’s I catalyst (0.1 equiv) was added 
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and the reaction mixture was stirred at 85
o
C under ethylene atmosphere for 2h. The 
mixture was cooled to rt, directly loaded on a silica column and purified by flash 
chromatography eluting with EtOAc/Hexane mixtures to afford pure dihydropyrroles 
4.12a-h.  
. 
 
N-benzoyl-(2-(2-bromophenyl)-3-(1-phenylvinyl)-2,5-dihydro)-pyrrole (4.12a).  
The treatment of enyne 4.9a (0.07 g, 0.16 mmol, 1.0 equiv) with Grubb’s I catalyst 
(0.013 g, 0.016 mmol, 0.1 equiv) according to the general procedure described above, 
followed by flash chromatography over silica eluting with EtOAc/Hexane (1:4) 
afforded dihydropyrrole 4.12a (0.065 g, 93%) as colorless oil: Rf = 0.6 
(EtOAc/Hexane 3:7). 
1
H NMR (400 MHz, CDCl3) δ 7.56 (d, J = 8.0 Hz, 1H), 7.54 (d, J = 6.4 Hz, 1H), 7.41 
(t, J = 7.2 Hz, 3H), 7.35-7.31 (m, 4.3H), 7.24-7.19 (m, 2.7H), 7.14 (t, J = 7.6 Hz, 1H), 
7.04-6.96 (m, 1H), 6.64 (s, 0.7H), 6.11 (s, 0.3H), 5.92 (s, 0.3H), 5.75 (s, 0.7H), 5.38 
(s, 0.7H), 5.28 (s, 0.3H), 5.16 (s, 0.7H), 5.09 (s, 0.3H), 4.84-4.66 (m, 1.3H), 4.27 (d, J 
= 16.0 Hz, 0.7H); The signals that integrate for less than 1H arise due to hindered 
rotation as confirmed by the temperature dependent 
1
H NMR recorded for the diene 
4.12a.  
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13
C NMR (125 MHz, CDCl3) δ (54.3), 56.9, (60.4), 67.6, (116.9), 117.6, 125.0, 125.9, 
127.2 (2C), 127.6, 127.7, 128.0, 128.1 (2C), 128.25 (2C), 128.28 (2C), 128.5, 129.1, 
(129.2), 130.1, 133.5, 136.1, (136.8), 139.5, (140.5), 140.7, 142.1, (142.2), 169.5, 
(171.1); Signals for the minor rotamer are given in parentheses. 
IR (cm
-1
) 1643, 1492, 1469; HRMS (ES
+
): calcd for C25H21BrNO (M+H)
+
 430.0807, 
found 430.0801. 
 
 
N-benzoyl-(2-(2-bromo-4,5-dimethoxyphenyl)-3-(1-phenylvinyl)-2,5-dihydro)-
pyrrole (4.12b).  
The treatment of enyne 4.9b (0.072 g, 0.15 mmol, 1.0 equiv) with Grubb’s I catalyst 
(0.012 g, 0.015 mmol, 0.1 equiv) according to the general procedure described above, 
followed by flash chromatography over silica eluting with EtOAc/Hexane (1:3) 
afforded dihydropyrrole 4.12b (0.058 g, 81%) as a yellow oil: Rf = 0.33 
(EtOAc/Hexane 3:7). 
1
H NMR (400 MHz, CDCl3) δ 7.55 (d, J = 7.2 Hz, 1H), 7.46-7.38 (m, 3H), 7.36-7.26 
(m, 4H), 7.22 (t, J = 6.8 Hz, 2H), 7.04 (d, J = 7.6 Hz, 2H), 6.82 (s, 0.5H), 6.48 (s, 
0.5H), 5.93 (s, 0.4H), 5.76 (s, 0.6H), 5.36 (s, 0.7H), 5.25 (s, 0.3H), 5.17 (s, 0.7H), 
5.10 (s, 0.3H), 4.83- 4.65 (m, 1.5H), 4.28 (d, J = 24.4 Hz, 0.5H), 3.87 (s, 2H), 3.86 (s, 
2H), 3.82 (s, 2H): The signals that integrate for less than 
1
H arise due to hindered 
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rotation as confirmed by the temperature dependent 
1
H NMR recorded for the diene 
4.12a.  
13
C NMR (125 MHz, CDCl3) δ (54.2), (55.9), 56.0, 56.1, 56.9, 67.9, 116.0, (116.9), 
117.6, 124.7, 125.9, 127.2 (2C), 127.71 (2C), 127.76, 128.0, 128.2 (2C), 128.3 (2C), 
128.4, 129.2, 130.2, (130.9), 136.2, 140.7, 142.2, 148.6, 149.0, 169.7; Signals for the 
minor rotamer are given in parentheses. 
IR (cm
-1
) 1643, 1444, 1159, 1026; HRMS (ES
+
): calcd for C27H25BrNO3 (M+H)
+
 
490.1018, found 490.1024. 
 
 
N-benzoyl-(2-(2-bromo-5-fluorophenyl)-3-(1-phenylvinyl)-2,5-dihydro)-pyrrole 
(4.12c).  
The treatment of enyne 4.9c (0.094 g, 0.21 mmol, 1.0 equiv) with Grubb’s I catalyst 
(0.018 g, 0.02 mmol, 0.1 equiv) according to the general procedure described above, 
followed by flash chromatography over silica eluting with EtOAc/Hexane (1:9) 
afforded dihydropyrrole 4.12c (0.068 g, 72%) as a colorless oil: Rf = 0.75 
(EtOAc/Hexane 3:7). 
1
H NMR (400 MHz, CDCl3) δ 7.58-7.47 (m, 2H), 7.46-7.35 (m, 3H), 7.31 (t, J = 6.8 
Hz, 3H), 7.24-7.14 (m, 2H), 7.09 (dd, J = 9.2 Hz, J = 2.8 Hz, 1H), 7.02 (d, J = 7.6 Hz, 
0.75H), 6.87 (td, J = 8.4 Hz, J = 2.8 Hz, 1H), 6.74 (br s, 0.25H), 6.57 (s, 0.75H), 6.03 
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(s, 0.25H), 5.94 (s, 0.25H), 5.76 (s, 0.75H), 5.34 (s, 0.75H), 5.23 (s, 0.25H), 5.16 (s, 
0.75H), 5.09 (s, 0.25H), 4.81- 4.63 (m, 1.25H), 4.26 (d, J = 16.0 Hz, 0.75H); The 
signals that integrate for less than 1H arise due to hindered rotation as confirmed by 
the temperature dependent 
1
H NMR recorded for the diene 4.12a.  
13
C NMR (125  MHz, CDCl3) δ (54.3), 56.7, 67.4, 116.5 (d, J = 22.3 Hz, 2C), 117.7, 
125.3, (125.5), 125.9, (126.5), 127.2 (2C), 127.83, 127.89, 127.9, 128.25 (2C), 128.27 
(d, J = 19.1 Hz, 2C), 128.6, (129.0), 129.4, 130.3, 134.6 (d, J = 7.6 Hz), 135.8, 
(136.6), (140.2), 140.5, (141.8), 142.0, 161.3 (d, J = 245.2 Hz), 169.6; Signals for the 
minor rotamer are given in parentheses. 
IR (cm
-1
) 1641, 1465, 1400; HRMS (ES
+
): calcd for C25H20BrFNO (M+H)
+
 
448.0712, found 448.0720. 
 
 
N-benzoyl-(2-(2-bromophenyl)-3-(1-(4-fluorophenyl)vinyl)-2,5-dihydro)-pyrrole 
(4.12d).  
The treatment of  enyne 4.9d (0.079 g, 0.17 mmol, 1.0 equiv) with Grubb’s I catalyst 
(0.015 g, 0.017 mmol, 0.1 equiv) according to the general procedure described above, 
followed by flash chromatography over silica eluting with EtOAc/Hexane (1:5) 
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afforded dihydropyrrole 4.12d (0.069 g, 87%) as a colorless heavy oil: Rf  = 0.47 
(EtOAc/Hexane 3:7). 
1
H NMR (400 MHz, CDCl3) δ 7.62-7.49 (m, 2H), 7.47-7.36 (m, 2H), 7.33 (t, J = 7.6 
Hz, 1H), 7.68-7.10 (m, 5H), 7.02 (q, J = 8.8 Hz, 3H), 6.62 (s, 0.7H), 6.09 (s, 0.3H), 
5.91 (s, 0.3H), 5.72 (s, 0.7H), 5.37 (s, 0.7H), 5.27 (s, 0.3H), 5.13 (s, 0.7H), 5.06 (s, 
0.3H), 4.84-4.66 (m, 1.5H), 4.28 (d, J = 16.4 Hz, 0.5H); The signals that integrate for 
less than 1H arise due to hindered rotation as confirmed by the temperature dependent 
1
H NMR recorded for the diene 4.12a.  
13
C NMR (125 MHz, CDCl3) δ (54.3), 56.9, 67.6, 115.1 (d, J = 21.3 Hz, 2C), (117.0), 
117.7, (124.0), 125.1, 125.9, 127.2 (2C), 127.7, 128.2 (2C), 128.5, 129.1, 129.2, 
[129.5, (d, J = 7.8 Hz, )], 129.5 (d, J = 8.0 Hz, 2C), 130.2, (132.6), 133.6, 136.1, 
(136.4), 136.7 (d, J = 3.1 Hz), (136.8), 139.4, 141.1, (141.2), (142.6), [162.4, (d, J = 
245.5 Hz, )], 162.3 (d, J = 245.0 Hz), 169.6, (171.1); Signals for the minor rotamer 
are given in parentheses. 
IR (cm
-1
) 1643, 1508, 1448; HRMS (ES
+
): calcd for C25H19BrFNONa (M+Na)
+
 
470.0532, found 470.0537. 
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N-benzoyl-(2-(2-bromophenyl)-3-(1-(4-fluorophenyl)vinyl)-2,5-dihydro)-pyrrole 
(4.12e).  
The treatment of enyne 4.9e (0.09 g, 0.2 mmol, 1.0 equiv) with Grubb’s I catalyst 
(0.016 g, 0.02 mmol, 0.1 equiv) according to the general procedure described above, 
followed by flash chromatography over silica eluting with EtOAc/Hexane (3:7) 
afforded dihydropyrrole 4.9e (0.057 g, 63%) as colorless oil: Rf = 0.45 
(EtOAc/Hexane 3:7). 
1
H NMR (400 MHz, CDCl3) δ 7.60-7.52 (m, 2H), 7.46-7.36 (m, 3H), 7.32 (t, J = 7.6 
Hz, 1H), 7.22 (d, J = 8.4 Hz, 2.5H), 7.18-7.09 (m, 1.5H), 7.00 (t, J = 7.2 Hz, 1H), 
6.85 (t, J = 9.2 Hz, 2H), 6.62 (br s, 0.7H), 6.09 (br s, 0.3H), 5.93 (s, 0.4H), 5.76 (s, 
0.6H), 5.32 (s, 0.6H), 5.20 (br s, 0.4H), 5.12 (s, 0.6H), 5.05 (s, 0.4H), 4.82-4.68 (m, 
1.4H), 4.28 (d, J = 16.0 Hz, 0.6H), 3.82 (s, 3H); The signals that integrate for less 
than 1H arise due to hindered rotation as confirmed by the temperature dependent 
1
H 
NMR recorded for the diene 4.9a.  
13
C NMR (125 MHz, CDCl3) δ (54.3), 55.2, 56.9, 67.6, 115.9, 116.7, (124.0), 124.8, 
125.9, 127.2 (2C), 127.6, (127.8), (128.1), 128.2 (2C), 128.4, 129.0 (2C), 129.2, 
129.3 (2C), (129.7), 130.1, (132.6), 132.9, 133.2, 133.5, 136.2, (136.8), (139.5), 
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141.60, (141.65), (142.9), 159.1, (159.2), 169.5, (171.2); Signals for the minor 
rotamer are given in parentheses. 
IR (cm
-1
) 1643, 1398, 1027; HRMS (ES
+
): calcd for C26H23BrNO2 (M+H)
+
 460.0912, 
found 460.0904. 
 
 
N-benzoyl-(2-(3-bromothiophen-2-yl)-3-(1-phenylvinyl)-2,5-dihydro)-pyrrole 
(4.12f).  
The treatment of enyne 4.9k (0.097 g, 0.22 mmol, 1.0 equiv) with Grubb’s I catalyst 
(0.018 g, 0.22 mmol, 0.1 equiv) according to the general procedure described above, 
followed by flash chromatography over silica eluting with EtOAc/Hexane (1:8) 
afforded dihydropyrrole 4.12f (0.079 g, 81%) as a colorless heavy oil: Rf  = 0.59 
(EtOAc/Hexane 3:7). 
1
H NMR (400 MHz, CDCl3) δ 7.25 (d, J = 6.4 Hz, 1H), 7.46-7.39 (m, 2H), 7.37-7.30 
(m, 6H), 7.25 (d, J = 4.8 Hz, 1H), 7.17 (t, J = 7.6 Hz, 1H), 6.94 (d, J = 5.6 Hz, 0.7H), 
6.73 (d, J = 3.6 Hz, 0.7H), 6.63 (d, J = 5.2 Hz, 0.3H), 6.11 (s, 0.3H), 5.87 (s, 0.3H), 
5.71 (s, 0.7H), 5.39 (s, 0.7H), 5.28 (s, 0.3H), 5.23 (s, 0.7H), 5.14 (s, 0.3H), 4.78- 4.64 
(m, 1.5H), 4.22 (d, J = 16.0 Hz, 0.5H); The signals that integrate for less than 1H 
arise due to hindered rotation as confirmed by the temperature dependent 
1
H NMR 
recorded for the diene 4.12a.  
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13
C NMR (125 MHz, CDCl3) δ (53.3), 56.0, 61.9, (63.6), (110.7), 110.8, (116.8), 
117.7, 124.7, (124.92), (124.99), (125.5), 125.8, (126.8), 127.3, 127.7, (127.8), 
(128.1), 128.22 (2C), 128.28 (2C), 128.3 (2C), (128.4), 128.7, (129.4), (129.5), 130.3 
(2C), 135.8, (136.5), 138.9, (139.9), (140.5), 140.6, 141.8, (141.9), 142.2, (143.1), 
169.4, (170.9); Signals for the minor rotamer are given in parentheses. 
IR (cm
-1
) 1643, 1577, 1446; HRMS (ES
+
): calcd for C23H18BrNOSNa (M+Na)
+
 
458.0190, found 458.0181. 
 
 
N-benzoyl-(2-(2-bromopyridin-3-yl)-3-(1-phenylvinyl)-2,5-dihydro)-pyrrole 
(4.12g).  
The treatment of enyne 4.9m (0.072 g, 0.17 mmol, 1.0 equiv) with Grubb’s I catalyst 
(0.014 g, 0.017 mmol, 0.1 equiv) according to the general procedure described above 
followed by flash chromatography over silica eluting with EtOAc/Hexane (1:3) 
afforded dihydropyrrole 4.12g (0.05 g, 69%) as a colorless oil: Rf = 0.55 
(EtOAc/Hexane 7:3). 
1
H NMR (400 MHz, CDCl3) δ 8.31 (ddd, J = 10.0 Hz, J = 6.0 Hz, J = 1.6 Hz, 0.7H), 
8.19 (br s, 0.3H), 7.78 (dd, J = 7.6 Hz, J = 1.6 Hz, 0.5H), 7.71 (dd, J = 8.0 Hz, J = 1.6 
Hz, 0.5H), 7.56 (d, J = 7.2 Hz, 2H), 7.42 (q, J = 7.2 Hz, 3H), 7.38-7.30 (m, 4H), 7.23-
7.29 (m, 1H), 7.20 (br s, 1H), 7.03 (br s, 0.5H), 6.49 (s, 0.5H), 6.15-5.90 (m, 0.3H), 
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5.83 (s, 0.7H), 5.34 (s, 0.5H), 5.28 (s, 0.5H), 5.19 (d, J = 4.0 Hz, 0.7H), 5.11 (d, J = 
11.2 Hz, 0.3H), 4.82-4.67 (m, 1.3H), 4.31 (d, J = 16.4 Hz, 0.7H); The signals that 
integrate for less than 1H arise due to hindered rotation as confirmed by the 
temperature dependent 
1
H NMR recorded for the diene 4.12a.
  
13
C NMR (125 MHz, CDCl3) δ (54.3), 57.1, (66.4), 67.8, 117.4, (117.7), (122.6), 
122.9, (125.7), 125.81, (125.89), 127.2 (2C), 127.91, 127.96, 128.1 (2C), 128.2 (2C), 
128.4 (2C), 128.7, 128.8, (129.7), 130.4, (134.2), 135.7, (136.5), (140.0), 140.2, 
142.0, (142.1), 148.7, (148.8), 149.1, (150.2), 169.9; Signals for the minor rotamer 
are given in parentheses. 
IR (cm
-1
) 1643, 1497, 1400; HRMS (ES
+
): calcd for C24H20BrN2O (M+H)
+
 431.0759, 
found 431.0769. 
 
 
N-benzoyl-(2-(2-bromopyridin-3-yl)-3-(1-(4-fluorophenyl)vinyl)-2,5-dihydro)-
pyrrole (4.12h).  
The treatment of enyne 4.9n (0.066 g, 0.147 mmol, 1.0 equiv) with Grubbs I catalyst 
(0.012 g, 0.015 mmol, 0.1 equiv) according to the general procedure described above 
followed by flash chromatography over silica eluting with EtOAc/Hexane (1:3) 
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afforded dihydropyrrole 4.12h (0.039 g, 60%) as a colorless oil: Rf = 0.5 
(EtOAc/Hexane 7:3). 
1
H NMR (400 MHz, CDCl3) δ 8.32 (br s, 0.8H), 8.1 (br s, 0.2H), 7.72 (d, J = 7.2 Hz, 
1H), 7.56 (d, J = 6.4 Hz, 2H), 7.49-7.38 (m, 4H), 7.25-7.14 (m, 1H), 7.08-6.97 (m, 
3.5H), 6.47 (s, 0.5H), 6.10-5.90 (m, 0.3H), 5.8 (s, 0.7H), 5.31 (s, 1H), 5.16 (s, 1H), 
4.85-4.65 (m, 1.3H), 4.25 (d, J = 16.8 Hz, 0.7H); The signals that integrate for less 
than 1H arise due to hindered rotation as confirmed by the temperature dependent 
1
H 
NMR recorded for the diene 4.12a.
  
13
C NMR (125 MHz, CDCl3) δ 57.9, 67.8, 115.2 (d, J = 21.3 Hz, 2C), 117.8, 122.9, 
(125.2), 125.7, 126.0, 127.2 (2C), 128.2 (d, J = 6.3 Hz), 128.42 (2C), 128.48, (128.8), 
(129.5), 129.8 (d, J = 7.7 Hz, 2C), 130.1, 130.5, (133.5), 135.7, 136.2, 141.1, 149.2, 
162.3 (d, J = 245.2 Hz), 170.0; Signals for the minor rotamer are given in 
parentheses. 
IR (cm
-1
) 1643, 1465, 1409; HRMS (ES
+
): calcd for C24H18BrFN2ONa (M+Na)
+
 
471.0484, found 471.0481. 
 
General procedure for the synthesis of dihydropyridines 4.13a-i:  
The solution of 1,7-enynes 4.9f-j, 4.9l or 4.9p-r (1.0 equiv) in toluene (5-10 mL) was 
degassed with ethylene for 5 min, Grubb’s II catalyst (0.1 equiv) was added, and the 
mixture was stirred at 85
o
C under ethylene atmosphere for 8h. The mixture was 
cooled to rt, directly loaded on a silica column and purified by flash chromatography 
eluting with EtOAc/Hexane mixtures to afford dihydropyridines 4.13a-i. 
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N-benzoyl-(2-(2-bromophenyl)-3-(1-phenylvinyl)-5,6-dihydropyridine (4.13a).  
The treatment of enyne 4.9f (0.12 g, 0.27 mmol, 1.0 equiv) with Grubb’s II catalyst 
(0.023 g, 0.027 mmol, 0.1 equiv) according to the general procedure described above, 
followed by flash chromatography over silica eluting with EtOAc/Hexane (1:8) 
afforded dihydropyridine 4.13a (0.108 g, 92%) as a colorless oil: Rf = 0.6 
(EtOAc/Hexane 3:7). 
1
H NMR (400 MHz, CDCl3) δ 7.70 (br s, 1H), 7.51 (d, J = 7.6 Hz, 3H), 7.45-7.40 (m, 
3H), 7.37-7.31 (m, 6H), 7.22 (t, J = 7.2 Hz, 1H), 6.97 (br s, 1H), 5.98 (br s, 1H), 5.15 
(br s, 1H), 5.04 (br s, 1H), 3.57 (br s, 1H), 3.16 (br s, 1H), 2.26 (br s, 1H), 2.11 (br s, 
1H); The broadening of some signals arise due to hindered rotation as suggested by 
the temperature dependent 
1
H NMR recorded for the diene 4.13a.  
13
C NMR (125 MHz, CDCl3) δ 26.7, 40.1, 52.9, 115.1, 125.1, 126.8, 127.3, 127.5, 
127.7, 128.0 (2C), 128.4, 128.9 (2C), 129.3, 129.9 (2C), 131.0, 133.8 (2C), 135.8, 
137.1, 138.6, 141.1, 147.0, 171.3. 
IR (cm
-1
) 1645, 1465, 1409; HRMS (ES
+
): calcd for C26H23BrNO (M+H)
+
 444.0963, 
found 444.0964. 
 
216 
 
 
N-benzoyl-(2-(2-bromo-4,5-dimethoxyphenyl)-3-(1-phenylvinyl)-5,6-
dihydropyridine (4.13b).  
The treatment of enyne 4.9g (0.055 g, 0.11 mmol, 1.0 equiv) with Grubb’s II catalyst 
(0.0093 g, 0.011 mmol, 0.1 equiv) according to the general procedure described 
above, followed by flash chromatography over silica eluting with EtOAc/Hexane 
(1:4) afforded  dihydropyridine 4.13b (0.048 g, 87%) as a colorless heavy oil: Rf  = 
0.4 (EtOAc/Hexane 3:7). 
1
H NMR (400 MHz, CDCl3) δ 7.68-7.49 (m, 3H), 7.48-7.28 (m, 7H), 7.16 (br s, 1H), 
7.02 (s, 1H), 6.88 (br s, 1H), 6.00 (br s, 1H), 5.20 (br s, 1H), 5.06 (br s, 1H), 3.91 (s, 
3H), 3.88 (s, 3H), 3.61 (br s, 1H), 3.21 (br s, 1H), 2.28 (br s, 1H), 2.11 (br s, 1H); The 
broadening of some signals arise due to hindered rotation as suggested by the 
temperature dependent 
1
H NMR recorded for the diene 4.13a.  
13
C NMR (125 MHz, CDCl3) δ 26.8, 40.2, 52.8, 56.18, 56.19, 114.1, 115.3, 116.4, 
127.4, 127.5, 127.9, 128.1 (2C), 128.3, 128.6, 128.8 (2C), 129.9 (2C), 130.6, 135.9, 
137.5, 141.0, 146.9, 147.6 (2C), 149.0, 171.1. 
IR (cm
-1
) 1643, 1440, 1205, 1026; HRMS (ES
+
): calcd for C28H26BrNO3Na (M+Na)
+
 
526.0994, found 526.0994. 
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N-benzoyl-(2-(2-bromo-5-fluorophenyl)-3-(1-phenylvinyl)-5,6-dihydropyridine 
(4.13c).  
The treatment of enyne 4.9h (0.09 g, 0.19 mmol, 1.0 equiv) with Grubb’s II catalyst 
(0.016 g, 0.019 mmol, 0.1 equiv) according to the general procedure described above, 
followed by flash chromatography over silica eluting with EtOAc/Hexane (1:9) 
afforded dihydropyridine 4.13c (0.079 g, 88%) as a yellow heavy oil: Rf  = 0.55 
(EtOAc/Hexane 3:7). 
1
H NMR (400 MHz, CDCl3) δ 7.63 (br s, 1H), 7.48-7.52 (m, 2H), 7.45-7.35 (m, 6H), 
7.34-7.30 (m, 2H), 7.24 (dd, J = 9.6 Hz, J = 2.8 Hz, 1H), 7.10-6.75 (m, 2H), 6.01 (br 
s, 1H), 5.13 (br s, 1H), 5.06 (br s, 1H), 3.60 (br s, 1H), 3.14 (br s, 1H), 2.25 (br s, 1H), 
2.11 (br s, 1H); The broadening of some signals arise due to hindered rotation as 
suggested by the temperature dependent 
1
H NMR recorded for the diene 4.13a.  
13
C NMR (125 MHz, CDCl3) δ 26.6, 40.2, 52.7, 115.2, 116.8, [117.7, (d, J = 22.1 
Hz)], 118.2 (d, J = 24.0 Hz), (119.1), 126.8, 127.4 (d, J = 12.0 Hz, 2C), 128.1 (2C), 
128.4, 128.81, 128.88 (2C), (129.3), 129.9, 130.1, 130.4, 133.8, 134.9 (d, J = 7.6 Hz, 
2C), (135.6), 136.7, 140.8, 146.9, 161.6 (d, J = 245.1 Hz), [161.9, (d, J = 246.7 Hz)], 
(171.4), 172.6; Signals for the minor rotamer are given in parentheses. 
IR (cm
-1
) 1649, 1465, 1445; HRMS (ES
+
): calcd for C26H22BrFNO (M+H)
+
 
462.0869, found 462.0862. 
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N-benzoyl-(2-(2-bromophenyl)-3-(1-(4-fluorophenyl)vinyl)-5,6-dihydropyridine 
(4.13d).  
The treatment of enyne 4.9i (0.08 g, 0.17 mmol, 1.0 equiv) with Grubb’s II catalyst 
(0.015 g, 0.017 mmol, 0.1 equiv) according to the general procedure described above, 
followed by flash chromatography over silica eluting with EtOAc/Hexane (1:9) 
afforded dihydropyridine 4.13d (0.068 g, 85%) as a colorless oil: Rf  = 0.6 
(EtOAc/Hexane 3:7). 
1
H NMR (400 MHz, CDCl3) δ 7.70 (br s, 1H), 7.62-7.47 (m, 4H), 7.44-7.38 (m, 3H), 
7.36-7.30 (m, 2H), 7.24-7.30 (m, 1H), 7.05 (t, J = 8.4 Hz, 2H), 6.93 (br s, 1H), 5.98 
(br s, 1H), 5.15 (br s, 1H), 5.02 (br s, 1H), 3.60 (br s, 1H), 3.17 (br s, 1H), 2.28 (br s, 
1H), 2.12 (br s, 1H); The broadening of some signals arise due to hindered rotation as 
suggested by the temperature dependent 
1
H NMR recorded for the diene 4.13a.  
13
C NMR (125 MHz, CDCl3) δ 26.7, 40.1, 53.0, 114.9 (d, J = 21.2 Hz, 2C), 115.4, 
125.1, 126.8, 127.5, 128.4, 128.9, 129.4, 130.0 (2C), 130.4 (d, J = 7.8 Hz, 2C ), 
130.9, 133.9 (2C), 135.8, 136.9 (d, J = 3.3 Hz), 137.3, 138.5, 146.1, 160.2 (d, J = 
244.5 Hz), 171.3. 
IR (cm
-1
) 1643, 1440, 1402; HRMS (ES
+
): calcd for C26H21BrFNONa (M+Na)
+
 
484.0688, found 484.0688. 
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N-benzoyl-(2-(2-bromophenyl)-3-(1-(4-methoxyphenyl)vinyl)-5,6-
dihydropyridine (4.13e).  
The treatment of enyne 4.9j (0.079 g, 0.17 mmol, 1.0 equiv) with Grubb’s II catalyst 
(0.014 g, 0.017 mmol, 0.1 equiv) according to the general procedure described above, 
followed by flash chromatography over silica eluting with EtOAc/Hexane (1:8) 
afforded dihydropyridine 4.13e (0.063 g, 80%) as a colorless oil: Rf = 0.45 
(EtOAc/Hexane 3:7). 
1
H NMR (400 MHz, CDCl3) δ 7.69 (br s, 1H), 7.50 (d, J = 6.4 Hz, 3H), 7.46-7.37 (m, 
3H), 7.34 (t, J = 7.6 Hz, 1H), 7.30-7.17 (m, 3H), 6.94 (br s, 1H), 6.91 (d, J = 8.8 Hz, 
2H), 6.03 (br s, 1H), 5.11 (br s, 1H), 5.02 (br s, 1H), 3.84 (s, 3H), 3.56 (br s, 1H), 
3.16 (br s, 1H), 2.27 (br s, 1H), 2.11 (br s, 1H); The broadening of some signals arise 
due to hindered rotation as suggested by the temperature dependent 
1
H NMR 
recorded for the diene 4.13a.  
13
C NMR (125 MHz, CDCl3) δ 25.3, 39.1, 52.0, 54.3, 112.3 (2C), 113.3, 124.3, 
125.7, 126.5, 127.3, 127.6, 128.2, 128.90 (2C), 128.93 (2C), 130.0, 132.3, 132.8 (2C), 
134.8, 136.4, 137.6, 145.6, 157.8, 170.3. 
IR (cm
-1
) 1639, 1485, 1446; HRMS (ES
+
): calcd for C27H25BrNO2 (M+H)
+
 474.1069, 
found 474.1069. 
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N-benzoyl-2-(3-bromothiophen-2-yl)-3-(1-phenylvinyl)-5,6-dihydropyridine 
(4.13f).  
The treatment of enyne 18b (0.17 g, 0.38 mmol, 1.0 equiv) with Grubb’s II catalyst 
(0.032 g, 0.038 mmol, 0.1 equiv) according to the general procedure described above, 
followed by flash chromatography over silica eluting with EtOAc/Hexane (1:9) 
afforded dihydropyridine 4.9l (0.14 g, 82%) as a colorless oil: Rf  = 0.55 
(EtOAc/Hexane 1:7). 
1
H NMR (400 MHz, CDCl3) δ 7.51-7.46 (br, 2H), 7.42 (t, J = 7.2 Hz, 3H), 7.40-7.30 
(m, 5H), 7.27 (d, J = 6.0 Hz, 1H), 7.09 (br, 1H), 7.03 (br, 1H), 5.89 (br, 1H), 5.37 (br, 
1H), 5.13 (br, 1H), 3.69 (br, 1H), 3.52 (br, 1H), 2.32 (br, 1H), 2.18 (br, 1H); The 
broadening of some signals arise due to hindered rotation as suggested by the 
temperature dependent 
1
H NMR recorded for the diene 4.13a.  
13
C NMR (125 MHz, CDCl3) δ 26.3, 40.2, 47.8, 111.1, 115.0, 125.3, 127.1, 127.4, 
128.0 (2C), 128.4 (2C), 128.6, 128.7 (2C), 129.8 (2C), 130.9, 135.8, 137.8, 138.3, 
141.1, 146.7, 170.2. 
IR (cm
-1
) 1640, 1431, 1447; HRMS (ES
+
): calcd for C24H20BrNOSNa (M+Na)
+
 
472.0347, found 472.0343. 
221 
 
 
N-benzoyl-(2'-bromo-3-(1-phenylvinyl)-5,6-dihydro-[2,3'-bipyridine] (4.13p).  
The treatment of enyne 4.9p (0.065 g, 0.15 mmol, 1.0 equiv) with Grubb’s II catalyst 
(0.012 g, 0.015 mmol, 0.1 equiv) according to the general procedure described above, 
followed by flash chromatography over silica eluting with EtOAc/Hexane (2:3) 
afforded dihydropyridine 4.13p (0.045 g, 69%) as a colorless heavy oil: Rf  = 0.3 
(EtOAc/Hexane 3:7). 
1
H NMR (400 MHz, CDCl3) δ 8.37 (s, 1H), 7.78 (d, J = 7.6 Hz, 1H), 7.53 (d, J = 7.2 
Hz, 2H), 7.47-7.30 (m, 9H), 6.92 (s, 1H), 6.05 (s, 1H), 5.14 (s, 1H), 5.07 (s, 1H), 3.63 
(br s, 1H), 3.05 (br s, 1H), 2.27 (br s, 1H), 2.11 (br s, 1H); The broadening of some 
signals arise due to hindered rotation as suggested by the temperature dependent 
1
H 
NMR recorded for the diene 4.13a.  
13
C NMR (125 MHz, CDCl3) δ 26.5, 40.2, 52.3, 115.4, 122.2, 127.5 (2C), 127.7, 
128.1 (2C), 128.4, 128.7 (2C), 129.5, 130.2 (2C), 135.5, 136.0, 136.2, 139.1, 140.6, 
144.8, 146.8, 149.1, 171.7. 
IR (cm
-1
) 1643, 1446, 1402; HRMS (ES
+
): calcd for C25H21BrN2ONa (M+Na)
+
 
467.0735, found 467.0742. 
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N-benzoyl-(2'-bromo-3-(1-(4-fluorophenyl)vinyl)-5,6-dihydro-[2,3'-bipyridine] 
(4.13q).  
The treatment of enyne 4.9q (0.1 g, 0.22 mmol, 1.0 equiv) with Grubb’s II catalyst 
(0.019 g, 0.022 mmol, 0.1 equiv) according to the general procedure described above, 
followed by flash chromatography over silica eluting with EtOAc/Hexane (2:3) 
afforded dihydropyridine 4.13q (0.062 g, 62%) as a colorless oil: Rf  = 0.35 
(EtOAc/Hexane 3:7). 
1
H NMR (400 MHz, CDCl3) δ 8.38 (s, 1H), 7.74 (dd, J = 7.2 Hz, J = 1.6 Hz, 1H ), 
7.52 (dd, J = 7.6 Hz, J = 1.2 Hz, 2H ), 7.47-7.39 (m, 3H), 7.32 (dd, J = 4.8 Hz, J = 2.8 
Hz, 1H ), 7.30-7.22 (m, 2H), 7.06 (t, J = 8.6 Hz, 2H), 6.86 (br s, 1H), 6.08 (s, 1H), 
5.13 (br s, 1H), 5.05 (s, 1H), 3.64 (br s, 1H), 3.05 (br s, 1H), 2.31 (br s, 1H), 2.14 (br 
s, 1H); The broadening of some signals arise due to hindered rotation as suggested by 
the temperature dependent 
1
H NMR recorded for the diene 4.13a. 
13
C NMR (125 MHz, CDCl3) δ 26.5, 40.2, 52.4, 115.1 (d, J = 21.2 Hz, 2C), 115.66, 
115.68, 122.1, 127.5 (2C), 128.5, 129.5, 130.2 (2C), 130.3 (d, J = 8.0 Hz, 2C), 135.4, 
135.8, 136.4 (d, J = 3.2 Hz), 139.0, 144.8, 146.0, 149.2, 162.3 (d, J = 245 Hz), 171.7. 
IR (cm
-1
) 1645, 1508, 1402; HRMS (ES
+
): calcd for C25H20BrFN2ONa (M+Na)
+
 
485.0641, found 485.0634. 
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N-benzoyl-(2'-bromo-3-(1-(4-methoxyphenyl)vinyl)-5,6-dihydro-[2,3'-bipyridine] 
(4.13r).  
The treatment of enyne 4.9r (0.1 g, 0.21 mmol, 1.0 equiv) with Grubb’s II catalyst 
(0.018 g, 0.021 mmol, 0.1 equiv) according to the general procedure described above, 
followed by flash chromatography over silica eluting with EtOAc/Hexane (2:3) 
afforded dihydropyridine 4.13r (0.058 g, 58%) as a colorless oil: Rf  = 0.3 
(EtOAc/Hexane 3:7). 
1
H NMR (400 MHz, CDCl3) δ 8.37 (d, J = 3.6 Hz, 1H), 7.75 (dd, J = 7.6 Hz, J = 1.6 
Hz, 1H ), 7.53 (dd, J = 7.6 Hz, J = 1.6 Hz, 2H ), 7.48-7.39 (m, 3H), 7.30 (dd, J = 4.8 
Hz, J = 2.8 Hz, 1H), 7.23 (d, J = 8.8 Hz, 2H), 6.94-6.88 (m, 2H), 6.87 (br s, 1H), 6.10 
(s, 1H), 5.09 (br s, 1H), 5.04 (s, 1H), 3.85 (s, 3H), 3.64 (br s, 1H), 3.04 (br s, 1H), 
2.31 (br s, 1H), 2.10 (br s, 1H); The broadening of some signals arise due to hindered 
rotation as suggested by the temperature dependent 
1
H NMR recorded for the diene 
4.13a.  
13
C NMR (125 MHz, CDCl3) δ 26.5, 40.3, 52.5, 55.1, 113.5 (2C), 114.8, 122.1, 
127.5, 128.4 (2C), 129.1, 129.8 (2C), 130.1 (2C), 132.8, 135.5, 136.0, 136.6, 139.1, 
144.8, 146.5, 149.1, 159.1, 171.7. 
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IR (cm
-1
) 1647, 1458, 1400; HRMS (ES
+
): calcd for C26H24BrN2O2 (M+H)
+
 
475.1021, found 475.1018. 
 
General procedure for the preparation of indenopyridines 4.21a-e and 
tetrahydrophenanthroline 4.23a-c:  
To a mixture of solid Pd(OAc)2 (0.1 equiv), PPh3 (0.2 equiv) and Cs2CO3 (2.0 equiv) 
in a sealed tube under argon was added a solution of  dienes 4.13a-e and 4.13g-i (1.0 
equiv) in DMF (2.0 mL). The tube was flushed with argon, capped and the reaction 
mixture was stirred at 120
o
C for 15 h. The mixture was cooled to rt, water (2 mL) was 
added and the mixture was extracted with EtOAc (3 x 20 mL). Combined organic 
layers were washed with brine, dried (anhydrous MgSO4) and solvents were removed 
under reduced pressure to afford crude products that were separated by flash 
chromatography over silica to afford indenopyridines 4.21a-e and 
tetrahydrophenanthroline 4.23a-c. 
 
         and        
(±) N-benzoyl-(4aS,5aS,9bR)-5a-phenyl-2,5,5a,9b-tetrahydro- 
cyclopropa[2,3]indeno[1,2-b]pyridine (4.21a) and N-benzoyl-(6-phenyl-3,4- 
dihydrobenzo[h]quinoline (4.20).   
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The treatment of diene 4.13a (0.1 g, 0.23 mmol, 1.0 equiv) with Pd(OAc)2 (0.005 g, 
0.023 mmol, 0.1 equiv), Cs2CO3 (0.147 g, 0.45 mmol, 2.0 equiv) and PPh3 (0.012 g, 
0.045 mmol, 0.2 equiv) according to the general procedure described above, followed 
by flash chromatography over silica eluting with EtOAc/Hexane (1:8) afforded 
indenopyridine 4.21a (0.066 g, 80%) as a fluffy white solid and continuous elution 
with EtOAc/Hexane (1:8) afforded benzoquinoline 4.20 (0.008 g, 10%) as a white 
solid.  
Analytical data for 4.21a: mp 73-78
o
C; Rf = 0.45 (EtOAc/Hexane 3:7). 
1
H NMR (400 MHz, CDCl3) δ 7.72 (d, J = 7.2 Hz, 1H), 7.52-7.42 (m, 5H), 7.35 (t, J 
= 7.6 Hz, 2H), 7.30-7.22 (m, 4H), 7.20 (t, J = 6.8 Hz, 1H), 6.98 (d, J = 7.2 Hz, 1H), 
6.09-6.01 (m, 2H), 5.47 (dd, J = 9.2 Hz, J = 2.8 Hz, 1H), 4.16-3.95 (m, 1H), 3.59 (d, 
J = 15.6 Hz, 1H), 2.31 (d, J = 5.6 Hz, 1H), 1.46 (d, J = 5.2 Hz, 1H). 
13
C NMR (125 MHz, CDCl3) δ 31.0, 40.1, 43.1, 46.5, 59.6, 123.6, 126.8 (2C), 126.9, 
127.0, 127.1, 127.9, 128.4 (2C), 128.5 (2C), 129.2, 129.6, 129.7 (2C), 131.2, 136.5, 
138.5, 142.8, 149.0, 170.5. 
IR (cm
-1
) 1627, 1600, 1444; HRMS (ES
+
): calcd for C26H21NONa (M+Na)
+
 
386.1521, found 386.1519.    
Analytical data for 4.20: mp 169-171
o
C; Rf = 0.5 (EtOAc/Hexane 3:7). 
1
H NMR (400 MHz, CDCl3) δ 7.89-7.80 (br m, 1.7H), 7.69-7.62 (m, 2.3H), 7.56-7.41 
(m, 7H), 7.24-7.19 (m, 2H), 7.06 (t, J = 6.8 Hz, 0.7H), 6.98 (t, J = 7.2 Hz, 1.3H), 
5.06-4.82 (m, 0.5H), 4.36-4.12 (m, 0.5H), 3.62-3.51 (br m, 0.4H), 3.43-3.33 (br m, 
0.6H), 3.16-3.01 (m, 1H), 2.86-2.68 (m, 1H), 2.53-2.41 (br m, 0.5H), 2.15-1.98 (br m, 
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0.5H), 1.87-1.69 (br m, 1H); The signals that integrate for less than 1H arise due to 
hindered rotation as confirmed by the temperature dependent 
1
H NMR recorded for 
the phenanthroline 4.23a. 
13
C NMR (125 MHz, CDCl3) δ (24.8), 24.9, (25.3), 25.9, 43.1, (47.8), 122.6, (123.1), 
(125.5), (125.6), 125.7, 126.2, 126.8, (127.1), 127.30, (127.35), 127.4 (2C), (127.5), 
127.6, (127.8), 128.02 (2C), (128.07), (128.2), (128.3), 128.3 (2C), 128.6, (129.4), 
129.6 (2C), (129.9), 130.0, (130.1), 130.8, (130.9), (132.0), 132.2, 132.3, (136.0), 
136.5, (136.7), 138.9, (139.6), 140.3, (140.9), 170.3, (172.6); Signals for the minor 
rotamer are given in the parentheses. 
IR (cm
-1
) 1641, 1490, 1467; HRMS (ES
+
): calcd for C26H22NO (M+H)
+
 364.1701, 
found 364.1696. 
 
 
(±) N-benzoyl-(4aS,5aS,9bR)-7,8-dimethoxy-5a-phenyl-2,5,5a,9b-tetrahydro- 
cyclopropa[2,3]indeno[1,2-b]pyridine (4.21b).  
The treatment of diene 4.13b (0.04 g, 0.08 mmol, 1.0 equiv) with Pd(OAc)2 (0.0018 
g, 0.008 mmol, 0.1 equiv), Cs2CO3 (0.058 g, 0.16 mmol, 2.0 equiv) and PPh3 (0.0042 
g, 0.016 mmol, 0.2 equiv) according to the general procedure described above, 
followed by flash chromatography over silica eluting with EtOAc/Hexane (1:4) 
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afforded indenopyridine 4.13b (0.026 g, 78%) as a light yellow solid: mp 220-222
o
C; 
Rf  = 0.35 (EtOAc/Hexane 3:7). 
1
H NMR (400 MHz, CDCl3) δ 7.51-7.43 (m, 5H), 7.39-7.32 (m, 2H), 7.31-7.23 (m, 
4H), 6.48 (s, 1H), 6.03-5.96 (m, 2H), 5.44 (dd, J = 9.2 Hz, J = 2.8 Hz, 1H), 4.08-3.98 
(m, 1H), 3.80 (s, 3H), 3.75 (s, 3H), 3.61 (d, J = 15.6 Hz, 1H), 2.29 (d, J = 5.6 Hz, 
1H), 1.40 (d, J = 5.2 Hz, 1H). 
13
C NMR (125 MHz, CDCl3) δ 31.0, 40.0, 43.1, 46.3, 56.0, 56.1, 59.7, 106.3, 109.4, 
126.80, 126.84 (2C), 128.4 (2C), 128.5 (2C), 129.1, 129.4 (2C), 129.6, 131.3, 134.1, 
136.5, 138.6, 140.9, 148.7, 149.2, 170.4. 
IR (cm
-1
) 1625, 1423, 1130, 1116; HRMS (ES
+
): calcd for C28H26NO3 (M+H)
+
 
424.1913, found 424.1913. 
 
 
(±) N-benzoyl-(4aS,5aS,9bR)-8-fluoro-5a-phenyl-2,5,5a,9b-tetrahydro- 
cyclopropa[2,3]indeno[1,2-b]pyridine (4.21c).  
The treatment of diene 4.13c (0.06 g, 0.13 mmol, 1.0 equiv) with Pd(OAc)2 (0.003 g, 
0.013 mmol, 0.1 equiv), Cs2CO3 (0.085 g, 0.26 mmol, 2.0 equiv) and PPh3 (0.0068 g, 
0.026 mmol, 0.2 equiv) according to the general procedure described above, followed 
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by flash chromatography over silica eluting with EtOAc/Hexane (1:4) afforded 
indenopyridine 4.21c (0.034 g, 71%) as a colorless heavy oil:  
Rf = 0.5 (EtOAc/Hexane 1:9). 
1
H NMR (400 MHz, CDCl3) δ 7.52-7.40 (m, 6H), 7.32-7.28 (m, 2H), 7.30-7.21 (m, 
3H), 6.90 (d, J = 6.4 Hz, 2H), 6.09-5.97 (m, 2H), 5.45 (dd, J = 9.2 Hz, J = 2.8 Hz, 
1H), 4.13-4.01 (m, 1H), 3.60 (d, J = 16.0 Hz, 1H), 2.29 (d, J = 5.6 Hz, 1H), 1.44 (d, J 
= 5.2 Hz, 1H). 
13
C NMR (125 MHz, CDCl3) δ 30.9, 40.3, 43.2, 45.7, 59.3, 113.5 (d, J = 22.5 Hz), 
115.1 (d, J = 23.0 Hz), 124.5 (d, J = 9.0 Hz), 126.8 (2C), 127.0, 128.4 (2C), 128.5 
(2C), 129.1, 129.6 (2C), 129.7, 131.0, 136.2, 138.3, 144.5 (d, J = 2.7 Hz), 144.9 (d, J 
= 8.1 Hz), 162.1 (d, J = 242.8.1 Hz), 170.5. 
IR (cm
-1
) 1625, 1600, 1483; HRMS (ES
+
): calcd for C26H21NFO (M+H)
+
 382.1607, 
found 382.1599. 
 
 
(±) N-benzoyl-(4aS,5aS,9bR)-5a-(4-fluorophenyl)-2,5,5a,9b-tetrahydro- 
cyclopropa[2,3]indeno[1,2-b]pyridine (4.21d).  
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The treatment of diene 4.13d (0.06 g, 0.13 mmol, 1.0 equiv) with Pd(OAc)2 (0.003 g, 
0.013 mmol, 0.1 equiv), Cs2CO3 (0.084 g, 0.26 mmol, 2.0 equiv) and PPh3 (0.007 g, 
0.026 mmol, 0.2 equiv) according to the general procedure described above, followed 
by flash chromatography over silica eluting with EtOAc/Hexane (1:9) afforded 
indenopyridine 4.21d (0.04 g, 81%) as a colorless oil:   
Rf  = 0.55 (EtOAc/Hexane 3:7).   
1
H NMR (400 MHz, CDCl3) δ 7.70 (d, J = 7.2 Hz, 1H), 7.54-7.41 (m, 5H), 7.26-7.18 
(m, 4H), 7.03 (t, J = 8.8 Hz, 2H), 6.94 (d, J = 7.6 Hz, 1H), 6.10-5.99 (m, 2H), 5.45 
(dd, J = 9.2 Hz, J = 2.4 Hz, 1H), 4.13-4.01 (m, 1H), 3.56 (d, J = 15.6 Hz, 1H), 2.25 
(d, J = 5.6 Hz, 1H), 1.46 (d, J = 5.2 Hz, 1H). 
13
C NMR (125 MHz, CDCl3) δ 31.2, 40.0, 43.0, 45.7, 59.5, 115.3 (d, J = 21.2 Hz, 
2C), 123.4, 126.8 (2C), 127.1, 127.2, 128.0, 128.5 (2C), 129.3, 129.6, 131.1, 131.2 (d, 
J = 8.1 Hz, 2C), 134.3 (d, J = 3.1 Hz), 136.4, 142.7, 148.8, 161.4 (d, J = 244.1 Hz), 
170.5. 
IR (cm
-1
) 1625, 1598, 1427; HRMS (ES
+
): calcd for C26H20FNONa (M+Na)
+
 
404.1427, found 404.1419. 
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(±) N-benzoyl-(4aS,5aS,9bR)-5a-(4-methoxyphenyl)-2,5,5a,9b-tetrahydro- 
cyclopropa[2,3]indeno[1,2-b]pyridine (4.21e).  
The treatment of diene 4.13e (0.038 g, 0.08 mmol, 1.0 equiv) with Pd(OAc)2 (0.002 
g, 0.008 mmol, 0.1 equiv), Cs2CO3 (0.052 g, 0.16 mmol, 2.0 equiv) and PPh3 (0.0042 
g, 0.016 mmol, 0.2 equiv) according to the general procedure described above, 
followed by flash chromatography over silica eluting with EtOAc/Hexane (1:8) 
afforded indenopyridine 4.21e (0.025 g, 80%) as a colorless oil:  
Rf  = 0.4 (EtOAc/Hexane 3:7).   
1
H NMR (400 MHz, CDCl3) δ 7.69 (d, J = 6.8 Hz, 1H), 7.52-7.42 (m, 5H), 7.26-7.15 
(m, 4H), 6.95 (d, J = 7.2 Hz, 1H), 6.88 (d, J = 8.8 Hz, 2H), 6.09-5.99 (m, 2H), 5.48 
(dd, J = 9.2 Hz, J = 2.8 Hz, 1H), 4.12-4.00 (m, 1H), 3.82 (s, 3H), 3.58 (d, J = 15.2 
Hz, 1H), 2.24 (d, J = 5.6 Hz, 1H), 1.40 (d, J = 5.2 Hz, 1H). 
13
C NMR (125 MHz, CDCl3) δ 31.3, 39.9, 43.0, 45.9, 55.2, 59.5, 113.8 (2C), 123.5, 
126.9 (2C), 127.0, 127.1, 127.9, 128.5 (2C), 129.0, 129.5, 130.6, 130.8 (2C), 131.5, 
136.6, 142.6, 149.3, 158.5, 170.5. 
IR (cm
-1
) 1625, 1598, 1245; HRMS (ES
+
): calcd for C27H23NO2Na (M+Na)
+
 
416.1626, found 416.1626. 
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N-benzoyl-(5-phenyl-2,3,4-trihydro)-1,7-phenanthroline (4.23a).  
The treatment of diene 4.13g (0.04 g, 0.09 mmol, 1.0 equiv) with Pd(OAc)2 (0.002 g, 
0.01 mmol, 0.1 equiv), Cs2CO3 (0.059 g, 0.18 mmol, 2.0 equiv) and PPh3 (0.0065 g, 
0.02 mmol, 0.2 equiv) according to the general procedure described above, followed 
by flash chromatography over silica eluting with EtOAc/Hexane (2:3) afforded 
phenanthroline 4.23a (0.022 g, 65%) as a light yellow powder: mp 190-193
o
C; Rf = 
0.3 (EtOAc/Hexane 3:7). 
1
H NMR (400 MHz, CDCl3) δ 8.93 (br s, 0.2H), 8.68 (br s, 0.3H), 8.15 (d, J = 6.4 Hz, 
0.3H), 8.05-7.90 (m, 1.5H), 7.82 (d, J = 5.2 Hz, 0.7H), 7.65-7.38 (m, 7H), 7.32-7.24 
(m, 1H), 7.22 (d, J = 7.2 Hz, 1H), 7.09 (t, J = 7.2 Hz, 1H), 7.00 (t, J = 6.8 Hz, 1H), 
4.86 (q, J = 8.4 Hz, 0.5H), 4.25 (br s, 0.5H), 3.57 (br s, 0.5H), 3.42 (br s, 0.5H), 3.14 
(d, J = 15.2 Hz, 0.5H), 2.93-2.70 (m, 1.5H), 2.47 (br s, 0.5H), 2.06 (br s, 0.5H), 1.81 
(br s, 1H); The signals that integrate for less than 1H arise due to hindered rotation as 
confirmed by the temperature dependent 
1
H NMR recorded for the phenanthroline 
4.23a.  
13
C NMR (125 MHz, CDCl3) δ (24.9), 25.0, (25.8), 43.5, (47.9), 53.4, 120.3, (120.8), 
122.8, (122.9), (127.5), 127.7 (2C), (127.8), 127.9, 128.1 (2C), (128.2), (128.3), 128.4 
(2C), 128.8, (129.2), 129.5 (2C), 130.3, 131.0, (131.1), (132.1), 132.5, (135.1), 
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(135.5), 136.0, 136.4, 139.6, (140.1), 142.6, (143.5), 146.7, 150.0, (170.2), 172.9; 
Signals for the minor rotamer are given in the parentheses. 
IR (cm
-1
) 1643, 1444, 1394; HRMS (ES
+
): calcd for C25H20N2ONa (M+Na)
+
 
387.1473, found 387.1475. 
 
 
N-benzoyl-(5-(4-fluorophenyl)-2,3,4-trihydro)-1,7-phenanthroline (4.23b).  
The treatment of diene 4.13h (0.055 g, 0.12 mmol, 1.0 equiv) with Pd(OAc)2 (0.0027 
g, 0.012 mmol, 0.1 equiv), Cs2CO3 (0.078 g, 0.24 mmol, 2.0 equiv) and PPh3 (0.0063 
g, 0.024 mmol, 0.2 equiv) according to the general procedure described above, 
followed by flash chromatography over silica eluting with EtOAc/Hexane (2:3) 
afforded phenanthroline 4.23b (0.03 g, 61%) as a colorless oil: Rf = 0.3 
(EtOAc/Hexane 3:7). 
1
H NMR (400 MHz, CDCl3) δ 8.91 (br s, 0.25H), 8.67 (br s, 0.25H), 8.15 (d, J = 6.8 
Hz, 0.25H), 7.91 (d, J = 8.8 Hz, 1.5H), 7.82 (d, J = 6.0 Hz, 0.75H), 7.62-7.52 (m, 
1.25H), 7.51-7.35 (m, 2.75H), 7.25-7.15 (m, 4H), 7.09 (t, J = 7.6 Hz, 1H), 7.00 (t, J = 
7.6 Hz, 1H), 4.94-4.80 (m, 0.5H), 4.30-3.05 (m, 0.5H), 3.72-3.72 (m, 0.5H), 3.42 (br 
s, 0.5H), 3.09 (d, J = 14.0 Hz, 0.5H), 2.85-2.70 (m, 1.5H), 2.48 (br, 0.5H), 2.12-2.00 
(m, 0.5H), 1.92-1.73 (m, 1H); The signals that integrate for less than 1H arise due to 
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hindered rotation as confirmed by the temperature dependent 
1
H NMR recorded for 
the phenanthroline 4.23a.
  
13
C NMR (125 MHz, CDCl3) δ (24.9), 25.0, (25.8), 43.4, 47.9, (53.4), 115.2, 115.5 
(d, J = 21.3 Hz, 2C), [115.5 (d, J = 21.3 Hz,)], 120.4, (121.0), (122.9), 126.8, 127.7 
(2C), (128.0), 128.1 (2C), 128.2, (128.5), (128.6), 128.8, (129.3), (129.9), (130.2), 
130.3 (d, J = 5.0 Hz), [130.8 (d, J = 7.6 Hz,)], 130.9, 131.1 (d, J = 7.5 Hz, 2C), [131.4 
(d, J = 8.2 Hz,)], 131.9, (132.3), (135.4), (135.6), 135.9, (136.6), 141.4, (142.3), 
146.7, (149.5), 150.2, 162.5 (d, J = 247 Hz), 170.2, (172.9); Signals for the minor 
rotamer are given in parentheses. 
IR (cm
-1
) 1643, 1467, 1402; HRMS (ES
+
): calcd for C25H20FN2O (M+H)
+
 383.1560, 
found 383.1547. 
 
 
N-benzoyl-(5-(4-methoxyphenyl)-2,3,4-trihydro)-1,7-phenanthroline (4.23c).  
The treatment of diene 4.13i (0.08 g, 0.169 mmol, 1.0 equiv) with Pd(OAc)2 (0.0038 
g, 0.017 mmol, 0.1 equiv), Cs2CO3 (0.11 g, 0.338 mmol, 2.0 equiv) and PPh3 (0.009 
g, 0.038 mmol, 0.2 equiv) according to the general procedure described above, 
followed by flash chromatography over silica eluting with EtOAc/Hexane (2:3) 
afforded phenanthroline 4.23c (0.04 g, 59%) as a colorless oil: Rf  = 0.25 
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(EtOAc/Hexane 3:7). 
1
H NMR (400 MHz, CDCl3) δ 8.91 (br s, 0.25H), 8.66 (br s, 
0.5H), 8.11 (d, J = 6.1 Hz, 0.25H), 7.93 (d, J = 8.4 Hz, 1.5H), 7.82 (d, J = 5.2 Hz, 
0.5H), 7.57 (s, 1.25H), 7.49-7.33 (m, 3H), 7.21 (d, J = 7.2 Hz, 1.25H), 7.13-6.96 (m, 
4.5H), 4.91-4.78 (m, 0.5H), 4.27-3.99 (m, 0.5H), 3.92 (s, 2H), 3.90 (s, 1H), 3.70-3.52 
(m, 0.5H), 3.41 (br s, 0.5H), 3.17 (d, J = 15.6 Hz, 0.5H), 2.93-2.70 (m, 1.5H), 2.47 
(br, 0.5H), 2.06 (br s, 0.5H), 1.92-1.75 (m, 1H); The signals that integrate for less 
than 1H arise due to hindered rotation as confirmed by the temperature dependent 
1
H 
NMR recorded for the phenanthroline 4.23a. 
13
C NMR (125 MHz, CDCl3) δ (25.0), 25.1, (25.8), 43.5, 47.9, (53.4), (55.3), 55.4, 
(113.7), 113.9 (2C), 120.2, (120.7), 122.7, (122.8), (126.8), 127.73 (2C), (127.76), 
128.1 (2C), (128.2), (128.3), 128.6, 128.8, (130.3), 130.4, 130.7 (2C), 130.9, (131.1), 
131.9, (132.5), 132.7, (135.0), (135.5), 136.0, 136.4, 142.2, (143.1), (146.8), 149.9, 
(159.0), 159.3, 170.2, (172.9); Signals for the minor rotamer is given in the 
parentheses. 
IR (cm
-1
) 1637, 1402, 1027; HRMS (ES
+
): calcd for C26H23N2O2 (M+H)
+
 395.1760, 
found 395.1763. 
 
General procedure for the synthesis of benzoindolines 4.22a-e, thiopheno 
indoline 4.24 and pyrroloquinoline 4.25a-b:  
A solution of the dienes 4.12a-h in DMF (2 mL) was added a mixture of solid 
Pd(OAc)2 (0.1 equiv) and NaOAc (1.1 equiv) in a sealed tube. The tube was flushed 
with argon, capped, and the reaction mixture was stirred at 120
o
C for 12h. The 
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mixture was cooled to rt, cold water (2 mL) was added and the mixture was extracted 
with EtOAc (3 x 20 mL). Combined organic layers were washed with brine, dried 
(anhydrous MgSO4), solvents were removed under reduced pressure to afford the 
crude products that were purified by flash chromatography over silica eluting with 
EtOAc/Hexane mixture to afford heterocycles benzoindolines 4.22a-e and 
pyrroloquinoline 4.25a-b. 
                                                                                                                                                                         
 
N-benzoyl-4-phenyl-2,3-dihydro-benzo[g]indole (4.22a).  
The treatment of diene 4.12a (0.048 g, 0.11 mmol, 1.0 equiv) with Pd(OAc)2 (0.0026 
g, 0.01 mmol, 0.1 equiv) and NaOAc (0.01 g, 0.12 mmol, 1.1 equiv) according to the 
general procedure described above, followed by flash chromatography over silica 
eluting with EtOAc/Hexane (1:9) afforded benzoindoline 4.22a (0.028 g, 71%) as a 
white solid: mp 178-180
o
C; Rf = 0.6 (EtOAc/Hexane 3:7). 
1
H NMR (400 MHz, CDCl3) δ 7.91-7.82 (m, 3H), 7.81-7.76 (m, 1H), 7.74 (s, 1H), 
7.58-7.35 (m, 9H), 7.43-7.38 (m, 1H), 4.29 (t, J = 7.6 Hz, 2H), 3.22 (t, J = 7.6 Hz, 
2H);  
13
C NMR (125 MHz, CDCl3) δ 30.9, 55.1, 123.8, 125.2, 125.5, 125.7 126.4, 127.4, 
128.3, 128.52 (2C), 128.54 (2C), 128.56 (2C), 128.9(2C), 130.3, 131.5, 133.9, 135.9, 
136.5, 139.5, 140.2, 170.8. 
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IR (cm
-1
) 1650, 1494, 1386; HRMS (ES
+
): calcd for C25H19NONa (M+Na)
+
 
372.1364, found 372.1375.  
 
 
N-benzoyl-(7,8-dimethoxy-4-phenyl-2,3-dihydro-benzo[g]indole (4.22b).  
The treatment of diene 4.12b (0.035 g, 0.07 mmol, 1.0 equiv) with Pd(OAc)2 (0.0016 
g, 0.007 mmol, 0.1 equiv) and NaOAc (0.0063 g, 0.077 mmol, 1.1 equiv) according 
to the general procedure described above, followed by flash chromatography over 
silica eluting with EtOAc/Hexane (1:3) afforded benzoindoline 4.22b (0.02 g, 68%) 
as a yellow oil: Rf  = 0.23 (EtOAc/Hexane 3:7). 
1
H NMR (400 MHz, CDCl3) δ 7.84 (d, J = 6.8 Hz, 2H), 7.60 (s, 1H), 7.57-7.45 (m, 
7H), 7.39 (t, J = 6.8 Hz, 1H), 7.18 (s, 1H), 7.02 (s, 1H), 4.28 (t, J = 7.2 Hz, 2H), 4.03 
(s, 3H), 3.91 (s, 3H), 3.21 (t, J = 7.6 Hz, 2H). 
13
C NMR (125 MHz, CDCl3) δ 30.6, 55.2, 55.8, 55.9, 104.3 106.6, 119.6, 124.8, 
127.1, 128.4 (2C), 128.5 (2C), 128.6, 128.7 (2C), 130.0, 131.31, 131.35 (2C), 134.7, 
136.3, 138.3, 140.4, 149.0, 149.9, 170.2. 
IR (cm
-1
) 1649, 1498, 1161, 1012; HRMS (ES
+
): calcd for C27H24O3N (M+H)
+
 
410.1756, found 410.1756.  
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N-benzoyl-(8-fluoro-4-phenyl-2,3-dihydro-benzo[g]indole (4.22c).  
The treatment of diene 4.12c (0.029 g, 0.065 mmol, 1.0 equiv) with Pd(OAc)2 
(0.0015 g, 0.006 mmol, 0.1 equiv) and NaOAc (0.006 g, 0.07 mmol, 1.1 equiv) 
according to the general procedure described above, followed by flash 
chromatography over silica eluting with EtOAc/Hexane (1:9) afforded benzoindoline 
4.22c (0.016 g, 65%) as a heavy oil: Rf  = 0.72 (EtOAc/Hexane 3:7). 
1
H NMR (400 MHz, CDCl3) δ 7.95-7.82 (m, 3H), 7.75 (s, 1H), 7.64-7.38 (m, 8H), 
7.28 (d, J = 1.2 Hz, 2H), 4.30 (t, J = 6.4 Hz, 2H), 3.23 (t, J = 6.8 Hz, 2H). 
13
C NMR (125 MHz, CDCl3) δ 30.9, 55.0, 109.2 (d, J = 23.0 Hz), 116.3 (d, J = 25.2 
Hz), 124.8 (d, J = 9.9 Hz), 126.3, 127.5 (2C), 128.5 (2C), 128.6 (2C), 128.8 (2C), 
130.7, 130.8, 131.0, 131.5, 131.6, 135.7, 135.8 (d, J = 2.7 Hz), 139.3 (d, J = 5.4 Hz), 
139.9, 160.1 (d, J = 245.1 Hz), 170.7. 
IR (cm
-1
) 1650, 1496, 1357; HRMS (ES
+
): calcd for C25H19FNO (M+H)
+
 368.1451, 
found 368.1446. 
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N-benzoyl-4-fluorophenyl-2,3-dihydro-benzo[g]indole (4.22d).  
The treatment of diene 4.12d (0.038 g, 0.085 mmol, 1.0 equiv) with Pd(OAc)2 (0.002 
g, 0.008 mmol, 0.1 equiv) and NaOAc (0.0078 g, 0.094 mmol, 1.1 equiv) according 
to the general procedure described above, followedby flash chromatography over 
silica eluting with EtOAc/Hexane (1:9) afforded benzoindoline 4.22d (0.024 g, 78%) 
as a heavy oil: Rf  = 0.75 (EtOAc/Hexane 3:7). 
1
H NMR (400 MHz, CDCl3) δ 7.92-7.87 (m, 3H), 7.81 (t, J = 3.2 Hz, 1H), 7.72 (s, 
1H), 7.61-7.58 (m, 1H), 7.53 (d, J = 7.6 Hz, 2H), 7.50-7.45 (m, 4H), 7.18 (t, J = 8.8 
Hz, 2H), 4.31 (t, J = 7.6 Hz, 2H), 3.20 (t, J = 7.2 Hz, 2H). 
13
C NMR (125 MHz, CDCl3) δ 30.9, 55.1, 115.4 (d, J = 21.2 Hz, 2C), 123.9, 125.2, 
125.6, 125.8, 126.3, 128.3, 128.5 (2C), 128.8 (2C), 130.15, 130.18 (d, J = 25.2 Hz, 
2C), 131.6, 133.9, 135.5, 135.9, 136.2 (d, J = 10.4 Hz), 139.6, 162.1 (d, J = 245.0 
Hz), 170.8. 
IR (cm
-1
) 1650, 1504, 1446; HRMS (ES
+
): calcd for C25H18FNONa (M+Na)
+
 
390.1270, found 390.1270. 
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N-benzoyl-4-methoxyphenyl-2,3-dihydro-benzo[g]indole (4.22e).  
The treatment of diene 4.12e (0.055 g, 0.12 mmol, 1.0 equiv) with Pd(OAc)2 (0.0027 
g, 0.012 mmol, 0.1 equiv) and NaOAc (0.011 g, 0.13 mmol, 1.1 equiv) according to 
the general procedure described above, followed by flash chromatography over silica 
eluting with EtOAc/Hexane (1:4) afforded benzoindoline 4.22e (0.03 g, 66%) as 
colorless oil: Rf  = 0.45 (EtOAc/Hexane 3:7). 
1
H NMR (400 MHz, CDCl3) δ 7.93-7.84 (m, 3H), 7.80 (d, J = 5.6 Hz, 1H), 7.73 (s, 
1H), 7.61-7.50 (m, 3H), 7.49-7.43 (m, 4H), 7.02 (d, J = 8.8 Hz, 2H), 4.30 (t, J = 7.2 
Hz, 2H), 3.89 (s, 3H), 3.23 (t, J = 7.6 Hz, 2H). 
13
C NMR (125 MHz, CDCl3) δ 31.0, 55.1, 55.3, 113.9 (2C), 123.6, 125.2, 125.3, 
125.6, 126.1, 128.2, 128.5 (2C), 128.8 (2C), 129.6 (2C), 130.4, 131.5, 132.6, 134.0, 
136.0, 136.1, 139.4, 159.0, 170.7. 
IR (cm
-1
) 1650, 1446, 1074; HRMS (ES
+
): calcd for C26H21NO2Na (M+Na)
+
 
402.1470, found 402.1466.  
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.  
N-benzoyl-5-phenyl-7,8-dihydro-thieno[3,2-g]indole (4.24).  
The treatment of diene 4.12f (0.05 g, 0.11 mmol, 1.0 equiv) with Pd(OAc)2 (0.0025 g, 
0.011 mmol, 0.1 equiv) and NaOAc (0.001 g, 0.012 mmol, 1.1 equiv) according to 
the general procedure described above, followed by flash chromatography over silica 
eluting with EtOAc/Hexane (1:9) afforded pyrrolobenzothiophene 4.24 (0.018 g, 
45%) as a colorless oil along with unreacted diene 4.12f (0.020 g, 31%) as a colorless 
heavy oil: Rf  = 0.45 (EtOAc/Hexane 3:7). 
1
H NMR (400 MHz, CDCl3) δ 7.81 (t, J = 1.2 Hz, 1H), 7.79 (t, J = 2.0 Hz, 1H), 7.71 
(s, 1H), 7.56-7.52 (m, 2H), 7.51-7.47 (m, 6H), 7.42-37 (m, 2H), 4.23 (t, J = 7.6 Hz, 
2H), 3.25 (t, J = 7.6 Hz, 2H). 
13
C NMR (125 MHz, CDCl3) δ 30.0, 53.7, 120.9, 123.3, 127.2, 127.3, 127.7, 128.3, 
128.4 (2C), 128.50 (2C), 128.51 (2C), 128.58 (2C), 131.3, 135.2, 135.7, 138.0, 140.3, 
141.5, 168.5. 
IR (cm
-1
) 1637, 1490, 1398; HRMS (ES
+
): calcd for C23H17NOSNa (M+Na)
+
 
378.0929, found 378.0934. 
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N-benzoyl-(4-phenyl-2,3-dihydro-pyrrolo[2,3-f]quinoline (4.25a).  
The treatment of diene 4.12g (0.032 g, 0.07 mmol, 1.0 equiv) with Pd(OAc)2 (0.0016 
g, 0.007 mmol, 0.1 equiv) and NaOAc (0.0063 g, 0.077 mmol, 1.1 equiv) according 
to the general procedure described above, followed by flash chromatography over 
silica eluting with EtOAc/Hexane (2:3) afforded pyrroloquinoline 4.25a (0.02 g, 
77%) as a colorless oil: Rf  = 0.2 (EtOAc/Hexane 3:7). 
1
H NMR (400 MHz, CDCl3) δ 8.92 (d, J = 2.4 Hz, 1H), 8.23 (d, J = 8.4 Hz, 1H), 8.06 
(s, 1H), 7.86 (d, J = 8.0 Hz, 2H), 7.62-7.47 (m, 7H), 7.43 (t, J = 7.2 Hz, 1H), 7.38 
(dd, J = 8.4 Hz, J = 4.0 Hz,  1H), 4.33 (t, J = 7.6 Hz, 2H), 3.27 (t, J = 7.6 Hz, 2H). 
13
C NMR (125 MHz, CDCl3) δ 30.7, 55.2, 119.5, 120.0, 127.1, 127.9, 128.2, 128.5 
(2C), 128.6 (2C), 128.70 (2C), 128.77 (2C), 130.9, 131.8, 134.4, 135.5, 139.3, 139.4, 
140.1, 149.8, 170.9. 
IR (cm
-1
) 1649, 1556, 1490; HRMS (ES
+
): calcd for C24H19N2O (M+H)
+
 351.1497, 
found 351.1490. 
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N-benzoyl-4-fluorophenyl-2,3-dihydro-pyrrolo[2,3-f]quinoline (4.25b).  
The treatment of diene 4.12h (0.03 g, 0.067 mmol, 1.0 equiv) with Pd(OAc)2 (0.0015 
g, 0.0067 mmol, 0.1 equiv) and NaOAc (0.006 g, 0.07 mmol, 1.1 equiv) according to 
the general procedure described above, followed by flash chromatography over silica 
eluting with EtOAc/Hexane (2:3) afforded pyrroloquinoline 4.25b (0.016 g, 65%) as 
a yellow oil: Rf = 0.3 (EtOAc/Hexane 3:7). 
1
H NMR (400 MHz, CDCl3) δ 8.92 (dd, J = 4.4 Hz, J = 1.6 Hz, 1H), 8.23 (d, J = 8.4 
Hz, 1H), 8.01 (s, 1H), 7.85 (d, J = 7.2 Hz, 2H), 7.59 (d, J = 7.2 Hz, 1H), 7.55-7.51 
(m, 4H), 7.38 (dd, J = 8.4 Hz, J = 4.0 Hz, 1H), 7.19 (t, J = 8.8 Hz, 2H), 4.34 (t, J = 
7.6 Hz, 2H), 3.24 (t, J = 7.6 Hz, 2H). 
13
C NMR (125 MHz, CDCl3) δ 30.6, 55.1, 115.7 (d, J = 21.3 Hz, 2C), 119.4, 120.2, 
127.3, 128.6 (2C), 128.7 (2C), 130.1 (d, J = 8.1 Hz, 2C), 130.6, 131.8, 134.0, 135.4, 
130.5 (d, J = 3.2 Hz), 138.8, 139.4, 148.1, 150.3, 162.5 (d, J = 246 Hz), 171.0. 
IR (cm
-1
) 1637, 1440, 1400; HRMS (ES
+
): calcd for C24H17FN2ONa (M+Na)
+
 
391.1223, found 391.1231. 
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General procedure for synthesis of propargyl alcohols 4.36a-b: 
To a cooled solution of phenylacetylene (1.1 equiv) at -75
o
C under argon, added n-
BuLi (2.5 M in Hexane, 1.0 equiv) dropwise and stirred the resulting yellow solution 
for 1 h at -75
o
C.  Then quickly added the THF solution of aldehyde 4.32a-b and 
stirred for 1 h. After this the solution was warmed to 0
o
C and stirred for 1 h and then 
at rt for 4 h. Quenched the reaction mixture with saturated solution of NH4Cl, 
extracted with (2 x 25 mL) ethylacetate. The combined organic layer was washed 
with brine, dried over anhydrous magnesium sulphate and evaporated to dry. The 
crude propargyl alcohols were used as such for subsequent reactions and were not 
fully characterized. 
 
 
1-(3-bromopyridin-4-yl)-3-phenylprop-2-yn-1-ol (4.36a). 
The treatment of aldehyde 4.32a (0.07 g, 0.38 mmol, 1.0 equiv) with phenylacetylene 
(40 µL, 0.42 mmol, 1.1 equiv) and n-BuLi (144 µL, 0.38 mmol, 1.0 equiv) according 
to the general procedure described above, produced crude 4.36a (0.095 g, 76%) as a 
light brown powder. The reaction was clean as analyzed by TLC and 
1
H NMR. Rf = 
0.25 (EtOAc/Hexane 3:7). 
1
H NMR (400 MHz, CDCl3) δ 8.75 (s, 1H), 8.61 (d, J = 4.8 Hz, 1H), 7.78 (d, J = 5.2 
Hz, 1H), 7.48-7.44 (m, 2H), 7.38-7.33 (m, 3H), 5.93 (s, 1H), 3.29 (br s, 1H). 
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1-(2-bromophenyl)-3-phenylprop-2-yn-1-ol (4.36b). 
The treatment of aldehyde 4.32b (0.192 g, 1.04 mmol, 1.0 equiv) with 
phenylacetylene (109 µL, 1.14 mmol, 1.1 equiv) and n-BuLi (394 µL, 1.04 mmol, 1.0 
equiv) according to the general procedure described above, produced crude 4.36b 
(0.251 g, 86%) as a clear oil. The reaction was clean as analyzed by TLC and 
1
H 
NMR. Rf = 0.35 (EtOAc/Hexane 3:7). 
1
H NMR (400 MHz, CDCl3) δ 7.87 (dd, J = 8.0 Hz, J = 1.6 Hz, 1H), 7.62 (dd, J = 7.6 
Hz, J = 0.8 Hz, 1H), 7.51-7.48 (m, 2H), 7.41 (td, J = 7.6 Hz, J = 1.2 Hz, 1H), 7.36-
7.32 (m, 3H), 7.24 (td, J = 8.0 Hz, J = 1.6 Hz, 1H), 6.04 (s, 1H), 2.38 (br , 1H). 
 
General procedure for Fe-catalyzed substitution of propargyl alcohol (4.36a-b): 
To the solution of propargyl alcohol 4.36a-b (1.0 equiv) in acetonitrile under argon, 
added neat 3-Buten-1-ol (3.0 equiv) and FeCl3 (0.05 equiv) successively and stirred 
the resulting brown solution at 60
o
C for 18 h.  Cooled the reaction mixture and 
evaporated the volatile components. The crude residue was adsorbed on silica and 
purified by flash column chromatography.  
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1-(3-bromopyridin-4-yl)-3-phenylprop-2-yn-1-one (4.40) and 1-(3-bromopyridin-
4-yl)-3-phenylprop-2-en-1-one (4.41). 
 
 
The treatment of crude propargyl alcohol 4.36a (0.11 g, 0.38 mmol, 1.0 equiv) with 
3-Buten-1-ol (99 µL, 1.15 mmol, 3.0 equiv), and FeCl3 (0.0032 g, 0.02 mmol, 0.05 
equiv) according to the general procedure described above, followed by flash 
chromatography over silica eluting with EtOAc/Hexane (3:7) afforded ynone 4.40  
(0.023 g, 21%) as a colorless oil and further elution EtOAc/Hexane (2:3) afforded 
enone 4.41 (0.019g, 17%) as a colorless oil along with unreacted 4.36a  
 
 
Analytical data for Ynone 4.40: 
Rf  = 0.35 (EtOAc/Hexane 3:7). 
1
H NMR (400 MHz, CDCl3) δ 8.92 (s, 1H), 8.73 (d, J = 4.8 Hz, 1H), 7.82 (d, J = 4.8 
Hz, 1H), 7.70-7.66 (m, 1H), 7.57-7.51 (m, 1H), 7.45 (t, J = 8.0 Hz, 2H),  
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13
C NMR (125 MHz, CDCl3) δ 87.4, 96.6, 117.8, 119.2, 124.5, 128.8 (2C), 131.6, 
133.6 (2C), 143.9, 148.7, 153.9, 176.1;  
IR (cm
-1
) 2194, 1658, 1488; HRMS (ES
+
) calcd for C14H9BrNO (M+H)
+
, 285.9868, 
found 285.9861. 
 
 
Analytical data for enone 4.41: 
Rf  = 0.30 (EtOAc/Hexane 3:7). 
1
H NMR (400 MHz, CDCl3) δ 8.87 (s, 1H), 8.68 (d, J = 4.8 Hz, 1H), 7.61-7.54 (m, 
2H), 7.48-7.38 (m, 4H), 7.33 (d, J = 4.8 Hz, 1H), 7.06 (d, J = 16.4 Hz, 1H),  
13
C NMR (125 MHz, CDCl3) δ 117.4, 122.9, 124.8, 128.8 (2C), 129.1 (2C), 131.6, 
133.7, 147.7, 148.60, 148.61, 152.0, 192.3,  
IR (cm
-1
) 1651, 1595, 1396; HRMS (ES
+
): calcd for C14H11BrNO (M+H)
+
 288.0024, 
found 288.0017. 
 
 
1-bromo-2-(1-(but-3-en-1-yloxy)-3-phenylprop-2-yn-1-yl) benzene (4.38). 
The treatment of crude propargyl alcohol 4.36b (0.045 g, 0.16 mmol, 1.0 equiv) with 
3-Buten-1-ol (24 µL, 0.48 mmol, 3.0 equiv), and FeCl3 (0.0013 g, 0.008 mmol, 0.05 
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equiv) according to the general procedure described above, followed by flash 
chromatography over silica eluting with EtOAc/Hexane (1:9) afforded enyne 4.38  
(0.031 g, 75%) as a colorless oil along with unreacted propargyl alcohol 4.36b (0.012 
g, 22%) 
Rf  = 0.8 (EtOAc/Hexane 3:7). 
1
H NMR (400 MHz, CDCl3) δ 7.86 (dd, J = 8.0 Hz, J = 1.6 Hz, 1H),  7.60 (dd, J = 
8.0 Hz, J = 1.2 Hz, 1H), 7.53-7.49 (m, 2H), 7.39 (td, J = 7.6 Hz, J = 1.2 Hz, 1H), 
7.36-7.31 (m, 3H), 7.22 (td, J = 7.6 Hz, J = 1.6 Hz, 1H), 5.96-5.85 (m, 1H), 5.70 (s, 
1H), 5.16 (dq, J = 12.4 Hz, J = 1.6 Hz, 1H),  5.08 (dq, J = 10.0 Hz, J = 1.2 Hz, 1H), 
3.91 (dt, J = 9.2 Hz, J = 6.8 Hz, 1H), 3.68 (dt, J = 8.8 Hz, J = 7.2 Hz, 1H), 2.48 (q, J 
= 6.8 Hz, 2H). 
13
C NMR (125 MHz, CDCl3) δ 34.1, 68.6, 71.3, 86.4, 87.3, 116.4, 122.5, 123.5, 
127.7, 128.3 (2C), 128.5, 129.3, 129.9, 131.8 (2C), 132.9, 135.0, 138.0. 
IR (cm
-1
) 1409, 1150; HRMS (ES
+
): calcd for C19H17BrONa (M+Na)
+
 363.0360, 
found 363.0364. 
 
 
6-(2-bromophenyl)-5-(1-phenylvinyl)-3,6-dihydro-2H-pyran (4.43). 
The treatment of enyne 4.42 (0.025 g, 0.07 mmol, 1.0 equiv) with Grubbs II catalyst 
(0.006 g, 0.007 mmol, 0.1 equiv) according to the general procedure described above 
248 
 
for 4.13a-e and 4.13g-i, followed by flash chromatography over silica eluting with 
EtOAc/Hexane (1:4) afforded pyran diene 4.43 (0.02 g, 79%) as a colorless oil: Rf  = 
0.55 (EtOAc/Hexane 3:7). 
1
H NMR (400 MHz, CDCl3) δ 7.61 (dd, J = 8.0 Hz, J = 1.2 Hz, 1H),  7.41 (dd, J = 
7.6 Hz, J = 1.6 Hz, 1H), 7.35-7.30 (m, 4H), 7.18 (td, J = 7.6 Hz, J = 1.2 Hz, 1H), 
6.13-6.08 (m, 1H), 5.95 (s, 1H),  4.92 (d, J = 17.0 Hz, 2H), 3.76 (dd, J = 4.8 Hz, J = 
2.0 Hz, 2H), 2.49-2.38 (m, 1H), 2.36-2.33 (m, 1H). 
13
C NMR (125 MHz, CDCl3) δ 25.7, 59.5, 74.7, 114.2, 125.6, 126.9, 127.4, 128.0 
(2C), 128.51, 128.54 (2C), 129.5, 130.3, 133.3, 137.7, 138.5, 140.9, 147.5. 
IR (cm
-1
) 1396, 1190; HRMS (ES
+
): calcd for C19H17BrONa (M+Na)
+
 363.0360, 
found 363.0366. 
 
 
5a-phenyl-2,5,5a,9b-tetrahydrocyclopropa[2,3]indeno[1,2-b]pyran (4.44). 
The diene 4.43 (0.02 g, 0.06 mmol, 1.0 equiv) was treated with Pd(OAc)2 (0.0013 g, 
0.006 mmol, 0.1 equiv), Cs2CO3 (0.039 g, 0.12 mmol, 2.0 equiv) and PPh3 (0.003 g, 
0.012 mmol, 0.2 equiv) according to the general procedure described for 4.21a-e and 
4.23a-c. Repeated purification via silica column chromatography did not afford pure 
4.44.  
Rf  = 0.5 (EtOAc/Hexane 3:7). 
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1
H NMR (400 MHz, CDCl3) δ 7.54-7.43 (m, 2H), 7.41-7.36 (m, 3H), 7.33-7.30 (m, 
1H), 7.25-7.22 (m, 2H), 7.02-6.97 (m, 1H), 5.93 (ddd, J = 9.6 Hz, J = 4.4 Hz, J = 1.6 
Hz, 1H), 5.27 (ddd, J = 10.4 Hz, J = 3.6 Hz, J = 1.2 Hz, 1H), 4.93 (s, 1H), 4.50-4.44 
(m, 1H), 4.36-4.28 (m, 1H), 1.87 (d, J = 5.2 Hz, 1H), 1.12 (d, J = 4.8 Hz, 1H), 
HRMS (ES
+
): calcd for C19H16ONa (M+Na)
+
 283.1099, found 283.1090. 
 
Development of a one-pot protocol for the synthesis of benzoindolines 4.22a, 4.22 
c, 4.22e and pyrroloquinoline 4.22g:  
 
The diene 4.12a (0.067 g, 0.15 mmol, 1.0 equiv) was treated with Pd(OAc)2 (0.0038 
g, 0.015 mmol, 0.1 equiv), NaOAc (0.014 g, 0.17 mmol, 1.1 equiv) according to the 
general procedure described for 4.22a-e and 4.25a-c. Toluene was used instead of 
DMF and no workup was done. Instead, reaction was loaded on a silica column and 
was purified by flash chromatography over silica eluting with EtOAc/Hexane (1:9) to 
recover the diene 4.12a (0.060 g, 89%).  
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The diene 4.12a (0.051 g, 0.12 mmol, 1.0 equiv) was treated with Pd(OAc)2 (0.0027 
g, 0.012 mmol, 0.1 equiv), Cs2CO3 (0.078 g, 0.24 mmol, 2.0 equiv) and PPh3 (0.0063 
g, 0.024 mmol, 0.2 equiv) according to the general procedure described for 4.21a-e 
and 4.23a-c. Toluene was used instead of DMF and no workup was done. Instead, 
reaction was loaded on a silica column and was purified by flash chromatography 
over silica eluting with EtOAc/Hexane (1:9) to afford benzoindoline 4.22a (0.027 g, 
65%) as a white solid.  
 
 
(Ethylene was bubbled through, 5 min) the solution of 4.9a (0.08 g, 0.18 mmol) in 
toluene (4 mL) in a 25 mL 2 neck RB fit with a reflux condenser. Grubbs I catalyst 
(0.015 g, 0.018 mmol) was added as a solid and the reaction mixture was stirred at 
85
o
C under ethylene atmosphere for 2 h. The reaction mixture was cooled to rt and 
purged with argon for 10 minutes. Pd(OAc)2 (0.0042 g, 0.018 mmol), PPh3 (0.012 g, 
0.03 mmol), Cs2CO3 (0.097 g, 0.37 mmol) were added as solids. The reaction mixture 
was stirred at 120
o
C for 15 h and cooled to rt.  Upon evaporation of toluene the crude 
mixture was loaded on a silica column and was eluted with EtOAc/Hexane (1:9) to 
afford pure benzoindoline 4.22a (0.045 g, 69% yield) as a white solid. 
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(Ethylene was bubbled through, 5 min) the solution of 4.9c (0.037 g, 0.08 mmol) in 
toluene (4 mL) in a 25 mL 2 neck RB fit with a reflux condenser. Grubbs I catalyst 
(0.007 g, 0.008 mmol) was added as a solid and the reaction mixture was stirred at 
85
o
C under ethylene atmosphere for 2 h. The reaction mixture was cooled to rt and 
purged with argon for 10 minutes. Pd(OAc)2 (0.002 g, 0.008 mmol), PPh3 (0.005 g, 
0.017 mmol), Cs2CO3 (0.055 g, 0.17 mmol) were added as solids. The reaction 
mixture was stirred at 120
o
C for 15 h and cooled to rt.  Upon evaporation of toluene 
the crude mixture was loaded on a silica column and was eluted with EtOAc/Hexane 
(1:9) to afford pure benzoindoline 4.22c (0.019 g, 61% yield) as a heavy oil. 
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(Ethylene was bubbled through, 5 min) the solution of 4.9e (0.04 g, 0.087 mmol) in 
toluene (4 mL) in a 25 mL 2 neck RB fit with a reflux condenser. Grubbs I catalyst 
(0.008 g, 0.009 mmol) was added as a solid and the reaction mixture was stirred at 
85
o
C under ethylene atmosphere for 2 h. The reaction mixture was cooled to rt and 
purged with argon for 10 minutes. Pd(OAc)2 (0.002 g, 0.009 mmol), PPh3 (0.005 g, 
0.017 mmol), Cs2CO3 (0.055 g, 0.17 mmol) were added as solids. The reaction 
mixture was stirred at 120
o
C for 15 h and cooled to rt.  Upon evaporation of toluene 
the crude mixture was loaded on a silica column and was eluted with EtOAc/Hexane 
(1:4) to afford pure benzoindoline 4.22e (0.021 g, 64% yield) as a colorless oil. 
 
 
 
 
(Ethylene was bubbled through, 5 min) the solution of 4.9g (0.051 g, 0.12 mmol) in 
toluene (4 mL) in a 25 mL 2 neck RB fit with a reflux condenser. Grubbs I catalyst 
(0.01 g, 0.012 mmol) was added as a solid and the reaction mixture was stirred at 
85
o
C under ethylene atmosphere for 2 h. The reaction mixture was cooled to rt and 
purged with argon for 10 minutes. Pd(OAc)2 (0.003 g, 0.012 mmol), PPh3 (0.009 g, 
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0.024 mmol), Cs2CO3 (0.078 g, 0.24 mmol) were added as solids. The reaction 
mixture was stirred at 120
o
C for 15 h and cooled to rt.  Upon evaporation of toluene 
the crude mixture was loaded on a silica column and was eluted with EtOAc/Hexane 
(2:3) to afford pure benzoindoline 4.22g (0.03 g, 71% yield) as a colorless oil. 
 
Development of a one-pot protocol for the synthesis of indenopyridines 4.21a, 
4.21c, 4.21e and phenanthrolines 4.23a-b:  
 
 
The diene 4.13a (0.049 g, 0.11 mmol, 1.0 equiv) was treated with Pd(OAc)2 (0.0025 
g, 0.011 mmol, 0.1 equiv), Cs2CO3 (0.072 g, 0.22 mmol, 2.0 equiv) and PPh3 (0.008 
g, 0.022 mmol, 0.2 equiv) according to the general procedure described for 4.21a-e 
and 4.23a-c. Toluene was used instead of DMF and no workup was done. Instead, the 
mixture was directly loaded on silica column and was purified by flash 
chromatography over silica eluting with EtOAc/Hexane (1:8) to afforded 
indenopyridine 4.21a (0.031 g, 77%) as a white fluffy solid. 
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(Ethylene was bubbled through, 5 min) the solution of 4.9f (0.103 g, 0.20 mmol) in 
toluene (10 mL) in a 25 mL 2 neck RB fit with a reflux condenser. Grubbs II catalyst 
(0.02 g, 0.02 mmol) was added as solid, and the reaction mixture was stirred at 85
o
C 
under ethylene atmosphere for 8 h. The reaction mixture was cooled to rt and purged 
with argon for 10 minutes. Pd(OAc)2 (0.0052 g, 0.02 mmol), PPh3 (0.015 g, 0.04 
mmol), Cs2CO3 (0.122 g, 0.46 mmol) were added as solids. The reaction mixture was 
stirred at 120
o
C for 15 h and cooled to rt.  Upon evaporation of toluene the crude 
mixture was loaded on to silica column and was eluted with EtOAc/Hexane (1:8)   to 
afford indenopyridine 4.21a  (0.063 g, 75% ) as a white fluffy solid and 
benzoquinoline 4.20 (0.001 g, 12% ) as a white solid. 
 
 
(Ethylene was bubbled through, 5 min) the solution of 4.9h (0.041 g, 0.09 mmol) in 
toluene (4 mL) in a 25 mL 2 neck RB fit with a reflux condenser. Grubbs II catalyst 
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(0.008 g, 0.009 mmol) was added as solid, and the reaction mixture was stirred at 
85
o
C under ethylene atmosphere for 8 h. The reaction mixture was cooled to rt and 
purged with argon for 10 minutes. Pd(OAc)2 (0.002 g, 0.009 mmol), PPh3 (0.007 g, 
0.018 mmol),  Cs2CO3 (0.059 g, 0.18 mmol) were added as solids. The reaction 
mixture was stirred at 120
o
C for 15 h and cooled to rt.  Upon evaporation of toluene 
the crude mixture was loaded on to silica column and was eluted with EtOAc/Hexane 
(1:4)   to afford indenopyridine 4.21c (0.023 g, 69%) as a colorless heavy oil. 
 
 
(Ethylene was bubbled through, 5 min) the solution of 4.9j (0.032 g, 0.07 mmol) in 
toluene (3 mL) in a 25 mL 2 neck RB fit with a reflux condenser. Grubbs II catalyst 
(0.006 g, 0.007 mmol) was added as solid, and the reaction mixture was stirred at 
85
o
C under ethylene atmosphere for 8 h. The reaction mixture was cooled to rt and 
purged with argon for 10 minutes. Pd(OAc)2 (0.002 g, 0.007 mmol), PPh3 (0.005 g, 
0.014 mmol),  Cs2CO3 (0.046 g, 0.14 mmol) were added as solids. The reaction 
mixture was stirred at 120
o
C for 15 h and cooled to rt. Upon evaporation of toluene 
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the crude mixture was loaded on to silica column and was eluted with EtOAc/Hexane 
(1:8) to afford indenopyridine 4.21e (0.019 g, 70%) as a colorless oil. 
 
 
(Ethylene was bubbled through, 5 min) the solution of 4.9p (0.043 g, 0.1 mmol) in 
toluene (3 mL) in a 25 mL 2 neck RB fit with a reflux condenser. Grubbs II catalyst 
(0.008 g, 0.01 mmol) was added as solid, and the reaction mixture was stirred at 85
o
C 
under ethylene atmosphere for 8 h. The reaction mixture was cooled to rt and purged 
with argon for 10 minutes. Pd(OAc)2 (0.002 g, 0.01 mmol), PPh3 (0.007 g, 0.02 
mmol),  Cs2CO3 (0.065 g, 0.2 mmol) were added as solids. The reaction mixture was 
stirred at 120
o
C for 24 h and cooled to rt. Upon evaporation of toluene the crude 
mixture was loaded on to silica column and was eluted with EtOAc/Hexane (2:3) to 
afford phenanthroline 4.23a (0.022 g, 61%) as a light yellow powder and (0.011g, 
25%) of RCM product 4.13g was recovered.  
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(Ethylene was bubbled through, 5 min) the solution of 4.9q (0.034 g, 0.07 mmol) in 
toluene (3 mL) in a 25 mL 2 neck RB fit with a reflux condenser. Grubbs II catalyst 
(0.006 g, 0.007 mmol) was added as solid, and the reaction mixture was stirred at 
85
o
C under ethylene atmosphere for 8 h. The reaction mixture was cooled to rt and 
purged with argon for 10 minutes. Pd(OAc)2 (0.002 g, 0.007 mmol), PPh3 (0.005 g, 
0.014 mmol),  Cs2CO3 (0.046 g, 0.14 mmol) were added as solids. The reaction 
mixture was stirred at 120
o
C for 15 h and cooled to rt. Upon evaporation of toluene 
the crude mixture was loaded on to silica column and was eluted with EtOAc/Hexane 
(2:3) to afford phenanthroline 4.23b (0.015 g, 56%) as a colorless oil and (0.01g, 
29%) of RCM product 4.13h was recovered. 
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GC Analysis of 9:1 mixture of 3.36a 
The GCMS data were collected on an Agilent 6890N gas chromatograph eluting into 
a Quattro Micro GC mass spectrometer (Micromass Ltd, Manchester UK). An HP-
5MS, 15 meter column with a 0.25 ID was used. The carrier gas was Helium using 
constant flow control set to 1.5 mL per minute. 1.0μl of sample was injected into the 
column with a 20:1 split ratio. The injector port temperature was 240
o
C. The 
chromatographic conditions were as follows: The initial column temperature was 
50
o
C with a 1 minute hold after which the temperature was increased 25
o
C/min to a 
final temperature of 300
o
C and held for 2 minutes. EI ionization was used with ion 
energy of 70V. The mass range was 45 to 400 m/z with a 0.3 scan time and an inter 
scan delay time of 0.07 seconds. 
 
The first spectra is of the single diastereomer (3.36a) and second is of the 9:1 
diastereomeric mixture (3.36a) 
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Assignment of relative stereochemistry of compounds 3.22, 3.33 and 3.36a using 
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HMBC-NMR: Long range correlation seen between H-3 and C-5. 
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GC-MS spectras for compounds 4.23a-c and 4.25a-b: 
 
The GCMS data were collected on an Agilent 6890N gas chromatograph eluting into 
a QuattroMicro GC mass spectrometer (Micromass Ltd, Manchester UK). An HP-
5MS, 15 meter column with a 0.25 ID was used. The carrier gas was Helium using 
constant flow control set to 1.5 mL per minute. 1.0μl of sample was injected into the 
column with a 20:1 split ratio. The injector port temperature was 240
o
C. The 
chromatographic conditions were as follows: The initial column temperature was 
50
o
C with a 1 minute hold after which the temperature was increased 25
o
C/min to a 
final temperature of 300
o
C and held for 2 minutes. EI ionization was used with 
ion energy of 70V. The mass range was 45 to 400 m/z with a 0.3 scan time and an 
inter scan delay time of 0.07 seconds. 
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                                         Pyrroloquinoline 4.25a      Quantitative integration table 
 
 
 
 
MS spectrum for the peak at 10.75 min retention time C24H18N2O = 350.1419 
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                                          Pyrroloquinoline 4.25b     Quantitative integration table 
 
 
 
 
 
MS spectrum for the peak at 10.54 min retention time C24H17FN2O = 368.1325 
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                            Oxidized pyrroloquinoline 4.25b   Quantitative integration table 
 
 
 
 
MS spectrum for the peak at 10.15 min retention time C24H15FN2O = 366.1168 
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                                          1,7-Phenanthroline 4.23a  Quantitative integration table 
 
 
 
 
 
MS spectrum for the peak at 10.57 min retention time C25H20N2O = 364.1576 
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                             1,7-Phenanthroline 4.23b        Quantitative integration table 
 
           
          
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
     MS spectrum for the peak at 9.61 min retention time C25H19FN2O = 382.1481 
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                            1,7-Phenanthroline 4.23c       Quantitative integration table 
 
 
 
 
             
      MS spectrum for the peak at 10.80 min retention time C26H22N2O2 = 394.1681 
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The thermal ellipsoids of 3.22, 4.20, 4.21b, 4.22a and 4.23a drawn at 50% probability 
level. 
                          
               
             3.22 (CCDC 858605)                                4.20 (CCDC 900884)        
 
 
 
           
 
   4.21b (CCDC 895234)          4.22a (CCDC 895235)        4.23a (CCDC 895233) 
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Table 1.  Crystal data and structure refinement for C33H39NO6S. 
Identification code  k68f 
Empirical formula  C33H39NO6S  
Formula weight  577.71 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  Orthorhombic 
Space group  Pna2(1) 
Unit cell dimensions a = 10.2039(6) Å = 90°. 
 b = 26.1416(15) Å = 90°. 
 c = 11.2558(7) Å  = 90°. 
Volume 3002.4(3) Å3 
Z 4 
Density (calculated) 1.278 Mg/m3 
386 
 
Absorption coefficient 0.153 mm-1 
F(000) 1232 
Crystal size 0.32 x 0.32 x 0.20 mm3 
Theta range for data collection 2.53 to 30.53°. 
Index ranges -14<=h<=14, -37<=k<=37, -16<=l<=16 
Reflections collected 34706 
Independent reflections 9033 [R(int) = 0.0404] 
Completeness to theta = 30.53° 99.4 %  
Absorption correction Multi-scan 
Max. and min. transmission 1.000 and 0.865 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 9033 / 1 / 526 
Goodness-of-fit on F2 1.081 
Final R indices [I>2sigma(I)] R1 = 0.0470, wR2 = 0.1070 
R indices (all data) R1 = 0.0490, wR2 = 0.1081 
Absolute structure parameter 0.06(5) 
Largest diff. peak and hole 0.729 and -0.255 e.Å-3 
 
Table 2.  Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (Å2x 103) 
for C33H39NO6S.  U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
________________________________________________________________________________ 
 x y z U(eq) 
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________________________________________________________________________________ 
S 5389(1) 4980(1) 4735(1) 14(1) 
O(1) 4857(1) 5366(1) 3964(1) 19(1) 
O(2) 5972(1) 5123(1) 5853(1) 20(1) 
O(3) -1713(1) 5911(1) 4597(1) 20(1) 
O(4) -1796(1) 5803(1) 2620(1) 23(1) 
O(5) 2418(1) 1696(1) 7950(1) 24(1) 
O(6) 3913(2) 1321(1) 6775(1) 35(1) 
N 4175(1) 4593(1) 5046(1) 13(1) 
C(1) 3327(1) 4438(1) 4021(1) 13(1) 
C(2) 3039(2) 3864(1) 4246(1) 13(1) 
C(3) 4230(1) 3684(1) 4976(1) 13(1) 
C(4) 4467(2) 4142(1) 5804(1) 15(1) 
C(5) 2107(1) 4763(1) 3925(1) 13(1) 
C(6) 1642(2) 4909(1) 2806(1) 14(1) 
C(7) 528(2) 5212(1) 2713(1) 14(1) 
C(8) -136(2) 5371(1) 3722(1) 13(1) 
C(9) 315(2) 5223(1) 4844(2) 16(1) 
C(10) 1429(2) 4916(1) 4940(1) 15(1) 
C(11) -1294(2) 5710(1) 3564(1) 16(1) 
C(12) -2830(2) 6249(1) 4498(2) 20(1) 
C(13) 2808(2) 3579(1) 3074(1) 16(1) 
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C(14) 2140(2) 3057(1) 3178(2) 19(1) 
C(15) 1934(2) 2812(1) 1961(2) 18(1) 
C(16) 1120(2) 2322(1) 1989(2) 21(1) 
C(17) 971(2) 2067(1) 771(2) 27(1) 
C(18) 258(2) 2388(1) -147(2) 30(1) 
C(19) 4055(2) 3181(1) 5606(1) 14(1) 
C(20) 4855(2) 2765(1) 5334(2) 18(1) 
C(21) 4624(2) 2289(1) 5837(2) 19(1) 
C(22) 3604(2) 2223(1) 6646(1) 16(1) 
C(23) 2828(2) 2642(1) 6958(2) 18(1) 
C(24) 3046(2) 3116(1) 6443(1) 17(1) 
C(25) 3357(2) 1700(1) 7116(2) 19(1) 
C(26) 2083(2) 1196(1) 8405(2) 24(1) 
C(27) 6550(2) 4624(1) 3931(2) 15(1) 
C(28) 6411(2) 4590(1) 2702(2) 18(1) 
C(29) 7240(2) 4269(1) 2068(2) 22(1) 
C(30) 8213(2) 3986(1) 2642(2) 23(1) 
C(31) 8350(2) 4035(1) 3870(2) 22(1) 
C(32) 7527(2) 4349(1) 4527(2) 18(1) 
C(33) 9113(2) 3646(1) 1941(2) 32(1) 
________________________________________________________________________________  
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Table 3.   Bond lengths [Å] and angles [°] for C33H39NO6S. 
_____________________________________________________ 
S-O(1)  1.4374(12) 
S-O(2)  1.4408(13) 
S-N  1.6373(13) 
S-C(27)  1.7576(16) 
O(3)-C(11)  1.345(2) 
O(3)-C(12)  1.4457(19) 
O(4)-C(11)  1.204(2) 
O(5)-C(25)  1.342(2) 
O(5)-C(26)  1.445(2) 
O(6)-C(25)  1.202(2) 
N-C(4)  1.4849(19) 
N-C(1)  1.4987(19) 
C(1)-C(5)  1.511(2) 
C(1)-C(2)  1.549(2) 
C(1)-H(1)  0.965(19) 
C(2)-C(13)  1.534(2) 
C(2)-C(3)  1.541(2) 
C(2)-H(2)  1.00(2) 
C(3)-C(19)  1.506(2) 
C(3)-C(4)  1.537(2) 
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C(3)-H(3)  1.01(2) 
C(4)-H(4A)  0.93(2) 
C(4)-H(4B)  0.90(2) 
C(5)-C(10)  1.395(2) 
C(5)-C(6)  1.399(2) 
C(6)-C(7)  1.390(2) 
C(6)-H(6)  0.92(2) 
C(7)-C(8)  1.387(2) 
C(7)-H(7)  0.90(2) 
C(8)-C(9)  1.399(2) 
C(8)-C(11)  1.488(2) 
C(9)-C(10)  1.396(2) 
C(9)-H(9)  0.88(2) 
C(10)-H(10)  0.96(2) 
C(12)-H(12A)  0.93(2) 
C(12)-H(12B)  0.86(2) 
C(12)-H(12C)  0.87(3) 
C(13)-C(14)  1.530(2) 
C(13)-H(13A)  1.00(2) 
C(13)-H(13B)  0.98(2) 
C(14)-C(15)  1.527(2) 
C(14)-H(14A)  1.01(3) 
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C(14)-H(14B)  1.07(2) 
C(15)-C(16)  1.526(2) 
C(15)-H(15A)  0.96(3) 
C(15)-H(15B)  0.94(3) 
C(16)-C(17)  1.532(3) 
C(16)-H(16A)  0.88(3) 
C(16)-H(16B)  1.04(2) 
C(17)-C(18)  1.517(3) 
C(17)-H(17A)  0.96(2) 
C(17)-H(17B)  1.02(3) 
C(18)-H(18A)  0.92(2) 
C(18)-H(18B)  0.95(3) 
C(18)-H(18C)  1.00(3) 
C(19)-C(20)  1.394(2) 
C(19)-C(24)  1.406(2) 
C(20)-C(21)  1.386(2) 
C(20)-H(20)  0.97(2) 
C(21)-C(22)  1.394(2) 
C(21)-H(21)  0.95(2) 
C(22)-C(23)  1.396(2) 
C(22)-C(25)  1.488(2) 
C(23)-C(24)  1.386(2) 
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C(23)-H(23)  0.96(3) 
C(24)-H(24)  0.95(2) 
C(26)-H(26A)  0.96(3) 
C(26)-H(26B)  0.85(3) 
C(26)-H(26C)  0.93(3) 
C(27)-C(28)  1.394(2) 
C(27)-C(32)  1.400(2) 
C(28)-C(29)  1.389(2) 
C(28)-H(28)  0.86(2) 
C(29)-C(30)  1.396(3) 
C(29)-H(29)  0.98(2) 
C(30)-C(31)  1.395(3) 
C(30)-C(33)  1.502(3) 
C(31)-C(32)  1.390(2) 
C(31)-H(31)  0.91(2) 
C(32)-H(32)  0.84(2) 
C(33)-H(33A)  0.89(3) 
C(33)-H(33B)  0.95(4) 
C(33)-H(33C)  0.90(4) 
 
O(1)-S-O(2) 120.10(7) 
O(1)-S-N 106.05(7) 
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O(2)-S-N 106.65(7) 
O(1)-S-C(27) 108.34(8) 
O(2)-S-C(27) 107.98(8) 
N-S-C(27) 107.05(7) 
C(11)-O(3)-C(12) 114.97(13) 
C(25)-O(5)-C(26) 115.05(14) 
C(4)-N-C(1) 110.09(12) 
C(4)-N-S 117.45(10) 
C(1)-N-S 116.09(10) 
N-C(1)-C(5) 112.21(12) 
N-C(1)-C(2) 104.21(12) 
C(5)-C(1)-C(2) 113.62(12) 
N-C(1)-H(1) 110.4(11) 
C(5)-C(1)-H(1) 109.1(11) 
C(2)-C(1)-H(1) 107.1(11) 
C(13)-C(2)-C(3) 115.50(13) 
C(13)-C(2)-C(1) 111.05(12) 
C(3)-C(2)-C(1) 103.50(12) 
C(13)-C(2)-H(2) 108.3(13) 
C(3)-C(2)-H(2) 109.8(13) 
C(1)-C(2)-H(2) 108.5(12) 
C(19)-C(3)-C(4) 114.48(12) 
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C(19)-C(3)-C(2) 115.12(12) 
C(4)-C(3)-C(2) 102.08(12) 
C(19)-C(3)-H(3) 109.9(11) 
C(4)-C(3)-H(3) 107.3(12) 
C(2)-C(3)-H(3) 107.3(11) 
N-C(4)-C(3) 103.79(12) 
N-C(4)-H(4A) 107.8(13) 
C(3)-C(4)-H(4A) 111.4(13) 
N-C(4)-H(4B) 108.9(13) 
C(3)-C(4)-H(4B) 111.2(13) 
H(4A)-C(4)-H(4B) 113.3(19) 
C(10)-C(5)-C(6) 119.46(13) 
C(10)-C(5)-C(1) 120.73(13) 
C(6)-C(5)-C(1) 119.80(14) 
C(7)-C(6)-C(5) 120.05(14) 
C(7)-C(6)-H(6) 119.8(12) 
C(5)-C(6)-H(6) 120.2(12) 
C(8)-C(7)-C(6) 120.61(14) 
C(8)-C(7)-H(7) 120.2(13) 
C(6)-C(7)-H(7) 119.0(13) 
C(7)-C(8)-C(9) 119.71(13) 
C(7)-C(8)-C(11) 118.00(14) 
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C(9)-C(8)-C(11) 122.27(14) 
C(10)-C(9)-C(8) 119.84(15) 
C(10)-C(9)-H(9) 118.3(15) 
C(8)-C(9)-H(9) 121.8(15) 
C(5)-C(10)-C(9) 120.31(14) 
C(5)-C(10)-H(10) 118.1(14) 
C(9)-C(10)-H(10) 121.6(14) 
O(4)-C(11)-O(3) 123.27(14) 
O(4)-C(11)-C(8) 124.30(15) 
O(3)-C(11)-C(8) 112.42(13) 
O(3)-C(12)-H(12A) 110.3(13) 
O(3)-C(12)-H(12B) 110.4(14) 
H(12A)-C(12)-H(12B) 109.8(19) 
O(3)-C(12)-H(12C) 102.2(16) 
H(12A)-C(12)-H(12C) 113(2) 
H(12B)-C(12)-H(12C) 111(2) 
C(14)-C(13)-C(2) 115.90(13) 
C(14)-C(13)-H(13A) 108.1(12) 
C(2)-C(13)-H(13A) 107.5(12) 
C(14)-C(13)-H(13B) 111.3(12) 
C(2)-C(13)-H(13B) 107.3(13) 
H(13A)-C(13)-H(13B) 106.3(18) 
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C(15)-C(14)-C(13) 111.56(14) 
C(15)-C(14)-H(14A) 108.5(14) 
C(13)-C(14)-H(14A) 111.6(14) 
C(15)-C(14)-H(14B) 109.3(12) 
C(13)-C(14)-H(14B) 110.3(12) 
H(14A)-C(14)-H(14B) 105.4(18) 
C(16)-C(15)-C(14) 114.09(15) 
C(16)-C(15)-H(15A) 110.5(15) 
C(14)-C(15)-H(15A) 110.2(16) 
C(16)-C(15)-H(15B) 109.2(15) 
C(14)-C(15)-H(15B) 109.7(15) 
H(15A)-C(15)-H(15B) 102(2) 
C(15)-C(16)-C(17) 113.56(15) 
C(15)-C(16)-H(16A) 108.0(16) 
C(17)-C(16)-H(16A) 109.6(17) 
C(15)-C(16)-H(16B) 104.8(13) 
C(17)-C(16)-H(16B) 114.0(14) 
H(16A)-C(16)-H(16B) 106(2) 
C(18)-C(17)-C(16) 114.64(16) 
C(18)-C(17)-H(17A) 110.4(15) 
C(16)-C(17)-H(17A) 107.3(15) 
C(18)-C(17)-H(17B) 106.8(15) 
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C(16)-C(17)-H(17B) 113.7(15) 
H(17A)-C(17)-H(17B) 103(2) 
C(17)-C(18)-H(18A) 107.4(16) 
C(17)-C(18)-H(18B) 110(2) 
H(18A)-C(18)-H(18B) 105(2) 
C(17)-C(18)-H(18C) 111.8(15) 
H(18A)-C(18)-H(18C) 111(2) 
H(18B)-C(18)-H(18C) 111(3) 
C(20)-C(19)-C(24) 118.82(14) 
C(20)-C(19)-C(3) 120.61(14) 
C(24)-C(19)-C(3) 120.52(13) 
C(21)-C(20)-C(19) 120.66(15) 
C(21)-C(20)-H(20) 119.7(13) 
C(19)-C(20)-H(20) 119.5(13) 
C(20)-C(21)-C(22) 120.36(15) 
C(20)-C(21)-H(21) 121.0(13) 
C(22)-C(21)-H(21) 118.4(13) 
C(21)-C(22)-C(23) 119.40(14) 
C(21)-C(22)-C(25) 118.18(14) 
C(23)-C(22)-C(25) 122.39(15) 
C(24)-C(23)-C(22) 120.27(15) 
C(24)-C(23)-H(23) 120.5(14) 
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C(22)-C(23)-H(23) 119.1(14) 
C(23)-C(24)-C(19) 120.42(15) 
C(23)-C(24)-H(24) 119.6(13) 
C(19)-C(24)-H(24) 120.0(13) 
O(6)-C(25)-O(5) 123.65(15) 
O(6)-C(25)-C(22) 124.29(16) 
O(5)-C(25)-C(22) 112.05(14) 
O(5)-C(26)-H(26A) 104.7(15) 
O(5)-C(26)-H(26B) 114.5(17) 
H(26A)-C(26)-H(26B) 104(2) 
O(5)-C(26)-H(26C) 109.4(15) 
H(26A)-C(26)-H(26C) 113(2) 
H(26B)-C(26)-H(26C) 112(2) 
C(28)-C(27)-C(32) 121.01(15) 
C(28)-C(27)-S 118.48(12) 
C(32)-C(27)-S 120.31(13) 
C(29)-C(28)-C(27) 119.12(15) 
C(29)-C(28)-H(28) 117.7(15) 
C(27)-C(28)-H(28) 123.1(15) 
C(28)-C(29)-C(30) 121.05(16) 
C(28)-C(29)-H(29) 120.3(13) 
C(30)-C(29)-H(29) 118.7(13) 
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C(31)-C(30)-C(29) 118.76(16) 
C(31)-C(30)-C(33) 120.85(18) 
C(29)-C(30)-C(33) 120.37(18) 
C(32)-C(31)-C(30) 121.39(16) 
C(32)-C(31)-H(31) 119.2(14) 
C(30)-C(31)-H(31) 119.3(14) 
C(31)-C(32)-C(27) 118.65(16) 
C(31)-C(32)-H(32) 121.2(15) 
C(27)-C(32)-H(32) 120.1(15) 
C(30)-C(33)-H(33A) 108.7(19) 
C(30)-C(33)-H(33B) 118(2) 
H(33A)-C(33)-H(33B) 108(3) 
C(30)-C(33)-H(33C) 108(2) 
H(33A)-C(33)-H(33C) 104(3) 
H(33B)-C(33)-H(33C) 109(3) 
_____________________________________________________________ 
Symmetry transformations used to generate equivalent atoms:  
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Table 4.   Anisotropic displacement parameters (Å2x 103)for C33H39NO6S.  The anisotropic 
displacement factor exponent takes the form: -22[ h2a*2U11 + ... + 2 h k a* b* U12 ] 
______________________________________________________________________________ 
 U11 U22 U33 U23 U13 U12 
______________________________________________________________________________ 
S 11(1)  14(1) 16(1)  0(1) 0(1)  -1(1) 
O(1) 16(1)  15(1) 26(1)  3(1) -2(1)  1(1) 
O(2) 16(1)  24(1) 19(1)  -5(1) -2(1)  -4(1) 
O(3) 17(1)  24(1) 17(1)  -1(1) -2(1)  7(1) 
O(4) 20(1)  27(1) 21(1)  -1(1) -5(1)  9(1) 
O(5) 27(1)  16(1) 29(1)  3(1) 8(1)  -1(1) 
O(6) 50(1)  18(1) 35(1)  5(1) 17(1)  8(1) 
N 10(1)  15(1) 14(1)  1(1) -2(1)  -1(1) 
C(1) 11(1)  15(1) 12(1)  1(1) 0(1)  1(1) 
C(2) 11(1)  14(1) 14(1)  0(1) 1(1)  1(1) 
C(3) 11(1)  15(1) 14(1)  2(1) 1(1)  1(1) 
C(4) 14(1)  17(1) 14(1)  2(1) -2(1)  0(1) 
C(5) 11(1)  12(1) 15(1)  1(1) 0(1)  0(1) 
C(6) 14(1)  17(1) 13(1)  -1(1) 1(1)  0(1) 
C(7) 15(1)  15(1) 13(1)  0(1) -3(1)  1(1) 
C(8) 10(1)  13(1) 15(1)  2(1) 0(1)  1(1) 
C(9) 14(1)  21(1) 13(1)  1(1) 2(1)  2(1) 
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C(10) 15(1)  18(1) 12(1)  2(1) 0(1)  2(1) 
C(11) 12(1)  16(1) 19(1)  1(1) 0(1)  0(1) 
C(12) 17(1)  20(1) 23(1)  -4(1) -1(1)  5(1) 
C(13) 16(1)  16(1) 16(1)  -1(1) -1(1)  -1(1) 
C(14) 21(1)  17(1) 18(1)  -2(1) -2(1)  -2(1) 
C(15) 15(1)  19(1) 22(1)  -5(1) 0(1)  0(1) 
C(16) 21(1)  21(1) 22(1)  -4(1) 0(1)  -5(1) 
C(17) 28(1)  26(1) 28(1)  -11(1) 1(1)  -6(1) 
C(18) 26(1)  43(1) 21(1)  -7(1) 2(1)  -8(1) 
C(19) 13(1)  16(1) 14(1)  2(1) -1(1)  0(1) 
C(20) 15(1)  21(1) 18(1)  3(1) 5(1)  3(1) 
C(21) 19(1)  18(1) 22(1)  2(1) 2(1)  7(1) 
C(22) 18(1)  15(1) 15(1)  1(1) 0(1)  1(1) 
C(23) 18(1)  17(1) 18(1)  2(1) 4(1)  1(1) 
C(24) 17(1)  17(1) 18(1)  0(1) 5(1)  3(1) 
C(25) 25(1)  15(1) 18(1)  3(1) -1(1)  0(1) 
C(26) 32(1)  16(1) 24(1)  2(1) 5(1)  -6(1) 
C(27) 11(1)  16(1) 18(1)  1(1) 1(1)  1(1) 
C(28) 14(1)  22(1) 18(1)  4(1) 0(1)  1(1) 
C(29) 17(1)  27(1) 20(1)  -1(1) 3(1)  0(1) 
C(30) 15(1)  22(1) 30(1)  -2(1) 5(1)  1(1) 
C(31) 13(1)  22(1) 32(1)  3(1) 0(1)  5(1) 
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C(32) 15(1)  22(1) 17(1)  3(1) -2(1)  1(1) 
C(33) 22(1)  35(1) 39(1)  -8(1) 6(1)  9(1) 
 
Table 5.   Hydrogen coordinates ( x 104) and isotropic displacement parameters (Å2x 103) 
for C33H39NO6S. 
________________________________________________________________________________ 
 x  y  z  U(eq) 
________________________________________________________________________________ 
 
H(1) 3810(19) 4459(7) 3285(17) 7(4) 
H(2) 2220(20) 3837(8) 4740(20) 23(5) 
H(3) 5000(20) 3664(8) 4417(18) 17(5) 
H(4A) 3880(20) 4144(8) 6440(20) 19(5) 
H(4B) 5310(20) 4158(8) 6036(19) 17(5) 
H(6) 2076(19) 4808(7) 2131(18) 8(4) 
H(7) 280(20) 5324(7) 1993(19) 12(5) 
H(9) -80(20) 5324(8) 5500(20) 20(5) 
H(10) 1750(20) 4801(8) 5700(20) 21(5) 
H(12A) -2580(20) 6560(8) 4169(18) 15(5) 
H(12B) -3430(20) 6110(8) 4070(20) 19(5) 
H(12C) -3080(20) 6276(9) 5240(20) 27(6) 
H(13A) 2250(20) 3803(7) 2560(20) 16(5) 
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H(13B) 3660(20) 3551(8) 2673(19) 19(5) 
H(14A) 2670(20) 2813(9) 3690(20) 31(6) 
H(14B) 1220(20) 3094(8) 3610(20) 21(5) 
H(15A) 2760(30) 2751(9) 1580(20) 33(6) 
H(15B) 1530(30) 3048(9) 1440(20) 33(6) 
H(16A) 340(20) 2398(9) 2280(20) 29(6) 
H(16B) 1570(20) 2093(9) 2620(20) 29(6) 
H(17A) 520(20) 1748(9) 890(20) 26(6) 
H(17B) 1840(30) 1959(10) 400(20) 35(7) 
H(18A) -520(20) 2487(9) 180(20) 26(6) 
H(18B) 720(30) 2697(13) -290(30) 67(10) 
H(18C) 120(30) 2196(10) -900(30) 35(7) 
H(20) 5550(20) 2804(9) 4750(20) 26(5) 
H(21) 5100(20) 1995(8) 5588(19) 17(5) 
H(23) 2180(20) 2603(9) 7580(20) 27(6) 
H(24) 2510(20) 3397(9) 6660(20) 20(5) 
H(26A) 1320(20) 1252(9) 8880(30) 35(6) 
H(26B) 1820(20) 985(10) 7880(20) 30(6) 
H(26C) 2780(20) 1067(9) 8840(20) 30(6) 
H(28) 5800(20) 4742(8) 2320(20) 21(5) 
H(29) 7160(20) 4239(8) 1200(20) 21(5) 
H(31) 9030(20) 3875(8) 4240(20) 22(5) 
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H(32) 7610(20) 4376(8) 5270(20) 19(5) 
H(33A) 9930(30) 3755(10) 2030(30) 47(8) 
H(33B) 8950(40) 3609(14) 1110(40) 86(13) 
H(33C) 9120(30) 3333(14) 2280(30) 63(10) 
________________________________________________________________________________ 
 
Table 6.  Torsion angles [°] for C33H39NO6S. 
________________________________________________________________ 
O(1)-S-N-C(4) 177.80(11) 
O(2)-S-N-C(4) -53.11(13) 
C(27)-S-N-C(4) 62.28(13) 
O(1)-S-N-C(1) 44.53(12) 
O(2)-S-N-C(1) 173.62(10) 
C(27)-S-N-C(1) -70.99(12) 
C(4)-N-C(1)-C(5) 127.01(13) 
S-N-C(1)-C(5) -96.46(13) 
C(4)-N-C(1)-C(2) 3.65(15) 
S-N-C(1)-C(2) 140.18(10) 
N-C(1)-C(2)-C(13) -151.42(12) 
C(5)-C(1)-C(2)-C(13) 86.15(16) 
N-C(1)-C(2)-C(3) -26.89(14) 
C(5)-C(1)-C(2)-C(3) -149.33(13) 
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C(13)-C(2)-C(3)-C(19) -74.28(16) 
C(1)-C(2)-C(3)-C(19) 164.13(12) 
C(13)-C(2)-C(3)-C(4) 161.09(13) 
C(1)-C(2)-C(3)-C(4) 39.50(14) 
C(1)-N-C(4)-C(3) 21.10(15) 
S-N-C(4)-C(3) -114.77(12) 
C(19)-C(3)-C(4)-N -162.21(12) 
C(2)-C(3)-C(4)-N -37.15(14) 
N-C(1)-C(5)-C(10) -39.38(19) 
C(2)-C(1)-C(5)-C(10) 78.53(17) 
N-C(1)-C(5)-C(6) 141.42(14) 
C(2)-C(1)-C(5)-C(6) -100.68(16) 
C(10)-C(5)-C(6)-C(7) 1.3(2) 
C(1)-C(5)-C(6)-C(7) -179.45(14) 
C(5)-C(6)-C(7)-C(8) -0.2(2) 
C(6)-C(7)-C(8)-C(9) -0.5(2) 
C(6)-C(7)-C(8)-C(11) 177.87(14) 
C(7)-C(8)-C(9)-C(10) 0.0(2) 
C(11)-C(8)-C(9)-C(10) -178.27(15) 
C(6)-C(5)-C(10)-C(9) -1.8(2) 
C(1)-C(5)-C(10)-C(9) 178.99(14) 
C(8)-C(9)-C(10)-C(5) 1.1(2) 
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C(12)-O(3)-C(11)-O(4) 0.5(2) 
C(12)-O(3)-C(11)-C(8) 179.37(13) 
C(7)-C(8)-C(11)-O(4) 9.8(2) 
C(9)-C(8)-C(11)-O(4) -171.86(16) 
C(7)-C(8)-C(11)-O(3) -169.06(14) 
C(9)-C(8)-C(11)-O(3) 9.3(2) 
C(3)-C(2)-C(13)-C(14) 79.38(17) 
C(1)-C(2)-C(13)-C(14) -163.19(13) 
C(2)-C(13)-C(14)-C(15) 178.82(14) 
C(13)-C(14)-C(15)-C(16) -172.72(14) 
C(14)-C(15)-C(16)-C(17) -177.44(16) 
C(15)-C(16)-C(17)-C(18) -62.6(2) 
C(4)-C(3)-C(19)-C(20) -124.01(16) 
C(2)-C(3)-C(19)-C(20) 118.13(16) 
C(4)-C(3)-C(19)-C(24) 58.68(19) 
C(2)-C(3)-C(19)-C(24) -59.19(19) 
C(24)-C(19)-C(20)-C(21) 3.0(3) 
C(3)-C(19)-C(20)-C(21) -174.39(15) 
C(19)-C(20)-C(21)-C(22) -1.6(3) 
C(20)-C(21)-C(22)-C(23) -0.9(3) 
C(20)-C(21)-C(22)-C(25) 177.13(16) 
C(21)-C(22)-C(23)-C(24) 1.8(3) 
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C(25)-C(22)-C(23)-C(24) -176.08(16) 
C(22)-C(23)-C(24)-C(19) -0.4(3) 
C(20)-C(19)-C(24)-C(23) -2.0(2) 
C(3)-C(19)-C(24)-C(23) 175.36(15) 
C(26)-O(5)-C(25)-O(6) -1.5(3) 
C(26)-O(5)-C(25)-C(22) 177.14(15) 
C(21)-C(22)-C(25)-O(6) -6.1(3) 
C(23)-C(22)-C(25)-O(6) 171.86(19) 
C(21)-C(22)-C(25)-O(5) 175.28(15) 
C(23)-C(22)-C(25)-O(5) -6.8(2) 
O(1)-S-C(27)-C(28) -27.01(15) 
O(2)-S-C(27)-C(28) -158.55(13) 
N-S-C(27)-C(28) 86.96(14) 
O(1)-S-C(27)-C(32) 158.04(13) 
O(2)-S-C(27)-C(32) 26.51(15) 
N-S-C(27)-C(32) -87.99(14) 
C(32)-C(27)-C(28)-C(29) 1.4(2) 
S-C(27)-C(28)-C(29) -173.50(13) 
C(27)-C(28)-C(29)-C(30) -0.7(3) 
C(28)-C(29)-C(30)-C(31) -0.6(3) 
C(28)-C(29)-C(30)-C(33) -179.15(18) 
C(29)-C(30)-C(31)-C(32) 1.2(3) 
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C(33)-C(30)-C(31)-C(32) 179.77(18) 
C(30)-C(31)-C(32)-C(27) -0.5(3) 
C(28)-C(27)-C(32)-C(31) -0.8(2) 
S-C(27)-C(32)-C(31) 174.01(13) 
________________________________________________________________ 
Symmetry transformations used to generate equivalent atoms:  
  
 
The thermal ellipsoid of tetrahydro indenopyridine 4.21a drawn at 50% probability level. 
The CCDC number is 895234 
 
                                  
                 
  Table 1.  Crystal data and structure refinement for C28H25NO3. 
Identification code  q10c 
Empirical formula  C28H25NO3 
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Formula weight  423.49 
Temperature  100(2) K 
Wavelength  1.54178 Å 
Crystal system  Monoclinic 
Space group  P2(1)/n 
Unit cell dimensions a = 12.5171(3) Å = 90°. 
 b = 9.7324(2) Å = 
101.0310(10)°. 
 c = 17.7685(4) Å  = 90°. 
Volume 2124.59(8) Å3 
Z 4 
Density (calculated) 1.324 Mg/m3 
Absorption coefficient 0.681 mm-1 
F(000) 896 
Crystal size 0.14 x 0.05 x 0.05 mm3 
Theta range for data collection 3.98 to 69.34°. 
Index ranges -14<=h<=13, -11<=k<=11, -20<=l<=21 
Reflections collected 19823 
Independent reflections 3872 [R(int) = 0.0172] 
Completeness to theta = 66.00° 99.7 %  
Absorption correction Multi-scan 
Max. and min. transmission 1.000 and 0.922 
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Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3872 / 0 / 390 
Goodness-of-fit on F2 1.053 
Final R indices [I>2sigma(I)] R1 = 0.0297, wR2 = 0.0738 
R indices (all data) R1 = 0.0316, wR2 = 0.0752 
Extinction coefficient 0.00090(13) 
Largest diff. peak and hole 0.214 and -0.180 e.Å-3 
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 Table 2.  Atomic coordinates  ( x 104) and equivalent  isotropic displacement parameters (Å2x 103) 
for C28H25NO3.  U(eq) is defined as one third of  the trace of the orthogonalized U ij tensor. 
________________________________________________________________________________  
 x y z U(eq) 
________________________________________________________________________________   
N 4151(1) 1092(1) 3058(1) 20(1) 
O(1) 4948(1) 112(1) 2156(1) 38(1) 
O(2) -532(1) 1982(1) 1004(1) 26(1) 
O(3) 1059(1) 1330(1) 357(1) 27(1) 
C(1) 4137(1) 2090(1) 3680(1) 24(1) 
C(2) 4186(1) 1329(1) 4421(1) 28(1) 
C(3) 3564(1) 226(1) 4412(1) 26(1) 
C(4) 2830(1) -129(1) 3682(1) 21(1) 
C(5) 1906(1) -1114(1) 3650(1) 23(1) 
C(6) 1631(1) 408(1) 3538(1) 19(1) 
C(7) 1401(1) 796(1) 2707(1) 18(1) 
C(8) 429(1) 1286(1) 2271(1) 20(1) 
C(9) 357(1) 1475(1) 1489(1) 20(1) 
C(10) 1239(1) 1127(1) 1133(1) 21(1) 
C(11) 2202(1) 650(1) 1571(1) 20(1) 
C(12) 2280(1) 517(1) 2362(1) 19(1) 
C(13) 3266(1) 60(1) 2941(1) 20(1) 
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C(14) 4974(1) 951(1) 2676(1) 23(1) 
C(15) 5961(1) 1857(1) 2900(1) 22(1) 
C(16) 6026(1) 3111(1) 2537(1) 27(1) 
C(17) 6979(1) 3872(1) 2691(1) 29(1) 
C(18) 7878(1) 3392(1) 3204(1) 27(1) 
C(19) 7812(1) 2151(1) 3574(1) 27(1) 
C(20) 6856(1) 1387(1) 3428(1) 26(1) 
C(21) 1244(1) 1248(1) 4135(1) 19(1) 
C(22) 989(1) 2636(1) 4005(1) 23(1) 
C(23) 684(1) 3444(1) 4574(1) 28(1) 
C(24) 631(1) 2892(1) 5286(1) 28(1) 
C(25) 876(1) 1516(1) 5418(1) 28(1) 
C(26) 1178(1) 706(1) 4852(1) 24(1) 
C(27) -1426(1) 2413(1) 1336(1) 30(1) 
C(28) 1823(1) 721(1) -42(1) 30(1) 
________________________________________________________________________________  
 
 Table 3.   Bond lengths [Å] and angles [°] for  C28H25NO3. 
_____________________________________________________  
N-C(14)  1.3437(14) 
N-C(1)  1.4744(13) 
N-C(13)  1.4805(13) 
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O(1)-C(14)  1.2294(13) 
O(2)-C(9)  1.3627(12) 
O(2)-C(27)  1.4235(14) 
O(3)-C(10)  1.3676(12) 
O(3)-C(28)  1.4245(14) 
C(1)-C(2)  1.5010(16) 
C(1)-H(1A)  0.976(14) 
C(1)-H(1B)  1.004(13) 
C(2)-C(3)  1.3246(17) 
C(2)-H(2)  0.947(14) 
C(3)-C(4)  1.4793(15) 
C(3)-H(3)  0.982(14) 
C(4)-C(5)  1.4954(15) 
C(4)-C(13)  1.5300(14) 
C(4)-C(6)  1.5638(14) 
C(5)-C(6)  1.5250(14) 
C(5)-H(5A)  0.986(13) 
C(5)-H(5B)  0.982(13) 
C(6)-C(21)  1.4912(14) 
C(6)-C(7)  1.4973(14) 
C(7)-C(12)  1.3846(14) 
C(7)-C(8)  1.3968(14) 
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C(8)-C(9)  1.3860(14) 
C(8)-H(8)  0.974(13) 
C(9)-C(10)  1.4157(15) 
C(10)-C(11)  1.3832(15) 
C(11)-C(12)  1.3973(14) 
C(11)-H(11)  0.969(13) 
C(12)-C(13)  1.5137(14) 
C(13)-H(13)  0.995(12) 
C(14)-C(15)  1.5085(15) 
C(15)-C(16)  1.3894(16) 
C(15)-C(20)  1.3932(16) 
C(16)-C(17)  1.3861(17) 
C(16)-H(16)  0.980(14) 
C(17)-C(18)  1.3855(17) 
C(17)-H(17)  0.967(15) 
C(18)-C(19)  1.3862(17) 
C(18)-H(18)  0.966(14) 
C(19)-C(20)  1.3905(16) 
C(19)-H(19)  0.956(14) 
C(20)-H(20)  0.978(14) 
C(21)-C(26)  1.3954(15) 
C(21)-C(22)  1.3971(15) 
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C(22)-C(23)  1.3910(16) 
C(22)-H(22)  0.982(13) 
C(23)-C(24)  1.3864(17) 
C(23)-H(23)  0.981(15) 
C(24)-C(25)  1.3839(17) 
C(24)-H(24)  0.976(14) 
C(25)-C(26)  1.3860(16) 
C(25)-H(25)  0.982(15) 
C(26)-H(26)  0.977(14) 
C(27)-H(27A)  0.996(15) 
C(27)-H(27B)  0.993(15) 
C(27)-H(27C)  0.999(15) 
C(28)-H(28A)  1.007(15) 
C(28)-H(28B)  0.966(15) 
C(28)-H(28C)  0.990(15) 
 
C(14)-N-C(1) 124.49(9) 
C(14)-N-C(13) 119.04(8) 
C(1)-N-C(13) 115.82(8) 
C(9)-O(2)-C(27) 117.13(8) 
C(10)-O(3)-C(28) 116.45(9) 
N-C(1)-C(2) 109.18(9) 
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N-C(1)-H(1A) 108.2(7) 
C(2)-C(1)-H(1A) 112.7(8) 
N-C(1)-H(1B) 107.7(7) 
C(2)-C(1)-H(1B) 111.2(7) 
H(1A)-C(1)-H(1B) 107.7(11) 
C(3)-C(2)-C(1) 117.67(10) 
C(3)-C(2)-H(2) 123.0(9) 
C(1)-C(2)-H(2) 119.3(9) 
C(2)-C(3)-C(4) 117.68(10) 
C(2)-C(3)-H(3) 124.0(8) 
C(4)-C(3)-H(3) 118.3(8) 
C(3)-C(4)-C(5) 122.02(9) 
C(3)-C(4)-C(13) 117.54(9) 
C(5)-C(4)-C(13) 116.39(9) 
C(3)-C(4)-C(6) 118.76(9) 
C(5)-C(4)-C(6) 59.75(7) 
C(13)-C(4)-C(6) 107.91(8) 
C(4)-C(5)-C(6) 62.35(7) 
C(4)-C(5)-H(5A) 116.5(7) 
C(6)-C(5)-H(5A) 118.7(7) 
C(4)-C(5)-H(5B) 117.8(7) 
C(6)-C(5)-H(5B) 116.4(7) 
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H(5A)-C(5)-H(5B) 115.1(10) 
C(21)-C(6)-C(7) 122.37(9) 
C(21)-C(6)-C(5) 122.41(9) 
C(7)-C(6)-C(5) 111.64(9) 
C(21)-C(6)-C(4) 119.97(8) 
C(7)-C(6)-C(4) 104.06(8) 
C(5)-C(6)-C(4) 57.90(7) 
C(12)-C(7)-C(8) 120.18(9) 
C(12)-C(7)-C(6) 111.60(9) 
C(8)-C(7)-C(6) 128.06(9) 
C(9)-C(8)-C(7) 118.99(10) 
C(9)-C(8)-H(8) 120.8(7) 
C(7)-C(8)-H(8) 120.2(7) 
O(2)-C(9)-C(8) 124.77(10) 
O(2)-C(9)-C(10) 114.60(9) 
C(8)-C(9)-C(10) 120.63(9) 
O(3)-C(10)-C(11) 124.96(10) 
O(3)-C(10)-C(9) 115.08(9) 
C(11)-C(10)-C(9) 119.94(9) 
C(10)-C(11)-C(12) 118.88(10) 
C(10)-C(11)-H(11) 120.5(7) 
C(12)-C(11)-H(11) 120.6(7) 
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C(7)-C(12)-C(11) 121.26(9) 
C(7)-C(12)-C(13) 111.72(9) 
C(11)-C(12)-C(13) 127.01(9) 
N-C(13)-C(12) 112.79(8) 
N-C(13)-C(4) 109.99(8) 
C(12)-C(13)-C(4) 103.99(8) 
N-C(13)-H(13) 105.8(7) 
C(12)-C(13)-H(13) 112.8(7) 
C(4)-C(13)-H(13) 111.6(7) 
O(1)-C(14)-N 122.35(10) 
O(1)-C(14)-C(15) 119.25(9) 
N-C(14)-C(15) 118.40(9) 
C(16)-C(15)-C(20) 119.33(10) 
C(16)-C(15)-C(14) 120.61(10) 
C(20)-C(15)-C(14) 119.84(10) 
C(17)-C(16)-C(15) 120.14(11) 
C(17)-C(16)-H(16) 119.7(8) 
C(15)-C(16)-H(16) 120.1(8) 
C(18)-C(17)-C(16) 120.62(11) 
C(18)-C(17)-H(17) 119.4(9) 
C(16)-C(17)-H(17) 120.0(9) 
C(17)-C(18)-C(19) 119.45(10) 
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C(17)-C(18)-H(18) 120.1(8) 
C(19)-C(18)-H(18) 120.5(8) 
C(18)-C(19)-C(20) 120.25(11) 
C(18)-C(19)-H(19) 119.4(8) 
C(20)-C(19)-H(19) 120.3(8) 
C(19)-C(20)-C(15) 120.19(11) 
C(19)-C(20)-H(20) 119.8(8) 
C(15)-C(20)-H(20) 120.0(8) 
C(26)-C(21)-C(22) 117.67(10) 
C(26)-C(21)-C(6) 121.75(9) 
C(22)-C(21)-C(6) 120.50(9) 
C(23)-C(22)-C(21) 120.81(10) 
C(23)-C(22)-H(22) 119.6(8) 
C(21)-C(22)-H(22) 119.6(8) 
C(24)-C(23)-C(22) 120.78(11) 
C(24)-C(23)-H(23) 121.0(8) 
C(22)-C(23)-H(23) 118.2(8) 
C(25)-C(24)-C(23) 118.82(11) 
C(25)-C(24)-H(24) 119.5(8) 
C(23)-C(24)-H(24) 121.6(8) 
C(24)-C(25)-C(26) 120.59(11) 
C(24)-C(25)-H(25) 119.4(8) 
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C(26)-C(25)-H(25) 120.0(8) 
C(25)-C(26)-C(21) 121.33(10) 
C(25)-C(26)-H(26) 118.3(8) 
C(21)-C(26)-H(26) 120.4(8) 
O(2)-C(27)-H(27A) 111.2(8) 
O(2)-C(27)-H(27B) 104.4(8) 
H(27A)-C(27)-H(27B) 110.3(11) 
O(2)-C(27)-H(27C) 110.8(8) 
H(27A)-C(27)-H(27C) 108.7(11) 
H(27B)-C(27)-H(27C) 111.5(12) 
O(3)-C(28)-H(28A) 111.1(8) 
O(3)-C(28)-H(28B) 104.9(8) 
H(28A)-C(28)-H(28B) 109.9(11) 
O(3)-C(28)-H(28C) 110.9(8) 
H(28A)-C(28)-H(28C) 109.0(11) 
H(28B)-C(28)-H(28C) 111.0(12) 
_____________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
  
 Table 4.   Anisotropic displacement parameters  (Å2x 103) for C28H25NO3.  The anisotropic 
displacement factor exponent takes the form:  -22[ h2 a*2U11 + ...  + 2 h k a* b* U12 ] 
______________________________________________________________________________  
421 
 
 U11 U22  U33 U23 U13 U12 
______________________________________________________________________________  
N 16(1)  21(1) 22(1)  -6(1) 2(1)  0(1) 
O(1) 31(1)  44(1) 43(1)  -25(1) 16(1)  -10(1) 
O(2) 22(1)  32(1) 22(1)  4(1) -1(1)  7(1) 
O(3) 31(1)  33(1) 18(1)  1(1) 3(1)  6(1) 
C(1) 19(1)  25(1) 30(1)  -11(1) 5(1)  -1(1) 
C(2) 18(1)  40(1) 23(1)  -11(1) 0(1)  4(1) 
C(3) 20(1)  35(1) 21(1)  1(1) 1(1)  7(1) 
C(4) 19(1)  19(1) 22(1)  1(1) 1(1)  4(1) 
C(5) 25(1)  18(1) 24(1)  3(1) 3(1)  2(1) 
C(6) 16(1)  18(1) 21(1)  2(1) 1(1)  0(1) 
C(7) 19(1)  14(1) 20(1)  -1(1) 2(1)  -2(1) 
C(8) 18(1)  18(1) 22(1)  0(1) 3(1)  0(1) 
C(9) 20(1)  18(1) 22(1)  1(1) -1(1)  0(1) 
C(10) 25(1)  18(1) 18(1)  0(1) 2(1)  -2(1) 
C(11) 20(1)  17(1) 22(1)  -3(1) 4(1)  -1(1) 
C(12) 19(1)  14(1) 22(1)  -2(1) 1(1)  -1(1) 
C(13) 18(1)  18(1) 22(1)  -3(1) 1(1)  1(1) 
C(14) 20(1)  24(1) 24(1)  -5(1) 3(1)  1(1) 
C(15) 20(1)  25(1) 21(1)  -6(1) 6(1)  1(1) 
C(16) 24(1)  30(1) 27(1)  1(1) 3(1)  3(1) 
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C(17) 31(1)  27(1) 29(1)  2(1) 10(1)  -2(1) 
C(18) 22(1)  31(1) 28(1)  -6(1) 10(1)  -6(1) 
C(19) 22(1)  31(1) 26(1)  -3(1) 2(1)  0(1) 
C(20) 26(1)  24(1) 26(1)  -1(1) 3(1)  -1(1) 
C(21) 13(1)  23(1) 21(1)  0(1) 1(1)  -2(1) 
C(22) 22(1)  24(1) 23(1)  2(1) 4(1)  0(1) 
C(23) 27(1)  25(1) 31(1)  -2(1) 4(1)  4(1) 
C(24) 23(1)  35(1) 26(1)  -7(1) 5(1)  2(1) 
C(25) 27(1)  37(1) 22(1)  2(1) 5(1)  -2(1) 
C(26) 24(1)  25(1) 24(1)  3(1) 4(1)  0(1) 
C(27) 22(1)  35(1) 30(1)  5(1) 1(1)  9(1) 
C(28) 33(1)  36(1) 21(1)  -3(1) 6(1)  3(1) 
______________________________________________________________________________  
 
 Table 5.   Hydrogen coordinates ( x 104) and isotropic  displacement parameters (Å2x 10 3) 
for C28H25NO3. 
________________________________________________________________________________  
 x  y  z  U(eq) 
________________________________________________________________________________  
  
H(1A) 4747(11) 2720(14) 3695(7) 27(3) 
H(1B) 3448(11) 2639(13) 3544(7) 26(3) 
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H(2) 4653(11) 1650(15) 4869(8) 35(4) 
H(3) 3546(11) -351(14) 4863(8) 32(3) 
H(5A) 1832(10) -1555(13) 4137(7) 24(3) 
H(5B) 1716(10) -1700(13) 3193(7) 24(3) 
H(8) -186(10) 1496(13) 2514(7) 22(3) 
H(11) 2815(10) 426(12) 1333(7) 21(3) 
H(13) 3594(10) -801(13) 2788(7) 20(3) 
H(16) 5399(12) 3459(14) 2169(8) 33(3) 
H(17) 7020(12) 4748(16) 2441(8) 38(4) 
H(18) 8546(12) 3916(14) 3296(8) 33(3) 
H(19) 8431(11) 1823(14) 3930(8) 29(3) 
H(20) 6816(11) 512(15) 3691(8) 32(3) 
H(22) 1027(10) 3046(13) 3506(7) 27(3) 
H(23) 511(11) 4414(16) 4459(8) 36(4) 
H(24) 441(11) 3454(14) 5696(8) 34(3) 
H(25) 831(11) 1113(15) 5918(8) 37(4) 
H(26) 1348(11) -260(14) 4967(7) 29(3) 
H(27A) -1759(11) 1621(15) 1561(8) 35(4) 
H(27B) -1953(12) 2809(15) 900(8) 38(4) 
H(27C) -1188(12) 3110(15) 1747(8) 36(4) 
H(28A) 2558(12) 1175(15) 100(8) 35(4) 
H(28B) 1525(12) 877(15) -578(8) 37(4) 
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H(28C) 1903(11) -273(16) 71(8) 36(4) 
________________________________________________________________________________  
 
 Table 6.  Torsion angles [°] for C28H25NO3. 
________________________________________________________________  
C(14)-N-C(1)-C(2) -112.61(11) 
C(13)-N-C(1)-C(2) 57.96(11) 
N-C(1)-C(2)-C(3) -43.76(13) 
C(1)-C(2)-C(3)-C(4) -3.05(15) 
C(2)-C(3)-C(4)-C(5) -164.16(10) 
C(2)-C(3)-C(4)-C(13) 39.29(14) 
C(2)-C(3)-C(4)-C(6) -93.70(12) 
C(3)-C(4)-C(5)-C(6) 107.00(11) 
C(13)-C(4)-C(5)-C(6) -96.21(9) 
C(4)-C(5)-C(6)-C(21) -107.47(10) 
C(4)-C(5)-C(6)-C(7) 93.42(9) 
C(3)-C(4)-C(6)-C(21) -0.71(14) 
C(5)-C(4)-C(6)-C(21) 111.63(10) 
C(13)-C(4)-C(6)-C(21) -137.74(9) 
C(3)-C(4)-C(6)-C(7) 140.70(10) 
C(5)-C(4)-C(6)-C(7) -106.96(9) 
C(13)-C(4)-C(6)-C(7) 3.66(10) 
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C(3)-C(4)-C(6)-C(5) -112.34(11) 
C(13)-C(4)-C(6)-C(5) 110.63(9) 
C(21)-C(6)-C(7)-C(12) 142.06(9) 
C(5)-C(6)-C(7)-C(12) -58.82(11) 
C(4)-C(6)-C(7)-C(12) 1.83(11) 
C(21)-C(6)-C(7)-C(8) -42.58(15) 
C(5)-C(6)-C(7)-C(8) 116.54(11) 
C(4)-C(6)-C(7)-C(8) 177.20(10) 
C(12)-C(7)-C(8)-C(9) 0.54(15) 
C(6)-C(7)-C(8)-C(9) -174.47(10) 
C(27)-O(2)-C(9)-C(8) 3.45(15) 
C(27)-O(2)-C(9)-C(10) -177.01(9) 
C(7)-C(8)-C(9)-O(2) -178.04(9) 
C(7)-C(8)-C(9)-C(10) 2.45(15) 
C(28)-O(3)-C(10)-C(11) 14.65(15) 
C(28)-O(3)-C(10)-C(9) -166.78(10) 
O(2)-C(9)-C(10)-O(3) -1.05(13) 
C(8)-C(9)-C(10)-O(3) 178.52(9) 
O(2)-C(9)-C(10)-C(11) 177.59(9) 
C(8)-C(9)-C(10)-C(11) -2.84(15) 
O(3)-C(10)-C(11)-C(12) 178.71(9) 
C(9)-C(10)-C(11)-C(12) 0.21(15) 
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C(8)-C(7)-C(12)-C(11) -3.21(15) 
C(6)-C(7)-C(12)-C(11) 172.57(9) 
C(8)-C(7)-C(12)-C(13) 177.38(9) 
C(6)-C(7)-C(12)-C(13) -6.84(12) 
C(10)-C(11)-C(12)-C(7) 2.80(15) 
C(10)-C(11)-C(12)-C(13) -177.89(9) 
C(14)-N-C(13)-C(12) -97.35(11) 
C(1)-N-C(13)-C(12) 91.54(11) 
C(14)-N-C(13)-C(4) 147.06(9) 
C(1)-N-C(13)-C(4) -24.05(12) 
C(7)-C(12)-C(13)-N -110.37(10) 
C(11)-C(12)-C(13)-N 70.26(13) 
C(7)-C(12)-C(13)-C(4) 8.76(11) 
C(11)-C(12)-C(13)-C(4) -170.61(10) 
C(3)-C(4)-C(13)-N -23.87(12) 
C(5)-C(4)-C(13)-N 178.26(8) 
C(6)-C(4)-C(13)-N 113.77(9) 
C(3)-C(4)-C(13)-C(12) -144.89(9) 
C(5)-C(4)-C(13)-C(12) 57.24(11) 
C(6)-C(4)-C(13)-C(12) -7.26(10) 
C(1)-N-C(14)-O(1) -179.37(11) 
C(13)-N-C(14)-O(1) 10.34(16) 
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C(1)-N-C(14)-C(15) 0.73(15) 
C(13)-N-C(14)-C(15) -169.56(9) 
O(1)-C(14)-C(15)-C(16) 88.56(14) 
N-C(14)-C(15)-C(16) -91.54(13) 
O(1)-C(14)-C(15)-C(20) -85.97(14) 
N-C(14)-C(15)-C(20) 93.93(12) 
C(20)-C(15)-C(16)-C(17) 1.10(16) 
C(14)-C(15)-C(16)-C(17) -173.46(10) 
C(15)-C(16)-C(17)-C(18) 0.25(17) 
C(16)-C(17)-C(18)-C(19) -1.11(17) 
C(17)-C(18)-C(19)-C(20) 0.61(17) 
C(18)-C(19)-C(20)-C(15) 0.74(17) 
C(16)-C(15)-C(20)-C(19) -1.59(16) 
C(14)-C(15)-C(20)-C(19) 173.01(10) 
C(7)-C(6)-C(21)-C(26) 161.17(10) 
C(5)-C(6)-C(21)-C(26) 4.28(15) 
C(4)-C(6)-C(21)-C(26) -64.59(13) 
C(7)-C(6)-C(21)-C(22) -22.32(14) 
C(5)-C(6)-C(21)-C(22) -179.22(9) 
C(4)-C(6)-C(21)-C(22) 111.92(11) 
C(26)-C(21)-C(22)-C(23) 0.18(15) 
C(6)-C(21)-C(22)-C(23) -176.47(10) 
428 
 
C(21)-C(22)-C(23)-C(24) 0.33(17) 
C(22)-C(23)-C(24)-C(25) -0.66(17) 
C(23)-C(24)-C(25)-C(26) 0.50(17) 
C(24)-C(25)-C(26)-C(21) 0.00(17) 
C(22)-C(21)-C(26)-C(25) -0.34(16) 
C(6)-C(21)-C(26)-C(25) 176.26(10) 
________________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
  
The thermal ellipsoid of tetrahydro indenopyridine 4.20 drawn at 50% probability level. The 
CCDC number is 900884. 
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  Table 1.  Crystal data and structure refinement for C26H21NO. 
Identification code  q01a 
Empirical formula  C26H21NO  
Formula weight  363.44 
Temperature  100(2) K 
Wavelength  1.54178 Å 
Crystal system  Triclinic 
Space group  P-1 
Unit cell dimensions a = 9.7537(3) Å = 74.1310(10)°. 
 b = 9.8726(3) Å = 81.6140(10)°. 
 c = 11.2156(3) Å  = 61.630(2)°. 
Volume 913.91(5) Å3 
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Z 2 
Density (calculated) 1.321 Mg/m3 
Absorption coefficient 0.619 mm-1 
F(000) 384 
Crystal size 0.26 x 0.14 x 0.08 mm3 
Theta range for data collection 4.10 to 69.22°. 
Index ranges -11<=h<=11, -11<=k<=11, -13<=l<=13 
Reflections collected 7593 
Independent reflections 2954 [R(int) = 0.0330] 
Completeness to theta = 66.00° 90.4 %  
Absorption correction Multi-scan 
Max. and min. transmission 1.000 and 0.807 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2954 / 0 / 309 
Goodness-of-fit on F2 1.135 
Final R indices [I>2sigma(I)] R1 = 0.0592, wR2 = 0.1776 
R indices (all data) R1 = 0.0666, wR2 = 0.1828 
Largest diff. peak and hole 0.427 and -0.375 e.Å-3 
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 Table 2.  Atomic coordinates  ( x 104) and equivalent  isotropic displacement parameters (Å2x 103) 
for C26H21NO.  U(eq) is defined as one third of  the trace of the orthogonalized Uij tensor. 
________________________________________________________________________________  
 x y z U(eq) 
________________________________________________________________________________   
O 4793(2) 3339(2) 41(1) 23(1) 
N 2151(2) 4739(2) 286(2) 20(1) 
C(1) 954(3) 6411(3) 69(2) 24(1) 
C(2) 1257(3) 7212(3) 907(2) 25(1) 
C(3) 1148(3) 6406(3) 2266(2) 24(1) 
C(4) 1717(2) 4640(3) 2491(2) 20(1) 
C(5) 2180(2) 3872(3) 1542(2) 20(1) 
C(6) 2579(2) 2222(3) 1781(2) 19(1) 
C(7) 2971(2) 1406(3) 821(2) 21(1) 
C(8) 3355(3) -165(3) 1081(2) 24(1) 
C(9) 3392(3) -1021(3) 2316(2) 24(1) 
C(10) 2990(3) -264(3) 3263(2) 22(1) 
C(11) 2554(2) 1373(3) 3031(2) 20(1) 
C(12) 2121(2) 2179(3) 4011(2) 21(1) 
C(13) 1718(3) 3765(3) 3720(2) 21(1) 
C(14) 2110(3) 1320(3) 5332(2) 21(1) 
C(15) 3188(3) 1079(3) 6155(2) 28(1) 
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C(16) 3218(3) 239(3) 7376(2) 31(1) 
C(17) 2170(3) -371(3) 7791(2) 27(1) 
C(18) 1068(3) -114(3) 6991(2) 24(1) 
C(19) 1038(3) 726(3) 5770(2) 23(1) 
C(20) 3533(2) 4333(3) -408(2) 19(1) 
C(21) 3380(3) 5080(3) -1768(2) 20(1) 
C(22) 4456(3) 5596(3) -2374(2) 23(1) 
C(23) 4406(3) 6174(3) -3649(2) 25(1) 
C(24) 3286(3) 6219(3) -4324(2) 25(1) 
C(25) 2214(3) 5715(3) -3724(2) 27(1) 
C(26) 2243(3) 5160(3) -2448(2) 25(1) 
________________________________________________________________________________ 
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 Table 3.   Bond lengths [Å] and angles [°] for  C26H21NO. 
_____________________________________________________  
O-C(20)  1.221(3) 
N-C(20)  1.391(3) 
N-C(5)  1.431(3) 
N-C(1)  1.476(3) 
C(1)-C(2)  1.519(3) 
C(1)-H(1A)  0.9900 
C(1)-H(1B)  0.9900 
C(2)-C(3)  1.529(3) 
C(2)-H(2A)  0.9900 
C(2)-H(2B)  0.9900 
C(3)-C(4)  1.513(3) 
C(3)-H(3A)  0.9900 
C(3)-H(3B)  0.9900 
C(4)-C(5)  1.374(3) 
C(4)-C(13)  1.412(3) 
C(5)-C(6)  1.438(3) 
C(6)-C(7)  1.420(3) 
C(6)-C(11)  1.426(3) 
C(7)-C(8)  1.365(3) 
C(7)-H(7)  0.98(2) 
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C(8)-C(9)  1.407(3) 
C(8)-H(8)  0.97(3) 
C(9)-C(10)  1.369(3) 
C(9)-H(9)  0.94(3) 
C(10)-C(11)  1.418(3) 
C(10)-H(10)  0.99(3) 
C(11)-C(12)  1.429(3) 
C(12)-C(13)  1.373(3) 
C(12)-C(14)  1.494(3) 
C(13)-H(4)  0.98(3) 
C(14)-C(15)  1.393(3) 
C(14)-C(19)  1.398(3) 
C(15)-C(16)  1.389(3) 
C(15)-H(15)  0.99(3) 
C(16)-C(17)  1.385(4) 
C(16)-H(16)  0.97(3) 
C(17)-C(18)  1.386(3) 
C(17)-H(17)  0.96(3) 
C(18)-C(19)  1.390(3) 
C(18)-H(18)  0.91(3) 
C(19)-H(19)  0.99(3) 
C(20)-C(21)  1.497(3) 
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C(21)-C(22)  1.391(3) 
C(21)-C(26)  1.395(3) 
C(22)-C(23)  1.386(3) 
C(22)-H(22)  1.00(3) 
C(23)-C(24)  1.395(3) 
C(23)-H(23)  0.97(3) 
C(24)-C(25)  1.378(3) 
C(24)-H(24)  0.97(3) 
C(25)-C(26)  1.385(3) 
C(25)-H(25)  0.9500 
C(26)-H(26)  0.98(3) 
 
C(20)-N-C(5) 119.04(18) 
C(20)-N-C(1) 119.35(19) 
C(5)-N-C(1) 113.47(18) 
N-C(1)-C(2) 108.87(18) 
N-C(1)-H(1A) 109.9 
C(2)-C(1)-H(1A) 109.9 
N-C(1)-H(1B) 109.9 
C(2)-C(1)-H(1B) 109.9 
H(1A)-C(1)-H(1B) 108.3 
C(1)-C(2)-C(3) 110.1(2) 
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C(1)-C(2)-H(2A) 109.6 
C(3)-C(2)-H(2A) 109.6 
C(1)-C(2)-H(2B) 109.6 
C(3)-C(2)-H(2B) 109.6 
H(2A)-C(2)-H(2B) 108.2 
C(4)-C(3)-C(2) 113.69(19) 
C(4)-C(3)-H(3A) 108.8 
C(2)-C(3)-H(3A) 108.8 
C(4)-C(3)-H(3B) 108.8 
C(2)-C(3)-H(3B) 108.8 
H(3A)-C(3)-H(3B) 107.7 
C(5)-C(4)-C(13) 119.0(2) 
C(5)-C(4)-C(3) 122.4(2) 
C(13)-C(4)-C(3) 118.5(2) 
C(4)-C(5)-N 120.1(2) 
C(4)-C(5)-C(6) 120.8(2) 
N-C(5)-C(6) 118.9(2) 
C(7)-C(6)-C(11) 118.5(2) 
C(7)-C(6)-C(5) 122.7(2) 
C(11)-C(6)-C(5) 118.8(2) 
C(8)-C(7)-C(6) 121.2(2) 
C(8)-C(7)-H(7) 119.7(15) 
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C(6)-C(7)-H(7) 119.1(15) 
C(7)-C(8)-C(9) 120.5(2) 
C(7)-C(8)-H(8) 119.2(16) 
C(9)-C(8)-H(8) 120.3(16) 
C(10)-C(9)-C(8) 119.9(2) 
C(10)-C(9)-H(9) 120.1(18) 
C(8)-C(9)-H(9) 120.1(18) 
C(9)-C(10)-C(11) 121.4(2) 
C(9)-C(10)-H(10) 121.1(16) 
C(11)-C(10)-H(10) 117.4(16) 
C(10)-C(11)-C(6) 118.5(2) 
C(10)-C(11)-C(12) 122.0(2) 
C(6)-C(11)-C(12) 119.6(2) 
C(13)-C(12)-C(11) 118.9(2) 
C(13)-C(12)-C(14) 120.2(2) 
C(11)-C(12)-C(14) 121.0(2) 
C(12)-C(13)-C(4) 122.9(2) 
C(12)-C(13)-H(4) 118.0(15) 
C(4)-C(13)-H(4) 119.1(15) 
C(15)-C(14)-C(19) 118.4(2) 
C(15)-C(14)-C(12) 120.3(2) 
C(19)-C(14)-C(12) 121.26(19) 
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C(16)-C(15)-C(14) 120.8(2) 
C(16)-C(15)-H(15) 121.5(14) 
C(14)-C(15)-H(15) 117.6(14) 
C(17)-C(16)-C(15) 120.2(2) 
C(17)-C(16)-H(16) 121.0(18) 
C(15)-C(16)-H(16) 118.8(18) 
C(16)-C(17)-C(18) 119.8(2) 
C(16)-C(17)-H(17) 119.7(17) 
C(18)-C(17)-H(17) 120.5(17) 
C(17)-C(18)-C(19) 120.0(2) 
C(17)-C(18)-H(18) 120.9(17) 
C(19)-C(18)-H(18) 119.1(17) 
C(18)-C(19)-C(14) 120.8(2) 
C(18)-C(19)-H(19) 121.7(19) 
C(14)-C(19)-H(19) 117.5(18) 
O-C(20)-N 122.38(19) 
O-C(20)-C(21) 121.24(19) 
N-C(20)-C(21) 116.18(18) 
C(22)-C(21)-C(26) 119.7(2) 
C(22)-C(21)-C(20) 119.35(19) 
C(26)-C(21)-C(20) 120.8(2) 
C(23)-C(22)-C(21) 120.1(2) 
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C(23)-C(22)-H(22) 122.0(18) 
C(21)-C(22)-H(22) 117.9(18) 
C(22)-C(23)-C(24) 119.8(2) 
C(22)-C(23)-H(23) 121.1(17) 
C(24)-C(23)-H(23) 119.1(17) 
C(25)-C(24)-C(23) 120.2(2) 
C(25)-C(24)-H(24) 120.8(17) 
C(23)-C(24)-H(24) 119.0(17) 
C(24)-C(25)-C(26) 120.2(2) 
C(24)-C(25)-H(25) 119.9 
C(26)-C(25)-H(25) 119.9 
C(25)-C(26)-C(21) 120.0(2) 
C(25)-C(26)-H(26) 121.1(16) 
C(21)-C(26)-H(26) 118.9(16) 
_____________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
  
 Table 4.   Anisotropic displacement parameters  (Å2x 103) for C26H21NO.  The anisotropic 
displacement factor exponent takes the form:  -22[ h2 a*2U11 + ...  + 2 h k a* b* U12 ] 
______________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
______________________________________________________________________________  
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O 21(1)  23(1) 22(1)  -5(1) -4(1)  -9(1) 
N 20(1)  21(1) 17(1)  -4(1) -3(1)  -7(1) 
C(1) 19(1)  25(1) 22(1)  -4(1) -3(1)  -7(1) 
C(2) 26(1)  19(1) 26(1)  -5(1) -1(1)  -8(1) 
C(3) 26(1)  24(1) 23(1)  -10(1) 0(1)  -10(1) 
C(4) 17(1)  24(1) 21(1)  -5(1) -3(1)  -10(1) 
C(5) 17(1)  25(1) 19(1)  -4(1) -4(1)  -9(1) 
C(6) 15(1)  23(1) 21(1)  -5(1) -5(1)  -8(1) 
C(7) 18(1)  25(1) 20(1)  -5(1) -4(1)  -8(1) 
C(8) 20(1)  28(1) 25(1)  -10(1) -3(1)  -11(1) 
C(9) 23(1)  19(1) 31(1)  -7(1) -3(1)  -10(1) 
C(10) 21(1)  23(1) 22(1)  -3(1) -3(1)  -10(1) 
C(11) 15(1)  23(1) 22(1)  -4(1) -4(1)  -8(1) 
C(12) 18(1)  26(1) 21(1)  -6(1) -5(1)  -10(1) 
C(13) 21(1)  26(1) 20(1)  -9(1) -2(1)  -12(1) 
C(14) 20(1)  22(1) 20(1)  -7(1) -3(1)  -7(1) 
C(15) 25(1)  37(2) 23(1)  -4(1) -4(1)  -15(1) 
C(16) 25(1)  44(2) 21(1)  -2(1) -8(1)  -14(1) 
C(17) 29(1)  25(1) 20(1)  -3(1) -2(1)  -8(1) 
C(18) 27(1)  24(1) 25(1)  -7(1) 0(1)  -14(1) 
C(19) 26(1)  24(1) 22(1)  -7(1) -4(1)  -12(1) 
C(20) 22(1)  19(1) 20(1)  -7(1) -2(1)  -10(1) 
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C(21) 21(1)  18(1) 19(1)  -7(1) -2(1)  -5(1) 
C(22) 23(1)  22(1) 24(1)  -7(1) -3(1)  -9(1) 
C(23) 28(1)  25(1) 23(1)  -6(1) 2(1)  -12(1) 
C(24) 31(1)  23(1) 18(1)  -6(1) -1(1)  -9(1) 
C(25) 28(1)  32(2) 23(1)  -10(1) -6(1)  -12(1) 
C(26) 26(1)  31(2) 22(1)  -7(1) -1(1)  -15(1) 
______________________________________________________________________________  
 
 Table 5.   Hydrogen coordinates ( x 104) and isotropic  displacement parameters (Å2x 10 3) 
for C26H21NO. 
________________________________________________________________________________  
 x  y  z  U(eq) 
________________________________________________________________________________  
  
H(1A) -95 6471 250 28 
H(1B) 996 6953 -810 28 
H(2A) 482 8344 750 30 
H(2B) 2307 7149 723 30 
H(3A) 1769 6592 2768 29 
H(3B) 49 6902 2555 29 
H(7) 2980(30) 1980(30) -40(20) 17(6) 
H(8) 3640(30) -690(30) 410(30) 24(7) 
442 
 
H(9) 3690(30) -2110(40) 2490(30) 34(8) 
H(10) 3010(30) -840(30) 4140(30) 27(7) 
H(4) 1400(30) 4310(30) 4400(20) 21(6) 
H(15) 3960(30) 1470(30) 5830(20) 21(6) 
H(16) 3990(30) 80(40) 7930(30) 37(8) 
H(17) 2180(30) -930(40) 8640(30) 34(7) 
H(18) 380(30) -520(30) 7250(20) 28(7) 
H(19) 270(40) 920(40) 5180(30) 42(8) 
H(22) 5220(40) 5580(40) -1860(30) 41(8) 
H(23) 5120(30) 6580(40) -4080(30) 35(8) 
H(24) 3290(30) 6590(30) -5220(30) 31(7) 
H(25) 1453 5749 -4188 33 
H(26) 1500(30) 4790(30) -2010(20) 26(7) 
________________________________________________________________________________  
 
 Table 6.  Torsion angles [°] for C26H21NO. 
________________________________________________________________  
C(20)-N-C(1)-C(2) -89.5(2) 
C(5)-N-C(1)-C(2) 58.8(2) 
N-C(1)-C(2)-C(3) -61.1(2) 
C(1)-C(2)-C(3)-C(4) 34.2(3) 
C(2)-C(3)-C(4)-C(5) -4.3(3) 
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C(2)-C(3)-C(4)-C(13) 177.94(19) 
C(13)-C(4)-C(5)-N 178.32(18) 
C(3)-C(4)-C(5)-N 0.6(3) 
C(13)-C(4)-C(5)-C(6) 3.4(3) 
C(3)-C(4)-C(5)-C(6) -174.30(18) 
C(20)-N-C(5)-C(4) 120.0(2) 
C(1)-N-C(5)-C(4) -28.5(3) 
C(20)-N-C(5)-C(6) -65.0(3) 
C(1)-N-C(5)-C(6) 146.50(19) 
C(4)-C(5)-C(6)-C(7) 176.05(19) 
N-C(5)-C(6)-C(7) 1.1(3) 
C(4)-C(5)-C(6)-C(11) -2.8(3) 
N-C(5)-C(6)-C(11) -177.78(18) 
C(11)-C(6)-C(7)-C(8) -1.6(3) 
C(5)-C(6)-C(7)-C(8) 179.53(19) 
C(6)-C(7)-C(8)-C(9) -0.9(3) 
C(7)-C(8)-C(9)-C(10) 2.2(3) 
C(8)-C(9)-C(10)-C(11) -0.9(3) 
C(9)-C(10)-C(11)-C(6) -1.6(3) 
C(9)-C(10)-C(11)-C(12) 179.5(2) 
C(7)-C(6)-C(11)-C(10) 2.8(3) 
C(5)-C(6)-C(11)-C(10) -178.25(18) 
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C(7)-C(6)-C(11)-C(12) -178.31(18) 
C(5)-C(6)-C(11)-C(12) 0.6(3) 
C(10)-C(11)-C(12)-C(13) 179.73(19) 
C(6)-C(11)-C(12)-C(13) 0.9(3) 
C(10)-C(11)-C(12)-C(14) -0.1(3) 
C(6)-C(11)-C(12)-C(14) -178.91(18) 
C(11)-C(12)-C(13)-C(4) -0.3(3) 
C(14)-C(12)-C(13)-C(4) 179.51(19) 
C(5)-C(4)-C(13)-C(12) -1.9(3) 
C(3)-C(4)-C(13)-C(12) 175.93(19) 
C(13)-C(12)-C(14)-C(15) -67.9(3) 
C(11)-C(12)-C(14)-C(15) 112.0(3) 
C(13)-C(12)-C(14)-C(19) 112.8(3) 
C(11)-C(12)-C(14)-C(19) -67.4(3) 
C(19)-C(14)-C(15)-C(16) 1.3(4) 
C(12)-C(14)-C(15)-C(16) -178.0(2) 
C(14)-C(15)-C(16)-C(17) 0.0(4) 
C(15)-C(16)-C(17)-C(18) -1.3(4) 
C(16)-C(17)-C(18)-C(19) 1.3(4) 
C(17)-C(18)-C(19)-C(14) 0.0(4) 
C(15)-C(14)-C(19)-C(18) -1.3(4) 
C(12)-C(14)-C(19)-C(18) 178.0(2) 
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C(5)-N-C(20)-O -5.5(3) 
C(1)-N-C(20)-O 141.1(2) 
C(5)-N-C(20)-C(21) 169.4(2) 
C(1)-N-C(20)-C(21) -44.0(3) 
O-C(20)-C(21)-C(22) -44.9(3) 
N-C(20)-C(21)-C(22) 140.1(2) 
O-C(20)-C(21)-C(26) 130.4(2) 
N-C(20)-C(21)-C(26) -44.6(3) 
C(26)-C(21)-C(22)-C(23) -0.5(4) 
C(20)-C(21)-C(22)-C(23) 174.9(2) 
C(21)-C(22)-C(23)-C(24) -0.8(4) 
C(22)-C(23)-C(24)-C(25) 1.1(4) 
C(23)-C(24)-C(25)-C(26) -0.1(4) 
C(24)-C(25)-C(26)-C(21) -1.3(4) 
C(22)-C(21)-C(26)-C(25) 1.6(4) 
C(20)-C(21)-C(26)-C(25) -173.8(2) 
________________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
  
The thermal ellipsoid of tetrahydro indenopyridine 4.22a drawn at 50% probability level. 
The CCDC number is 895235 
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  Table 1.  Crystal data and structure refinement for C25H19NO. 
Identification code  v63a 
Empirical formula  C25H19NO  
Formula weight  349.41 
Temperature  100(2) K 
Wavelength  1.54178 Å 
Crystal system  Orthorhombic 
Space group  Pbca 
Unit cell dimensions a = 23.8895(15) Å = 90°. 
 b = 9.8805(6) Å = 90°. 
 c = 30.8596(19) Å  = 90°. 
Volume 7284.1(8) Å3 
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Z 16 
Density (calculated) 1.274 Mg/m3 
Absorption coefficient 0.601 mm-1 
F(000) 2944 
Crystal size 0.15 x 0.06 x 0.01 mm3 
Theta range for data collection 2.86 to 67.66°. 
Index ranges -21<=h<=28, -11<=k<=11, -36<=l<=37 
Reflections collected 62045 
Independent reflections 6473 [R(int) = 0.0393] 
Completeness to theta = 67.66° 98.4 %  
Absorption correction Multi-scan 
Max. and min. transmission 1.000 and 0.804 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 6473 / 0 / 487 
Goodness-of-fit on F2 1.025 
Final R indices [I>2sigma(I)] R1 = 0.0315, wR2 = 0.0794 
R indices (all data) R1 = 0.0374, wR2 = 0.0842 
Largest diff. peak and hole 0.209 and -0.208 e.Å-3 
 
 Table 2.  Atomic coordinates  ( x 104) and equivalent  isotropic displacement parameters (Å2x 103) 
for C25H19NO.  U(eq) is defined as one third of  the trace of the orthogonalized U ij tensor. 
________________________________________________________________________________  
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 x y z U(eq) 
________________________________________________________________________________   
O(1) 2849(1) 1961(1) -7(1) 26(1) 
N(1) 2526(1) 3713(1) 396(1) 22(1) 
C(1) 2035(1) 4206(1) 649(1) 25(1) 
C(2) 2123(1) 3581(1) 1098(1) 28(1) 
C(3) 2752(1) 3422(1) 1116(1) 22(1) 
C(4) 2968(1) 3538(1) 707(1) 21(1) 
C(5) 3551(1) 3549(1) 619(1) 21(1) 
C(6) 3791(1) 3755(1) 204(1) 24(1) 
C(7) 4359(1) 3796(1) 155(1) 26(1) 
C(8) 4716(1) 3630(1) 516(1) 26(1) 
C(9) 4497(1) 3425(1) 920(1) 24(1) 
C(10) 3909(1) 3385(1) 985(1) 21(1) 
C(11) 3677(1) 3211(1) 1404(1) 22(1) 
C(12) 3109(1) 3218(1) 1478(1) 22(1) 
C(13) 2483(1) 2801(1) 61(1) 21(1) 
C(14) 1980(1) 2872(1) -227(1) 21(1) 
C(15) 1797(1) 1654(1) -405(1) 27(1) 
C(16) 1339(1) 1636(1) -679(1) 31(1) 
C(17) 1072(1) 2831(1) -787(1) 31(1) 
C(18) 1261(1) 4046(1) -619(1) 31(1) 
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C(19) 1713(1) 4074(1) -335(1) 26(1) 
C(20) 2875(1) 3021(1) 1920(1) 22(1) 
C(21) 2414(1) 2180(1) 1991(1) 26(1) 
C(22) 2195(1) 2017(1) 2403(1) 29(1) 
C(23) 2433(1) 2677(1) 2753(1) 29(1) 
C(24) 2897(1) 3491(1) 2690(1) 28(1) 
C(25) 3116(1) 3661(1) 2277(1) 24(1) 
O(31) 5481(1) 3885(1) 1673(1) 24(1) 
N(31) 6097(1) 4213(1) 2227(1) 21(1) 
C(31) 6350(1) 5237(1) 2521(1) 23(1) 
C(32) 6019(1) 5051(1) 2943(1) 21(1) 
C(33) 5842(1) 3580(1) 2918(1) 19(1) 
C(34) 5886(1) 3152(1) 2495(1) 19(1) 
C(35) 5781(1) 1800(1) 2364(1) 20(1) 
C(36) 5903(1) 1265(1) 1946(1) 23(1) 
C(37) 5799(1) -67(1) 1855(1) 26(1) 
C(38) 5562(1) -930(1) 2170(1) 26(1) 
C(39) 5454(1) -456(1) 2577(1) 23(1) 
C(40) 5578(1) 909(1) 2691(1) 20(1) 
C(41) 5527(1) 1370(1) 3124(1) 20(1) 
C(42) 5661(1) 2677(1) 3248(1) 19(1) 
C(43) 5876(1) 4512(1) 1827(1) 21(1) 
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C(44) 6161(1) 5586(1) 1565(1) 23(1) 
C(45) 5835(1) 6345(1) 1281(1) 26(1) 
C(46) 6084(1) 7225(1) 990(1) 32(1) 
C(47) 6663(1) 7331(1) 973(1) 35(1) 
C(48) 6989(1) 6568(1) 1251(1) 34(1) 
C(49) 6740(1) 5709(1) 1552(1) 28(1) 
C(50) 5603(1) 3087(1) 3711(1) 20(1) 
C(51) 5406(1) 4366(1) 3830(1) 24(1) 
C(52) 5330(1) 4702(1) 4264(1) 27(1) 
C(53) 5446(1) 3764(1) 4586(1) 28(1) 
C(54) 5645(1) 2494(1) 4474(1) 27(1) 
C(55) 5724(1) 2158(1) 4041(1) 23(1) 
________________________________________________________________________________  
 
 Table 3.   Bond lengths [Å] and angles [°] for  C25H19NO. 
_____________________________________________________  
O(1)-C(13)  1.2248(14) 
N(1)-C(13)  1.3757(15) 
N(1)-C(4)  1.4366(15) 
N(1)-C(1)  1.4885(15) 
C(1)-C(2)  1.5339(17) 
C(1)-H(1A)  0.9900 
451 
 
C(1)-H(1B)  0.9900 
C(2)-C(3)  1.5111(16) 
C(2)-H(2A)  0.9900 
C(2)-H(2B)  0.9900 
C(3)-C(4)  1.3706(17) 
C(3)-C(12)  1.4194(17) 
C(4)-C(5)  1.4168(17) 
C(5)-C(6)  1.4175(17) 
C(5)-C(10)  1.4265(17) 
C(6)-C(7)  1.3656(18) 
C(6)-H(6A)  0.9500 
C(7)-C(8)  1.4114(18) 
C(7)-H(7A)  0.9500 
C(8)-C(9)  1.3685(18) 
C(8)-H(8A)  0.9500 
C(9)-C(10)  1.4193(16) 
C(9)-H(9A)  0.9500 
C(10)-C(11)  1.4180(17) 
C(11)-C(12)  1.3775(17) 
C(11)-H(11A)  0.9500 
C(12)-C(20)  1.4857(16) 
C(13)-C(14)  1.4954(16) 
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C(14)-C(19)  1.3900(17) 
C(14)-C(15)  1.3942(16) 
C(15)-C(16)  1.3815(19) 
C(15)-H(15A)  0.9500 
C(16)-C(17)  1.383(2) 
C(16)-H(16A)  0.9500 
C(17)-C(18)  1.3836(19) 
C(17)-H(17A)  0.9500 
C(18)-C(19)  1.3887(18) 
C(18)-H(18A)  0.9500 
C(19)-H(19A)  0.9500 
C(20)-C(25)  1.3944(17) 
C(20)-C(21)  1.3976(17) 
C(21)-C(22)  1.3853(18) 
C(21)-H(21A)  0.9500 
C(22)-C(23)  1.3831(19) 
C(22)-H(22A)  0.9500 
C(23)-C(24)  1.3839(19) 
C(23)-H(23A)  0.9500 
C(24)-C(25)  1.3874(17) 
C(24)-H(24A)  0.9500 
C(25)-H(25A)  0.9500 
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O(31)-C(43)  1.2256(14) 
N(31)-C(43)  1.3729(15) 
N(31)-C(34)  1.4281(14) 
N(31)-C(31)  1.4875(14) 
C(31)-C(32)  1.5331(16) 
C(31)-H(31A)  0.9900 
C(31)-H(31B)  0.9900 
C(32)-C(33)  1.5153(15) 
C(32)-H(32A)  0.9900 
C(32)-H(32B)  0.9900 
C(33)-C(34)  1.3758(16) 
C(33)-C(42)  1.4222(16) 
C(34)-C(35)  1.4178(16) 
C(35)-C(36)  1.4219(16) 
C(35)-C(40)  1.4248(16) 
C(36)-C(37)  1.3691(17) 
C(36)-H(36A)  0.9500 
C(37)-C(38)  1.4118(18) 
C(37)-H(37A)  0.9500 
C(38)-C(39)  1.3670(17) 
C(38)-H(38A)  0.9500 
C(39)-C(40)  1.4248(16) 
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C(39)-H(39A)  0.9500 
C(40)-C(41)  1.4168(16) 
C(41)-C(42)  1.3850(16) 
C(41)-H(41A)  0.9500 
C(42)-C(50)  1.4908(16) 
C(43)-C(44)  1.4987(16) 
C(44)-C(49)  1.3897(18) 
C(44)-C(45)  1.3925(17) 
C(45)-C(46)  1.3836(18) 
C(45)-H(45A)  0.9500 
C(46)-C(47)  1.386(2) 
C(46)-H(46A)  0.9500 
C(47)-C(48)  1.384(2) 
C(47)-H(47A)  0.9500 
C(48)-C(49)  1.3906(18) 
C(48)-H(48A)  0.9500 
C(49)-H(49A)  0.9500 
C(50)-C(51)  1.3987(17) 
C(50)-C(55)  1.4010(16) 
C(51)-C(52)  1.3887(17) 
C(51)-H(51A)  0.9500 
C(52)-C(53)  1.3877(18) 
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C(52)-H(52A)  0.9500 
C(53)-C(54)  1.3861(18) 
C(53)-H(53A)  0.9500 
C(54)-C(55)  1.3894(17) 
C(54)-H(54A)  0.9500 
C(55)-H(55B)  0.9500 
 
C(13)-N(1)-C(4) 118.48(9) 
C(13)-N(1)-C(1) 123.22(10) 
C(4)-N(1)-C(1) 105.70(9) 
N(1)-C(1)-C(2) 103.48(9) 
N(1)-C(1)-H(1A) 111.1 
C(2)-C(1)-H(1A) 111.1 
N(1)-C(1)-H(1B) 111.1 
C(2)-C(1)-H(1B) 111.1 
H(1A)-C(1)-H(1B) 109.0 
C(3)-C(2)-C(1) 102.20(10) 
C(3)-C(2)-H(2A) 111.3 
C(1)-C(2)-H(2A) 111.3 
C(3)-C(2)-H(2B) 111.3 
C(1)-C(2)-H(2B) 111.3 
H(2A)-C(2)-H(2B) 109.2 
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C(4)-C(3)-C(12) 120.76(11) 
C(4)-C(3)-C(2) 109.40(10) 
C(12)-C(3)-C(2) 129.83(11) 
C(3)-C(4)-C(5) 123.16(11) 
C(3)-C(4)-N(1) 110.32(10) 
C(5)-C(4)-N(1) 126.44(11) 
C(4)-C(5)-C(6) 124.89(11) 
C(4)-C(5)-C(10) 115.95(11) 
C(6)-C(5)-C(10) 119.12(11) 
C(7)-C(6)-C(5) 120.58(11) 
C(7)-C(6)-H(6A) 119.7 
C(5)-C(6)-H(6A) 119.7 
C(6)-C(7)-C(8) 120.51(12) 
C(6)-C(7)-H(7A) 119.7 
C(8)-C(7)-H(7A) 119.7 
C(9)-C(8)-C(7) 120.44(11) 
C(9)-C(8)-H(8A) 119.8 
C(7)-C(8)-H(8A) 119.8 
C(8)-C(9)-C(10) 120.65(11) 
C(8)-C(9)-H(9A) 119.7 
C(10)-C(9)-H(9A) 119.7 
C(11)-C(10)-C(9) 121.22(11) 
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C(11)-C(10)-C(5) 120.07(11) 
C(9)-C(10)-C(5) 118.71(11) 
C(12)-C(11)-C(10) 122.45(11) 
C(12)-C(11)-H(11A) 118.8 
C(10)-C(11)-H(11A) 118.8 
C(11)-C(12)-C(3) 117.49(11) 
C(11)-C(12)-C(20) 121.48(10) 
C(3)-C(12)-C(20) 121.03(10) 
O(1)-C(13)-N(1) 121.30(11) 
O(1)-C(13)-C(14) 120.22(10) 
N(1)-C(13)-C(14) 118.46(10) 
C(19)-C(14)-C(15) 119.82(11) 
C(19)-C(14)-C(13) 123.56(10) 
C(15)-C(14)-C(13) 116.56(11) 
C(16)-C(15)-C(14) 120.15(12) 
C(16)-C(15)-H(15A) 119.9 
C(14)-C(15)-H(15A) 119.9 
C(15)-C(16)-C(17) 120.05(12) 
C(15)-C(16)-H(16A) 120.0 
C(17)-C(16)-H(16A) 120.0 
C(16)-C(17)-C(18) 119.97(12) 
C(16)-C(17)-H(17A) 120.0 
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C(18)-C(17)-H(17A) 120.0 
C(17)-C(18)-C(19) 120.51(12) 
C(17)-C(18)-H(18A) 119.7 
C(19)-C(18)-H(18A) 119.7 
C(18)-C(19)-C(14) 119.46(11) 
C(18)-C(19)-H(19A) 120.3 
C(14)-C(19)-H(19A) 120.3 
C(25)-C(20)-C(21) 118.10(11) 
C(25)-C(20)-C(12) 120.75(11) 
C(21)-C(20)-C(12) 121.15(11) 
C(22)-C(21)-C(20) 120.69(12) 
C(22)-C(21)-H(21A) 119.7 
C(20)-C(21)-H(21A) 119.7 
C(23)-C(22)-C(21) 120.45(12) 
C(23)-C(22)-H(22A) 119.8 
C(21)-C(22)-H(22A) 119.8 
C(22)-C(23)-C(24) 119.65(12) 
C(22)-C(23)-H(23A) 120.2 
C(24)-C(23)-H(23A) 120.2 
C(23)-C(24)-C(25) 120.00(12) 
C(23)-C(24)-H(24A) 120.0 
C(25)-C(24)-H(24A) 120.0 
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C(24)-C(25)-C(20) 121.10(12) 
C(24)-C(25)-H(25A) 119.5 
C(20)-C(25)-H(25A) 119.5 
C(43)-N(31)-C(34) 122.82(10) 
C(43)-N(31)-C(31) 123.91(9) 
C(34)-N(31)-C(31) 106.79(9) 
N(31)-C(31)-C(32) 103.15(9) 
N(31)-C(31)-H(31A) 111.1 
C(32)-C(31)-H(31A) 111.1 
N(31)-C(31)-H(31B) 111.1 
C(32)-C(31)-H(31B) 111.1 
H(31A)-C(31)-H(31B) 109.1 
C(33)-C(32)-C(31) 102.45(9) 
C(33)-C(32)-H(32A) 111.3 
C(31)-C(32)-H(32A) 111.3 
C(33)-C(32)-H(32B) 111.3 
C(31)-C(32)-H(32B) 111.3 
H(32A)-C(32)-H(32B) 109.2 
C(34)-C(33)-C(42) 120.65(10) 
C(34)-C(33)-C(32) 108.78(10) 
C(42)-C(33)-C(32) 130.56(10) 
C(33)-C(34)-C(35) 123.18(10) 
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C(33)-C(34)-N(31) 110.52(10) 
C(35)-C(34)-N(31) 126.06(10) 
C(34)-C(35)-C(36) 124.94(11) 
C(34)-C(35)-C(40) 116.10(10) 
C(36)-C(35)-C(40) 118.78(10) 
C(37)-C(36)-C(35) 120.50(12) 
C(37)-C(36)-H(36A) 119.8 
C(35)-C(36)-H(36A) 119.8 
C(36)-C(37)-C(38) 120.76(11) 
C(36)-C(37)-H(37A) 119.6 
C(38)-C(37)-H(37A) 119.6 
C(39)-C(38)-C(37) 120.14(11) 
C(39)-C(38)-H(38A) 119.9 
C(37)-C(38)-H(38A) 119.9 
C(38)-C(39)-C(40) 120.76(11) 
C(38)-C(39)-H(39A) 119.6 
C(40)-C(39)-H(39A) 119.6 
C(41)-C(40)-C(35) 119.93(10) 
C(41)-C(40)-C(39) 121.20(11) 
C(35)-C(40)-C(39) 118.81(11) 
C(42)-C(41)-C(40) 122.74(11) 
C(42)-C(41)-H(41A) 118.6 
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C(40)-C(41)-H(41A) 118.6 
C(41)-C(42)-C(33) 117.20(10) 
C(41)-C(42)-C(50) 119.79(10) 
C(33)-C(42)-C(50) 123.00(10) 
O(31)-C(43)-N(31) 122.38(11) 
O(31)-C(43)-C(44) 119.94(10) 
N(31)-C(43)-C(44) 117.54(10) 
C(49)-C(44)-C(45) 119.50(11) 
C(49)-C(44)-C(43) 122.00(11) 
C(45)-C(44)-C(43) 117.84(11) 
C(46)-C(45)-C(44) 120.36(13) 
C(46)-C(45)-H(45A) 119.8 
C(44)-C(45)-H(45A) 119.8 
C(45)-C(46)-C(47) 120.10(12) 
C(45)-C(46)-H(46A) 119.9 
C(47)-C(46)-H(46A) 119.9 
C(48)-C(47)-C(46) 119.74(12) 
C(48)-C(47)-H(47A) 120.1 
C(46)-C(47)-H(47A) 120.1 
C(47)-C(48)-C(49) 120.43(13) 
C(47)-C(48)-H(48A) 119.8 
C(49)-C(48)-H(48A) 119.8 
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C(44)-C(49)-C(48) 119.83(12) 
C(44)-C(49)-H(49A) 120.1 
C(48)-C(49)-H(49A) 120.1 
C(51)-C(50)-C(55) 118.03(11) 
C(51)-C(50)-C(42) 122.00(10) 
C(55)-C(50)-C(42) 119.92(10) 
C(52)-C(51)-C(50) 120.90(11) 
C(52)-C(51)-H(51A) 119.6 
C(50)-C(51)-H(51A) 119.6 
C(53)-C(52)-C(51) 120.35(12) 
C(53)-C(52)-H(52A) 119.8 
C(51)-C(52)-H(52A) 119.8 
C(54)-C(53)-C(52) 119.52(11) 
C(54)-C(53)-H(53A) 120.2 
C(52)-C(53)-H(53A) 120.2 
C(53)-C(54)-C(55) 120.28(11) 
C(53)-C(54)-H(54A) 119.9 
C(55)-C(54)-H(54A) 119.9 
C(54)-C(55)-C(50) 120.92(11) 
C(54)-C(55)-H(55B) 119.5 
C(50)-C(55)-H(55B) 119.5 
_____________________________________________________________  
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Symmetry transformations used to generate equivalent atoms:  
  
 Table 4.   Anisotropic displacement parameters  (Å2x 103) for C25H19NO.  The anisotropic 
displacement factor exponent takes the form:  -22[ h2 a*2U11 + ...  + 2 h k a* b* U12 ] 
______________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
______________________________________________________________________________  
O(1) 28(1)  20(1) 30(1)  -2(1) 2(1)  3(1) 
N(1) 21(1)  23(1) 23(1)  -3(1) -3(1)  3(1) 
C(1) 21(1)  29(1) 26(1)  -6(1) -3(1)  6(1) 
C(2) 21(1)  37(1) 25(1)  -3(1) -2(1)  4(1) 
C(3) 21(1)  20(1) 26(1)  -2(1) -1(1)  1(1) 
C(4) 22(1)  17(1) 25(1)  -2(1) -4(1)  3(1) 
C(5) 22(1)  15(1) 26(1)  0(1) -1(1)  2(1) 
C(6) 25(1)  20(1) 27(1)  2(1) -2(1)  1(1) 
C(7) 27(1)  23(1) 29(1)  4(1) 4(1)  0(1) 
C(8) 21(1)  23(1) 37(1)  2(1) 2(1)  0(1) 
C(9) 22(1)  19(1) 32(1)  1(1) -4(1)  1(1) 
C(10) 22(1)  15(1) 28(1)  -1(1) -2(1)  1(1) 
C(11) 22(1)  18(1) 25(1)  0(1) -6(1)  1(1) 
C(12) 22(1)  18(1) 25(1)  -1(1) -3(1)  1(1) 
C(13) 25(1)  16(1) 23(1)  3(1) 2(1)  -2(1) 
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C(14) 24(1)  21(1) 19(1)  0(1) 2(1)  -4(1) 
C(15) 31(1)  22(1) 28(1)  -4(1) 4(1)  -4(1) 
C(16) 35(1)  32(1) 27(1)  -10(1) 3(1)  -13(1) 
C(17) 29(1)  44(1) 19(1)  1(1) -3(1)  -12(1) 
C(18) 33(1)  29(1) 31(1)  8(1) -8(1)  -5(1) 
C(19) 31(1)  20(1) 28(1)  1(1) -7(1)  -6(1) 
C(20) 20(1)  19(1) 26(1)  2(1) -2(1)  4(1) 
C(21) 24(1)  23(1) 31(1)  0(1) -2(1)  0(1) 
C(22) 22(1)  23(1) 40(1)  6(1) 3(1)  2(1) 
C(23) 29(1)  30(1) 29(1)  7(1) 5(1)  8(1) 
C(24) 30(1)  30(1) 25(1)  -1(1) -3(1)  5(1) 
C(25) 22(1)  23(1) 28(1)  2(1) -2(1)  1(1) 
O(31) 25(1)  24(1) 24(1)  -2(1) -4(1)  1(1) 
N(31) 25(1)  18(1) 19(1)  -1(1) -1(1)  -3(1) 
C(31) 30(1)  20(1) 21(1)  -2(1) -2(1)  -6(1) 
C(32) 27(1)  18(1) 19(1)  0(1) -1(1)  -2(1) 
C(33) 18(1)  18(1) 22(1)  -1(1) -2(1)  1(1) 
C(34) 16(1)  19(1) 22(1)  0(1) -2(1)  1(1) 
C(35) 16(1)  20(1) 22(1)  -2(1) -3(1)  2(1) 
C(36) 20(1)  24(1) 25(1)  -2(1) -3(1)  1(1) 
C(37) 24(1)  27(1) 26(1)  -9(1) -4(1)  3(1) 
C(38) 22(1)  20(1) 37(1)  -8(1) -6(1)  0(1) 
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C(39) 19(1)  20(1) 32(1)  -1(1) -4(1)  -1(1) 
C(40) 15(1)  20(1) 26(1)  -2(1) -3(1)  1(1) 
C(41) 17(1)  19(1) 24(1)  1(1) -1(1)  0(1) 
C(42) 17(1)  19(1) 22(1)  0(1) -1(1)  1(1) 
C(43) 24(1)  19(1) 20(1)  -3(1) 1(1)  4(1) 
C(44) 32(1)  20(1) 17(1)  -4(1) 2(1)  1(1) 
C(45) 37(1)  21(1) 22(1)  -4(1) 2(1)  6(1) 
C(46) 53(1)  21(1) 22(1)  0(1) 0(1)  6(1) 
C(47) 57(1)  26(1) 21(1)  0(1) 8(1)  -7(1) 
C(48) 39(1)  36(1) 26(1)  -3(1) 6(1)  -9(1) 
C(49) 33(1)  29(1) 21(1)  0(1) -1(1)  -3(1) 
C(50) 17(1)  20(1) 22(1)  0(1) 0(1)  -4(1) 
C(51) 26(1)  22(1) 23(1)  2(1) 0(1)  0(1) 
C(52) 32(1)  24(1) 26(1)  -3(1) 3(1)  0(1) 
C(53) 32(1)  33(1) 20(1)  -1(1) 3(1)  -5(1) 
C(54) 30(1)  29(1) 23(1)  7(1) -2(1)  -6(1) 
C(55) 24(1)  19(1) 25(1)  2(1) -1(1)  -3(1) 
______________________________________________________________________________  
 
 Table 5.   Hydrogen coordinates ( x 104) and isotropic  displacement parameters (Å2x 10 3) 
for C25H19NO. 
________________________________________________________________________________  
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 x  y  z  U(eq) 
________________________________________________________________________________  
  
H(1A) 1680 3891 518 30 
H(1B) 2032 5207 664 30 
H(2A) 1987 4190 1330 33 
H(2B) 1932 2695 1123 33 
H(6A) 3556 3865 -41 29 
H(7A) 4515 3936 -125 32 
H(8A) 5110 3661 477 32 
H(9A) 4741 3308 1160 29 
H(11A) 3923 3084 1643 26 
H(15A) 1987 836 -339 32 
H(16A) 1207 801 -793 38 
H(17A) 760 2819 -978 37 
H(18A) 1080 4867 -697 37 
H(19A) 1837 4908 -217 32 
H(21A) 2248 1716 1754 31 
H(22A) 1879 1448 2446 34 
H(23A) 2278 2573 3035 35 
H(24A) 3067 3932 2930 34 
H(25A) 3434 4223 2237 29 
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H(31A) 6302 6164 2404 28 
H(31B) 6753 5059 2566 28 
H(32A) 6257 5221 3199 26 
H(32B) 5690 5659 2952 26 
H(36A) 6057 1837 1729 27 
H(37A) 5888 -415 1576 31 
H(38A) 5477 -1843 2098 31 
H(39A) 5295 -1044 2787 28 
H(41A) 5394 757 3338 24 
H(45A) 5439 6256 1286 32 
H(46A) 5859 7759 803 39 
H(47A) 6834 7925 770 42 
H(48A) 7385 6632 1237 40 
H(49A) 6966 5207 1748 33 
H(51A) 5322 5015 3612 28 
H(52A) 5199 5578 4339 33 
H(53A) 5388 3991 4882 34 
H(54A) 5728 1851 4693 33 
H(55B) 5863 1287 3967 27 
________________________________________________________________________________  
 
 Table 6.  Torsion angles [°] for C25H19NO. 
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________________________________________________________________  
C(13)-N(1)-C(1)-C(2) 111.53(11) 
C(4)-N(1)-C(1)-C(2) -29.39(12) 
N(1)-C(1)-C(2)-C(3) 27.05(12) 
C(1)-C(2)-C(3)-C(4) -15.87(13) 
C(1)-C(2)-C(3)-C(12) 162.64(12) 
C(12)-C(3)-C(4)-C(5) -4.13(18) 
C(2)-C(3)-C(4)-C(5) 174.54(10) 
C(12)-C(3)-C(4)-N(1) 178.95(10) 
C(2)-C(3)-C(4)-N(1) -2.38(13) 
C(13)-N(1)-C(4)-C(3) -122.65(11) 
C(1)-N(1)-C(4)-C(3) 20.48(12) 
C(13)-N(1)-C(4)-C(5) 60.55(15) 
C(1)-N(1)-C(4)-C(5) -156.32(11) 
C(3)-C(4)-C(5)-C(6) -175.65(11) 
N(1)-C(4)-C(5)-C(6) 0.76(18) 
C(3)-C(4)-C(5)-C(10) 2.07(16) 
N(1)-C(4)-C(5)-C(10) 178.48(10) 
C(4)-C(5)-C(6)-C(7) 177.68(11) 
C(10)-C(5)-C(6)-C(7) 0.03(17) 
C(5)-C(6)-C(7)-C(8) 0.17(18) 
C(6)-C(7)-C(8)-C(9) 0.04(18) 
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C(7)-C(8)-C(9)-C(10) -0.46(18) 
C(8)-C(9)-C(10)-C(11) -178.25(11) 
C(8)-C(9)-C(10)-C(5) 0.64(17) 
C(4)-C(5)-C(10)-C(11) 0.62(15) 
C(6)-C(5)-C(10)-C(11) 178.48(10) 
C(4)-C(5)-C(10)-C(9) -178.28(10) 
C(6)-C(5)-C(10)-C(9) -0.43(16) 
C(9)-C(10)-C(11)-C(12) 177.57(11) 
C(5)-C(10)-C(11)-C(12) -1.31(17) 
C(10)-C(11)-C(12)-C(3) -0.62(17) 
C(10)-C(11)-C(12)-C(20) 179.45(10) 
C(4)-C(3)-C(12)-C(11) 3.28(17) 
C(2)-C(3)-C(12)-C(11) -175.09(12) 
C(4)-C(3)-C(12)-C(20) -176.79(11) 
C(2)-C(3)-C(12)-C(20) 4.84(19) 
C(4)-N(1)-C(13)-O(1) -9.30(16) 
C(1)-N(1)-C(13)-O(1) -145.63(11) 
C(4)-N(1)-C(13)-C(14) 172.00(10) 
C(1)-N(1)-C(13)-C(14) 35.66(15) 
O(1)-C(13)-C(14)-C(19) -144.80(12) 
N(1)-C(13)-C(14)-C(19) 33.92(17) 
O(1)-C(13)-C(14)-C(15) 32.38(16) 
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N(1)-C(13)-C(14)-C(15) -148.90(11) 
C(19)-C(14)-C(15)-C(16) -2.02(18) 
C(13)-C(14)-C(15)-C(16) -179.31(11) 
C(14)-C(15)-C(16)-C(17) 2.08(19) 
C(15)-C(16)-C(17)-C(18) -0.61(19) 
C(16)-C(17)-C(18)-C(19) -0.9(2) 
C(17)-C(18)-C(19)-C(14) 1.0(2) 
C(15)-C(14)-C(19)-C(18) 0.49(18) 
C(13)-C(14)-C(19)-C(18) 177.59(11) 
C(11)-C(12)-C(20)-C(25) 42.66(16) 
C(3)-C(12)-C(20)-C(25) -137.26(12) 
C(11)-C(12)-C(20)-C(21) -136.67(12) 
C(3)-C(12)-C(20)-C(21) 43.40(16) 
C(25)-C(20)-C(21)-C(22) 1.48(17) 
C(12)-C(20)-C(21)-C(22) -179.17(11) 
C(20)-C(21)-C(22)-C(23) -0.46(18) 
C(21)-C(22)-C(23)-C(24) -0.92(19) 
C(22)-C(23)-C(24)-C(25) 1.24(19) 
C(23)-C(24)-C(25)-C(20) -0.19(18) 
C(21)-C(20)-C(25)-C(24) -1.16(17) 
C(12)-C(20)-C(25)-C(24) 179.49(11) 
C(43)-N(31)-C(31)-C(32) 124.87(11) 
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C(34)-N(31)-C(31)-C(32) -27.40(11) 
N(31)-C(31)-C(32)-C(33) 27.29(11) 
C(31)-C(32)-C(33)-C(34) -18.61(12) 
C(31)-C(32)-C(33)-C(42) 160.65(11) 
C(42)-C(33)-C(34)-C(35) -2.94(17) 
C(32)-C(33)-C(34)-C(35) 176.41(10) 
C(42)-C(33)-C(34)-N(31) -177.54(10) 
C(32)-C(33)-C(34)-N(31) 1.81(13) 
C(43)-N(31)-C(34)-C(33) -136.00(11) 
C(31)-N(31)-C(34)-C(33) 16.64(12) 
C(43)-N(31)-C(34)-C(35) 49.59(16) 
C(31)-N(31)-C(34)-C(35) -157.77(11) 
C(33)-C(34)-C(35)-C(36) -169.82(11) 
N(31)-C(34)-C(35)-C(36) 3.91(18) 
C(33)-C(34)-C(35)-C(40) 5.24(16) 
N(31)-C(34)-C(35)-C(40) 178.97(10) 
C(34)-C(35)-C(36)-C(37) 178.30(11) 
C(40)-C(35)-C(36)-C(37) 3.36(17) 
C(35)-C(36)-C(37)-C(38) 0.99(18) 
C(36)-C(37)-C(38)-C(39) -2.75(18) 
C(37)-C(38)-C(39)-C(40) 0.04(17) 
C(34)-C(35)-C(40)-C(41) -4.01(15) 
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C(36)-C(35)-C(40)-C(41) 171.37(10) 
C(34)-C(35)-C(40)-C(39) 178.71(10) 
C(36)-C(35)-C(40)-C(39) -5.91(16) 
C(38)-C(39)-C(40)-C(41) -172.97(11) 
C(38)-C(39)-C(40)-C(35) 4.28(16) 
C(35)-C(40)-C(41)-C(42) 0.63(17) 
C(39)-C(40)-C(41)-C(42) 177.85(10) 
C(40)-C(41)-C(42)-C(33) 1.83(16) 
C(40)-C(41)-C(42)-C(50) -179.26(10) 
C(34)-C(33)-C(42)-C(41) -0.73(16) 
C(32)-C(33)-C(42)-C(41) -179.91(11) 
C(34)-C(33)-C(42)-C(50) -179.60(10) 
C(32)-C(33)-C(42)-C(50) 1.21(18) 
C(34)-N(31)-C(43)-O(31) -0.05(17) 
C(31)-N(31)-C(43)-O(31) -148.04(11) 
C(34)-N(31)-C(43)-C(44) -175.83(10) 
C(31)-N(31)-C(43)-C(44) 36.19(15) 
O(31)-C(43)-C(44)-C(49) -136.80(12) 
N(31)-C(43)-C(44)-C(49) 39.08(16) 
O(31)-C(43)-C(44)-C(45) 33.82(16) 
N(31)-C(43)-C(44)-C(45) -150.29(10) 
C(49)-C(44)-C(45)-C(46) -0.75(17) 
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C(43)-C(44)-C(45)-C(46) -171.62(11) 
C(44)-C(45)-C(46)-C(47) 1.78(18) 
C(45)-C(46)-C(47)-C(48) -1.01(19) 
C(46)-C(47)-C(48)-C(49) -0.8(2) 
C(45)-C(44)-C(49)-C(48) -1.02(18) 
C(43)-C(44)-C(49)-C(48) 169.45(11) 
C(47)-C(48)-C(49)-C(44) 1.79(19) 
C(41)-C(42)-C(50)-C(51) -141.33(11) 
C(33)-C(42)-C(50)-C(51) 37.52(16) 
C(41)-C(42)-C(50)-C(55) 35.94(15) 
C(33)-C(42)-C(50)-C(55) -145.21(11) 
C(55)-C(50)-C(51)-C(52) -0.37(17) 
C(42)-C(50)-C(51)-C(52) 176.95(11) 
C(50)-C(51)-C(52)-C(53) -0.48(19) 
C(51)-C(52)-C(53)-C(54) 0.93(19) 
C(52)-C(53)-C(54)-C(55) -0.54(19) 
C(53)-C(54)-C(55)-C(50) -0.31(18) 
C(51)-C(50)-C(55)-C(54) 0.76(17) 
C(42)-C(50)-C(55)-C(54) -176.62(11) 
________________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
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 The thermal ellipsoid of tetrahydro indenopyridine 4.23a drawn at 50% probability level. 
The CCDC number is 895233 
 
                          
 
 
 
 
Table 1.  Crystal data and structure refinement for C25H20N2O. 
Identification code  q03c 
Empirical formula  C25H20N2O  
Formula weight  364.43 
Temperature  100(2) K 
Wavelength  1.54178 Å 
Crystal system  Monoclinic 
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Space group  P2(1) 
Unit cell dimensions a = 8.1060(2) Å = 90°. 
 b = 5.9470(2) Å = 
101.3800(10)°. 
 c = 19.3890(5) Å  = 90°. 
Volume 916.30(4) Å3 
Z 2 
Density (calculated) 1.321 Mg/m3 
Absorption coefficient 0.635 mm-1 
F(000) 384 
Crystal size 0.19 x 0.05 x 0.04 mm3 
Theta range for data collection 2.32 to 68.69°. 
Index ranges -9<=h<=8, -7<=k<=6, -23<=l<=23 
Reflections collected 7765 
Independent reflections 2767 [R(int) = 0.0196] 
Completeness to theta = 66.00° 98.9 %  
Absorption correction Multi-scan 
Max. and min. transmission 1.000 and 0.886 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2767 / 1 / 253 
Goodness-of-fit on F2 1.057 
Final R indices [I>2sigma(I)] R1 = 0.0272, wR2 = 0.0725 
476 
 
R indices (all data) R1 = 0.0275, wR2 = 0.0728 
Absolute structure parameter 0.0(2) 
Largest diff. peak and hole 0.159 and -0.121 e.Å-3 
 
 Table 2.  Atomic coordinates  ( x 104) and equivalent  isotropic displacement parameters (Å2x 103) 
for C25H20N2O.  U(eq) is defined as one third of  the trace of the orthogonalized Uij tensor. 
________________________________________________________________________________  
 x y z U(eq) 
________________________________________________________________________________   
O 3209(1) 3108(2) 1143(1) 29(1) 
N(1) 2383(1) 3758(2) 2187(1) 27(1) 
N(2) 7798(2) 7717(2) 2519(1) 29(1) 
C(1) 1256(2) 2928(3) 2643(1) 32(1) 
C(2) 1897(2) 672(3) 2943(1) 32(1) 
C(3) 3688(2) 882(3) 3376(1) 28(1) 
C(4) 4703(2) 2761(3) 3133(1) 23(1) 
C(5) 6374(2) 3158(3) 3520(1) 23(1) 
C(6) 7366(2) 4736(3) 3289(1) 24(1) 
C(7) 6748(2) 6109(3) 2699(1) 24(1) 
C(8) 5057(2) 5843(3) 2339(1) 25(1) 
C(9) 4086(2) 4068(3) 2554(1) 24(1) 
C(10) 4438(2) 7415(3) 1800(1) 29(1) 
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C(11) 5484(2) 9039(3) 1638(1) 32(1) 
C(12) 7162(2) 9094(3) 2005(1) 31(1) 
C(13) 2075(2) 3256(3) 1474(1) 25(1) 
C(14) 275(2) 3001(3) 1109(1) 25(1) 
C(15) -937(2) 4595(3) 1180(1) 29(1) 
C(16) -2567(2) 4379(3) 803(1) 33(1) 
C(17) -3002(2) 2558(3) 360(1) 34(1) 
C(18) -1806(2) 969(3) 284(1) 33(1) 
C(19) -160(2) 1199(3) 652(1) 29(1) 
C(20) 7036(2) 1828(3) 4170(1) 23(1) 
C(21) 6616(2) 2413(3) 4815(1) 28(1) 
C(22) 7204(2) 1125(3) 5413(1) 29(1) 
C(23) 8210(2) -730(3) 5376(1) 26(1) 
C(24) 8653(2) -1291(3) 4744(1) 28(1) 
C(25) 8069(2) -16(3) 4146(1) 25(1) 
________________________________________________________________________________  
 
 Table 3.   Bond lengths [Å] and angles [°] for  C25H20N2O. 
_____________________________________________________  
O-C(13)  1.2235(16) 
N(1)-C(13)  1.3865(17) 
N(1)-C(9)  1.4351(17) 
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N(1)-C(1)  1.4764(18) 
N(2)-C(12)  1.315(2) 
N(2)-C(7)  1.3708(19) 
C(1)-C(2)  1.513(3) 
C(1)-H(1A)  0.9900 
C(1)-H(1B)  0.9900 
C(2)-C(3)  1.532(2) 
C(2)-H(2A)  0.9900 
C(2)-H(2B)  0.9900 
C(3)-C(4)  1.518(2) 
C(3)-H(3A)  0.9900 
C(3)-H(3B)  0.9900 
C(4)-C(9)  1.376(2) 
C(4)-C(5)  1.4332(19) 
C(5)-C(6)  1.368(2) 
C(5)-C(20)  1.495(2) 
C(6)-C(7)  1.414(2) 
C(6)-H(6)  0.9500 
C(7)-C(8)  1.4191(19) 
C(8)-C(10)  1.417(2) 
C(8)-C(9)  1.427(2) 
C(10)-C(11)  1.362(2) 
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C(10)-H(10)  0.9500 
C(11)-C(12)  1.405(2) 
C(11)-H(11)  0.9500 
C(12)-H(12)  0.9500 
C(13)-C(14)  1.4992(19) 
C(14)-C(19)  1.391(2) 
C(14)-C(15)  1.391(2) 
C(15)-C(16)  1.384(2) 
C(15)-H(15)  0.9500 
C(16)-C(17)  1.384(2) 
C(16)-H(16)  0.9500 
C(17)-C(18)  1.382(2) 
C(17)-H(17)  0.9500 
C(18)-C(19)  1.390(2) 
C(18)-H(18)  0.9500 
C(19)-H(19)  0.9500 
C(20)-C(25)  1.386(2) 
C(20)-C(21)  1.4035(19) 
C(21)-C(22)  1.392(2) 
C(21)-H(21)  0.9500 
C(22)-C(23)  1.382(2) 
C(22)-H(22)  0.9500 
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C(23)-C(24)  1.384(2) 
C(23)-H(23)  0.9500 
C(24)-C(25)  1.387(2) 
C(24)-H(24)  0.9500 
C(25)-H(25)  0.9500 
 
C(13)-N(1)-C(9) 119.19(10) 
C(13)-N(1)-C(1) 120.92(12) 
C(9)-N(1)-C(1) 113.25(11) 
C(12)-N(2)-C(7) 117.18(13) 
N(1)-C(1)-C(2) 108.68(12) 
N(1)-C(1)-H(1A) 110.0 
C(2)-C(1)-H(1A) 110.0 
N(1)-C(1)-H(1B) 110.0 
C(2)-C(1)-H(1B) 110.0 
H(1A)-C(1)-H(1B) 108.3 
C(1)-C(2)-C(3) 110.82(13) 
C(1)-C(2)-H(2A) 109.5 
C(3)-C(2)-H(2A) 109.5 
C(1)-C(2)-H(2B) 109.5 
C(3)-C(2)-H(2B) 109.5 
H(2A)-C(2)-H(2B) 108.1 
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C(4)-C(3)-C(2) 113.71(12) 
C(4)-C(3)-H(3A) 108.8 
C(2)-C(3)-H(3A) 108.8 
C(4)-C(3)-H(3B) 108.8 
C(2)-C(3)-H(3B) 108.8 
H(3A)-C(3)-H(3B) 107.7 
C(9)-C(4)-C(5) 119.25(13) 
C(9)-C(4)-C(3) 122.56(12) 
C(5)-C(4)-C(3) 118.18(12) 
C(6)-C(5)-C(4) 119.78(12) 
C(6)-C(5)-C(20) 120.23(12) 
C(4)-C(5)-C(20) 119.99(12) 
C(5)-C(6)-C(7) 121.59(12) 
C(5)-C(6)-H(6) 119.2 
C(7)-C(6)-H(6) 119.2 
N(2)-C(7)-C(6) 117.99(12) 
N(2)-C(7)-C(8) 122.74(13) 
C(6)-C(7)-C(8) 119.20(13) 
C(10)-C(8)-C(7) 117.14(14) 
C(10)-C(8)-C(9) 124.61(13) 
C(7)-C(8)-C(9) 118.23(13) 
C(4)-C(9)-C(8) 121.59(12) 
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C(4)-C(9)-N(1) 119.41(12) 
C(8)-C(9)-N(1) 118.83(12) 
C(11)-C(10)-C(8) 119.50(13) 
C(11)-C(10)-H(10) 120.3 
C(8)-C(10)-H(10) 120.3 
C(10)-C(11)-C(12) 118.89(14) 
C(10)-C(11)-H(11) 120.6 
C(12)-C(11)-H(11) 120.6 
N(2)-C(12)-C(11) 124.45(14) 
N(2)-C(12)-H(12) 117.8 
C(11)-C(12)-H(12) 117.8 
O-C(13)-N(1) 122.16(12) 
O-C(13)-C(14) 120.42(12) 
N(1)-C(13)-C(14) 117.36(11) 
C(19)-C(14)-C(15) 119.54(13) 
C(19)-C(14)-C(13) 118.66(13) 
C(15)-C(14)-C(13) 121.66(13) 
C(16)-C(15)-C(14) 120.25(15) 
C(16)-C(15)-H(15) 119.9 
C(14)-C(15)-H(15) 119.9 
C(15)-C(16)-C(17) 120.02(14) 
C(15)-C(16)-H(16) 120.0 
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C(17)-C(16)-H(16) 120.0 
C(18)-C(17)-C(16) 120.15(14) 
C(18)-C(17)-H(17) 119.9 
C(16)-C(17)-H(17) 119.9 
C(17)-C(18)-C(19) 120.05(15) 
C(17)-C(18)-H(18) 120.0 
C(19)-C(18)-H(18) 120.0 
C(18)-C(19)-C(14) 119.97(14) 
C(18)-C(19)-H(19) 120.0 
C(14)-C(19)-H(19) 120.0 
C(25)-C(20)-C(21) 118.70(13) 
C(25)-C(20)-C(5) 120.63(12) 
C(21)-C(20)-C(5) 120.67(13) 
C(22)-C(21)-C(20) 120.11(14) 
C(22)-C(21)-H(21) 119.9 
C(20)-C(21)-H(21) 119.9 
C(23)-C(22)-C(21) 120.32(12) 
C(23)-C(22)-H(22) 119.8 
C(21)-C(22)-H(22) 119.8 
C(22)-C(23)-C(24) 119.80(13) 
C(22)-C(23)-H(23) 120.1 
C(24)-C(23)-H(23) 120.1 
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C(23)-C(24)-C(25) 120.13(13) 
C(23)-C(24)-H(24) 119.9 
C(25)-C(24)-H(24) 119.9 
C(20)-C(25)-C(24) 120.91(13) 
C(20)-C(25)-H(25) 119.5 
C(24)-C(25)-H(25) 119.5 
_____________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
  
 Table 4.   Anisotropic displacement parameters  (Å2x 103) for C25H20N2O.  The anisotropic 
displacement factor exponent takes the form:  -22[ h2 a*2U11 + ...  + 2 h k a* b* U12 ] 
______________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
______________________________________________________________________________  
O 26(1)  41(1) 20(1)  2(1) 6(1)  8(1) 
N(1) 20(1)  43(1) 18(1)  0(1) 3(1)  3(1) 
N(2) 34(1)  28(1) 25(1)  -1(1) 9(1)  -2(1) 
C(1) 22(1)  55(1) 20(1)  -2(1) 5(1)  -1(1) 
C(2) 27(1)  45(1) 24(1)  -3(1) 8(1)  -9(1) 
C(3) 26(1)  34(1) 23(1)  0(1) 6(1)  -1(1) 
C(4) 22(1)  28(1) 20(1)  -3(1) 6(1)  1(1) 
C(5) 23(1)  26(1) 19(1)  -3(1) 5(1)  4(1) 
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C(6) 22(1)  28(1) 21(1)  -3(1) 3(1)  1(1) 
C(7) 27(1)  25(1) 21(1)  -2(1) 7(1)  3(1) 
C(8) 28(1)  29(1) 19(1)  -1(1) 7(1)  5(1) 
C(9) 21(1)  34(1) 18(1)  -3(1) 4(1)  4(1) 
C(10) 29(1)  35(1) 22(1)  1(1) 6(1)  10(1) 
C(11) 45(1)  28(1) 25(1)  5(1) 11(1)  11(1) 
C(12) 43(1)  28(1) 26(1)  0(1) 12(1)  -1(1) 
C(13) 26(1)  30(1) 20(1)  1(1) 4(1)  5(1) 
C(14) 26(1)  33(1) 16(1)  2(1) 4(1)  2(1) 
C(15) 27(1)  36(1) 23(1)  -4(1) 3(1)  2(1) 
C(16) 26(1)  42(1) 29(1)  0(1) 3(1)  8(1) 
C(17) 26(1)  50(1) 22(1)  4(1) 0(1)  -3(1) 
C(18) 37(1)  41(1) 21(1)  -5(1) 5(1)  -7(1) 
C(19) 32(1)  33(1) 22(1)  -1(1) 9(1)  2(1) 
C(20) 19(1)  29(1) 21(1)  0(1) 2(1)  -4(1) 
C(21) 26(1)  33(1) 24(1)  -1(1) 5(1)  6(1) 
C(22) 28(1)  40(1) 20(1)  -1(1) 8(1)  0(1) 
C(23) 25(1)  30(1) 22(1)  4(1) 1(1)  -5(1) 
C(24) 28(1)  27(1) 27(1)  -2(1) 1(1)  4(1) 
C(25) 26(1)  30(1) 20(1)  -3(1) 4(1)  0(1) 
______________________________________________________________________________  
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 Table 5.   Hydrogen coordinates ( x 104) and isotropic  displacement parameters (Å2x 10 3) 
for C25H20N2O. 
________________________________________________________________________________  
 x  y  z  U(eq) 
________________________________________________________________________________  
  
H(1A) 96 2769 2367 39 
H(1B) 1234 4009 3029 39 
H(2A) 1890 -410 2554 38 
H(2B) 1142 86 3245 38 
H(3A) 3625 1146 3875 33 
H(3B) 4285 -560 3352 33 
H(6) 8498 4914 3530 28 
H(10) 3303 7337 1555 34 
H(11) 5086 10116 1282 38 
H(12) 7885 10200 1872 38 
H(15) -645 5835 1489 35 
H(16) -3387 5482 848 39 
H(17) -4126 2400 107 40 
H(18) -2109 -281 -19 39 
H(19) 668 125 592 34 
H(21) 5928 3690 4844 33 
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H(22) 6913 1523 5848 35 
H(23) 8596 -1618 5783 32 
H(24) 9358 -2552 4719 33 
H(25) 8381 -412 3715 30 
________________________________________________________________________________  
 
 Table 6.  Torsion angles [°] for C25H20N2O. 
________________________________________________________________  
C(13)-N(1)-C(1)-C(2) 90.57(15) 
C(9)-N(1)-C(1)-C(2) -60.60(16) 
N(1)-C(1)-C(2)-C(3) 59.93(15) 
C(1)-C(2)-C(3)-C(4) -28.89(17) 
C(2)-C(3)-C(4)-C(9) -3.10(19) 
C(2)-C(3)-C(4)-C(5) 177.58(12) 
C(9)-C(4)-C(5)-C(6) -3.73(19) 
C(3)-C(4)-C(5)-C(6) 175.61(13) 
C(9)-C(4)-C(5)-C(20) 177.15(13) 
C(3)-C(4)-C(5)-C(20) -3.51(19) 
C(4)-C(5)-C(6)-C(7) 4.4(2) 
C(20)-C(5)-C(6)-C(7) -176.46(12) 
C(12)-N(2)-C(7)-C(6) -174.75(13) 
C(12)-N(2)-C(7)-C(8) 2.2(2) 
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C(5)-C(6)-C(7)-N(2) 177.13(13) 
C(5)-C(6)-C(7)-C(8) 0.0(2) 
N(2)-C(7)-C(8)-C(10) -3.7(2) 
C(6)-C(7)-C(8)-C(10) 173.26(12) 
N(2)-C(7)-C(8)-C(9) 178.02(12) 
C(6)-C(7)-C(8)-C(9) -5.02(19) 
C(5)-C(4)-C(9)-C(8) -1.40(19) 
C(3)-C(4)-C(9)-C(8) 179.28(12) 
C(5)-C(4)-C(9)-N(1) -176.62(12) 
C(3)-C(4)-C(9)-N(1) 4.1(2) 
C(10)-C(8)-C(9)-C(4) -172.40(13) 
C(7)-C(8)-C(9)-C(4) 5.74(19) 
C(10)-C(8)-C(9)-N(1) 2.8(2) 
C(7)-C(8)-C(9)-N(1) -179.02(12) 
C(13)-N(1)-C(9)-C(4) -123.22(15) 
C(1)-N(1)-C(9)-C(4) 28.49(19) 
C(13)-N(1)-C(9)-C(8) 61.43(19) 
C(1)-N(1)-C(9)-C(8) -146.85(13) 
C(7)-C(8)-C(10)-C(11) 2.08(19) 
C(9)-C(8)-C(10)-C(11) -179.77(13) 
C(8)-C(10)-C(11)-C(12) 0.7(2) 
C(7)-N(2)-C(12)-C(11) 0.9(2) 
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C(10)-C(11)-C(12)-N(2) -2.4(2) 
C(9)-N(1)-C(13)-O -1.4(2) 
C(1)-N(1)-C(13)-O -150.88(15) 
C(9)-N(1)-C(13)-C(14) -178.55(13) 
C(1)-N(1)-C(13)-C(14) 31.9(2) 
O-C(13)-C(14)-C(19) 47.6(2) 
N(1)-C(13)-C(14)-C(19) -135.16(15) 
O-C(13)-C(14)-C(15) -128.14(16) 
N(1)-C(13)-C(14)-C(15) 49.1(2) 
C(19)-C(14)-C(15)-C(16) 0.5(2) 
C(13)-C(14)-C(15)-C(16) 176.17(13) 
C(14)-C(15)-C(16)-C(17) 0.8(2) 
C(15)-C(16)-C(17)-C(18) -1.0(2) 
C(16)-C(17)-C(18)-C(19) -0.2(2) 
C(17)-C(18)-C(19)-C(14) 1.5(2) 
C(15)-C(14)-C(19)-C(18) -1.6(2) 
C(13)-C(14)-C(19)-C(18) -177.44(13) 
C(6)-C(5)-C(20)-C(25) -80.47(18) 
C(4)-C(5)-C(20)-C(25) 98.64(15) 
C(6)-C(5)-C(20)-C(21) 99.91(16) 
C(4)-C(5)-C(20)-C(21) -80.98(18) 
C(25)-C(20)-C(21)-C(22) -1.3(2) 
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C(5)-C(20)-C(21)-C(22) 178.32(13) 
C(20)-C(21)-C(22)-C(23) 0.3(2) 
C(21)-C(22)-C(23)-C(24) 0.9(2) 
C(22)-C(23)-C(24)-C(25) -1.0(2) 
C(21)-C(20)-C(25)-C(24) 1.2(2) 
C(5)-C(20)-C(25)-C(24) -178.38(13) 
C(23)-C(24)-C(25)-C(20) -0.1(2) 
________________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
  
  
 
 
